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ABSTRACT 
 
In Malaysia, the application of various assisted reproductive technologies (ART), 
particularly reproductive cloning, in goat production system, is still at the infancy stage. 
Thus, this pioneering study was conducted with the aim to produce cloned caprine 
embryos through intraspecies somatic cell nuclear transfer (intraspSCNT) and 
interspecies somatic cell nuclear transfer (interspSCNT) techniques using caprine ear 
skin fibroblast cell as donor karyoplast as well as developing a protocol for caprine 
SCNT (intraspSCNT and interspSCNT). The caprine intraspSCNT and interspSCNT 
(caprine karyoplast-bovine cytoplast) studies were carried out using caprine and bovine 
oocytes obtained from the abattoir-derived ovaries or via laparoscopic ovum pick-up 
(LOPU) technique on superstimulated does. The collected oocytes were subsequently 
cultured in in vitro maturation (IVM) medium according to the optimised duration. The 
matured oocytes were then subjected to enucleation process. This was followed by the 
transfer of caprine ear skin fibroblast cell into the enucleated oocytes. The couplets were 
electrofused and chemically activated before in vitro cultured in CO2 (5%) incubator at 
38.5°C in humidified atmosphere for 8 days. The cloned blastocyst was stained with 
Hoechst 33342 dye for blastomere enumeration. The data were presented as mean±SEM 
and were analysed using one-way ANOVA. The significant differences among 
treatments were further analysed by DMRT and P<0.05 was considered significant. 
In Experiment 1, the effect of different sources of gonadotrophin (PMSG versus 
pFSH) on caprine superstimulatory responses was evaluated. Both PMSG and pFSH 
employed in the designated regimes have relatively similar potential to stimulate 
caprine ovaries for oocyte retrieval via LOPU with the average oocyte yield of 11 and 
12 oocytes per doe, respectively. However, the efficacy of PMSG could not surpass the 
pFSH, particularly when it was employed in the repeated ovarian stimulation and oocyte 
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retrieval protocols. This was indicated by the lower number of oocyte yielded from 
PMSG treated group than pFSH (P<0.05) group at the third OR cycle. 
In Experiment 2, the effect of different sources of caprine oocytes (LOPU- 
versus abattoir-derived ovaries) on the oocyte yield, grades and maturation performance 
was investigated. Oocyte retrieval from LOPU source produced better quality oocytes 
(Grades A and B) (39 to 40%) compared to abattoir source (18 to 32%), even though the 
oocyte yield was lower in LOPU. Correspondingly, caprine oocytes from LOPU gave 
higher maturation rate than abattoir-derived ovaries (79.6% versus 69.7%, respectively) 
when the optimised IVM duration was used. The optimum IVM durations for caprine 
oocytes retrieved from LOPU- and abattoir derived-ovaries determined in this 
laboratory setting were 18 to 22 hours and 22 to 26 hours, respectively. 
In Experiment 3, production of cloned bovine and gaur embryos via 
intraspSCNT and interspSCNT approaches was carried out as a preliminary study for 
caprine SCNT research. Both cloned bovine and gaur embryos could be produced in 
vitro up to hatched blastocyst stage with no significant difference (P>0.05) in their 
developmental rate (18.6% and 19%, respectively). 
In Experiment 4, improvement on the in vitro cloned caprine embryos 
production by considering the effects of maturation duration, activation treatment and in 
vitro culture protocol was carried out. Caprine oocytes from superstimulated does which 
was matured at 18 to 22 hours gave a significantly (P<0.05) higher maturation rate, 
enucleation rate and IVD rates (2-cell to morula stage) than oocytes which was matured 
at 23 to 27 hours after intraspSCNT. Both activation protocols [(7% EtOH + CD-CHX) 
and (CaI + 6-DMAP)] had comparable efficiency in inducing the development of 
caprine reconstructed embryos. KSOMaa basal medium supported the in vitro 
development of cloned caprine embryos better than mSOFaa in the one-step culture 
system as cloned blastocyst could only be developed when cultured in KSOMaa as in 
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this study. Increasing glucose supplementation to 2.78 mM in KSOMaa medium at Day 
2 of in vitro culture (IVC) enhanced the cloned caprine blastocyst rate (19.9%) and 
promoted hatching of blastocyst (15.6%). 
In Experiment 5, the efficacy of producing cloned caprine embryos using 
intraspecies SCNT (intraspSCNT) versus interspecies SCNT (interspSCNT) approaches 
was evaluated. Both intraspSCNT and interspSCNT approaches enabled production of 
cloned caprine blastocyst with the rate of 17.3% and 8.3%, respectively. However, the 
efficiency of interspSCNT approach was still low compared to the intraspSCNT 
approach. No pregnancy was detected after the attempt of embryo transfer on the cloned 
caprine embryos. 
In a nutshell, the present study resulted in several novel findings in Malaysia 
animal reproduction research scenario. This includes the success in producing cloned 
caprine embryos up to hatched blastocyst stage through intraspSCNT and interspSCNT 
(caprine karyoplast-bovine cytoplast) approaches using caprine ear skin fibroblast cell; 
the discovery of a new IVC system that could support the caprine embryos in vitro 
development to blastocyst stage (using KSOMaa at Day 0 to Day 2 and increasing the 
glucose supplementation to 2.78 mM in KSOMaa for Day 2 to Day 8 of in vitro culture); 
protocols for caprine intraspSCNT and interspSCNT were developed and could be 
served as references for future studies related to goat somatic cell nuclear transfer in this 
laboratory.  
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ABSTRAK 
Di Malaysia, aplikasi pelbagai teknologi reproduksi berbantu (ART), terutamanya 
teknologi pengklonan, dalam sistem produksi kambing, masih pada tahap permulaan. 
Maka, kajian julung kali ini telah dilakukan dengan matlamat untuk menghasilkan klon 
embrio kaprin melalui teknik pemindahan nukleus sel somatik intraspesies- 
(intraspSCNT) dan interspesies (interspSCNT) dengan menggunakan sel fibroblas kulit 
telinga kaprin sebagai penderma karioplas dan juga membangunkan satu protokol untuk 
SCNT kaprin (intraspSCNT dan interspSCNT). Kajian intraspSCNT dan interspSCNT 
(karioplas kaprin-sitoplas bovin) kaprin telah dijalankan dengan menggunakan oosit 
kaprin dan bovin yang diperolehi daripada ovari diambil dari rumah sembelihan atau 
melalui teknik pungutan ovum secara laparoskopik (LOPU) ke atas kambing betina 
yang disuperstimulasikan. Oosit yang dikumpulkan kemudiannya dikultur dalam 
medium pematangan in vitro (IVM) mengikut tempoh masa yang telah dioptimumkan. 
Oosit matang kemudiannya telah melalui proses enukleasi. Ini diikuti dengan 
pemindahan sel fibroblast kulit telinga kaprin ke dalam oosit yang telah dienukleasikan. 
Kuplet dielektrofusikan dan diaktifkan secara kimia sebelum dikultur in vitro dalam 
inkubator CO2 (5%) pada suhu 38.5°C dalam suasana atmosfera lembap selama 8 hari. 
Blastosis klon diwarnakan dengan pewarna Hoechst 33342 untuk penghitungan 
blastomer. Data telah dibentangkan sebagai min±SEM dan dianalisis dengan 
menggunakan ANOVA sehala. Perbezaan yang signifikan di antara perlakuan telah 
dianalisis selanjutnya dengan DMRT dan P<0.05 dianggap sebagai signifikan.  
 Dalam Eksperimen 1, kesan sumber gonadotropin yang berbeza (PMSG lawan 
pFSH) terhadap respons superstimulasi kaprin telah dinilai. Kedua-dua PMSG dan 
pFSH yang digunakan dalam rejim yang direkabentuk mempunyai potensi yang agak 
sama untuk stimulasi ovari kaprin bagi perolehan oosit melalui LOPU dengan purata 
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perolehan oosit masing-masing sebanyak 11 dan 12 oosit per kambing betina. Walau 
bagaimanapun, keberkesanan PMSG tidak dapat memintasi pFSH, terutamanya bila ia 
digunakan dalam protokol stimulasi ovari dan perolehan oosit yang berulang. Ini telah 
ditunjukkan melalui bilangan oosit yang diperolehi yang lebih rendah daripada 
kumpulan disuntik PMSG berbanding kumpulan pFSH (P<0.05) di kitar OR ketiga. 
 Dalam Eksperimen 2, kesan sumber oosit kaprin yang berbeza (LOPU- lawan 
ovari daripada rumah sembelihan) terhadap perolehan oosit, gred dan prestasi 
kematangan telah dikaji. Oosit yang diperolehi daripada sumber LOPU menghasilkan 
kualiti oosit yang lebih baik (Gred A dan B) (39 ke 40%) berbanding dengan sumber 
rumah sembelihan (18 ke 32%), walaupun pemerolehan oosit adalah rendah bagi LOPU. 
Sejajar dengan itu, oosit kaprin daripada LOPU memberi kadar pematangan yang lebih 
tinggi daripada ovari yang diperolehi daripada rumah sembelihan (masing-masing 
79.6% lawan 69.7%) apabila tempoh IVM yang dioptimumkan telah digunakan. 
Tempoh IVM yang optimum bagi oosit kaprin yang diperolehi daripada LOPU- dan 
ovari daripada rumah sembelihan yang ditentukan dalam suasana makmal ini adalah 
masing-masing 18 hingga 22 jam dan 22 hingga 26 jam. 
 Dalam Eksperimen 3, penghasilan embrio bovin dan gaur klon melalui 
pendekatan intraspSCNT dan interspSCNT telah dilaksanakan sebagai kajian awalan 
bagi penyelidikan SCNT kaprin. Kedua-dua klon embrio bovin dan gaur dapat 
dihasilkan secara in vitro sehingga tahap blastosis tetas dengan kadar perkembangan 
yang tidak berbeza secara signifikan (masing-masing 18.6% dan 19%). 
 Dalam Eksperimen 4, penambahbaikan penghasilan klon embrio kaprin in vitro 
dengan mempertimbangkan kesan tempoh pematangan, perlakuan pengaktifan dan 
protokol kultur in vitro telah dilaksanakan. Oosit kaprin daripada kambing betina yang 
disuperstimulasikan yang telah dimatang dalam tempoh 18 hingga 22 jam memberi 
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kadar pematangan, kadar enukleasi dan kadar perkembangan in vitro (IVD) (2-sel 
hingga tahap morula) yang lebih tinggi secara signifikan (P<0.05) selepas intraspSCNT 
berbanding oosit yang dimatang dalam tempoh 23 hingga 27 jam. Kedua-dua protokol 
pengaktifan [(7% EtOH + CD-CHX) dan (CaI + 6-DMAP)] mempunyai keberkesanan 
yang setanding dalam menginduksi perkembangan embrio rekonstruksi kaprin. Medium 
asas KSOMaa menampung perkembangan in vitro klon embrio kaprin lebih baik 
daripada mSOFaa dalam sistem kultur satu langkah di mana blastosis klon hanya dapat 
dihasilkan bila dikultur dalam KSOMaa seperti dalam kajian ini. Meningkatkan 
suplementasi glukosa kepada 2.78 mM dalam medium KSOMaa pada hari kedua kultur 
in vitro (IVC) meningkatkan kadar klon blastosis kaprin (19.9%) dan menggalakkan 
penetasan blastosis (15.6%). 
 Dalam Eksperimen 5, keberkesanan dalam penghasilan klon embrio kaprin 
menggunakan pendekatan SCNT intraspesies (intraspSCNT) berbanding interspesies 
(interspSCNT) telah dinilaikan. Kedua-dua pendekatan intraspSCNT dan interspSCNT 
membolehkan penghasilan klon blastosis kaprin dengan kadar masing-masing 17.3% 
dan 8.3%. Walau bagaimanapun, keberkesanan pendekatan interspSCNT adalah masih 
rendah berbanding pendekatan intraspSCNT. Tiada kebuntingan dikesan selepas 
percubaan pemindahan embrio ke atas klon embrio kaprin. 
 Secara ringkasnya, kajian ini telah menghasilkan beberapa penemuan yang 
baharu dalam senario penyelidikan reproduksi haiwan di Malaysia. Ini termasuk 
kejayaan dalam menghasilkan klon embrio kaprin sehingga tahap blastosis tetas melalui 
pendekatan intraspSCNT dan interspSCNT (karioplas kaprin- sitoplas bovin) 
menggunakan sel fibroblas kulit telinga kaprin; penemuaan satu sistem IVC baru yang 
dapat menampung perkembangan in vitro embrio kaprin ke tahap blastosis 
(menggunakan KSOMaa pada Hari 0 hingga Hari 2 dan meningkatkan suplementasi 
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glukosa hingga 2.78 mM dalam KSOMaa pada Hari 2 hingga Hari 8 kultur in vitro); 
protokol untuk intraspSCNT dan interspSCNT kaprin telah dibangunkan dan ini dapat 
digunakan sebagai rujukan untuk penyelidikan yang melibatkan pemindahan nukleus 
kambing dalam makmal ini pada masa hadapan. 
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Chapter 1 
1.0     INTRODUCTION 
 
1.1 BACKGROUND 
The application of assisted reproduction technologies (ART) in goat breeding program 
becomes a limelight in the 21
st 
century. The yearly increasing demand of goat meat 
consumption and its dairy products worldwide, served as the moving gear in goat 
breeding industries to multiply the goat population via the application of ART besides 
sustaining the conventional breeding program. Among the ART that are applied in goat 
farming industry, reproductive cloning technology in production of cloned goat 
embryos is foreseen to facilitate the effort of mass goat production in just a short time 
frame.  
 Reproductive cloning, in particular somatic cell nuclear transfer (SCNT) is a 
laboratory technique used to create genetically identical embryos by replacing the 
genetic material of an oocyte (recipient cytoplast) with the genetic material of a somatic 
cell (donor karyoplast) from an adult organism to be cloned. SCNT can be conducted 
using two approaches either using recipient cytoplast and donor karyoplast of the same 
species, termed as intraspecies SCNT (intraspSCNT) or of different species termed as 
interspecies SCNT (interspSCNT).  The commonly used somatic cell in SCNT includes 
mammary epithelial (Wilmut et al., 1997), cumulus cells (Wakayama et al., 1998), 
foetal fibroblast cells (Cibelli et al., 1998) and skin fibroblast cells (Kato et al., 2000).  
 Generally, the SCNT procedure involves a series of steps such as enucleation, 
donor karyoplast transfer, activation, in vitro culture and embryo transfer.  Either in 
vitro or in vivo matured oocytes could be used as the recipient cytoplast. Removal of the 
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genetic material of the matured recipient cytoplast (enucleation) is carried out using 
either squeezing or aspiration technique. Following enucleation of the oocyte, a somatic 
cell (donor karyoplast) is injected into the perivitelline space or directly into the 
cytoplasm of the enucleated oocyte (WCICI method) (Onishi et al., 2000). The 
enucleated oocyte and the donor cell in the perivitelline space are fused by electrofusion. 
After fusion of the donor nuclei and the enucleated oocyte, the reconstructed oocyte is 
activated by either chemical or mechanical stimulation. The activated reconstructed 
oocytes were subjected to in vitro culture, followed by transfer of the cloned embryos 
into a suitable recipient. 
 The SCNT technique offers several promises not only in the field of agriculture 
but also in the field of genetic conservation, medicine and basic cellular dynamic study. 
In the field of agriculture, particularly livestock industry, SCNT has the potential to 
impact animal breeding in as fundamental a manner as artificial insemination. Given its 
current high costs and relatively low success, SCNT will likely be used to improve 
production characteristics of food producing animals by providing breeding animals, 
just as any breeding program would select the most elite animals with desirable traits, 
(e.g. for milk containing extra nutrients or meat with more consistent in taste and 
quality) for breeding, and not as production animals.  Cloning has the relative advantage 
of allowing for the propagation of animals with known phenotypes to serve as 
additional breeding animals. This is critically important in breeding programs, 
especially when it may take years to "prove" the merit of a sire or dam. Second, it 
allows the propagation of animals whose reproductive function may be impaired. Third, 
it allows the propagation of valuable deceased animals from which tissue samples have 
been appropriately collected or preserved, which may have profound implications for 
species or breeds nearing extinction. Finally, for the first time, cloning allows for the  
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careful study of the "nature-nurture" interactions that influence breeding programs by 
allowing a large enough sample of genetically identical animals to be raised in different 
environments, or with different diets. Such studies have been impossible to perform 
prior to the advent of SCNT and are likely to yield important information for 
developing livestock species to live in areas that have, until this time, been marginal for 
food animal production.  
 Conservation has been highlighted recently as an area where the SCNT 
technique may be useful. It may preserve and propagate endangered species that 
reproduce poorly in zoos until their habitats can be restored and populations 
reintroduced to the wild. Attempts have been made with the Giant Panda for instance. 
This technique allows maintenance or increase of the overall genetic diversity of a 
species by introducing new genes from preserved specimens or animals in other wild 
and captive populations of the same species back into a diminishing gene pool. SCNT, 
specifically interspecies SCNT (interspSCNT) may even recreate extinct species, if 
viable tissues or cells have been banked or are available. However, the work requires 
interspecies embryo transfer, as the surrogate female is usually a different but closely 
related species. The first endangered animal was born after cloned gaur interspSCNT 
embryos were transferred into a cattle that served as the surrogate mother (Lanza et al., 
2000). 
 For the field of medicine, the greatest potential of the SCNT technique is in 
medical therapeutics in particular therapeutic cloning. Through SCNT approach, one’s 
own embryonic stem cell (ESC) could be derived from the cloned preimplantation 
embryo produced. The ESC is useful in the treatment of degenerative diseases such as 
Parkinson’s, AIDS, diabetes and muscular dystrophy.  
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 SCNT can also be applied in xenotransplantation in which pig hearts, amongst 
other organs, engineered to lack the enzyme alpha-galactosyl transferase that creates 
proteins triggering hyperacute immune reactions may then be tolerated in human bodies. 
SCNT can also be used to grow autologous haematopoietic stem cells and bone marrow 
to replace blood-forming organs damaged by disease or radiation. Besides that it can be 
used in cancer treatment by cloning cells from cancerous tissue and introducing specific 
characteristics leading to early cell death (e.g. short telomeres). Reintroducing the 
altered cells could decrease the capacity for division and replication in the tumor. 
 In terms of the basic cellular dynamic study, SCNT served as a tool to study the 
nuclear reprogramming mechanism. When a nucleus from a differentiated somatic cell, 
is transplanted into an enucleated oocyte, nuclear reprogramming is initiated, leading to 
the generation of an entire individual, which is a genetically identical clone of the 
original somatic cell. Such nuclear-transfer experiments have shown definitively that all 
of the genes required to create an entire organism are present in the nucleus of the 
specialised cell and can be activated on exposure to reprogramming factors present in 
the oocyte. In other words, cell specialisation involves a change in gene expression, not 
in gene content, and the process of differentiation can be fully reversed (Yamanaka and 
Blau, 2010).  
 Up to date, various cloned animals were successfully produced such as sheep 
(Wilmut et al., 1997), cattle (Cibelli et al., 1998; Kato et al., 1998), goat (Baguisi et al., 
1999), pig (Polejaeva et al., 2000), mouse (Wakayama et al., 1998) and monkey (Meng 
et al., 1997) via intraspecies SCNT (intraspSCNT). Extinct animals like gaur (Lanza et 
al., 2000), mouflon (Loi et al., 2001), bucardo (Folch et al., 2009) and banteng 
(Sansinena et al., 2005) were also successfully produced via interspSCNT approach. 
There were also several attempts to produce cloned animals via intergeneous SCNT 
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(Loi et al., 2011) however none of the cloned embryos successfully developed to term 
after embryo transfer.  Even though live births were reported using both intraspSCNT 
and interspSCNT approaches, the overall efficiency is still low. To surmount this 
problem, there is still a wide scope of research which needs to be carried out to improve 
the technical and elucidate the biological factors influencing the success rate of SCNT. 
 
1.2 STATEMENT OF PROBLEMS 
Generally, the number of studies and the overall success rate of SCNT applied on 
caprine species is still low compared to other domestic animals like the bovine and 
ovine. Therefore there are still many areas of research that can be carried out to increase 
the success rate of caprine SCNT. Today, there are still several important questions 
pertinent to caprine SCNT such as: 
1) How can we surmount the issue of shortage in caprine oocytes for countries that 
are deficient in obtaining caprine ovaries from abattoir? 
2) If LOPU was employed in the caprine oocyte retrieval programme, which source 
of gonadotrophins or supertimulation regime can be used to increase the oocyte 
yield? 
3) What is the meiotic competency and developmental fate of LOPU and abattoir-
derived oocytes? 
4) Do both the LOPU and abattoir –derived caprine oocytes matured optimally at 
the same IVM duration range? 
5) Is the oocyte age (duration of MII arrest) affecting the developmental 
competency of the caprine reconstructed embryos? 
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6) Is the commonly used activation treatment for bovine SCNT such as 7% EtOH + 
CD-CHX could induce the development of caprine reconstructed oocytes and is 
the efficiency similar to the CaI + 6-DMAP activation treatments that are 
commonly used in caprine SCNT study? 
7) What is the alternative IVC medium that can be used besides the common 
medium such as mSOFaa which is used in the current available caprine IVP 
study? 
8) How can the blastocyst rate be improved in caprine SCNT and pertaining to this, 
will the improvement in IVC system influence the blastocyst production 
positively? 
9) Last but not least is the current available caprine intraspSCNT protocols 
published could support the production of caprine intraspSCNT embryos 
similarly in all the laboratory setting?    
 
1.3 JUSTIFICATION OF THE STUDY 
Justification on the need and importance of this study was addressed by focusing on 4 
issues. Firstly how intraspSCNT and interspSCNT can be beneficial to goat breeding 
industry? Why caprine is chosen as the experimental animal model? Why ear skin 
fibroblast cell is chosen as the donor nuclei or karyoplast? Why bovine oocyte is chosen 
as the recipient cytoplast for interspSCNT? 
 The SCNT either via intraspSCNT or interspSCNT approach could enable 
gender selection and production of elite goats with desirable traits, (e.g., for meat with 
consistent in leanness and taste as well as for milk production containing extra nutrients) 
in a more predictable manner compared to other ART involving fertilisation process by 
sperm. Farmers could develop the somatic cell line of the selected goats with known 
7 
 
phenotypes to be cloned in advance and cryopreserve the somatic cell lines for future 
usage. Cryopreservation of the somatic cell lines or cloned embryos provided 
convenience for propagation to be carried out without affected by the constraints of time 
and space.  Furthermore, transgenic goats carrying genes that express pharmaceutical 
properties could be produced by SCNT approach through the usage of genetically 
modified somatic cell lines as donor karyoplasts. Besides that, the approach of 
interspSCNT allows the propagation of valuable deceased animals from which tissue 
samples have been appropriately collected or preserved, which may have profound 
implications for species or breeds nearing extinction such as serow goats. 
 Caprine was chosen as the model animal for this research due to the fact that it is 
a relatively convenient domestic species in terms of size and husbandry for current 
biological investigation and application. Its relatively short gestation period and its 
potential to produce diversified products of commercial value even justified further the 
importance of using caprine as the experimental model in this research; hoping that the 
findings of this study could be applied in the industry level. In Malaysia, goat meat is 
known to be an attractive choice for farming and production as it carries less taboo 
connotations unlike other types of meat and is more accessible in a multiracial and 
multi-religious country such as Malaysia. In addition, in a growing health conscious 
society, goat meat is steadily becoming a choice meat for many as it is has significantly 
lower fat (3%) compared to other meats such as cattle and sheep (16%). Besides that, 
goats are also known as the foster mother of man as their milk is considered better for 
human nutrition than milk of other species of livestock.  
 In this study, ear skin fibroblast cell is chosen as the donor karyoplast for the 
cloned caprine embryo production via intraspSCNT and interspSCNT due to the fact 
that adult skin fibroblasts cell are an easy-to-obtain source of donor DNA without the 
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limitations of animal age, sex, and physiological state. Thus, the gender of the cloned 
caprine produced can be selected and determined before development. In comparison to 
using other cell types such as cumulus, mammary epithelial, mural granulosa and 
oviductal cells in SCNT, the outcome are only limited to the production of female 
cloned embryos as these cell are only available from female donors (Wilmut et al., 1997; 
Wakayama et al., 1998). In addition, these cells are more difficult for long term culture 
compared to adult skin fibroblast cell. 
 As far as Malaysia is concerned, the possible main obstacle to produce cloned 
goat embryos by intraspSCNT approach is the paucity of goat ovary sources from 
abattoir, thus an alternative in using oocyte from closely-related species as recipient 
cytoplast are foreseen to overcome this hurdle. As bovine oocytes are relatively 
abundant in Malaysia and several studies have shown that ooplasm of bovine can 
support early development of embryos produced by interspSCNT of different 
mammalian species such as sheep, pigs, rats (Dominko et al., 1999) and gaur (Lanza et 
al., 2000), thus an experiment was carried out using bovine oocytes to produce cloned 
caprine embryos using interspSCNT approach in this research. Moreover, up to date 
there was no report available on caprine interspSCNT research using bovine as recipient 
cytoplast to generate cloned caprine embryos. Therefore, the findings of this experiment 
may contribute some new information on the research field of animal interspSCNT. 
 
1.4 OBJECTIVES OF THE STUDY 
The overall objective of this study was to produce cloned caprine embryos through 
intraspSCNT and interspSCNT techniques using caprine ear skin fibroblast cells as 
donor karyoplast. Since this study was pioneering the approach in producing cloned  
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caprine embryos in the local setting of Animal Biotechnology-Embryo Laboratory, 
University of Malaya as well as in the animal reproduction field of Malaysia, 
development of a SCNT protocol was also one of the major focus in this study. As a 
consequence, a series of experiments were designed to achieve this goal. 
To achieve this goal, the following specific objectives were set to: 
a) Study the effect of different sources of gonadotrophin (PMSG versus pFSH) on 
caprine superstimulatory responses. 
b) Study the effect of different sources of caprine oocytes (LOPU- versus abattoir-
derived ovaries) on the oocyte yield, grades and maturation performance.  
c) Determine an optimised IVM duration range for caprine oocytes retrieved from 
LOPU- and abattoir- derived ovaries. 
d) Develop cloned bovine and gaur embryos via intraspecies and interspecies 
SCNT approaches: a preliminary study for caprine SCNT research. 
e) To study the effect of two different IVM intervals on cloned caprine IVD 
competency using ovarian-superstimulated caprine oocyte. 
f) To study the effect of two different activation protocols on the IVD competency 
of reconstructed caprine embryos. 
g) To study the effect of two different IVC media on the IVD competency of 
reconstructed caprine embryos. 
h) To study the effect of increasing glucose concentration in KSOMaa medium at 
Day 2 culture on the IVD competency of reconstructed caprine embryos. 
i) To compare the efficacy of producing cloned caprine embryos using intraspecies 
versus interspecies SCNT approaches. 
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Chapter 2 
2.0     REVIEW OF LITERATURE 
 
2.1 BACKGROUND 
Since 1930s, remarkable discoveries were obtained in the field of animal reproductive 
cloning. A dramatic research transition field from nature’s ancient unassisted cloning to 
the modern era attempt to clone mammals in the laboratory has generated the 
discoveries of the possibility in producing viable cloned offspring through nuclear 
transfer technique. Nuclear transfer is not a new technique. It was first used in 1952 to 
study early development in frogs and in the 1980's the technique was used to clone 
cattle and sheep using cells taken directly from early embryos. In 1995, Ian Wilmut, 
Keith Campbell and colleagues created live lambs - Megan and Morag - from embryo 
derived cells that had been cultured in the laboratory for several weeks. This was the 
first time live animals had been derived from cultured cells and their success opened up 
the possibility of introducing much more precise genetic modifications into farm 
animals. 
 In 1997, Wilmut et al. (1997) in Roslin Institute and PPL Therapeutics 
announced their success in creating a cloned sheep named Dolly, it is the first animal 
cloned from a differentiated somatic cell taken from the mammary gland of an adult 
animal. The success of somatic cell nuclear transfer (SCNT) in cloning animal was 
further assured with the report by Wakayama et al. (1998) who successfully produced 
over 50 cloned mice using cumulus cell as donor karyoplast. Since then, the cloning of 
cattle, sheep, mice, goats and pigs have been reported (Table 2.1). 
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Table 2.1: Timeline of pioneering success in producing cloned animals of various  
       species using SCNT approach 
Year Author Species (cloned live birth) 
 
1997 Wilmut et al. Sheep (Dolly) 
 
1998 Kato et al. Cow 
 
1998 Wakayama et al. Mouse 
 
1999 Baguisi et al. Goat 
 
2000 Polejaeva et al. Pig 
 
2000 Lanza et al. Gaur 
 
2002 Chesne et al. Rabbit 
 
2002 Shin et al. Cat 
 
2003 Zhou et al. Rat 
 
2003 Galli et al. Horse 
 
2004 Gomez et al. Wild cat 
 
2005 Lee et al. Dog 
 
2005 Sansinena et al. Banteng 
 
2005 Shi et al. Swamp buffalo 
 
2006(b) Li et al. Ferret 
 
2007 Kim et al. Gray wolf 
 
2009 Folch et al. Burcado 
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2.2 REGULATION OF REPRODUCTION IN FEMALE GOATS 
The success in any animal in vitro production study could not be accomplished without 
the scientific understanding of the physiological process that occurs in the experimental 
animal on study. Since female goats were used as the donor for oocyte retrieval and as 
recipient for the embryo transfer experiments, oestrus synchronisation and 
superovulation protocols are required to control as well as to stimulate the reproductive 
events in the does. Thus, a brief review was made on the oestrous cycle, oestrus 
synchronisation and superovulation treatments of the doe in the following subsections.    
 
2.2.1 Oestrous Cycle 
The oestrous cycle refers to the recurring physiologic changes that are induced by 
reproductive hormones in most mammalian placental females. Oestrus was defined by 
McDonald (1980) as the sexual and fertile period of time which females of most 
mammalian will mate with males. The duration of oestrus was found to be varied 
between species. Edey (1983) reported that oestrus in sheep last for 30 hours while in 
goats, Evan and Maxwell (1987) found that the oestrus last for 25 to 30 hours. 
Chemineau et al. (1991) and Squires (2003) in their findings showed that the corpus 
luteum (CL) formed after luteinisation of the ovulating follicle is active where the 
secretion of the important amount of progesterone occurs during the luteal phase (14 
days in the ewe and 16 days in the goats). Afterwards, luteolysis (CL regresses) occurs 
and a new cycle begins. Goats are known to be polyestrous as they have a number of 
cycles one after the other unless pregnancy occurs. The duration of the oestrous cycle 
depends on the development of the CL (Asdell, 1946) which is the dominant factor in 
the reproductive cycle in most species of the animals (John, 1971). The animals were 
said to have normal oestrous cycle when the oestrous cycle length was 21 ± 3 days 
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(Massita, 2003). Previous studies demonstrated that the duration of oestrous cycle can 
be influenced by factors such as, the age of the animal, breeds, stage of breeding season 
and environmental stress (Edey, 1983; Chibooka et al., 1988; Devendra and McLeroy, 
1982; Jainudeen et al., 2000). 
 The duration of oestrous cycle for young animal was reported to be shorter and 
the period of intense oestrous was lesser compared to aged animals (Edey, 1983; 
Symington and Oliver, 1966). In goats, the oestrous cycle are classified as short (less 
than 17 days), normal (17 to 25 days) and long (more than 25 days) according to studies 
conducted by Gonzalez and Bury (1982), Thangavelu and Mukherjee (1982) and 
Massita (2003). In terms of breed factors, Katjang goats was reported to have an 
average length of oestrous cycle from 19 to 23 days (Thangavelu and Mukherjee, 1982); 
while for the Jermasia and Boer crossbred goats, the average oestrous length ranged 
between 19 to 22 days (Massita, 2003). Besides that, the oestrus duration of goat was 
observed to be shorter at the end of breeding season and in the first breeding season of 
young does. A summary on the characteristic events of oestrous cycle in doe are 
depicted in Table 2.2. 
  
Table 2.2: Characteristics of oestrus in goats 
Characteristic events Average time 
Duration of oestrous cycle 18-21 days 
Duration of oestrus 24-48 hours 
Time of ovulation 21-36 hours after oestrus 
Source: Modified from Devendra and McLeroy (1982) and Jainudeen et al. (2000). 
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 Generally, the periods of the oestrous cycle can be divided into four phase: 
prooestrus, oestrus, metaoestrus and dioestrus. These periods occur in a cyclic and 
sequential manner. In brief, proestrus refers to the period just before oestrus. It begins 
with the regression of the CL and drop in progesterone and extends to the start of the 
oestrus. One or several follicles of the ovary are starting to grow, their number being 
specific for the species. This phase can last as short as 4 to 5 days or as long as 3 weeks. 
Some animal may experience vaginal secretions, showing interest towards male goat 
but still refused sexually receptivity. Oestrus refers to the phase when female is sexually 
receptive (in heat). At this phase, ovarian follicles grow rapidly and maturing as well as 
the oestrogen secretions exerts their maximal influence. Metoestrus is a brief phase (3 to 
5 days) that occurs with the cessation of oestrus or shortly after ovulation. During this 
phase the signs of oestrogen stimulation subside and the CL starts to form with multiple 
ovulations. Dioestrus is the longest phase in the oestrous cycle. This is a stage where the 
females refuse sexual activity with the male goats. During this period, the activity of CL 
functions fully, producing progesterone in which the size of CL decrease and ends with 
the regression of the CL. 
  
2.2.2 Sign of Oestrus 
During the oestrous cycle, each female will exhibit signs of oestrus for certain time. 
Sign of oestrus are indicators of onset of oestrus or heat and, therefore they are very 
important for oestrus detection. There two category of oestrus signs, namely the primary 
and secondary signs. The primary symptoms are the most reliable and most acceptable 
in indicating the oestrus behaviour in most animals. The best method of oestrus 
detection is by observing the primary symptoms exhibited by the female in response to 
the male. In goats, the primary symptoms that were usually portrayed including sign of 
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seeking out bucks, wagging of the tail when being exposed to the male, mounting 
behaviour and also bleating. This signs are obvious and generally more frequent if the 
male is absent (Chemineau, 1991). Besides that, physical signs such as redness and 
swelling of the vulva and a clear mucous discharge from the vulva also demonstrate that 
the female was in oestrus.  
 On the other hand, the secondary sign of oestrus that are used to detect does on 
oestrus including, restlessness, frequent urination, isolation and general loss of appetite 
and constant vocalisations. However, this signs are known to be less reliable because 
they vary in length and may confuse with the symptoms of a minor health problem. 
Although it is possible to detect oestrus signs in the doe as described above, but a doe in 
heat may not exhibit all the signs at the same time. These signs appear and disappear 
progressively with the onset and termination of oestrus behaviour.  In order to obtain 
optimal results in oestrus detection, a routine check-up of heat twice daily (morning and 
evening) is indispensable (De Guzman, 1989).  
 
2.2.3 Endocrinology Changes during Oestrous Cycle in Doe 
Understanding on the endocrine patterns that occur during natural oestrus is important 
prior designing any oestrus synchronisation and supertimulation regime. The main 
events of the oestrous cycle are related to the period of growth of the ovarian follicles 
and the corpus luteum.  Unlike the ewe, the information on hormonal changes during 
oestrous cycles in goat is sparse. According to Jainudeen et al. (2000), the sequence of 
hormonal events during the oestrus cycle is similar for both ewe and doe but the doe has 
longer progesterone phase than the ewe. Thus, due to the relatively similar hormonal 
events between ewe and doe, the hormonal patterns of LH, progesterone, oestradiol and 
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prostaglandin F2 alpha (PGF2α) during the oestrous cycle of sheep was used as the 
reference to the endocrinology study of the doe (Figure 2.1). 
 During oestrus, the concentration of progesterone in blood is low (Pineda, 2003) 
and it remains low until Day 3 of early dioestrus. From Day 3 of dioestrus, progesterone 
levels will increase rapidly, reaching to maximal levels by Day 8 and remains stagnant 
until Days 11 to 12. By Day 13 of dioestrus, progesterone levels decline rapidly due to 
the abrupt regression of the CL caused by the lytic action of prostaglandin PGF2α 
which formed in the endometrium under the influence of progesterone and reaching the 
ovary by local route (Berisha and Schams, 2005) (Figure 2.1; [1]). This action 
subsequently causes the Graafian follicle to secrete significant amounts of androgen and 
oestrogen which reach peak values about Day 16 (Pineda, 2003) of the cycle (Figure 2.1; 
[2]). The rising oestrogen secretion triggers off a surge of LH released from the pituitary 
gland in episodic pulse after a time lag of about 12 hours (Figure 2.1; [3]). Oestrogen 
will induce the LH surge in the absence of progesterone. LH which enters the follicular 
fluid and acts on the target granulosa cells will cause ovulation, and follicular 
enlargement. The drop of progesterone level to less than 1 ng/ml and the rise of the 
oestrogen and androgen levels in the peripheral blood eventually bring the animal into 
behavioural oestrus (Figure 2.1; [4]). Ovulation occurs about 24 hours after the onset of 
the LH peak and the rises of the oestradiol in blood (Figure 2.1; [5]). Progesterone 
levels begin to rise as the CL develops and gradually acquires an increasing dependence 
on the constant low secreation of pituitary LH and prolactin for its maintenance and 
secretory activity. The high level of progesterone in the luteal phase prevents any 
sudden surge of LH release in response to the occasional waves of follicular 
development and oestrogen secretion that occur (Figure 2.1; [6]).  
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Figure 2.1: A model of the sheep oestrous cycle, indicating the sequence of hormone 
changes and the relationship between hormonal levels leading up to oestrus and 
ovulation. Description to key numbers are reflected in text (Adapted from Mohd Nadzir, 
2006). 
 
 
2.2.4 Follicular Dynamics 
Ovarian follicular development during oestrus cycle was observed to occur in a wave-
like pattern (Figueiredo et al., 1997) and each wave being characterized by the 
synchronous development of a group of follicles (Baruselli et al., 1997). The term of 
follicular wave is defined as one or more antral follicles growing from 3 mm to ≥ 5 mm 
in diameter before regression (De Castro et al., 1999). The number of follicular waves 
that present during oestrous cycle varies among species. In cattle, 2 to 3 waves were 
detected while the growth of ovarian follicles in doe is characterised by the presence of 
4 or more waves of follicle growth in the same cycle and it is in the final wave where 
the dominant follicle ovulates (De Castro et al., 1999; Medan et al., 2005). Unlike other 
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farm animals, the subsequent follicular wave begins even though the dominant follicle 
of the previous wave is still in its peak of development. This behaviour strongly 
suggests that follicular dominance is less apparent in the ovary of doe. Medan et al. 
(2005) also found that each follicular wave is preceded by an increase in FSH secretion. 
 
2.2.5 Ovulation 
Ovulation is defined as the rupture of the matured ovarian follicle on the surface of the 
ovary. The point of ovulation can be seen in the resulting corpus luteum for days after 
ovulation in most of the species. Ovulation is controlled by gonadotrophic hormones: 
FSH is predominant during the phase of follicular growth and LH is generally regarded 
as inducing ovulation and CL formation. In goat, LH was released from the pituitary in 
a surge (30 to 50 ng/ml) (Bono et al., 1983), which induces the final preparation of the 
follicle 24 hours prior ovulation phase. At ovulation in goats, the level of LH in blood 
reduces rapidly but FSH level begins to increase (Bono et al., 1983). 
 
2.2.6 Oestrus Synchronisation 
Oestrus sunchronisation is a hormonal treatment conducted to manipulation the 
response of female reproduction physiology in a timely manner. The control of oestrus 
and ovulation in farm animals remains the basis and a prerequisite for the success of 
controlled breeding. It is also a key element of all the ART-protocols in livestock and 
has a major influence to increase the overall efficiencies of these programmes 
(Baldassarre and Karatzas, 2004). Application of oestrus synchronisation plays an 
important role in fixing the time of breeding, AI, LOPU for oocyte or embryo collection 
and embryo transfer (ET). This technique has been developed since 1960s and this 
19 
 
treatment is important particularly for doe as the duration of both oestrous cycle and 
oestrus is variable; furthermore detection cannot be accomplished safely without a buck 
(Chemineau et al., 1991).   
 Synchronisation of oestrus approaches in livestock generally focus on either 
manipulating luteal or the follicular phase of the oestrus cycle. Up to date there is a 
number of synchronisation methods developed for goats. The most widely used method 
in the doe is the treatment of progesterone or progestagen for 9 to 11 days followed by a 
luteolytic does of prostaglandin (or an analogue) administered in the period 36 to 48 
hours prior to removal of intravaginal sponge (Baldassarre and Karatzas, 2004).   
 The progesterone treatment can be delivered through an intravaginal sponge, a 
CIDR (controlled internal drug release) device or alternatively using a subcutaneous 
implant (Evans and Maxwell, 1987; Frietas et al., 1997). Among the progesterone 
treatments mentioned, CIDR device is more commonly used. The CIDR device is 
developed in New Zealand and it is made of progesterone-impregnated medical silicone 
elastomers, with T-shaped vaginal insert containing 0.3 g of progesterone. The CIDR is 
inserted into the vagina of the treated females by a specialised applicator that collapses 
the wings for insertion. A thin nylon tail attached to the end of the CIDR is exteriorized 
through the vagina and is used to remove the device. CIDR delivers progesterone at 
controlled rate into the vagina and then into the bloodstream of the treated animals. 
After CIDR insertion, the presence of progesterone exerts a negative feedback effect on 
the hypothalamus, suppressing the release of two GnRH, that are, lutenising hormone 
(LH) releasing hormone and follicle stimulating hormone (FSH) releasing hormone 
which triggers the release of LH and FSH, respectively. This event prevents oestrus and 
ovulation. After removal of CIDR, the level of progesterone in the blood stream 
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declines which stimulates consequently a visible heat or oestrus behaviour (Massita, 
2003).  
 
2.2.7 Superovulation  
Superovulation is a method for increasing the large number of ova released by the ovary 
induced with hormonal treatment. This method is important to accelerate genetic 
improvement in any species. Superovulation treatment could induce maturation, 
ovulation and to increase the number of follicles available for in vivo matured oocyte or 
in vivo produced embryo collection. While for superstimulation, usually the regime 
focus to just increase the number of follicles for the purpose of oocyte collection. 
Generally, the hormonal treatment for superstimulation and superovulation were quite 
similar. The principle of inducing superovulation in doe are similar as in cattle and ewe. 
An exogenous follicle-stimulating gonadotrophin is administered that mimics the effect 
of FSH the end of luteal phase of the cycle (days 9-11) or around 48 hours before FSH 
near the end of the synchronising treatments. 
 There are many ways to superovulate domestic animals, whereby each has its 
advantages and disadvantages. The major commercial products applied in most species 
are equine chorionic gonadotrophin (eCG, previously called PMSG) and FSH. 
Commercial preparations are partly purified from mare’s serum and porcine pituitary 
glands, respectively. PMSG is used to stimulate ovarian activity during seasonal 
anoestrus and usually used concurrently following oestrus synchronisation. PMSG tend 
to be a practical hormone for superovulation due to its advantages of lower cost, most 
readily available, single dose protocol of up to 1500 IU to 2000 IU. However, the 
superovulatory response of PMSG can be quite variable and is usually lower than in 
FSH-induced superovulation (Amoah and Gelaye, 1990). PMSG-induced 
21 
 
superovulation is usually associated with problems like the present of high number of 
non-ovulated follicles, early regression of CL, short or irregular oestrous cycle and 
potential risk of embryo expulsion (Amoah and Gelaye, 1990). Thus a combination of 
eCG and hCG was widely used to superovulate does (Medan et al., 2003). On the other 
hand, FSH-induced does is known to give better ovarian responses and produced more 
oocyte than PMSG (Tsunada and Sugie, 1989; Pendelton et al., 1992). However, the 
requirement of multiple dosage injection when using FSH is rather labour-intensive and 
this poses a drawback of using FSH.  
 In order to surmount the cumbersome and the high expenses issue of using FSH, 
the attempts of using a ‘one-shot’ treatment regimen consisting of a single dose of FSH 
combined with the moderate dose of eCG (e.g., 60-80 mg FSH and 300 IU eCG) were 
reported (Batt et al., 1993; Baldassarre et al., 2002; Gibbons et al., 2007) and the 
outcome is almost equalled the oocyte or embryo yield with the traditional multiple 
injection regimen. 
 Besides the type of hormonal regimen influence the superovulatory response, 
both intrinsic and extrinsic factors are responsible for the variability as well. Intrinsic 
factors included genetic, age, stage of oestrous cycle during hormonal treatment (Wani 
et al., 1990; Mahmood et al., 1991) and extrinsic factors like season, nutrition and 
health state (Holtz, 2005) were identified to contribute to the variability in ovarian 
response. The timeline of significant finding in oestrus synchronisation and 
superovulation in does and ewes has been depicted in Table 2.3.        
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Table 2.3: Timeline of significant finding in oestrus synchronisation and superovulation 
       in does and ewes 
Year Author Significant finding 
1983 Armstrong et al. Stimulating an anoestrous doe with PMSG 
(400 IU) at the time or two days before 
removal of progestagen induced 2 to 3 
follicles per doe. 
 
1986 Greyling and 
Van Niekerk 
Two injections of cloprostenol synthetic 
analogue at the rate of 62.5, 125.0 and 250 
µg, administered 14 days apart, were 
effective in synchronising doe during 
breeding season. 
 
1989 Hamra et al. Using CIDR for 14 days and PMSG (750 IU) 
at withdrawal of subcutaneous implant, 92% 
oestrus response and 64% fertility were 
achieved. 
 
1989 Tsunoda and Sugie Higher numbers of oocytes were recovered 
with FSH-treated (9.4) than PMSG-treated 
(5.7) does. 
 
1990 Amoah and Gelaye Superovulation with PMSG are prone to 
premature regression of the induced CL, 
results in short cycles and have the potential 
risk of embryo expulsion. 
 
1991 Chemineau et al. Effective oestrus synchronisation was 
achieved using prostaglandin after Day 5 of 
oestrous cycle in does and ewes. 
 
1994 Mani et al. Good superovulation was achieved in Angora 
doe with porcine FSH (22 mg) divided in 4 
decreasing dosage, injected twice daily, 
commenced one day before sponge removal 
after 17 days of progestagen treatment. 
 
1994 Krisher et al. Prostaglandin F2a (PGF2a) and GnRH is an 
effective supplement used with FSH 
superovulation regimens in dairy does which 
enhance early embryo collection for DNA 
microinjection studies.  
 
1996 Freitas et al. During anoestrus, fluorogestone acetate 
(FGA) intravaginal sponges for 11 days in 
conjunction with PMSG (750 IU) and 
cloprostenol (50 µg) 48 hours before sponge 
removal resulted in 87.5 and 93.8% oestrus 
response and fertility, respectively in Alpine 
does. 
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(continued) 
Year Author Significant finding 
1997 Mellado and Valdes Found that ear implantation periods for both 
does and ewes usually extend from 9 to 14 
days and often combined with PMSG and/or 
PGF2α at 2 days before the end of ear 
implantation. 
 
1997 Samsul Does that have been synchronised with CIDR 
for 17 days together with PMSG 2 days 
before CIDR removal provided 100% oocyte 
recovery and 41.2% fertilisation rates, 
respectively. 
 
1998 Muna et al. Oestrus synchronisation in Sudanese Nubian 
does was achieved with double dose of 
cloprostenol (125 µg) together with 
intravaginal sponges impregnated with 
progesterone inserted for 16 days.  
 
2000 Kusian et al. Indicated that two intramuscular injections of 
cloprostenol (125 µg) administered 10 days 
apart in Mashana does were as effective as 
the progestagen treatments tested. 
 
2001 Oliveira et al. Oestrus synchronisation using CIDR for 9 
days combined with eCG (100 IU) and 
cloprostenol at CIDR removal results a 100% 
oestrus in Saanen does within 24 hours. 
 
2002 Motlomelo et al. Concluded that the use of CIDR led to a 
shorter interval to onset of oestrus than 6-
methyl-17-acetoxy-progesterone (MAP) and 
FGA. 
 
2004 Romano The use of FGA and MAP sponges and 
CIDRs with PG administration at the time of 
pessary removal induced efficient oestrus 
response and acceptable fertility in Nubian 
doe.  The use of CIDR can be considered a 
worthy alternative to replace intravaginal 
sponges. 
 
2006 Mohd Nadzir Oestrus of mixed breeds of does was 
synchronised with CIDR for 10, 14, 17 or 21 
days plus a single dose of 125 µg 
cloprostenol 36 hours before CIDR removal 
and superovulated with 70 mg FSH 
(Ovagen™) plus 1000 IU hCG (Profasi) 36 
hours before LOPU resulted in recovery of 
3.7- 6.7 oocytes per doe. 
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(continued) 
Year Author Significant finding 
2007 Cox and Alfaro Oestrus of ewes and does were synchronised 
with CIDR-G
®
 and superovulated with six 
injections of pFSH (Ovagen™) every 12 
hours starting after 48 hours of CIDR-G 
insertion resulted in recovery of 14.6 oocytes 
per ewe and 21.9 oocytes per doe, 
respectively. 
 
2007 Baldassarre et al. Oestrus of aged Saanen and Toggenburg does 
was synchronised with MAP sponges for 10 
days plus a single dose of 125 µg 
cloprostenol 36 hours before sponge removal 
and superovulated with 80 mg NIH-FSH-P1 
(Follotrophin-V) plus 300 IU eCG 36 hours 
before LOPU resulted in recovery of 15.7 
oocyte per doe.  
 
2007 Gibbons et al. Oestrus of ewes and does were synchronised 
with MAP sponges plus 50 µg PGF2a and 
superovulated with 60 mg NIH-FSH-P1 
(Folltrophin-V) plus 300 IU eCG 24 hours 
before LOPU resulted in recovery of 5.5- 8.8 
oocytes per ewe and 5.6- 8.0 oocytes per doe, 
respectively. 
 
2008 Melican and 
Gavin 
Repeated superovulation and oestrus 
synchronisation in Saanen, Alpine and 
Toggenburg does with norgestomet implant 
or CIDR-G
®
, and non-surgical embryo 
retrieval, coupled with surgical embryo 
transfer, expedited the production of progeny 
from transgenic founder does. 
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2.3 CAPRINE OOCYTE RETRIEVAL 
Generally, caprine oocyte can be collected from both live and dead does. Oocyte from 
live does can be collected using method such as laparotomy, laparoscopic ovum pick-up 
(LOPU) or transvagainal ultrasound-guided aspiration (TUGA). While oocytes from 
dead does can be obtained from the ovaries collected at post-mortem or from abattoir at 
slaughter. Ovaries from abattoir were subjected to either slicing or aspiration technique 
for oocyte retrieval. 
 Oocyte retrieval from slaughter does using aspiration method can be performed 
using needle of 18 to 22 G by puncturing and aspirating the follicular content. Besides 
that, oocyte retrieval can also be conducted using slicing method in which the surface of 
the ovaries was sliced in chequerbox manner followed by simple rinsing (Martino et al., 
1994). This approach was reported to produce more number of oocyte yield compared 
to aspiration method (Martino et al., 1994; Pawshe et al., 1996). Even though abattoir is 
an easy and cheapest source of oocyte worldwide, in Malaysia, this source is extremely 
limited due to low slaughtering activities as a consequence of shortage of breeding stock 
and when slaughtered, usually older or culled does are choosen (Rajikin, 1995). Thus 
OR from live does is an important alternative for embryo IVP study in Malaysia.   
 The oocyte recovery from live does can be accomplished with or without 
performing hormonal stimulation on the does prior retrieval. Oocyte retrieval via 
laparotomy is known to be invasive, causing adhesion of ovaries and other visera and 
other surgery related complication (Melican and Gavin, 2008). Thus, oocyte retrieval 
via LOPU and TUGA have been of preference as it is recognized as less traumatic than 
the standard laparotomy (Koeman et al., 2003; Melican and Gavin, 2008). In 
comparison to LOPU, TUGA is more commonly used in large domestic animal and not 
much practice was reported in small ruminants like caprine. In a study conducted by 
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Graft et al. (1999), the number of follicles and oocytes retrieved from does using TUGA 
(9.5 and 4.3, respectively) was less than LOPU approach (17.4 and 14.4, respectively). 
Thus, at present, LOPU is still one of the best techniques for oocyte recovery from live 
does. LOPU is advantageous in which it allows repetition of the minor surgical retrieval 
procedure to be carried out more frequently and more oocyte retrieval (OR) cycle 
during the reproductive live of a valuable female (Baldassarre et al., 2007). LOPU 
usually resulted in > 5 oocytes aspirated per donor and it does not cause ovarian damage 
after several OR cycle (Alberio et al., 2002; Baldassarre and Karatzas, 2004). OR on 
does after multidose hormonal treatments via LOPU can be repeated at short intervals, 
even 4 days (Tervit et al., 1992). 
 
 
2.4 IN VITRO MATURATION OF CAPRINE OOCYTES 
The technology of in vitro production (IVP) of embryo is enhanced with the 
incorporation of the in vitro maturation (IVM) procedure. The IVM procedure enable 
mature oocytes to be generated ex vivo which involves the removal of cumulus oocyte 
complexes (COCs) from antral follicles of ovaries and culturing them in essential 
standard cell culture conditions until it reaches MII stage (Gilchrist and Thompson, 
2007). The mature oocytes must be able to undergo both nuclear and ooplasmic 
maturation before they can be used for IVP of embryos. 
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2.4.1 Nuclear Maturation and Cytoplasmic Maturation 
Both nuclear and cytoplasmic maturation are essential to ensure normal fertilisation and 
embryo development. When fully grown oocytes are removed from their follicles to be 
cultured in vitro, meiosis spontaneously resumed despite cytoplasmic maturity (Hyttel 
et al., 1997). 
 Nuclear maturation is reflected by the modification of the chromatin status from 
the dictyate phase (germinal vesicle) to the Metaphase II stage. Under in vitro condition, 
two major events are known to occur in order for the nuclear maturation to take place. 
First, the COC is removed from the influence of follicular environment and second, 
physical contact with mural granulosa cells is ruptured, terminating intercellular 
communication via the gap junctions. This chemico-physico stimulation of the oocyte 
causes condensation of the chromatin and breakdown of the GV leading to MII phase. 
At this point, a second artificial meiotic arrest is known to occur (Edwards, 1965). 
 On the other hand, cytoplasmic maturation encompasses all the changes in the 
distribution and organization of the individual organells from the GV to the Metaphase 
II stage. The cytoplasmic maturation includes the occurrence of stage-specific processes, 
such as the synthesis of specific proteins (Schultz and Kopf, 1995), the ability to release 
cortical granules, to release calcium from intracellular stores (Carroll et al., 1996), to re-
localise mitochondria and to decondense sperm head (Thibault, 1977). Complete 
cytoplasmic maturation is essential as it is known to affect the subsequent 
developmental competency of the in vitro-derived zygotes (Eppig, 1996). 
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2.4.2 In vitro maturation (IVM) media 
The ability of oocyte to undergo maturation in vitro requires appropriate dynamics 
within its microenvironment. A number of maturation media have been developed in 
different laboratory for IVM of goat oocytes. The general goat oocyte maturation 
medium contains TCM-199 supplemented with pyruvate, heat in activated serum, 
hormones and other additional supplementation (Ongeri et al., 2001; Izquierdo et al., 
2002). 
 In most caprine IVM media, supplementation of gonadotrophins (FSH and LH) 
and oestradiol-17β are reported to improve maturation rates significantly (Keskintepe et 
al., 1994; Izquierdo et al., 1999). The concentration of these hormones used varies 
among researchers. The range of concentration reported for FSH and LH was 0.1 to 10 
µg/ml and 3 to 100 µg/ml, respectively (Cognié et al., 2003; Martino et al., 1995; 
Ongeri et al., 2001; Keskintepe et al., 1994). While for oestradiol-17β, the usual 
concentration is 1 µg/ml or some cases it is not supplemented at all in the IVM medium 
(Keskintepe et al., 1994; Pawshe et al., 1994b; Keefer et al., 2002). The 
supplementation of gonadotrophins in IVM medium was reported to enhance oocyte 
quality and development by possible alteration of metabolic processes. While for 
oestradiol, it is essential for cytoplasmic maturation in which it stimulates DNA 
polymerase β and enhanced the synthesis of presumed male pronucleus growth factors. 
The blastocyst production was reported to increase for oocytes matured in the presence 
of oestradiol-17β (Pawshe and Totey, 2003). 
 Supplementation of serum is usually included in IVM media because it is known 
to contain unidentified growth factors, hormones and peptides that may enhance the 
growth and development of oocytes. The source of serum that was used includes foetal 
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bovine serum (FBS), foetal calf serum (FCS), steer serum or oestrus goat serum (OGS) 
(Keskintepe et al., 1994; Crozet et al., 2000; Rodríguez-González et al., 2003).  
 Other supplementation like cysteamine or cystein, growth factors and vitamins 
was also included in IVM medium (Lott et al., 2011). Both cysteamine and cystein is a 
low molecular weight thiol that increases the intracytoplasmic oocyte glutathione (GSH) 
concentration and improves embryo development as well (De Matos and Furnus, 2000). 
GSH participates in various mechanisms such as amino acid transport, protein synthesis 
and protection against oxidative damage.  Growth promoting factors like epidermal 
growth factor is also reported to enhance maturation of goat oocytes by triggering signal 
through MAPK pathway during IVM in goat cumulus cell. Bormann et al. (2003) also 
suggested that inclusion of vitamins into IVM medium increases the overall blastocyst 
development and mean blastocyst cell number. 
 
2.4.3 In Vitro Maturation Duration 
Earlier studies have reported a wide range of IVM duration required for the completion 
of meiosis in goat, ranging from 16 to 32 hours (Pawshe et al., 1994a; Crozet et al., 
1995; Sharma et al., 1996). Differences in the reported IVM duration among researchers 
might be attributed to variations in the culture conditions and sources of oocytes. 
 Cognié et al. (2003) and Pawshe et al. (1994a) reported that caprine oocytes 
derived from stimulated ovaries generally started to mature as early as 16 hours after the 
initiation of maturation process and completed at 24 hours. Sharma et al. (1996) on the 
other hand demonstrated that oocytes collected from non-stimulated abattoir-derived 
ovaries achieve high maturation rate at 32 hours. Shorter IVM duration, 27 hours have 
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been reported for goat oocyte retrieved from ovaries procured from gonadotrophin 
treated goats (De Smedt et al., 1992). 
 The IVM duration may affect not only the meiotic competency of the oocyte but 
it also influence the IVD of the oocytes after fertilisation or nuclear transfer. Prolonged 
MII arrest was reported to cause oocyte aging which leads to chromosomal anomalies 
and impair the development of embryos (Marston and Chang, 1964). It is thought that 
the oocyte aging process is related to changes in concentration of calcium ions (Yoon 
and Fissore, 2007), reactive oxygen species, activity of M-phase promoting factor (MPF) 
and mitogen-activated protein kinase (MAPK) (Miao et al., 2009). A summary of 
significant findings in IVM for goat oocytes is depicted in Table 2.4. 
 
Table 2.4: Timeline of significant findings in IVM of goat oocytes 
Year Author Significant finding 
1992 De Smedt et al. Culturing abattoir COCs, 86% maturation rate 
was obtained from oocytes derived from 2- 6 
mm sized follicles, whereas only 24% of 
oocytes from 1- 1.8 mm sized follicles were 
matured. 
 
1995 Crozet et al. Culturing COCs from superovulated and 
oestrus synchronised slaughtered doe ovaries 
in TCM-199 + FCS (10%) for 27 hours, 70, 
83 and 97% maturation rates were obtained, 
respectively, from COCs derived from 
follicles of 2- 3 mm, 3.1- 5 mm and >5 mm in 
diameter. 
 
1995 Martino et al. Culturing abattoir-derived prepubertal goat 
COCs in TCM-199 + FBS (10%) for 27 
hours, 72.0 and 76.9% maturation rates were 
obtained in presence or absence of GCs, 
respectively. 
 
1996 Sharma et al. Culturing abattoir-derived COCs in TCM-199 
+ OGS (20%), 71.6, 59.7, 55.8 and 50.3% 
maturation rates were obtained respectively, 
after 32, 36, 31 and 24 hours of IVM. 
 
31 
 
(continued) 
Year Author Significant finding 
1996 Gall et al. Culturing COCs from hormonally stimulated 
slaughtered goat ovaries in TCM-199 + FCS 
(10%), 22 and 96% maturation rates were 
obtained, respectively, after 20 and 27 hours 
of IVM of COCs derived from 2- 6 mm sized 
follicles.  However, only 3.5 and 8% 
maturation rates were obtained with COCs 
from 1- 1.8 mm sized follicles after 20 an 27 
hours of IVM. 
 
1999 Malik et al. Culturing abattoir-derived COCs for 28 
hours, 63.6, 55.6 and 44.6% maturation rates 
were obtained, respectively, in TCM-199 + 
OGS (20%), goat peritoneal fluid and rabbit 
peritoneal fluid media. 
 
2000 Samaké et al. Culturing COCs from superovulated and 
oestrus synchronised does in TCM-199 + 
FBS (10%) for 24 hours, 100% maturation 
rates were obtained from COCs retrieved by 
both laparotomy and ovariectomy methods. 
 
2001 Rho et al. Culturing abattoir-derived COCs in M-199 + 
FCS (10%), 73, 55 and 30% maturation rates 
were obtained, respectively, after 27, 24 and 
20 hours of IVM. 
 
2002 Cognié et al. Culturing goat oocytes in TCM-199 + FF 
(10%) with (+) or without (-) cysteamine (100 
µM), maturation rates of 21% (-) and 32% 
(+); 46% (-) and 71% (+); and 72% (-) and 
79% (+) were obtained, respectively, after 
culturing for 16, 20 and 24 hours.  
 
2003 Rodriguez- 
Gonzalez et al. 
Culturing abattoir-derived prepubertal goat 
COCs in TCM-199 + SS (10%) supplemented 
with 100 µM cysteamine for 27 hours, 
significantly higher maturation rate was 
obtained from brilliant cresyl blue (BCB) 
positive (Blue colour) COCs (89.5%) than 
BCB negative COCs (72.1%) or unselected 
(control) COCs (67.3%).  
 
2005 Nagar and 
Purohit 
Culturing abattoir-derived COCs with 
different concentration of EGF in TCM-199 
medium for 28 hours, 34.1, 55.6, 64.5, 52.4, 
and 49.2% maturation rates were obtained, 
respectively, with supplementation of 0, 10, 
20, 50 and 100 ng/ml EGF. 
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(continued) 
Year Author Significant finding 
2006 
2007 
Phua; 
Amir 
Culturing LOPU-derived oocytes from 
oestrus synchronised and superovulated does 
in TCM-199 + OGS (10%), 31.0- 67.8% 
maturation rates were obtained after 18 to 24 
hours of IVM. 
 
2008 Abdullah et al. Oocytes yield after a prolonged interval 
between hormonal stimulation and LOPU (72 
hours) achieve maturation rate of 82%. 
   
2010 Kwong et al. Oocytes yield after a prolonged interval 
between hormonal stimulation and LOPU 
(66- 72 hours) achieve maturation rate of 75% 
after subjected to IVM duration of 18- 22 
hours. 
 
 
2.5 SOMATIC CELL NUCLEAR TRANSFER (SCNT) 
Somatic cell nuclear transfer (SCNT) cloning involves removing nuclear DNA from a 
mature oocyte (enucleation) and inserting a donor cell nucleus (reconstruction) derived 
from a somatic cell. The donor nucleus is then subjected to a complete “reprogramming” 
by undetermined factors located inside the ooplasm, which enable the complete set of 
instructions that were once turned off in the differentiated donor nucleus to become 
active and commence development, not as another somatic cell, but as a 1-cell embryo 
(Campbell, 1999). 
 
2.5.1 Manipulation Technique 
Each group of researchers has its own specific technique in producing cloned animal. 
There are three manipulation techniques successfully developed for SCNT namely, 
Roslin technique, Honolulu technique and handmade cloning. The former two 
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approaches were widely used and both share the same concept as the somatic donor 
karyoplast used were in G0 stage.  
  Roslin Technique was developed in the Roslin Institute, by Ian Wilmut, Keith 
Campbell and fellow researchers. This approach involve the enucleation of a matured 
sheep oocytes by squeezing approach and subsequently a cell cycle- synchronised donor 
cell (mammary gland cell) by serum starvation was injected into the perivitelline space 
of the oocyte. An electrical pulse was used to fuse the donor cell with the oocyte 
cytoplast, at the same time activate the development of the reconstructed oocyte. In their 
study, the cloned sheep embryos were cultured in sheep’s oviduct and subsequently 
transferred into the uterus of the surrogate mother. The first successful delivered cloned 
sheep name Dolly was produced using this approach (Wilmut et al., 1997). 
 Honalulu technique was developed in the University of Hawaii by Teruhiko 
Wakayama and Ryuzo Yanagimachi. In this manipulation method, enucleation was 
carried out using aspiration technique and the donor cell or karyoplast (cumulus cell) 
were injected into the cytoplasm of the oocytes after breaking the cell membrane of the 
donor cell. The reconstructed oocyte was then subjected to chemical activation 
treatment prior in vitro culture to develop cloned embryos. Using this approach, they 
had successfully produced cloned mice (Wakayama et al., 1998). Both Roslin and 
Honalulu techniques required delicate instrumentation, special manual skills and hard, 
concentrated work. Ever since both these technique were successfully used to cloned 
sheep and mice, other researcher using both approaches had successfully produced 
cloned cattle, goat and pig (Table 2.1) 
 Handmade cloning is an alternative method in which it does not involve the use 
of micromanipulator and reconstructed embryos were leave to develop without zona 
pellucida. The only successful published attempt to make cloning without manipulation 
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was the bovine system established by Peura et al. (1998, 2001) based on removal of the 
zona pellucida, oriented enucleation with a handheld blade under a stereomicroscope, 
and fusion with a blastomer by using the AC current in the fusion chamber to keep cells 
together. The overall efficiency of this system was commeasurable with that of 
traditional cloning, but initial attempts to apply the procedure for somatic cell nuclear 
transfer were unsuccessful (Trounson et al., 1998). Later the improved handmade 
cloning technique was developed for somatic cell nuclear transfer (Vajta et al., 2001). 
Handmade cloned offspring have been produced in cattle (Tecirlioglu et al., 2003; Vajta 
et al., 2003), horse (Lagutina et al., 2005), pig (Du et al., 2005) and buffalo (George et 
al., 2011). 
 
2.5.2 SCNT Approach 
2.5.2.1 Intraspecies SCNT 
Intraspecies SCNT (intraspSCNT) approach involves the transplantation of a donor cell 
(karyoplast) into a recipient enucleated oocyte (cytoplast) of the same species. 
Generally the success rate of intraspSCNT approach is higher compared to  
interspSCNT approach and this might be attributed to the fact that the phylogenetic 
distance between the animals in which the oocyte and somatic cell was derived in 
intraspSCNT approach is closely related. In the intraspSCNT approach, the efficacy was 
further influenced by the application of autologous and heterologous approach.  
 Autologous SCNT refer to the method in which somatic nucleus of a female 
donor is transferred to its own enucleated oocyte (Yang et al., 2006), while 
heterologous approach involve the transfer of a donor cell into an enucleated oocyte of 
the unrelated individual of the same species. Using the autologous approach, the 
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molecular and genetic between the nucleus and cytoplasm of the cloned embryos could 
be preserved. On a more cellular level, the interaction between the donor nucleus and 
recipient cytoplast may influence a number of important biological functions in SCNT 
during nuclear reprogramming. When considering the karyoplast-cytoplast interaction, 
mitochondria are the most abundant organelle in cytoplasm and play an important role 
in development by supplying energy for normal cellular functions. Mitochondrial DNA 
(mtDNA) is supplied mainly by the recipient oocyte during SCNT, but is regulated by 
genes in the donor nucleus. Under the high oxygen environment, and with limited DNA 
repair ability, mtDNA has high rates of heritable polymorphism and de novo mutation 
which can result in many haplotypes. In cattle, oocytes with various mtDNA haplotypes 
usually have different ATP content and this may affect the efficiency of in vitro 
production of embryos (Bruggerhoff, 2002; Yan et al., 2010). By using autologous 
SCNT approach, this hurdle could be solved.  
 In caprine SCNT study, the first cloned kid was produced in the year 1999 by 
using intraspSCNT approach. Even though live cloned kids were produced, the overall 
efficiency is still low. Subsequent studies were carried out by various laboratories to 
improve the caprine intraspSCNT efficiency as depicted in Table 2.5.  
 
Table 2.5: Timeline of significant findings intraspSCNT in caprine 
Year Author Significant event/ finding 
1999 Baguisi et al. First report on goat SCNT live birth in which 3 
female offsprings were produced using foetal 
somatic cells as donor karyoplast.  
2001 Keefer et al. Both in vitro transfected caprine foetal 
fibroblast cells could direct full term 
development following nuclear transfer. 
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(continued) 
Year Author Significant event/ finding 
2001 Reggio et al. First report of cloned goats produced from 
nuclear transfer using cytoplasts derived from 
abattoir ovaries. 
2001 Zou et al. The survival rate of cloned-caprine embryos 
obtained by injection was higher than that 
derived from fusion (62.7 and 45.9%). 
2002 Guo et al. The results of microsatellite DNA analyses 
indicated that the 2 kids were from the same 
donor fibroblast cell line derived from an adult 
caprine ear skin. 
2002 Keefer et al. No significant differences in the rates of 
pregnancy and nuclear transfer efficiency 
between granulosa cells and foetal fibroblast 
cells. 
2002 Zou et al. A foreign gene, such as the neo-resistant gene 
could be introduced into caprine foetal 
fibroblast cells and that the resulting transgenic 
cells were capable of being cloned to produce 
100% transgenic animals. 
2003 Das et al. Reported that 300 V resulted in better 
electrofusion and cytochalasin B blocked 
synchronised cells and fast growing skin 
fibroblast cells of caprine could be used for 
nuclear transfer. 
2003 Ohkoshi et al. Caprine nuclear transfer using anterior pituitary 
cells in an in vitro culture system had the 
developmental potential to produce offspring 
after embryo transfer. 
2004 Zhang et al. Donor cell cycle at stage G0/G1 might be 
efficient ways to improve the developmental 
competence of reconstituted caprine embryos 
than stage G2/M. 
2005 Melican et al. More offspring were produced utilising 
karyoplast cultured in low serum versus cycling 
cells grown to confluence to synchronise 
G0/G1 stage cells. In addition, more live 
offspring were produced using donor cells 
harvested by partial compared with complete 
trypsinisation. 
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(continued) 
Year Author Significant event/ finding 
2006 Lan et al. The fusibility and in vitro developmental 
potential of embryos reconstructed from foetal 
fibroblasts at passages 20 to 25 were 
significantly lower than those of embryos 
reconstructed from foetal fibroblasts at 
passages 3 to 5 and the cloning efficiency of 
the long term cultured cells was low (0.5%).  
2006  Shen et al. SCNT is a viable technique for goat cloning 
and that increase electrical field strength for 
both fusion and activation of reconstructed 
embryos appeared to be beneficial for the 
development of cloned embryos. 
2007 Chen et al. The method of telophase II enucleation 
combined with whole cell intracytoplasmic 
injection (WCICI) could properly reprogramme 
the somatic cells, and WCICI could provide an 
efficient and less labour-intensive protocol in 
Asian yellow goat cloning. 
2008 Daniel et al. The difference in membrane surface properties 
between cumulus and fibroblast cell may 
contribute to the higher fusion rate obtained in 
cumulus cells for cloned caprine embryo 
production. 
2008 Tao et al. Both interspecies and intraspecies 
reconstructed cloned-caprine embryos have 
similar development changes in the zona 
pellucida, rough endoplasmic reticulum, Golgi 
apparatus and nucleolus when compared with 
in vivo produced embryos. 
2008 Wang et al. Successfully developed an effective method to 
screen transgenic donor cells and improve the 
production efficiency of transgenic embryos. 
2009 Tao et al. Optimised nuclear transfer protocol and proper 
hCG treatment led to the successful birth of a 
cloned goat. 
2009 Yuan et al. Live goats were generated by SCNT from 
caprine mammary gland epithelial cells using 
long term cultured cell lines (25 to 27 
passages). 
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(continued) 
Year Author Significant event/ finding 
2010 Akshey et al. The foetal fibroblast cell was a suitable 
candidate as nuclear donor and the flat surface 
culture system was suitable for zone-free 
blastocyst development by the hand-made 
cloning technique in the goat. 
2010 Zhang et al. Successfully produced functional expression of 
hGCase in mammary gland cells and normal 
development to Day 40 of cloned embryos 
carrying the hGCase gene. 
2010 Dalman et al. The use of full confluency was suitable for cell 
cycle synchronisation because it arrested cells 
at the G0/G1 phase and also induced less 
apoptosis in comparison with the serum 
starvation group. 
2011 Abdullah et al. Cloned-caprine embryos could be produced in 
vitro via both intraspSCNT and interspSCNT 
approaches in which the efficacy of 
interspSCNT approach was comparable to that 
of intraspSCNT approach. 
2011 Akshey et al. First report of effect of treatment of donor cells 
with roscovitine and different activation 
methods on handmade cloned embryo 
production in goat. 
2011 Liu et al. CB treatment for 2 to 3 h between fusion and 
activation was an efficient method for 
generating cloned goats by SCNT. In addition, 
increasing the number of embryos transferred 
to each recipient resulted in more live offspring 
from fewer recipients. 
2011 Nasr-Esfahani et al. First report of successful live and survived 
birth of cloned and transgenic kids using zona- 
free method of SCNT.  
2011 Tang et al. mSOF medium supplemented with 10% FBS 
could better support the development of cloned 
caprine embryos and he blastocysts cultured in 
this medium could develop to term and gave 
birth to a healthy kid at term. 
 
39 
 
2.5.2.2 Interspecies SCNT  
Interspecies SCNT (interspSCNT) approach involves transplantation of a donor cell 
(karyoplast) into a recipient enucleated oocyte (cytoplast) of a different 
species/family/order /class. The interspSCNT approach would be beneficial in any 
situation, in which an alternative source of ooplasm is needed, due to either ethical or 
technical considerations, such as establishing primate ESCs from interspSCNT embryos 
or cloning endangered species, respectively. The ultimate endpoints of these 
applications are either (1) to generate a preimplantation embryo to be used as a source 
of ESCs or (2) to produce live offspring in all animals with the exception of human. 
 Successful interspSCNT, either giving birth to live offspring or producing nearly 
termed fetuses, has been achieved by several groups concerned with the conservation of 
endangered species. The first interspSCNT offspring was reported for the gaur by Lanza 
et al. (2000) but unfortunately died within the first 48 hours. Using domestic sheep 
(Ovis aries) as recipient cytoplasts, two pregnancies were established after interspSCNT 
using an exotic argali (Ovis ammon) for donor karyoplasts, however both of these 
pregnancies were reported to have been lost by 59 days of gestation (White et al., 1999). 
More recently, domestic sheep (Ovis aries) enucleated oocytes used as cytoplasts for 
adult mouflon cells (Ovis orientalis musimon) resulted in one live offspring (Loi et al., 
2001).  
 The animal species in which their oocytes were reported to be used as the 
recipient cytoplast for the interspSCNT studies included cattle (Dominko et al., 1999; 
Lanza et al., 2000; Yoon et al., 2001), rabbit (Chen et al., 2002; Wen et al., 2005), pig 
(Ikumi et al., 2004; Hashem et al., 2007), goat (Folch et al., 2009), buffalo (Lu et al., 
2005; Yang et al., 2010), sheep (Loi et al., 2001), domestic cat (Gomez et al., 2004) and 
dog (Kim et al., 2007). While the type of somatic cells commonly employed in 
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interspSCNT  study included dermal fibroblasts (Lanza et al., 2000), granulosa cells 
(Loi et al., 2001) and foetal fibroblasts (Kitiyanant et al., 2001) which resulted in either 
offspring or blastocyst production.  
 Even though, cloned offspring were able to be produced using interspSCNT 
approach, the overall efficiency of cloning is low in all species owing to not only the 
incomplete nuclear reprogramming of differentiated cells but also the factors of 
mitochondria/ genomic DNA compatibility, embryonic genome activation of the donor 
nucleus by the recipient oocyte and the availability of suitable foster mothers for 
interspSCNT embryos (Loi et al., 2011). 
 Since this study involve the production of caprine interspSCNT embryos using 
bovine cytoplast, a summary of interspecies cloning using ruminant oocyte as recipient 
cytoplast was presented in Table 2.6 for reference. 
  
 
 
 
 
 
 
 
 
 
41 
 
Table 2.6: Summary of interspecies cloning using ruminant oocyte as recipient cytoplast 
Taxonomic 
relationship 
Recipient cytoplast species Donor karyoplast 
Species (Cloned species) 
Type of donor 
karyoplast 
Significant 
development 
References 
 
Intersubspecies 
(intraspecies) 
 
Goat 
(Saanen) 
 
Goat 
(Boer) 
 
Ear skin fibroblast cell 
 
Offspring 
 
Jian-Quan et al., 2007 
  
Swamp buffalo 
(Bubalus bubalis carabensis) 
 
River buffalo 
(Bubalus bubalis bubalis) 
 
Ear skin fibroblast cells 
 
Offspring 
 
Yang et al., 2010 
 
Interspecies 
(intrageneric) 
 
Cattle  
(Bos taurus) 
 
Gaur 
(Bos gaurus) 
 
Skin fibroblast cells 
 
Offspring 
 
Lanza et al., 2000 
   
Yak 
(Bos grunniens) 
 
Cumulus cells 
 
Ear skin fibroblast cell 
 
Blastocyst: 10.9% 
 
Blastocyst: 28.0% 
 
Murakami et al., 2005 
 
Li et al., 2007 
   
 
Banteng 
(Bos javanicus) 
 
 
Ear skin fibroblast cells 
 
 
Blastocyst: 15– 28% 
 
 
Sansinena et al., 2005 
  
Goat 
(Capra hirus) 
 
Burcado 
(Capra pyrenaica pyrenaica) 
 
Ear skin fibroblast cells 
 
Offspring 
 
Folch et al., 2009 
  
Sheep 
(Ovis aries) 
 
Argala 
(Ovis ammon) 
 
European Mouflon 
(Ovis orientalis musimon) 
 
Skin fibroblast cell 
 
 
Granulosa cell 
 
Foetuses: 50 days old 
 
 
Offspring 
 
White et al., 1999 
 
 
Loi et al., 2001 
4
1
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(continued) 
Taxonomic Recipient cytoplast species Donor karyoplast 
species (Cloned species) 
Type of donor 
karyoplast 
Significant 
development 
References 
 
Intergeneric 
(intrafamily) 
 
Cattle 
(Bos taurus) 
 
Buffalo 
(Bubalus bubalus) 
 
Foetal fibroblast cells 
 
Ear skin fibroblast cells 
 
Blastocyst: 33.0% 
 
Blastocyst: 4.5% 
 
Kitiyanant et al., 2001 
 
Lu et al., 2005 
   
Sheep 
(Ovis aries) 
 
Ear skin fibroblast cells 
 
Blastocyst: 18.0% 
 
Blastocyst: 24.0% 
 
Dominko et al., 1999 
 
Hua et al., 2008 
   
Goat 
(Capra hircus) 
 
Foetal fibroblast cells 
 
 
Blastocyst: 7.9% 
 
Song et al., 2008 
   
African buffalo 
(Syncerus caffer) 
 
Eland 
(Taurotragus oryx) 
 
Ear skin fibroblast cells 
 
Blastocyst: 3.5% 
 
 
Blastocyst: 2.0% 
 
 
Matshikiza et al., 
2004 
   
Takin 
(Burdocas taxicolor) 
 
Ear skin fibroblast cells 
 
Blastocyst: 5.0% 
 
Li et al., 2006a 
 
 
4
2
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(continued) 
Taxonomic 
relationship 
Recipient cytoplast species Donor karyoplast 
Species (Cloned species) 
Type of donor 
karyoplast 
Significant 
development 
References 
  
Buffalo 
(Bubalus bubalus) 
 
Cattle 
(Bos taurus) 
 
Ear skin fibroblast cells 
 
Blastocyst: 3.0% 
 
Lu et al., 2005 
  
Sheep 
(Ovis aries) 
 
Goat 
(Capra hircus) 
 
Foetal fibroblast cells 
 
Blastocyst: 7.4% 
 
Ma et al., 2008 
 
Interfamily 
(intraorder) 
 
Cattle 
(Bos taurus) 
 
Pig 
(Sus scrofa) 
 
Ear skin fibroblast cells 
 
Skin fibroblast cells 
 
Blastocyst: 6.0% 
 
Blastocyst: 3.9% 
 
Dominko et al., 1999 
 
Uhm et al., 2007 
  
Sheep 
(Ovis aries) 
 
Camel 
(Camelus bactriancus) 
 
Ear skin fibroblast cells 
 
Blastocyst: 0% 
 
Zhou and Guo, 2006 
 
Interorder 
(intraclass) 
 
Cattle 
(Bos taurus) 
 
Rhesus monkey 
(Macaca mulatta) 
 
Crab-eating monkey 
(Maccaca fascicularis) 
 
Ear skin fibroblast cells 
 
 
Skin fibroblast cells 
 
Blastocyst: 16.6% 
 
 
16-cell: Not Available 
 
Dominko et al., 1999 
 
 
Lorthongpanich et al., 
2008 
   
Mouse 
(Mus musculus) 
 
Embryonic fibroblast 
cells 
 
8-cell: 6.2% 
 
Arat et al., 2003 
  
Goat 
(Capra hirus) 
 
Human 
(Homo sapiens recens) 
 
Neural stem cells 
 
Blastocyst: 10.7% 
 
Sha et al., 2009 
4
3
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(continued) 
Taxonomic 
relationship 
Recipient cytoplast species Donor karyoplast 
Species (Cloned species) 
Type of donor 
karyoplast 
Significant 
development 
References 
 
Interclass 
 
Cattle 
(Bos taurus) 
 
Fowl 
(Gallus gallus domesticus) 
 
Embryonic fibroblast 
cells 
 
Blastocyst: 3.0% 
 
Kim et al., 2004 
4
4
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2.6 FACTORS AFFECTING NUCLEAR TRANSFER. 
 
2.6.1  Micromanipulation  
Nuclear transfer is a complex procedure, which involve the micromanipulation 
procedure such as enucleation and donor karyoplast transfer prior activation, in vitro 
culture and embryo transfer. Each of these steps affects the overall efficiency of the 
cloning outcome. 
 
2.6.1.1 Enucleation  
Prior to nuclear transfer (NT), the recipient oocyte DNA has to be removed or destroyed 
without compromising viability and reprogramming potential of the cytoplast. 
Enucleation can be accomplished by using solely mechanical approach or with 
chemical-assisted enucleation approach and centrifugal enucleation.  
 The solely mechanical approach is usually carried out using squeezing approach. 
Presuming that the MII plate located adjacent to the first polar body (PB-1), a slit is 
made in the zona pellucida above PB-1 with a microneedle and subsequently by 
applying mild pressure, PB-1 and a small amount of cytoplasm assumed containing MII 
plate was squeezed out (Tsunoda et al., 1989). The squeezed out material is subjected to 
Hoechst 33342 dye to confirm positive enucleation. This technique is also known as 
‘blind squeezing method’.  By using this enucleation method, the oocyte can be avoided 
from the harmful effects of ultraviolet (UV) light.  The detrimental effects of DNA dyes 
and ultraviolet light exposure on oocytes and their developmental potential have been 
documented in the past (Smith et al., 1993; Dominko et al., 2000). Although this 
technique eliminates the use of UV light, it has been documented that first polar bodies 
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of a metaphase-II oocyte often migrate and do not always remain in proximity to the 
chromosomes in the metaphase-II spindle (Bordignon and Smith, 1998; Dominko et al., 
2000; Liu et al., 2000). 
 An alternative to the ‘blind squeezing’ enucleation approach is the chemically 
assisted enucleation. Fluorochrome labeled enucleation was accomplished by labeling 
the matured oocyte DNA with fluorochrome (Hoechst 33342) prior enucleation (Critser 
and First, 1986). The labeled oocyte was subjected to UV irradiation during enucleation 
to locate the MII spindle. Fluorochrome labeled enucleation was reported to produce 
higher enucleation efficiency (Westhusin et al., 1992; Smith, 1993), however when 
these oocyte were exposed to UV light for > 30 seconds, it was reported to cause a loss 
in membrane integrity, decreases methionine incorporation, alters protein synthesis 
patterns in the oocytes (Smith, 1993). Pretreatment of oocytes with 3% sucrose was also 
effective in aiding the visualisation of the metaphase spindle and chromosomes with 
standard light microscopy (Wang et al., 2001) and a 0.3 M sucrose treatment was found 
to be effective in facilitating the localisation of the mouse and bovine chromosomes 
(Liu et al., 2002b). Demecolcine is another chemical that could be used to assist in 
enucleation of oocytes by causing membrane protrusion that contained the condensed 
chromosomes, which were easily visualised and aspirated into a pipette without the 
need of staining (Yin et al., 2002). Other chemically-induced enucleation method 
includes using etoposide (Elsheikh et al., 1998), etoposide in conjunction with 
cycloheximide (Fulka and Moor, 1993), and ethanol with demecolcine (Ibanez et al., 
2003). While these methods greatly facilitate the enucleation process, development of 
NT embryos following chemically-induced enucleation remains lower than 
development of mechanically enucleated oocytes (Gasparrini et al., 2003). 
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 Because the enucleation step requires a high degree of visual and manual control, 
other methods of enucleation have also been explored such as centrifugal enucleation 
and zona-free with manual bisection approach. The centrifugal enucleation method 
takes advantage of the fact that the genetic material is heavier than the cytoplasm. If 
zona-free oocytes are centrifuged in an appropriate gradient in the presence of a 
cytoskeletal inhibitor, a karyoplast containing the metaphase plate can be separated 
from the cytoplasm (Wagoner et al., 1996). While for the zona-free with manual 
bisection approach, the MII oocytes were stripped of their zonae pellucidae using 
pronase and manually bisected using an Ultra Sharp splitting blade (AB Technologies, 
Pullman, WA). The demi-oocytes were then stained for nuclear DNA and only those 
without a metaphase spindle were selected for fusion with donor somatic cells (Oback et 
al., 2003; Vajta et al., 2003). 
 As for species with fragile oocytes or hard zona pellucida, such as the mouse 
and the horse, Piezo-driven enucleation and reconstruction (Wakayama et al., 1998; 
Choi et al., 2002b) are usually incorporated. This is because the Piezo drill generates 
mechanical pulses that travel longitudinally along the microinjection pipette and vibrate 
the pipette tip, drilling through the zona pellucida and the oolema are facilitated without 
producing any net forward movement of the pipette.  
 The success of removing the nuclear material of the matured oocytes without 
causing damage to the cytoplast could not be accomplish without the use of the 
cytoskeletal inhibitor cytochalasin B (CB) (McGrath and Solter, 1983). Treating mouse 
oocytes with CB prevented damage to the oocyte plasma membrane and allowed the 
insertion of a glass pipette through the zona pellucida without lysing the oocyte.  
 Enucleation of oocytes can be conducted at the metaphase II (MII) or telophase 
II (TII) of the oocyte cell cycle stage. When enucleation was conducted at MII stage, 
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PB-1 was used as a marker for the location of the MII plate and the efficiency of 
enucleating oocyte at this stage was reported to be less effective (Li et al., 2004). The 
problem with this approach is that in many cases the metaphase plate is not close to PB-
1. This factor can result in a proportion of the oocytes containing residual DNA 
following enucleation. An alternative to the enucleation of MII oocytes is the 
enucleation of activated oocytes at telophase of the second meiotic division (telophase II: 
TII). Mechanical aspiration of the extruding second polar body (PB-2) and surrounding 
cytoplasm following activation is an effective and reliable enucleation method without 
the need for visualisation of the DNA by exposure to UV light. In addition, significantly 
less of the oocyte cytoplasm is removed when compared to enucleation of MII oocytes 
which may be beneficial to the developmental competence of the recipient cytoplast 
(Bordignon and Smith, 1998). 
 
2.6.1.2 Transfer of donor karyoplast 
Generally the two approaches that commonly used to introduce the donor karyoplast 
into the enucleated oocyte are: a) cell is transferred to the perivitelline space of the 
enucleated oocyte (Sub-Zonal Injection-SUZI) and subsequently electro-fused with 
direct current (DC) pulse; (b) donor cell is directly injected into the cytoplast of the 
enucleated oocyte (Whole Cell Intracytoplasmic Injection- WCICI). 
 The SUZI followed by electrofusion method was commonly used in cloning 
domestic animals and it has been successfully applied to produce viable cloned animals 
like sheep (Wilmut et al., 1997), cattle (Kato et al., 1998), goat (Baguisi et al., 1999), 
pigs (Polejaeva et al., 2000).  
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 Electrofusion is the most widely used method in which the cell-oocyte couplets 
are placed in a largely nonionic, slightly hypotonic medium between two parallel 
electrodes and a high-voltage direct-current pulse delivered such that membrane 
breakdown is achieved (Zimmermann and Vienken, 1982). The pulse strength and 
duration must be determined experimentally, because conditions will vary slightly 
among different laboratories. The electrical pulse results in inversion of membrane 
phospholipids (breakdown), thus creating holes in the membrane; on healing, the 
membranes are fused. Therefore, too high a voltage for too long will result in lysis. 
However, if the voltage or duration is too low, poor fusion rates will be result.  
 The success of electric fusion requires precise alignment of the membranes to be 
fused perpendicular to the electric current, close contact between these membranes, and 
delicately timed species-speciﬁc duration and strength of the applied electric ﬁeld 
(Zimmermann and Vienken, 1982). The electrical field strength (kV/cm), and the 
number and time interval of electric pulse (Ozil and Huneau, 2001) are believed to 
influence the developing capacity of reconstructed oocyte. Miyoshi et al. (2001) 
reported that a low fusion rate in cattle may occur when the orientation of the cell and 
enucleated oocyte to the electrode is not correct, there is little or no cell-to-cell contact, 
or both. Conversely, the efﬁciency of electrofusion seems to increase with the rise of the 
electric ﬁeld strength and duration until these values reach a critical level. However, 
high levels of intracellular Ca
2+
 caused by the extension of pulse duration have a 
detrimental effect on the cell function or structures (Izant, 1983).  
 The WICIC technique can be carried out using conventional micropipette or 
with the Piezo-driven injection pipette. The WCICI approach involves the direct 
injection of donor cell into an enucleated oocyte, bypassing the fusion process. By using 
conventional micropipette, this approach is known to be less labour intensive, cost 
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effective while its efficiency is comparable with other approach (Lee et al., 2003). On 
the other hand, the Piezo-driven WICIC approach is usually applied in cloning species 
such as mouse and horse in which the oocytes are fragile and their zona pellucidae are 
hard (Wakayama et al., 1998; Choi et al., 2002b). With this invention, the efficiency of 
the mouse cloning procedure has improved as the issue of hard zona pellucida was 
solved. 
 
2.6.2 Activation 
2.6.2.1 Mechanism of activation 
The transition from mature oocyte to developing embryo requires a coordinated series 
of events, collectively known as egg activation. Egg activation includes changes to egg 
coverings to prevent polyspermy, release of oocyte meiotic arrest, generation of haploid 
female and male pronuclei, changes in maternal mRNAs and protein populations, and 
cytoskeletal rearrangements. In many animals, egg activation is triggered by sperm 
entry during fertilisation, which increases intracellular calcium within the oocyte 
(Swann and Ozil, 1994). These calcium oscillations thereby regulate the cascade of 
events including the cortical granule reaction (Miyazaki et al., 1990), zona pellucida 
reaction (Yanagimachi, 1994) and the escape from the metaphase-II arrest (Whitaker 
and Irvine, 1984). After a few hours, a series of events makes fertilisation complete, 
through the inactivation of maturation promoting factor (MPF) and of mitogen activated 
protein kinase that leads to resumption and completion of meiosis, DNA synthesis and 
pronuclei formation (Moos et al., 1996).  
 MPF was described as a complex of two subunits: a catalytic subunit, p34
cdc2
 
and a regulatory subunit, cyclin B. p34
cdc2
 is a protein kinase regulated by changes in its 
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phosphorylation state and by its association with cyclin. Throughout the cell cycle, the 
level of p34
cdc2
 remains constant but the level of cyclin varies. MPF peaks at metaphase 
in association with nuclear envelope breakdown, chromatin condensation, 
reorganisation of the cytoskeleton and the formation of the mitotic spindle (Doree and 
Galas, 1994; Moos et al., 1996). In order for the cell to exit MII arrest, inactivation of 
MPF is necessary and this involves cyclin proteolysis by the proteosome system 
(Glotzer et al., 1991). 
 In vertebrates, mature oocytes are arrested at metaphase-II of the meiotic 
division, with elevated MPF activity maintained by a cytostatic factor (CSF), which 
prevents the ubiquitin dependent degradation of cyclin B and thus, inactivation of MPF. 
Intracellular Ca
2+
 oscillations triggered by sperm down-regulate CSF activity and allow 
for the degradation of cyclin. Proteolytic degradation of cyclin B and subsequent MPF 
inactivation releases oocytes from metaphase arrest and allows the beginning or 
resumption of mitotic cycles (Lorca et al., 1993). 
 
2.6.2.2  Artificial activation  
However, in nuclear transfer, the absence of sperm-induced fertilisation steps leads to 
the requirement of artificial activation in order to trigger nuclear reprogramming and 
further embryonic development (Wells et al., 1999). Different artificial protocols have 
been developed to activate mammalian oocytes by simulating the biochemical and 
physiological events that normally occur during sperm-oocyte interaction as describe 
earlier.  
 Intracellular calcium rise can be induced in the oocytes without spermatozoa, 
using several chemical activating agents and electrical stimulation as a consequence, 
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oocyte is released from metaphase arrest but levels of MPF are not properly reduced and 
further development is impaired (Rinaudo et al., 1997). In order to overcome this 
limitation, additional agents inhibiting protein synthesis or protein phosphorylation can 
be added and higher activation and in vitro development rates are observed in several 
species (Susko-Parrish et al., 1994; Mitalipov et al., 2001). 
 Calcium signaling can be stimulated using chemical agents such as Ca
2+ 
ionophore, 7% ethanol, strontium chloride, phorbol ester and thimerosal (Nakada and 
Mizuno, 1998). Ionophore A23187 promotes the release of intracellular Ca
2+
 stores but 
also facilitates the influx of extracellular Ca
2+
 ions (Kline and Kline, 1992). Ionomycin 
is another potent Ca
2+
 ionophore currently used in NT protocols (Cibelli et al., 1998; 
Wells et al., 1999). It mobilises intracellular Ca
2+
 by depletion of Ca
2+
 stores. Exposure 
of matured oocytes to 7% ethanol for 5 to 7 min induces successful activation and 
pronuclear formation (Presicce and Yang, 1994) by promoting the formation of IP3 and 
the influx of extracellular Ca
2+
. The substances mentioned above induce a single Ca
2+
 
rise in the oocyte. However, the initial Ca
2+
 rise is normally followed by Ca
2+
 
oscillations during fertilisation in mammals. Strontium chloride induces multiple Ca
2+
 
transients probably by displacing bound Ca
2+
 in the oocyte (Whittingham and Siracusa, 
1978) but also by inducing intracellular Ca
2+
 release (Kline and Kline, 1992). Strontium 
chloride has been successfully used to activate mouse oocytes after NT (Wakayama et 
al., 1998).  
 Electrical stimulation is an alternative to chemical activation to induce Ca
2+
 
influx through the formation of pores in the plasma. However, when this approach was 
used in a calcium and magnesium-free medium followed by incubation in 6-DMAP, the 
electroporation is known to induce the production of inositol 1, 4, 5-trisphosphate (IP3) 
that leads to intracellular Ca
2+
 release. The combination of electroporation of IP3 and 6-
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DMAP has been used to activate parthenogenetic and NT rabbit embryos (Mitalipov et 
al., 1999; Liu et al., 2002a). 
 Inhibition of protein synthesis could be achieved using cycloheximide (CHX) 
while protein phosphorylation can be inhibited with 6- dimethylaminopurine (6-DMAP), 
an analogue to puromycin. Protein synthesis inhibitors (CHX) probably activate 
mammalian eggs by blocking the continuous synthesis of cyclin B that is required to 
stimulate the cell cycle protein kinase CDK1 (Moses and Kline, 1995). 6-DMAP 
appears to stimulate the tyrosine phosphorylation of p34
cdc2
, consequently blocking the 
MPF activity (Jessus et al., 1991). However it is worth to note that detrimental effects 
of these non-specific, broad spectrum protein synthesis and/or kinase inhibitors are 
suspected during later embryonic development. 
 
2.6.2.3 Production of parthenotes 
Parthenotes can be efficiently obtained in vitro with a variety of mechanical, chemical, 
and electrical stimuli using oocytes of several species at different stages along oocyte 
meiosis resulting in parthenotes with different chromosome complements. According to 
the method of production, mammalian parthenotes can be either haploid or diploid. The 
developmental capacity of parthenotes is influenced by the resulting ploidy and genetic 
information. In some species, the development of both haploid and diploid parthenotes 
has been reported. These studies demonstrated that the haploid condition can impair 
cleavage at early stages (Escriba and Garcia-Ximenez, 2000; Kim et al., 1997; Lagutina 
et al., 2004).  
 Parthenogenetic activation can be performed in oocytes at the second metaphase 
resulting in the extrusion of the second polar body and leading to the formation of a 
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haploid parthenote. This method is rarely used since, in this case, the developmental 
competence is reduced compared to normal embryos and to diploid parthenotes (Henery 
and Kaufman, 1992).  Diploid parthenotes are easily obtained: they can be derived from 
MII oocytes whose sister chromatids of the chromosome segregate without being 
extruded into the second polar body: thus the oocyte retains its diploid status, either 
homozygous or including cross-over associated heterozygosity in a single pronucleus. 
However, even the failure of diploid parthenotes to sustain a prolonged development 
highlights the need for biparental chromosome complement and, indirectly, the different 
and sometimes opposite developmental role of imprinted genes. Diploid parthenotes can 
be obtained in two main different ways. The most common one consists in combining 
the activation of MII oocytes with exposure to an inhibitor of the extrusion of the 
second polar body without affecting the formation and movement of pronuclei (Balakier 
and Tarkowski, 1967). Alternatively, a diploid parthenote can be generated by treating 
the oocyte with cytochalasin D during in vitro maturation before activation. This drug 
binds to the positive end of F-actin and blocks further addition of G-actin monomers 
preventing the extrusion of the first polar body. This protocol leads to the formation of 
tetraploid oocytes (Kubiak et al., 1991). The diploid status is then re-established at the 
end of oocyte maturation with the extrusion of the second polar body.  
 Using one or the other method has important consequences on the genetic make-
up of the parthenotes. In fact, performing the oocyte activation before the inhibition of 
the second polar body extrusion determines the formation of highly homozygous 
parthenotes, since the diploid status of the parthenotes is obtained after the segregation 
of sister chromatids. In this case, the degree of heterozygosity depends only on the 
extent of crossing over taking place during the prophase of the first meiotic division 
which is very limited in most species (Rougier and Werb, 2001). On the contrary, 
extrusion of homologous chromosomes does not take place when the first polar body 
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extrusion is inhibited. In this case activation is induced in a tetraploid oocyte and the 
diploid status is reached again after the extrusion of the second polar body. As a 
consequence, the segregation of sister chromatids occurs only at this stage, therefore the 
parthenotes have the same proportion of chromosomes derived from the mother and the 
father of the donor as the oocyte and its donor. Parthenotes generated in this way, not 
only are genetically identical to each other but have the same heterozygosity of their 
mother (Kubiak et al., 1991). 
 
2.6.3 In Vitro Culture 
2.6.3.1 Culture medium  
IVC of cloned embryos before transfer is one of the important steps in achieving 
pregnancy and delivery. Following NT and activation, bovine embryos are generally 
cultured in vitro for 6- 7 days prior to transfer. To date no in vitro embryo culture 
system rivals in vivo culture in terms of development efficiency and embryo quality 
when considering the outcome of any assisted reproduction approach. Although several 
system developed for the culture of in vitro fertilised embryos have been employed, it is 
unclear whether those are suitable for supporting preimplantation development of 
cloned embryos. The physiology of cloned embryos during early development has not 
been elucidated yet and if different requirement for exogenous substrate are found 
between IVF and cloned embryos, the composition of media employed should be 
further modified (Choi et al., 2002a). Suboptimal culture environment can affect the 
embryo morphology, embryonic growth, gene expression, postnatal growth and 
subsequently the phenotype (Kruip and denDaas, 1997; Summers and Biggers, 2003; 
Fleming et al., 2004; Thompson et al., 2007). 
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 Caprine intraspSCNT embryos have been successfully cultured in different 
media such as TCM-199 (Baguisi et al., 1999), Charles Rosenkrans (CR1) (Guo et al., 
2002; Lan et al., 2006; Chen et al., 2007), synthetic oviductal fluid (SOF) (Melican et 
al., 2005; Liu et al., 2011) and G1/G2 medium (Reggio et al., 2001) supplemented with 
serum or chemically defined compositions. 
 Serum generally contains beneficial substances for embryonic development and 
consequently foetal bovine serum (FBS) has been widely supplemented to embryo 
culture media. A higher developmental rate to the blastocyst stage was generally 
obtained from media supplemented with serum (Gardner, 1994; Pinyopummintr and 
Bavister, 1994; VanLangendonckt et al., 1997). However, it has been demonstrated that 
serum has a biphasic effect on embryonic development. The presence of serum in the 
medium may affect the speed of embryonic development, morphology, ultrastructure, 
metabolism and the gene expression profiles (Thompson et al., 2007). This is often 
associated with the large offspring syndrome (LOS) (Thompson et al., 1995; Sinclair et 
al., 1999). Therefore, almost all media used for embryo culture generally contain bovine 
serum albumin (BSA), instead of serum as a source of protein to improve embryonic 
development, blastocyst formation and the hatching rates (Thompson, 2000; George et 
al., 2008). 
 Glucose, pyruvate and lactate are important energy sources for mammalian 
embryos (Brinster et al., 1965). While glucose is necessary for the last part of IVC, 
pyruvate and lactate are important energy supplements for early stages of embryo 
development in vitro (Schini and Bavister, 1988). In general, embryos throughout pre-
elongation development are reliant on oxidative phosphorylation via oxidation of 
pyruvate and amino acids. for the generation of ATP for embryo development (Javed 
and Wright, 1991; Rieger et al., 1992a,b; Gardner et al., 1993; Thompson et al., 1996, 
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2000). However, there is a switch to an increased contribution of glycolysis during 
compaction and blastulation (Gardner et al., 1993; Thompson et al., 1996, 2000). 
Failure to depress glycolysis during pre-compaction is one factor associated with the 
‘‘8- to 16-cell’’ developmental block (Gardner et al., 1997; Thompson et al., 1992). 
Therefore, culture media should be designed to suppress glycolysis during pre-
compaction development followed by removal of the suppression during post-
compaction development. The former is often confused with complete removal of 
glucose from culture medium throughout pre-elongation development. However, this is 
unlikely to benefit the embryo, as glucose plays other roles including ribose and 
NADPH production through the pentose–phosphate pathway. In particular, ribose 
synthesis is important for the embryo, as this molecule is a precursor for DNA and RNA 
synthesis, which is essential for embryonic development. Such metabolic intermediates 
have been detected in sheep embryos following incubation with [U-
14
C]- glucose, as 
well as incorporation into non-glycogen macromolecules (Thompson et al., 1995). 
 The requirements of early embryos as they progress through development and 
the temporal relationship between the reproductive tract fluid milieu and embryo 
development, has led to the concept that media components and physical conditions 
should be altered during culture to achieve improved development. This concept has 
subsequently been termed sequential media systems or two-step culture system 
(Gardner et al., 1997). Metabolic regulation is a relatively new concept, but has its 
origins before the beginning of this decade. Perhaps, the best known example of 
metabolic regulation is the use of ethylenediamine tetraacetic acid (EDTA), a non-
selective chelator of divalent cations during embryo development. Several studies have 
shown that when in vitro glucose concentrations are higher than in vivo, early embryo 
development is retarded or even blocked (Seshagiri and Bavister, 1989; Chatot et al., 
1989; Thompson et al., 1992).This has been likened to the ‘‘Crabtree-effect’’, whereby 
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oxidative phosphorylation is depressed due to an abnormally high glycolytic rate  
(Seshagiri and Bavister, 1989). Until recently, this was generally controlled by reducing 
the concentration of or even removing, glucose within the culture medium (e.g. Chatot 
et al., 1989). However, such conditions are unphysiological, as glucose is found in 
lumen fluids of the reproductive tract (Gardner et al., 1993). A previously unrelated 
observation is that EDTA addition during mouse in vitro embryo development 
overcame culture-induced development ‘‘2-cell’’ blocks (Mehta and Kiessling, 1990). It 
is believed that EDTA sequesters the toxic effects of contaminating heavy metal cations, 
most likely by inhibiting the production of reactive oxygen species, catalysed by ions 
such as Fe
2+
and Cu
2+
  reviewed by Johnson and Nasr-Esfahini (1994). However, Lane 
and Gardner (1997) have demonstrated that, at a cellular level, EDTA depresses 
glycolytic rates within pre-compaction mouse embryos, a result also demonstrated for 
cattle embryos by Gardner et al. (1997). 
 
2.6.3.2 Oxygen tension 
Oxygen  concentration  in  air  (20%),  which  is  generally  employed  for  in  vitro  
culture  of embryos, is  considerably  higher  than  intraluminal  oxygen  tension  in  the 
reproductive  tract  of  most mammals (Fischer et al., 1993).  There are inconsistent 
reports regarding effects of low O2 tension on in vitro development of preimplantation 
embryos. While some studies have reported beneficial effects (Fukui et al., 1991; 
Fujitani et al., 1997), others have reported either no effect (Betterbed and Wright, 1985), 
or even an adverse effect (Van der Westerlaken et al., 1992), of low oxygen 
concentrations on embryonic development.  Improved embryo development in an 
atmosphere containing 5% oxygen compared with higher oxygen concentration has 
been achieved (Fukui et al., 1991; Fujitani et al., 1997; Lonergan et al., 1999).  The  
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discrepancy in  glycogen  levels  of  blastocysts  derived  in  vitro  or  obtained  in  vivo  
could  be  attributed  to  differences  in  the  oxygen  levels  between the two  systems 
(Khurana and Wales, 1989).  Intrauterine oxygen concentration appears to be in the 
range of 1.5 to 7%. Poor development of embryos under atmospheric air (high oxygen 
concentration  for  example), may be attributed  to  the  production  of  free  oxygen  
radicals  (Bavister, 1995).  Even a short incubation (4 hours) of rabbit embryos at 20% 
O2 led to alterations of gene expression indicating a severe stress response (Koerber et 
al., 1998).  Other  investigators  have reported  the  necessity of  using  a  high  oxygen  
concentration  for  optimal  embryonic development in the presence of co-cultures 
(Fukui et al., 1991; Nagao et al., 1994). 
 
2.6.4 Cytoplast Source and Quality 
In vivo sourced oocytes were used as recipient cytoplasts at the initial era of cloning. 
This was an expensive system, but with improvements to IVM procedures, much less  
expensive slaughterhouse derived oocytes could be substituted for in vivo oocytes 
(Keefer et al., 1993; Reggio et al., 2001). In mice in vivo derived oocytes are still used 
for SCNT. This fact is particularly intriguing when you consider the high developmental 
competency of in vivo sourced mouse zygotes as compared to the lower developmental 
competency of in vitro produced cattle or goat zygotes; yet, cattle and goat SCNT using 
in vitro produced oocytes results in much higher success rates on a perfused couplet 
basis than mice (Yang et al., 2007). 
 Oocytes and zygotes at different stages of development have been used as 
recipients for NT. Choice of metaphase II, telophase II or zygotic stage relates in part to 
coordination of cell cycles, but also to ease of enucleation, exposure to reprogramming 
factors and/or activated cytoplasm (Bordignon et al., 1998; Polejaeva et al., 2006). 
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2.6.5 Donor Cell 
2.6.5.1 Selection of donor cell type and duration of cell culture 
Various cell types, such as embryonic cells (Campbell et al., 1993, 1996; Cheong et al., 
1993), fibroblasts (Kato et al., 1998), mammary gland cells (Wilmut et al., 1997), 
cumulus granulosa cells (Wakayama et al., 1998), oviduct cells (Kato et al., 2000), 
leukocytes (Galli et al., 1999), mural granulosa cells (Wells et al., 1999), germ cells 
(Bordignon et al., 2003), embryonic stem cells (Eggan et al., 2001) and liver cells 
(Brem and Kuhholzer, 2002) have been used as donor cells for production of cloned 
animals. However, it is still unclear which type is the most efficient for nuclear transfer 
into oocytes (Kato et al., 2000). 
 Initial study on the production of cloned animal used adult somatic cells derived 
from female reproductive system such as mammary gland (Wilmut et al., 1997), oviduct 
(Kato et al., 1998), cumulus and mural granulosa cells (Wakayama et al., 1998; Wells et 
al., 1999; Kato et al., 2000). However, the limitation of using these cell type is only 
female cloned could be generated if SCNT was performed using these cell type.   
 Foetal cells are believed to have less genetic damage and more proliferative 
ability (as measured by cell doublings) than adult somatic cells, they have been the cell 
type of choice as nuclear donors (Hill et al., 2000). However, this presents a limitation 
in that the individual the donor cells are derived from (a foetus) has not had the chance 
to demonstrate its genetic merit (an adult) prior to somatic cell nuclear transfer. 
 Genetic damage may occur during the in vitro culture of donor cells prior to NT. 
Culturing somatic cells especially for prolonged periods is known to alter ploidy, 
genomic stability and post-translation histone modifications, factors which are known to 
reduce cloning efficiency (Jang et al., 2004). Therefore, fresh or short-term cultured 
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(<10 subpassages) donor cells have been the cell type of choice for the production of 
cloned embryos. In contrast, one study reported higher developmental rates to the 
blastocyst stage for embryos reconstituted with adult somatic cells that had been sub-
passaged 10 to 15 times compared with that of embryos reconstituted from cells with a 
lower number of sub-passages (Kubota et al., 2000). In addition, cloned calves were 
obtained from embryos reconstituted with high sub-passaged cells, with all cloned 
foetuses derived from low sub- passaged donor cells aborting during pregnancy (Kubota 
et al., 2000). Results within and among various research laboratories are often 
conflicting due to procedural effect, oocyte variability, inherent differences among 
donor cell lines, age of donor animals or to effects of in vitro culture conditions.. 
 
2.6.5.2 Stages of donor cell cycle 
The stage of the donor cell cycle is a major factor in the success of nuclear transfer in 
mammals (Wilmut et al., 1997; Campbell et al., 1996). Quiescent donor cells arrested in 
the G1 or G0 stage of the cell cycle have been used to produce mice (Wakayama et al., 
1998), pigs (Onishi et al., 2000; Polejaeva et al., 2000), sheep (Wells et al., 1997),  
cattle (Wells et al., 1999) and goat (Baguisi et al., 1999). Methods of arresting cells in 
this phase of the cycle have been explored using reversible cycle inhibitors (Alessi et al., 
1998), non-pharmaceutical treatments such as mitotic shake-off to select recently 
divided cells in G1 or contact inhibition to select cells in G0/G1 (Boquest et al., 1999; 
Kasinathan et al., 2001), serum starvation (Kues et al., 2000) and cell confluency as a 
donor cell treatment prior to nuclear transfer. The specific method used to arrest donor 
cells can markedly affect foetal survival to term and neonatal survival (Gibbons et al., 
2002). However, proliferating cells have also been successfully used for NT (Cibelli et 
al., 1998), although the exact stage of the donor cell cycle was never verified. Thus far, 
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only statistical probabilities on cell stage percentages in G0/G1, G2, M and S-phases 
have been provided as evidence of the cell cycle stage (Boquest et al., 1999). 
 Roscovitine or nocodazol is a cyclin dependent kinase (CDK) 2 inhibitor that 
effectively arrests fibroblasts in the G0/G1 quiescent phase of the cell cycle (Alessi et 
al., 1998) and can be used to maintain bovine oocytes at the germinal vesicle stage of 
maturation by inhibiting meiosis promoting factor, a member of the CDK family 
(Mermillod et al., 2000). Following roscovitine removal, cells arrested in G0/G1 
resumed cycling and entered the S phase as expected (Alessi et al., 1998), and oocytes 
arrested at the germinal vesicle stage progressed to metaphase II (Mermillod et al., 
2000), indicating that the effects of roscovitine were fully reversible. In the SCNT 
research, the use of cell cycle synchronised donor cell probably impacts the capacity of 
the nucleus to be reprogrammed due to the reduced transcriptional efficiency in the 
quiescent cell; however, this hypothesis has not been tested. 
 
2.6.6 Epigenetics   
Epigenetics refers to stable and heritable changes in gene expression beyond the scope 
of conventional genetics. In other words, gene expression in a cell is not controlled 
exclusively by the DNA sequence, but also by these stable “epigenetic” influences to 
specific genes (Jaenisch and Bird, 2003). In addition to their importance in 
differentiation of tissue types during development, epigenetic alterations can also arise 
randomly or as a result of environmental influence. The genome adapts to 
developmental or environmental cues either by post-synthetic modification to DNA or 
by modification of proteins associated with DNA. It is believed that epigenetic 
modifications have arisen and evolved as a genome defense against viruses and other 
parasitic sequences (Matzke et al., 1999). Cellular differentiation occurs as a 
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consequence of epigenetic modifications imposed upon the genome. These epigenetic 
modifications direct the expression patterns of cell-type-specific genes; therefore SCNT 
necessitates the reprogramming of the donor cell carrying cell-type specific epigenetic 
modifications in order for every cell type to be derived from a once-differentiated donor 
cell. It is widely believed that incomplete or improper epigenetic reprogramming 
following SCNT results in the low efficiency as well as the phenotypic problems 
observed in clones. 
 A variety of epigenetic modifications to DNA and its associated proteins have 
been characterised. These modifications can serve either to silence expression or to 
enhance transcription of specific genes. Predominant epigenetic modifications include 
DNA methylation, and modifications to histones including methylation, acetylation, 
ribosylation, phosphorylation, and ubiquitination (Glotzer et al., 1991).  
   
2.6.6.1 Epigenetic reprogramming following nuclear transfer 
Epigenetic reprogramming is essential in order for SCNT be successful. During nuclear 
reprogramming epigenetic marks are erased from the donor nucleus genome, resulting 
in an erasure of tissue-specific gene expression patterns effectively resetting the cell to a 
totipotent state (Santos and Dean, 2004). Studies evaluating the epigenetic status of 
embryos following SCNT have demonstrated deficiencies in epigenetic reprogramming 
frequently occur. These deficiencies are made manifest in several ways including 
changes in histone modifications, DNA methylation patterns, and gene expression. 
 Several studies have evaluated differences in epigenetic modifications following 
SCNT. Hypermethylation of lysine 9 on histone H3 (H3-K9) as well as DNA 
hypermethylation was reported in the majority of bovine preimplantation SCNT 
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embryos in one study (Santos et al., 2003). A number of studies evaluating the 
reprogramming dynamics of epigenetic modifications in vitro following NT have also 
been reported. Evaluation of DNA methylation patterns in developing NT embryos 
indicates demethylation and remethylation events are not always faithfully recapitulated 
in the mouse (Chung et al., 2003; Shi and Haaf, 2002) and the cow (Bordignon et al., 
2001; Dean et al., 2001). It is also clear that histone acetylation is sometimes aberrant in 
bovine SCNT embryos (Enright et al., 2003). This incomplete epigenetic 
reprogramming is the predominant explanation for the frequent aberrant gene 
expression in NT embryos and the subsequent failures in development (Santos et al., 
2003). 
 Immunofluorescent staining of bovine NT embryos with an antibody directed 
against 5-methyl-cytosine by Dean et al. (2001) demonstrated the occurrence of active 
demethylation of the donor chromatin shortly after fusion similar to the active 
demethylation of sperm chromatin observed following fertilization (Dean et al., 2001). 
However, de novo methylation occurred starting in 4-cell NT embryos as compared to 
normal bovine embryos, which exhibit de novo methylation at the 8- to 16-cell stage 
(Dean et al., 2001). The enzymes responsible for DNA demethylation may follow a 
pattern of activity similar to maturation promoting factor (MPF) with high activity prior 
to activation and a diminishing of activity following activation. Further research will be 
required to determine those dynamics, but based on one study there appears to be a 
critical window of time in which active demethylation can occur following fusion (Dean 
et al., 2001). The idea of this critical window between fusion and activation is supported 
by the work of Bourc'his et al. (2001) in which active demethylation was not observed 
when activation was performed at the time of fusion (Bourc'his et al., 2001).  
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 Other studies have focused on epigenetic reprogramming of specific genes 
following SCNT. Evaluation of methylation patterns of imprinted genes following 
SCNT indicates methylation errors at imprinted loci are common (Mann et al., 2003). In 
addition, errors in X-inactivation (Eggan et al., 2000) and failures to activate important 
pluripotency genes have been observed in SCNT embryos (Boiani et al., 2002). Critical 
errors in the fundamental epigenetic state of chromatin during early development 
following SCNT are likely the foundation for the numerous other deficiencies observed 
in clones (Fulka and Fulka, 2007). 
 The use of chromatin remodeling agents such as Trichostatin A (TSA), scriptaid 
and m-Carboxycinnamic Acid Bishydroxamide (CBHA) was reported to be able to 
improve epigenetic reprogramming during nuclear transfer (NT) (Kishigami et al., 2006; 
Nguyen et al., 2009; Dai et al., 2010). These chromatin remodeling agents function as 
histone-deacetylase inhibitor (HDACi), which enhances the pool of acetylated histones 
(Yoshida et al., 1990; Dai et al., 2010) and DNA demethylation (Hattori et al., 2004) 
which were important in modifying the epigenetic configuration.  
 
2.7 EMBRYO TRANSFER 
The first embryo transfer (ET) in goat was reported by Warwick et al. (1934). In early 
sixties, fundamental and physiological studies related to ET in small ruminant were 
performed by several famous scientists (Thibier and Guerin, 2000). Three methods of 
ET namely, laparoscopic ET, surgical ET and transcervical ET have been reported in 
small ruminants (Stefani et al., 1990; Flores-Foxworth et al., 1992) of which 
laparoscopic ET is more successful (Abdullah et al., 1995; Ishwar and Memon, 1996). 
The success of ET depends on several factors including management of recipient does, 
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oestrus synchronisation in recipients and the technical skill during transfer (Ishwar and 
Memon, 1996).   
 Developmental anomalies produced by SCNT after embryo transfer include low 
pregnancy rates, an unacceptably high level of losses during early and late pregnancy, 
stillbirths, early postnatal deaths, short life-span, obesity and malformations. The term 
most frequently used to describe some of these developmental anomalies is “large 
offspring syndrome” (LOS). Essentially, LOS refers to increased birth weight. The 
occurrence of LOS seems to be species-speciﬁc: it is quite frequent in cattle, sheep and 
mice, and some elements have also been described in humans after assisted reproductive 
procedures. However, almost no malformations were detected in pigs and goats 
(Betthauser et al., 2000; Reggio et al., 2001; Behboodi et al., 2005), although these 
results require conﬁrmation.  
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Chapter 3 
3.0 MATERIALS AND METHODS 
 
3.1 INTRODUCTION 
The main objectives of this study were to produce cloned caprine embryos and kids via 
intraspecies- and interspecies somatic cell nuclear transfer approaches (intraspSCNT 
and interspSCNT, respectively) as well as to develop nuclear transfer protocol using 
skin fibroblast cell as donor karyoplast for our laboratory. In experiments pertaining to 
caprine intraspSCNT, oocytes as recipient cytoplasts were obtained from two sources, 
namely abattoir derived ovaries and laparoscopic ovum pick-up (LOPU) from 
superstimulated does. As for caprine interspSCNT, oocytes were obtained from abattoir 
derived bovine ovaries. The ovary sample collections from abattoir for both species 
were carried out once or twice weekly, depending on the availability of females to be 
slaughtered. Oocyte retrieval via LOPU surgery was conducted once a week on either 
one or two superstimulated does in each LOPU session. All the media and reagent 
preparations, processing of abattoir and LOPU oocytes retrieval, nuclear transfer and 
embryo transfer surgeries were carried out at the Nuclear Transfer and Reprogramming 
(NaTuRe) Laboratory, Institute of Research Management and Monitoring (IPPP), 
University of Malaya. The duration of the entire caprine intraspSCNT and interspSCNT 
research was carried out in this laboratory between November 2008 and April 2011. 
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3.2 MATERIALS  
The following materials were used in this study: such as livestock ovarian and ear tissue 
samples, various equipment, chemicals, reagents and media as well as labwares and 
disposables. Each component mentioned above will be described briefly in the 
subsequent sections: 
 
3.2.1 Livestock Ovarian and Ear Tissue Samples 
Caprine and bovine oocytes were used as the recipient cytoplasts for the production of 
cloned embryos and parthenotes. While caprine, bovine and gaur ear skin tissues were 
biopsied to develop skin fibroblast cell lines that served as the donor karyoplasts for the 
SCNT research. The caprine oocytes were retrieved either by LOPU on superstimulated 
does or slicing of ovaries collected from abattoir source. On the other hand, the source 
of bovine oocytes was solely retrieved from abattoir-derived ovaries.  
 
3.2.1.1 Experimental does 
A total of 45 does were used in the present study of which 33 does were assigned for 
LOPU oocyte retrieval donors and 12 does for embryo transfer recipients. All the does 
selected for this study were represented by various breeds of caprine such as Boer 
crossbred, Jamnapari and mixed breeds (crosses among breeds namely Jermasia, 
Katjang, Boer and Jamnapari) that aged between 6 and 48 months old at the time of 
experiments. All the does used in this entire study for oocyte retrieval were kept and 
well maintained in the ISB Mini Livestock Farm, University of Malaya in accordance 
with the animal welfare guidelines. All the does were fed with a sufficient diet 
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consisting of Napier grass and pellet feed (goat/sheep pellet, KMM Berhad, Malaysia) 
and given water ad libitum. 
 
3.2.1.2 Abattoir-derived ovaries 
A total of 96 caprine ovaries and 132 bovine ovaries were obtained from the abattoir for 
oocyte retrieval. Both caprine and bovine ovaries used in this study, except for 
Experiment 1 and 3 (preliminary study for goat SCNT), were collected from Abattoir 
Complex, Department of Veterinary Services, Shah Alam, Selangor and Senawang, 
Negeri Sembilan, Malaysia, whenever the ovary samples were available. Bovine ovaries 
used in Experiment 4 were collected from Abattoir Complex Praputtabaht, Saraburi, 
Thailand as this preliminary study was conducted in Embryo Technology and Stem Cell 
Research Centre (ESRC), Suranaree University of Technology, Nakhon Ratchasima, 
Thailand (between Oct 2009 and Dec 2009). All the ovaries were transported to the 
laboratory in thermos flask (37°C) within duration of 1 to 3 hours after slaughter. The 
ovary transporting medium (Table 3.2) consisted of normal saline (0.9%; Sigma-
Aldrich Co., USA) supplemented with penicillin and streptomycin (Sigma-Aldrich Co., 
USA). The ovaries were collected from does and cows that their breed, origin, health 
condition, phases of oestrus cycle and pregnancy were unknown as the records were not 
available. 
 
3.2.1.3 Source of ear skin fibroblast cell 
Caprine ear skin fibroblast cell lines used in this study were cultured from ear skin 
tissue biopsied from caprine of Jermasia and Boer breeds reared in ISB Mini Livestock 
Farm, University of Malaya and Rumpun Asia Sdn. Bhd, Ulu Yam, Selangor.  On the 
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other hand, the bovine and gaur skin fibroblast cells were obtained from the available 
cryopreserved cell line bank developed in ESRC, Thailand. Both male and female 
caprine, bovine and gaur skin fibroblast cell lines were used as the donor karyoplast for 
the production of cloned caprine, bovine and gaur embryos, respectively. As for caprine, 
criteria for karyoplast selection was based on special characteristics such as body 
conformation and health of the donors for both sexes. 
 
3.2.2 Equipment 
The list of equipment with details such as model number, manufacturer and supplier’s 
name used in this present study are presented in Appendix Table 1.1.  The major 
equipment used comprised of autoclave, centrifuge, CO2 incubator, electrofusion 
machine, fluorescent microscope, flushing and aspiration system, freezer (-80ºC) 
inverted microscope with micromanipulators, laminar air flow work station, liquid 
nitrogen tank, microforge, micropipette grinder, micropipette puller, osmometer, oven,  
pH meter, stage warmer, stereomicroscope, surgical set, ultrapure water purification 
system and water bath. 
 
3.2.2.1 Inverted microscope and micromanipulation system features 
The core equipment for SCNT manipulation requires an inverted microscope that is 
attached with micromanipulation system. An Olympus inverted microscope (IX71; 
Olympus Optical Co., Ltd, Japan) that fitted with objective lenses (4x, 10x, 20x and 40x) 
and Hoffman modulation contrast system (Normaski system) was utilised.  This 
inverted microscope was fitted with additional features such as the transparent stage 
warmer (37°C), camera and a connection to the personal computer.  
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The hydraulic micromanipulation system used in conjunction with this microscope 
comprised of the following components: 
1) The first component consists of a set of left and right arms attached to the 
microscope stage via microscope mounting adapter (ON-IX99-2). The left and 
right arms with the universal joints (UT-21) on both side served to clench the 
stainless holding pipette and enucleation or injection pipette holder, respectively.  
2) The movements of the left and right arms are controlled by a pair of drop handle 
joysticks and a pair of motorised positioners. The drop handle joysticks through 
an oil hydraulic mechanism controlled the three-dimensional fine (X-Y-Z axes) 
positioning of the microtools. While the three-dimensional coarse movements 
were performed electrically with the motorised positioners. 
3) The holding and injection units were controlled with air. Both the units consist 
of a stainless microtool holder connected to a completely airtight syringe (3 ml) 
through the polystyrene tubing. While the enucleation pipette (squeezing needle) 
unit is attached to an electrode holder (H-7) without the need of air control. 
 
3.2.2.2 Electrofusion machine 
The donor karyoplast was introduced into the enucleated oocyte via electrofusion 
method. The needle fusion approach was adapted whereby the cell fusion system (SUT 
F-1; Suranaree University of Technology, Thailand) connected to a pair of platinum 
electrodes was used. The platinum electrodes were attached to the left and right arms of 
the micromanipulator. Both electrodes were aligned at the bottom of the petri dish 
containing fusion medium. Movement of the electrodes was controlled by the left and 
right joystick. 
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3.2.3 Chemicals, Reagents and Media 
All the solutions and media used in this research were prepared using analytical grade 
laboratory chemicals and reagents. Most of the chemicals, reagents and media used 
were purchased from Sigma-Aldrich Co., USA, unless otherwise stated. A detailed list 
of the chemicals, reagents and media with catalogue number, manufacturer’s and 
supplier’s company name is presented in Appendix Table 1.2. 
 
3.2.4 Labwares and Disposables 
In general, the main disposables used for oocyte retrieval and SCNT studies involved   
graduated test tubes, CE marked dishes for IVF (35 mm diameter), polystyrene with 
surface treated for cell culture dishes (35 and 60 mm diameter) and polystyrene with 
poly-D-lysine surface coated culture flasks (75 and 175 cm
2
 culture area). A detailed list 
of labwares and disposables with manufacturer’s name used in the study is tabulated in 
Appendix Table 1.3 
 
3.3 METHODOLOGY 
Generally, the description of the research methodology section involved 4 main 
subsections, namely: 1) The standard maintenance of research laboratory, 2) Preparation 
of stocks and media, 3) Preparation of microtools and 4) Experimental procedure. 
 
3.3.1 Standard Maintenance of Research Laboratory 
The general maintenance of a laboratory specifically related to living cell culture 
involves strict observation of cleanliness practices. In order to obtain favourable 
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outcome in any IVP endeavour, the organisation of the laboratory structure is ensured to 
be free from distraction and the risk of accident as well as the contamination 
possibilities in the laboratory are kept to the minimal level. Throughout the research, the 
following elements of aseptic practices and maintenance precaution were observed. 
 
3.3.1.1 Personal hygiene & safety 
The general practices of personal hygiene observed in the laboratory include, wearing of 
clean lab coat, appropriate face mask, hair cap and gloves (if necessary). Besides that, 
the practice of washing hand with disinfectant before and after any experiment is a must 
to reduce loosely adherent microorganisms on the skin that would otherwise be likely to 
be blown onto the culture.  
 
3.3.1.2 Work surface cleanliness and sterilisation 
Prior commencing any experiment, the surface of the working bench, laminar flow hood, 
microscopes stage and surface of any equipment were swabbed liberally with ethanol 
(70%) for sterilisation purpose. The residual traces of ethanol (70%) were allowed to 
evaporate for at least 10 to 15 minutes before commencing any of the experimental 
work. Any spillages that occurred during the experiment were wiped immediately with 
tissue paper and the surface was swabbed with ethanol (70%). Once the work completed, 
all the apparatus on the working surface were arranged back to its respective storage 
place and ultimately the entire working surfaces were swabbed again with ethanol 
(70%). In order to maintain sterility of the laminar flow hood, the ultraviolet (UV) light 
in the laminar flow hood was switched on overnight. 
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3.3.1.3 Labwares cleanliness and sterilisation 
Cleaning of all glassware and non-disposable items used in this study such as Scott 
bottles, beakers, volumetric flasks, measuring cylinders, magnetic stirrer, conical tubes 
and etc. was done scrupulously. All the used labwares were rinsed with tap water to 
remove traces of chemical before soaking in diluted detergent (7X
®
-PF) overnight. The 
labwares were brushed and rinsed thoroughly in four complete changes of tap water 
followed by three changes of deionized water or reverse osmosis (RO) water. After the 
washing process was completed, all the labwares were dried upside down in the oven 
(60°C). Dried glasswares that did not have an attached cap such as beakers, volumetric 
flasks and measuring cylinders were covered with aluminium foil. On the other hand, 
screw-cap glasswares were loosely capped (half to one turn so that they stayed on) and 
covered with aluminium foil. As for other clean-dried, non-disposable item such as 
screw-capped conical tube, the cap was loosely screwed on the top before packed in 
autoclavable bag. A piece of autoclave tape labelled with the researcher’s ID and date 
was placed on all the cleaned labwares before sterilising in the autoclave machine for 20 
to 25 minutes at 121°C, 15 psi. After sterilisation, all the labwares were dried in the 
oven before placing it in the appropriate storage cabinets which were securely covered. 
In order to prevent vacuum forming in the glass bottle after removing from the oven, the 
cap of the bottle was untightened until it was completely cooled to room temperature 
(25°C).  
 On the other hand, sterilisation for the non-autoclavable labwares such as 
polystyrene culture dishes, microtools for the SCNT procedure, oocyte collection tubes 
and mouth piece were conducted using the application of UV light for at least 2 hours 
inside the laminar flow hood.  
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3.3.1.4 Maintenance of embryo culture environment (CO2 incubator) 
The IVP of embryos in this laboratory used a chamber with CO2 (5%) in humidified air 
to maintain the correct physiological pH (pH 7.3 to 7.4) and a temperature of 38.5°C.  
The accurate calibration of incubator was ensured and monitoring of the temperature 
with an external temperature check device was conducted weekly.  
 Besides that, the cleanliness of the incubator was done monthly according to the 
regime that involved wiping the inner surface of the incubators and door with ethanol 
(70%). The residual traces of ethanol were ensured to evaporate completely before 
using the incubator. The tray and racks of the incubator were washed with mild 
detergent (7X
®
-PF) followed by a final rinse with sterile reverse osmosis (RO) water. 
Prior placing the tray and racks back into the incubator, it is important to ensure that the 
tray and all racks were completely dried and sterilised using UV light for 30 minutes. 
The tray was then filled up with sterile RO water to generate a humidified environment 
in the incubator. In order to maintain a stabilised culture environment, repeated opening 
and closing of the incubator’s door was kept to the minimum. 
 
3.3.2 Preparation of Stock Solutions and Media 
Preparation of any culture media requires accurate measurements of each chemical 
component. In order to achieve this, preparation of stock solutions in a concentrated 
form is required. The practice of stock solutions preparation also enables experimenter 
to save time and conserves materials during the subsequent weekly culture media 
preparation process. 
 Water forms the most basic and common component in all stock solution and 
medium preparation, thus it is vital to use a reliable source of treated ultrapure water. 
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All the media used in this study were prepared from scratch, using embryo or tissue 
culture-tested chemicals and water. The treated water was processed via Milli-Q
®
- RO 
Pulse pure water system that combines reverse osmosis and electrodeionisation (EDI) 
components to yield high quality surface water. Pre-filtered water first passed through 
reverse osmosis which removed 95-99% of a broad spectrum of organics, ions, bacteria, 
pyrogens and particles. Water processed through reverse osmosis was directed to an 
EDI module which used a combination of ion-exchange (IE) membranes, IE resin and 
direct current to remove ions from water. The Milli-Q
®
- RO Pluse product water was 
sent to a temporary storage reservoir in which water was recirculated for 2 hours/day 
through a 185 nm UV oxidation system which oxidised organics and destroyed bacteria 
in the stored water to reduce any inherent contamination. The reverse osmosis 
performance was monitored daily by recording the percentages of ionic rejection, feed 
and product conductivity as well as temperature. The acceptable rejection rates ranged 
from 95-99%. While EDI purification must be able to provide 10-15 MΩ-cm water with 
< 30 parts per billion (ppb) total organic carbon (TOC).  
 The Milli-Q®- RO Pluse -processed water in the storage reservoir was supplied 
to a Milli-Q® PF Plus ultrapure water system. Within the Milli-Q PF system, the water 
was further processed through purification pack which contained nuclear-grade, high 
purity, IE resin and a special organic scavenging resin. This process produced 18.2 MΩ-
cm water with organic levels < 8 ppb TOC. The ultrapure water was further purified 
through a 5000 Da hollow-fibre ultrafilter. All proteins, particles, organics and 
endotoxins (> 5000 Da) were removed as the water was processed from the exterior into 
the interior lumen of the fibres. The final polished water was then passed through a 
membrane filter (0.22 µm) to scavenge any trace particles from the water and also to 
prevent reverse bacterial contamination from incoming air from the environment.  
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 The preparation of fundamental stock solutions and media were conducted in the 
laminar air flow work station. All the chemicals in powder form were weighed using 
digital analytical balance while chemical in liquid form were measured using disposable 
plastic pipette, micropipette or measuring cylinder. In order to facilitate the dissolving 
and mixing of chemical components in the medium preparation (except medium that 
contain serum and PVP), a magnetic stirrer with moderate speed was used.   
  The fresh oocyte or embryo culture media prepared weekly or biweekly were 
subjected to pH and osmolarity measurements. The pH and osmolarity of the media 
were adjusted to 7.2 to 7.4 and 280 to 300 mOsm/kg, respectively prior use. The stock 
solutions and media were filtered once again using syringe filter (0.22 µm pore size) for 
sterility assurance prior aliquot. All the bottles or tubes that were used to keep the stock 
solution and media were labelled (Name and concentration of the media, ID of the 
personnel and date of preparation) and sealed with parafilm prior storing in the 
refrigerator (3-5°C) or freezer (-20°C) appropriately. 
  
3.3.2.1 Preparation of normal saline solution 
Normal saline solution is 0.9% (w/v) sodium chloride in water and it is also known as a 
physiological solution. The isotonic property of normal saline is suitable to prevent 
dehydration of live tissue, thus it was used for washing and collection of any tissue 
specimen in this study. Normal saline was prepared in a Scott bottle (1 litre) by 
dissolving sodium chloride (9 g) in Milli-Q water (1 litre). The normal saline solution 
was autoclaved at 115°C, 10 minutes and kept for 3 months in the refrigerator (3-5°C) 
for future use. 
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3.3.2.2 Preparation of heparinised saline solution 
In this study, heparinised saline solution is required during LOPU and embryo transfer 
surgeries. Generally, animals that undergo abdominal surgeries such as those on the 
uterus, and ovaries are prone to have adhesions as the body heals inside. Adhesions are 
bands of fibrous scar tissue that form on abdominal organs, causing the organs to stick 
to one another or to the wall of the abdomen. Thus as a preventive measure to the 
occurrence of adhesion after the LOPU and embryo transfer surgeries, heparinised 
saline solution was filled into the abdomen or pelvic area of the does before suturing the 
incised wound. The heparinised saline solution will linger in the abdominal cavity for a 
few days before it is absorbed, which prevents any major adhering. 
 The heparinised saline solution was prepared by dissolving heparin (0.05 g) in 
the autoclaved normal saline (1000 ml) as depicted in Table 3.1. The solution was 
mixed well using magnetic stirrer with moderate speed. This solution can be kept for 1 
month in the refrigerator (3-5°C) for future use. 
 
 
Table 3.1: Composition of heparinised saline solution  
Chemical component 
(catalogue number) 
Final concentration Quantity/1000 ml 
Autoclaved normal saline 1 x 1000 ml 
Heparin 
(H0777) 
7 USP/ml 0.05 g 
(Storage temperature: 3-5°C; shelf life: 1 month) 
Note: 1 mg of heparin contains 140 USP units. 
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3.3.2.3 Preparation of ovary collection medium 
Ovary collection medium (OCM) was prepared for the purpose of washing and 
collecting ovaries from abattoir. The OCM consisted of normal saline (0.9% NaCl) 
solution supplemented with penicillin G sodium salt and streptomycin sulphate salt that 
serve as antibiotic agents. In order to prepare OCM with the final volume of 1000 ml as 
depicted in Table 3.2, penicillin G sodium salt (60 µg/ml) and streptomycin sulphate 
salt (50 µg/ml) were weighed and dissolved in normal saline solution (1000 ml). Prior 
ovary collection, the required amount of OCM in use was aliquot and warmed in the 
water bath at 37-38°C. Extra OCM can be stored in the refrigerator (3-5°C) with the 
shelf life of 1 month for future use. 
 
 
Table 3.2: Composition of ovary collection medium 
Chemical component 
(catalogue number) 
Final concentration Quantity/1000 ml 
Autoclaved normal saline 1  x 1000 ml 
Penicillin G sodium salt 
(P3032)  
0.17 mM 0.06 g 
Streptomycin sulphate salt 
(S1277)  
0.07 mM 0.05 g 
(Storage temperature: 3-5°C; shelf life: 1 month) 
 
3.3.2.4 Preparation of phosphate-buffered saline solution without calcium chloride 
 and magnesium chloride, PBS(-) 
Generally, PBS(-) solution was prepared for dual purpose. It was used as diluent for the 
preparation of certain chemical stock solution as it is a form of balanced salt solution.  
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Besides that, it was used in tissue culture work for washing and suspending cells. PBS(-) 
was prepared according to the list of chemical composition depicted in Table 3.3. All 
the chemicals in powdered form were weighed and dissolved one after another, 
according to sequence in Milli-Q water dispensed in a Scott bottle (500 ml). A magnetic 
stirrer at moderate speed was used to facilitate the dissolving and mixing of the 
chemical component in the solution. The well mixed PBS(-) solution was filter-
sterilised using syringe filter (0.22 µm pore size) before use. The solution can be kept in 
the refrigerator (3-5°C) with the shelf life of not more than 3 months. 
 
 
Table 3.3: Composition of PBS(-) 
Chemical components  
(catalogue number) 
Final concentration (mM) 
 
Quantity/500 ml 
NaCl (S5886) 171   5.00 g 
KCl (P5405) 3.35  0.125 g 
Na2HPO4 (S5136) 10.1  0.72 g 
KH2PO4 (S5655) 1.84  0.125 g 
Milli-Q water - 500 ml 
(Storage temperature: 3-5°C; shelf life: 3 months) 
 
3.3.2.5 Preparation of penicillin G sodium salt and streptomycin sulphate salt stock 
 solution [100x] 
The penicillin G sodium salt and streptomycin sulphate salt (PS) stock solution with the 
concentration of 100x was prepared according to the composition presented in Table 3.4. 
The stock solution was filter-sterilised (0.22 µm pore size) before aliquot in sterile 
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microcentrifuge tubes (200 µl). PS stock solution was then stored in the freezer (-20°C) 
with the maximum shelf life of 6 months. 
 
Table 3.4: Composition of PS stock [100x] solution 
Chemical component 
(catalogue number) 
Final concentration Quantity/10 ml 
PBS(-) solution 1 x 10 ml 
Penicillin G sodium salt 
(P3032)  
168.4 mM 0.6 g 
Streptomycin sulphate salt 
(S1277)  
137.2 mM 1.0 g 
(Storage temperature: -20°C; shelf life: 6 months) 
 
3.3.2.6 Preparation of oocyte retrieval medium 
In this study, Dulbecco’s phosphate buffered saline (DPBS) supplemented with 
polyvinylpyrrolidone (PVP), average molecular weight of 360,000 (PVP-360) was used 
as oocyte retrieval (OR) medium. DPBS is a balanced salt solution supplemented with 
the buffer’s phosphate group to maintain media in the physiological pH range (7.2-7.4) 
and at the same time maintaining cell tonicity. In order to prevent oocyte from sticking 
to glass or tissue culture ware during oocyte manipulation, PVP-360 was supplemented 
as a source of surfactant. 
 In OR via LOPU procedure, this medium was used as flushing medium whereby 
microvolumes of this medium was flushed into the ovarian follicles on the surface of 
the ovary via an aspiration system (a vacuum pump) and subsequently, the follicular 
fluids containing oocyte from the follicles were aspirated into a sterile round-bottom 
test tube (15 ml) which was pre-warmed (37°C) by a test tube heating system. Each 
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collection tube was used to collect the aspirated fluids of approximately 3 ml before 
passing the tube to the embryologist for oocyte searching under the dissecting 
microscope. Similar medium was also used in OR from abattoir derived ovaries for 
rinsing and slicing ovary as well as for oocyte collection.  
  The DPBS stock solution was prepared according to the composition depicted 
in Table 3.5.  The DPBS was prepared in a one litre bottle by dissolving 10 tablets of 
DPBS (Dulbecco A, BR0014G; Oxoid Ltd., England) in one litre of Milli-Q water (one 
tablet in each 100 ml of Milli-Q water). A magnetic stirrer at moderate speed was used 
to facilitate the dissolving and mixing of the chemical component in the solution. 
Subsequently, PS [100x] stock solution (1 ml) was added and the final solution was 
filter-sterilised  (0.22 µm pore size) before kept in the refrigerator (3-5°C) with the shelf 
life of 1 month.  
   
Table 3.5: Composition of DPBS stock solution 
Chemical component 
(catalogue number) 
Final concentration  Quantity/1000 ml 
PBS tablets 
(Dulbecco A, BR0014G) 
1x 10 tablets 
PS stock [100x] 1x 1.00 ml 
Milli-Q water - 1000 ml 
(Storage temperature: 3-5°C; shelf life: 1 month) 
  
 The working solution for oocyte retrieval was prepared by adding PVP-360 
powder (0.5 g) into DPBS stock solution (500 ml) dispended in a Scott bottle (Table 
3.6). The PVP-360 was left to dissolve on its own in the DPBS stock solution without 
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any stirring motion to avoid foam formation. Thus, the preparation of oocyte retrieval 
medium was made preferably 12 hours prior use to ensure the PVP-360 was dissolved 
completely. For oocyte retrieval medium or flushing medium used in LOPU procedure, 
heparin (0.018 g) was supplemented. 
 The oocyte retrieval solution was then filter-sterilised (0.22 µm pore size) before 
using and the solution can be kept in the refrigerator (3-5°C) for future use, not more 
than 2 weeks. 
 
 
Table 3.6: Composition of oocyte retrieval medium (working solution) 
Chemical component 
(catalogue number) 
Final concentration Quantity/500 ml 
DPBS stock solution 1 x 500 ml 
PVP-360 
(Sigma, PVP-360)  
0.1%  0.50 g 
*Heparin 
(H0777) 
5 USP/ml 0.018 g 
(Storage temperature: 3-5°C; shelf life: 2 weeks) 
Note: * Heparin was only supplemented for oocyte retrieval medium used in LOPU.  
 
 
3.3.2.7 Heat-inactivation of foetal bovine serum 
Serum is known to contain growth factors, which promote cell proliferation, adhesion 
factors and antitrypsin activity, which promote cell attachment. It is also a source of 
minerals, lipids and hormones, many of which may be bound to protein. Besides that, 
serum could also regulates cell membrane permeability and serves as a carrier for lipids, 
enzyme, micronutrients and trace elements into the cell.   
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 In this study, foetal bovine serum (FBS) was used as the serum supplement in 
some of the cell culture media. The FBS originate from USA was purchased from 
Gibco® and once it arrives in the laboratory, the FBS was stored frozen (-20°C) to 
preserve the stability of components in the FBS. Since the FBS (Gibco
®
, Cat. No. 
16000-044) purchased was not heat-inactivated, pre-treatment of heat-inactivating the 
FBS was carried out in the laboratory before supplementing in the culture media. 
 The frozen FBS was thawed in the refrigerator (3-5°C) to avoid or limit the 
amount of precipitation. Any precipitate that appears after thawing may be removed by 
transferring the FBS to sterile tubes and centrifuged (400 x G) for 5 minutes. The FBS 
was heated up to 56°C for 30 minutes to destroy the heat-sensitive complement proteins. 
The purpose of this is to avoid cell lysis from an immune reaction between the serum 
proteins and the cells. During the heat-inactivation treatment, the temperature (56°C) 
and time (30 minutes) was monitored accurately to avoid denaturing other beneficial 
proteins components in the FBS. The heat-inactivated FBS was cooled to room 
temperature (25°C) prior to aliquot in sterile conical bottom tubes (50 ml). The FBS 
aliquots were stored in the freezer (-20°C) with a maximum shelf life of 6 months. Extra 
frozen-thawed aliquot tubes were stored in the refrigerator (3-5°C) to avoid repeating 
the freeze/thaw cycle. 
 
3.3.2.8 Preparation of in vitro maturation (IVM) medium 
Formulation of in vitro maturation (IVM) medium in this study was similar for both 
caprine and bovine oocytes. Fresh IVM medium that consisted of TCM-199 as base 
medium supplemented with sodium pyruvate (0.2 mM), follicle stimulating hormone (1 
µg/ml), oestradiol-17β (1 µg/ml), gentamicin sulphate salt (25 µg/ml) and FBS (10%) 
85 
 
was prepared weekly. For convenient purposes, stock solutions of the supplements were 
prepared in advance as depicted in Table 3.7. 
Table 3.7: Stock solutions for IVM medium 
Stock solution  
(catalogue number) 
Concentration 
(mg/ml) 
Method of preparation 
(Storage temperature and shelf life) 
Follicle stimulating 
hormone, FSH 
(Folltropin
®
-V) 
 
5  Folltropin
®
-V (5 mg) powder was 
dissolved in solvent (1 ml), aliquot (110 
µl) in microcentrifuge tube, sealed with 
parafilm, wrapped with aluminium foil 
and stored (-20°C) for 6 months 
 
Oestradiol-17β 
(E8875) 
 
 
1  
 
Oestradiol-17β (1 mg) was dissolved in 
sterile filtered ethanol, GR grade, 95% 
(1 ml), aliquot in cryovial, sealed with 
parafilm, wrapped with aluminium foil 
and stored (3-5°C) for 6 months 
Gentamicin sulphate salt 
(G3632) 
50  Gentamicin sulphate  salt (1 g) was 
dissolved in DPBS (20 ml), sterile 
filtered and aliquot (1 ml) in cryovial, 
sealed with parafilm, wrapped with 
aluminium foil and stored (3-5ºC) for 12 
months 
Sodium pyruvate 
(P3662) 
2.2  Sodium pyruvate (2.2 mg) was 
dissolved in TCM199 (1 ml), sterile 
filtered and aliquot in microcentrifuge 
tube (1.5 ml), sealed with parafilm, 
wrapped with aluminum foil and stored 
(3-5ºC) for 2-3 days 
  
 Generally, the working solution of the IVM medium (10 ml) was prepared a day 
prior to use as it required equilibration in a CO2 incubator (5%) for at least 4 hours. The 
TCM- 199 (8.9 ml) that served as the basal medium was measured using a disposable 
plastic pipette (10 ml) and dispensed into a sterile conical tube (15 ml). Subsequently, 
the L-Cysteine hydrochloride (0.9 mg) was weighed and added into the Tissue Culture 
Medium-199 (TCM-199). The L-Cysteine hydrochloride dissolved on its own, which 
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ultimately forms a yellow layer on the bottom of the conical tube. The medium was 
mixed by gently inverting the conical tube back and forth a few times (5x). Then, other 
stock solutions such as FSH (10 µl), sodium pyruvate (100 µl), gentamicin (5 µl) and 
heat-inactivated FBS (1 ml) were added into the conical tube as depicted in Table 3.8. 
Prior to adding oestradiol-17β, the medium was filter-sterilised using a syringe filter 
(0.22 µm pore size). The oestradiol-17β stock solution was added at the concentration 
of 1.0 µl/ml, according to the final volume of the IVM medium after filter. Finally, the 
IVM working solution was mixed gently before aliquot (5 ml/tube). The aliquot tubes 
were stored in refrigerator (3-5°C) with the maximum shelf life of 1 week. 
 
 
Table 3.8: Composition of IVM medium  
Chemical component 
(catalogue number) 
Final concentration Quantity/10 ml 
TCM-199 
(11150-059) 
Basal medium 8.9 ml 
L-Cysteine hydrochloride 
(C7477) 
0.57 mM 0.9 mg 
 
FSH stock solution 
 
5 µg/ml 
 
10 µl 
 
Sodium pyruvate stock solution 
 
22 µg/ml 
 
100 µl 
 
Gentamicin stock solution 
 
25 µg/ml 
 
5 µl 
 
FBS 
(16000-044) 
 
10 % 
 
1 ml 
 
*Oestradiol-17β 
 
1.0 µl/ml 
 
~9.5 µl  
(Storage temperature: 3-5°C; shelf life: 1 week) 
Note: * Add oestradiol-17β at the concentration of 1.0 µl/ml of the final volume after 
 filter.  
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3.3.2.9 Preparation of medium for somatic cell line production 
The process of producing somatic cell line, in particular adherent cell type and the 
establishment of cryopreserved somatic cell banking in this study require media such as 
(a) Tissue culture medium, (b) PBS(-) solution, (c) Trypsin-EDTA solution and (d) 
Freezing medium.  
 
3.3.2.9 (a) Preparation of tissue culture medium  
There are varieties of complete media formulated and available commercially for cell 
culture. Among them, Eagles’s Minimal Essential Medium (MEM) is the commonly 
used basal medium in tissue culture. In this study, α-MEM, an improved version of the 
existing MEM formula that contains additional amino acids and vitamins, as well as 
nucleosides and lipoic acid was used as the basal medium to propagate caprine ear skin 
fibroblast cell (Freshney, 2000). The nutrients in α-MEM basal medium alone are not 
sufficient to support cell growth. Thus supplementation of FBS and penicillin G/ 
streptomycin sulphate salt (PS) into the α-MEM basal medium was done to form a 
complete tissue culture medium. 
 
 (i) Tissue culture medium (stock solution)  
 The α-MEM (Cat. no.: M0644) stock solution was prepared in advance by 
dissolving one bottle of α-MEM powder (10.1 g) in Milli-Q water (1 litre). The solution 
was mixed well using magnetic stirrer (3 minutes) with moderate speed and 
subsequently, sodium bicarbonate (2.2 g) was weighed and mixed into the α-MEM 
solution as depicted in Table 3.9. The final mixture of stock solution was filter-sterilised 
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(0.22 µm pore size) and kept in the refrigerator (3-5°C) for the maximum shelf life of 3 
months. 
 
 
Table 3.9: Composition of α-MEM stock solution  
Chemical component 
(catalogue number) 
Final concentration Quantity/1000 ml 
α-MEM 
(M0644)  
Basal medium 10.1 g 
 
NaHCO3  
(S5761) 
 
26.2 mM 
 
2.2 g 
 
Milli-Q water 
 
- 
 
1000 ml 
(Storage temperature: 3-5°C; shelf life: 3 months) 
 
 
 (ii) Primary explant culture medium (working solution) 
Generally, the culture medium for primary explant culture consists of α-MEM stock 
solution supplemented with FBS (10%) and PS (Table 3.10). In the initial 5 days of 
primary explant culture, a higher concentration of antibiotics (PS, [3x]) was 
supplemented into the culture medium to prevent contamination derived from the 
biopsied tissue. Once the outgrowth of cells was observed, usually from day 5 onwards, 
the primary explant culture medium was replenished with the tissue culture medium that 
contain lower concentration of PS [1x]. Reduction in the concentration of antibiotics in 
the tissue culture medium for the subsequent cell culture is essential to minimise the 
anti-metabolic effects of the antibiotic that can cross-react with the mammalian cells. 
 All the primary explant culture media prepared were filter-sterilised using 
syringe filter (0.22 µm pore size) prior to use. These media were kept in the refrigerator 
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(3-5°C) with the shelf life of 2 weeks. The culture medium was warmed up in the water 
bath (37°C) prior feeding the cells.   
 
 
Table 3.10: Composition of primary cell culture medium  
Chemical component 
(catalogue number) 
Final concentration Quantity/100 ml 
α-MEM stock   - 90 ml 
FBS 
(16000-044) 
10% 10 ml 
 
*PS stock [100x] 
 
3x or  
1x 
 
300 µl or 
100 µl 
(Storage temperature: 3-5°C; shelf life: 2 weeks) 
Note: *PS [3x] for first 5 days of primary explant culture, PS [1x] from day 5 to 9.
   
 
 (iii) Cell line culture medium (working solution) 
The culture medium for cell line culture consisted of similar tissue culture medium 
composition mentioned above with the concentration of antibiotic (PS, [1x]) as depicted 
in Table 3.11. The cell line culture medium was filter-sterilised using syringe filter 
(0.22 µm pore size) and kept in the refrigerator (3-5°C) with the shelf life of 2 weeks. 
Prior to use, the culture medium was warmed up in the water bath (37°C). 
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Table 3.11: Composition of cell line culture medium  
Chemical component 
(catalogue number) 
Final concentration Quantity/100 ml 
α-MEM stock   - 90 ml 
FBS 
(16000-044) 
10% 10 ml 
 
PS stock [100x] 
 
1x 
 
100 µl 
(Storage temperature: 3-5°C; shelf life: 2 weeks) 
 
 
3.3.2.9 (b) Preparation of PBS(-)  
In tissue culture work, phosphate-buffered saline solution without calcium chloride and 
magnesium chloride (PBS(-)) was used for washing and suspending cells. In an 
adherent monolayer tissue culture system, calcium and magnesium ions are known to 
promote cell to cell and cell to substrate binding. In order to facilitate the disaggregation 
of cells during trypsinisation, the adherent cells were washed with PBS(-) prior to 
trypsinisation. This was done with the purpose of reducing the concentration of divalent 
cations and traces of FBS proteins that present in the tissue culture medium which 
would inhibit trypsin action. The PBS(-) was prepared according to the chemical 
composition depicted in Table 3.3. 
 
3.3.2.9 (c) Preparation of trypsin-EDTA solution 
The caprine ear skin fibroblast primary culture and cell line culture were propagated as 
an adherent monolayer. Thus, the attachment of cells to each other and to the culture 
substrate is mediated by cell surface glycoproteins and Ca
2+
. Other proteins and 
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proteoglycans derived from the cells and from the serum supplemented become 
associated with the cell surface and the surface of the substrate and facilitate cell 
adhesion. Hence, in order to dissociate cells from the substrate and to generate single 
cell suspension during subculture or cell harvesting, digestive enzyme that breakdown 
peptide bond and Ca
2+
 chelator are required. In this study, enzyme trypsin (0.25%) 
supplemented with ethylenediaminetetraacetic acid (EDTA) that chelates Ca
2+
 was used. 
 Trypsin (0.5 g) was first dissolved in the PBS(-) solution (200 ml) and 
subsequently, EDTA (0.08 g) was added. The solution was mixed well using magnetic 
stirrer before adding penicillin G/streptomycin sulphate (PS) stock (200 µl) (Table 3.12). 
The final solution was filter-sterilised using syringe filter (0.22 µm pore size) before 
kept in the refrigerator (3-5°C) for future use with the shelf life of 1 month.  
 
 
Table 3.12: Composition of trypsin-EDTA solution  
Chemical component 
(catalogue number) 
Final concentration Quantity/200 ml 
Trypsin  
(T4799) 
0.25% 0.5 g 
 
EDTA 
(E9884) 
 
 
1.37 mM 
 
0.08 g 
PBS(-) solution - 200 ml 
 
PS stock [100x] 
 
1x 
 
200 µl 
(Storage temperature: 3-5°C; shelf life: 1 month) 
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3.3.2.9 (d) Preparation of freezing medium 
Cryopreservation is an important process in tissue culture whereby cells or whole 
tissues are preserved by cooling to low sub-zero temperatures such as -196°C in the 
liquid nitrogen for long term storage purposes. Generally, the cryopreservation medium 
or freezing medium is formulated to contain cryoprotectants. Cryoprotectants such as 
ethylene glycol, dimethyl sulfoxide (DMSO), glycerol, and sucrose could help to reduce 
cryo-injuries on the cells due to extracellular ice formation, dehydration and 
intracellular ice formation.  
 In this study, freezing medium was prepared by supplementing DMSO (10%) 
into the tissue culture medium used for cell line propagation (Table 3.13). The freezing 
medium was prepared fresh on the day of cryopreservation with the amount just 
sufficiently to cater the amount of cell to be cryopreserved. Preparation of freezing 
medium in mass volume is not encouraged as the shelf life is short (5 days) kept in the 
refrigerator (3-5°C).  
 
 
Table 3.13: Composition of freezing medium  
Chemical component 
(catalogue number) 
Final concentration Quantity/50 ml 
Tissue culture medium  
(working solution + PS [1x]) 
- 45 ml 
 
DMSO  
(D5879) 
 
10% 
 
5 ml 
(Storage temperature: 3-5°C; shelf life: 5 days) 
 
 
 
93 
 
3.3.2.10 Preparation SCNT manipulation media  
The general SCNT procedure involves three steps: enucleation of the oocyte (recipient 
cytoplast), insertion of donor cell (via sub-zonal injection followed by electrofusion) 
and the activation of reconstructed embryo.  A series of media such as hyaluronidase 
solution, oocyte holding solution at normal air environment (EmCare
®
), Cytochalasin B, 
incubated-oocyte holding solution (used in 38.5°C, 5% CO2), fusion medium and 
activation chemical are required on the day of experiment to reconstruct the embryo 
according to the three main steps mentioned above.  
 
 
3.3.2.10 (a) Preparation of hyaluronidase solution 
Hyaluronidase is an enzyme used to denude or remove cumulus cells from COCs after 
in vitro maturation in this study. The hyaluronidase solution (0.2%) was prepared by 
dissolving bovine testes-derived hyaluronidase powder (0.1 g) in mDPBS with PVP-360 
solution (50 ml) as depicted in Table 3.14. The prepared solution was filter-sterilised 
using syringe filter (0.22 µm pore size), aliquot (150 µl) in microcentrifuge tubes and 
stored for 6 months in freezer (-20°C). 
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Table 3.14: Composition of hyaluronidase solution 
Chemical component 
(catalogue number) 
Final concentration Quantity/50 ml 
Hyaluronidase  
(H4272) 
0.2% 0.1 g 
 
PVP-360 
 
 
0.1%  
 
0.05 g 
mDPBS  1x 50 ml 
(Storage temperature: -20°C; shelf life: 6 months) 
 
 
3.3.2.10 (b) Oocyte holding solution at normal air environment 
Commercially available EMCARE
TM
 holding solution manufactured by ICPbio 
Reproduction, New Zealand was used as a holding solution for oocyte and embryo at 
normal air environment. According to the description adapted from the product 
factsheet, this solution consist of optimised nutritional composition that enhances 
embryo development, MOPS buffer, New Zealand-origin bovine albumin that serve as 
protective surfactant and energy source, as well as kanamycin sulphate antibiotic. 
 The EMCARE
TM
 holding solution was aliquot (10 ml) in conical tube (15 ml) 
and stored in the refrigerator (3-5°C) for 6 months or according to the expiry date 
printed on the product label. The oocyte holding solution was warmed in the water bath 
(37°C) prior to use.  
 
3.3.2.10 (c) Preparation of cytochalasin B solution 
Cytochalasin B (CB) is a cell-permeable mycotoxin isolated from Drechslera 
dematoidea. It acts as an inhibitor of microfilament formation by preventing actin 
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polymerisation. Thus it was used in the oocyte enucleation step as a cytoskeletal 
relaxant agent to prevent ooplasm lysis and damage during this procedure. 
 
(i) Cytochalasin B stock solution  
The CB stock solution was prepared in advance by dissolving CB powder (1 mg) in 
DMSO (1 ml) as depicted in Table 3.15. The stock solution was mixed well by gently 
pipetting in and out before aliquot (10 µl) into microcentrifuge tubes (1.5 ml). The 
aliquot tubes were wrapped with aluminium foil before keeping in the freezer (-20°C) 
with the shelf life of 6 months. 
 
Table 3.15: Composition of cytochalasin B stock solution 
Chemical component 
(catalogue number) 
Final concentration Quantity/1 ml 
Cytochalasin B  
(C6762) 
1 mg/ml 0.001 g 
DMSO 
(D5879) 
- 1 ml 
(Storage temperature: -20°C; shelf life: 6 months) 
 
(ii) Cytochalasin B working solution  
The CB working solution was prepared by diluting the defrosted stock solution (10 µl) 
with EmCare
®
, oocyte holding solution (990 µl) as shown in Table 3.16. This procedure 
was carried out just before the preparation of micromanipulation dish.  
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Table 3.16: Composition of cytochalasin B working solution 
Chemical component 
(catalogue number) 
Final concentration Quantity/1 ml 
Cytochalasin B stock solution 
 
10 µg/ml 10 µl 
EmCare
®
 solution - 990 µl 
 
 
3.3.2.10 (d) Preparation of incubated-oocyte holding solution 
In order to avoid the exposure of oocytes to the room temperature too long during the 
SCNT manipulation procedure, batches of manipulated oocytes were kept in the 
incubator (38.5°C, 5% CO2 in air) at the interval of conducting the oocyte enucleation, 
donor cell insertion and activation of reconstructed embryo procedure.  
 TCM-199 supplemented with FBS (10%) was used as the oocyte holding 
solution (Table 3.17) under the incubated environment (38.5°C, 5% CO2 in air). The 
incubated-oocyte holding solution was filter-sterilised using syringe filter (0.22 µm pore 
size). Prior to use, the incubated-oocyte holding solution was equilibrated at least 3 
hours in the incubator (38.5°C, 5% CO2 in air). 
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Table 3.17: Composition of incubated-oocyte holding solution 
Chemical component 
(catalogue number) 
Final concentration Quantity/5 ml 
TCM-199 - 4.5 ml 
FBS  
(16000-044) 
10% 0.5 ml 
(Storage temperature: 3-5°C; shelf life: 1 week) 
 
 
 
3.3.2.10 (e) Preparation of fusion solution 
The donor cell (donor karyoplast) was introduced into the enucleated oocyte (recipient 
cytoplast) via sub-zonal injection followed by fusion. Fusion of the karyoplast-cytoplast 
couplets were accomplished by electrical stimulation in a medium that is non-ionic and 
slightly hypotonic. In this study, Zimmermann’s fusion medium (ZFM) formulated by 
Zimmermann and Vienken (1982) was used. ZFM was prepared according to the 
chemical composition depicted in Table 3.18. The ZFM was filter-sterilised using 
syringe filter (0.22 µm pore size) and kept in the refrigerator (3-5°C) with the shelf life 
of 3 months. Prior to use, the ZFM solution was warmed to 37°C in the water bath.  
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Table 3.18: Composition of ZFM solution 
Chemical component 
(catalogue number) 
Final concentration Quantity/125 ml 
Sucrose 
(S7903) 
0.28 mM 11.98 g  
 
Mg(C2H3O2)2.4H2O 
 
0.5 mM 
 
  0.0134 g 
(M0631) 
 
Ca(C2H3O2)2 
 
 
0.1 mM 
 
 
  0.002 g 
(C4705) 
 
K2HPO4 
 
 
1.0 mM 
 
 
  0.0218 g 
(P3786) 
 
L-Glutathione 
(G4251) 
 
 
0.1 mM 
 
 
  0.0039 g 
 
BSA-V 
(A6003) 
 
0.001% 
 
  0.0013 g 
 
Milli-Q 
 
- 
 
125 ml 
(Storage temperature: 3-5°C; shelf life: 3 months) 
 
  
3.3.2.10 (f) Preparation of activation medium 
Oocyte activation is a process that occurs in order to enable oocyte exit from the MII 
arrest. In physiological condition, sperm entry initiates oocyte activation by inducing 
intracellular calcium (Ca
2+
) oscillation. After a few hours, a series of biochemical events 
make fertilisation complete, through the inactivation of maturation promoting factor 
(MPF) and of mitogen-activated protein kinase (MAPk) that leads to resumption and 
completion of meiosis, DNA synthesis and pronuclei formation. However, in nuclear 
transfer (in the absence of sperm), artificial oocyte activation procedure that closely 
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mimic normal fertilisation such as mechanical, chemical or physical stimuli that elicit 
one or several Ca
2+
 transients are required. In this study, chemical activation procedure 
was incorporated. There are several chemical that could be used as activation agents 
such as calcium ionophore (CaI), Ionomycin, 7% ethanol (EtOH), cycloheximide 
(CHX), cytochalasin D (CD) and strontium chloride (SrCl). Some of these activation 
chemicals can be used singly or in combinations of two or more. Two chemical 
activation protocols were used in this study namely: 
 Protocol A: EtOH [7%] (5 min) followed with CD [1.25 µg/ml] + CHX [10 
          µg/ml] (5 h); for gaur interspSCNT, caprine interspSCNT, bovine 
          intraspSCNT and PA embryos production 
 
 Protocol B: CaI [5 µM] (5 min) followed with 6-DMAP [2 mM ] (4 h),  
        developed by Shen et al. (2008); for caprine intraspSCNT,   
        interspSCNT and PA embryos production 
 
(i) Preparation of ethanol solution (7%) 
Ethanol (EtOH; 7%), is one of the oocyte activation agents that promotes the formation 
of inositol 1,4,5-trisphosphate (IP3) and the influx of extracellular Ca
2+
. The exposure of 
matured oocytes to EtOH (7%) is reported to be (5-7 minutes) effective in inducing 
successful activation and pronuclear formation (Presicce and Yang, 1994). The EtOH 
(7%) was prepared by diluting absolute EtOH (70 µl) with oocyte holding solution, 
EmCare
®
 (930 µl) as depicted in Table 3.19. The EmCare
®
 solution was pre-warmed in 
a water bath (37°C) before diluting the absolute EtOH,   
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Table 3.19: Composition of EtOH (7%) solution  
Chemical component 
(catalogue number) 
Final concentration Quantity/ 1ml 
Absolute EtOH 
 
7% 70 µl 
EmCare
®
 - 930 µl 
EtOH: Ethanol. 
 
(ii) Preparation of cytochalasin D solution 
Cytochalasin D is a cell permeable fungal toxin that inhibits actin polymerisation. Thus, 
it may function to prevent the release of second polar body after activation of the 
matured oocytes by disrupting the spindle formation (Sun et al., 2001). 
 
(ii.a) Preparation of cytochalasin D stock solution 
The initial CD stock solution (1
st
 stock) with the concentration of 1 mg/ml was prepared 
by dissolving CD powder (1 mg) with DMSO (1 ml) as shown in Table 3.20. A serial 
dilution of this CD stock solution to the concentration of 0.1 mg/ml (2
nd
 stock) was 
done by mixing the CD 1
st
 stock solution (0.5 ml) with TCM-199 (5 ml) as depicted in 
Table 3.21. The CD 2
nd
 stock solution was aliquot (12.5 µl) into microcentrifuge tubes 
(1.5 ml) wrapped with aluminium foil and stored in the freezer (-20°C) with the shelf 
life of 3 months. 
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Table 3.20: Composition of cytochalasin D 1
st
 stock solution 
Chemical component 
(catalogue number) 
Final concentration Quantity/ 1ml 
Cytochalasin D 
(C8273) 
1 mg/ml 0.001 g 
DMSO 
(D5879) 
- 1        ml 
(Storage temperature: -20°C; shelf life: 6 months) 
 
 
Table 3.21: Composition of cytochalasin D 2
nd
 stock solution 
Chemical component 
(catalogue number) 
Final concentration Quantity/ 5 ml 
CD (1
st 
 stock) 
(C8273) 
0.1 mg/ml 0.5 ml 
TCM-199 
(11150-059) 
- 4.5 ml 
(Storage temperature: -20°C; shelf life: 3 months) 
CD: cytochalasin D. 
 
(iii) Preparation of cycloheximide solution 
Cycloheximide (CHX) is an antibiotic produced by Streptomycin griseus. CHX is 
known to be a protein synthesis inhibitor that activates mammalian oocytes by blocking 
the continuous synthesis of cyclin B that is required to stimulate the cell cycle protein 
kinase CDK 1 (Moses and Kline, 1995).  
 
(iii.a) Preparation of cycloheximide stock solution 
The CHX stock solution was prepared by dissolving CHX powder (5 mg) in TCM-199 
solution (5 ml) as depicted in Table 3.22. The stock solution was aliquot (10 µl) into 
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microcentrifuge tubes (1 ml) wrapped with aluminium foil and stored in the freezer (-
20°C) with the shelf life of 3 months. 
 
Table 3.22: Composition of cycloheximide stock solution 
Chemical component 
(catalogue number) 
Final concentration Quantity/ 5 ml 
Cycloheximide 
(C7698) 
1 mg/ ml  0.005 g 
TCM-199 
(11150-059) 
- 5 ml 
(Storage temperature: -20°C; shelf life: 3 months) 
 
(iv) Preparation of cytochalasin D – cycloheximide working solution 
The CD-CHX working solution was prepared fresh on the day of experiment by mixing 
the CD 2
nd
 stock solution and CHX stock solution with IVC medium. This activation 
protocol was used in gaur interspSCNT experiment, thus the IVC medium that was used 
to dilute the CD-CHX stock was modified synthetic oviductal fluid (mSOF) as depicted 
in Table 3.23. Prior to use, CD-CHX solution was equilibrated in the incubator (5% 
CO2, 38.5°C) for a least 4 hours. 
 
Table 3.23: Composition of CD- CHX working solution 
Chemical component 
(catalogue number) 
Final concentration 
(µg/ml) 
Quantity  
(µl) 
CD (2
nd
 stock) solution 
 
 1.25    12.5  
CHX stock solution 10.0    10.0  
IVC medium - 977.5  
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(v) Preparation of calcium ionophore solution 
Calcium ionophore (CaI) promotes the release of intracellular Ca
2+
 and also facilitates 
the influx of extracellular Ca
2+
 (Kline and Kline, 1992).  
 
(v.a) Calcium ionophore stock solution 
The calcium ionophore (CaI) stock solution [500 µM] was prepared by dissolving CaI 
powder (0.001 g) in DMSO (3.82 ml) as depicted in Table 3.24. The CaI stock solution 
was aliquot (10 µl) in microcentrifuge tubes (1.5 ml), wrapped with aluminium foil and 
kept in the freezer (-20°C) for the shelf life of 3 months.  
 
 
Table 3.24: Composition of calcium ionophore stock solution 
Chemical component 
(catalogue number) 
Final concentration Quantity 
Calcium ionophore  
(C7522) 
500 µM 0.001 g 
DMSO 
(D5879) 
- 3.82 ml 
(Storage temperature: -20°C; shelf life: 3 months) 
 
 
(v.b) Calcium ionophore working solution 
The CaI stock solution (10 µl) was defrosted in room temperature prior subjected to 
dilution with IVC medium (990 µl) as depicted in Table 3.25. The final concentration of 
CaI working solution was 5 µM and this working solution must be equilibrated in the 
incubator (38.5°C, 5% CO2 in air) at least 4 hours prior to use.  
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Table 3.25: Composition of calcium ionophore working solution 
Chemical component 
(catalogue number) 
Final concentration Quantity/1 ml 
Calcium ionophore stock solution 5 µM 10 µl 
IVC medium - 990 µl 
 
 
(vi) Preparation of 6-dimethylaminopurine (6-DMAP) solution 
6-dimethylaminopurine (6-DMAP) is a kinase inhibitor that was usually used after a 
brief exposure of the oocytes to CaI, in order to generate a persistent kinase inactivation.  
 
(vi.a)  6-dimethylaminopurine (6-DMAP) stock solution 
6-DMAP stock solution [0.2 M] was prepared by dissolving 6-DMAP powder (0.1 g) in 
Milli-Q water (3.08 ml) as shown in Table 3.26.  The stock solution was aliquot (10 µl) 
in microcentrifuge tubes (1.5 ml), wrapped with aluminium foil and stored in the freezer 
(-20°C) with the shelf life of 6 months. 
 
Table 3.26: Composition of 6-DMAP stock solution 
Chemical component 
(catalogue number) 
Final concentration Quantity 
6-DMAP  
(D2629) 
0.2 M 0.1 g 
Milli-Q water - 3.08 ml 
(Storage temperature: -20°C; shelf life: 6 months) 
6-DMAP: 6-dimethylaminopurine. 
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(vi.b)  6-dimethylaminopurine working solution 
The 6-DMAP stock solution (10 µl) was defrosted at room temperature (25°C) prior 
subjected to dilution with IVC medium (990 µl) as depicted in Table 3.27. The final 
concentration of 6-DMAP working solution was 2 mM and this working solution must 
be equilibrated in the incubator (38.5°C, 5% CO2 in air) at least 4 hours prior to use.  
 
 
Table 3.27: Composition of 6-DMAP working solution 
Chemical component 
(catalogue number) 
Final concentration Quantity/ 1ml 
6-DMAP stock solution 
 
2 mM 10 µl 
IVC medium - 990 µl 
6-DMAP: 6-dimethylaminopurine. 
 
3.3.2.11 Preparation of in vitro culture medium 
There were two different in vitro culture (IVC) media used in this study that incorporate 
either the basal medium of modified synthetic oviduct fluid (mSOF) or potassium 
simplex optimisation medium with amino acid (KSOMaa). The mSOF medium was 
used to culture both gaur, bovine and caprine cloned embryos, while KSOMaa was used 
only in the caprine intraspSCNT and interspSCNT study. 
 
3.3.2.11(a) Preparation of modified synthetic oviduct fluid medium 
Synthetic oviduct fluid (SOF) medium was originally formulated by Tervit et al. (1972) 
and further modification of this medium (mSOF) was done by Takahashi and First 
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(1992). As culture medium need to be freshly prepared weekly or biweekly with 
accurate but time consuming measurements, hence stock solutions in a concentrated 
form (10x) was prepared for the convenient purpose of the subsequent working solution 
(1x) preparation procedure (Nagy et al., 2003). 
 
(i) Preparation of modified synthetic oviduct fluid stock solution 
All the components, except phenol red were weighed accordingly to the measurements 
depicted in Table 3.28 using a digital balance and contained in a measuring cylinder 
(100 ml). Ultrapure Milli-Q water (approximately 40 ml) was added to dissolve the 
chemical components and followed by the addition of phenol red (0.5%) solution. The 
entire solution was mixed well using the magnetic stirrer at a moderate speed. Then 
ultrapure water was added again to make the final volume (50 ml). The resulting mSOF 
stock medium was filter-sterilised using syringe filter (0.22 µm pore size), stored in 
screw cap bottle (50 ml) for a shelf life of 1 month. 
Table 3.28: Composition of modified synthetic oviduct fluid stock solution [10x] 
Chemical component 
(catalogue number) 
Concentration at 1x  
(mM) 
Quantity/50 ml 
NaCl (S5886) 107.70  3.1470 g 
KCl (P5405)      7.16  0.2669 g 
KH2PO4 (P5655)     1.19  0.0810 g 
Phenol red, 0.5% (P0290) - 500 µl 
CaCl2.2H2O (C7902)     1.71  0.1257 g 
MgCl2.6H2O (M2393)     0.49  0.0498 g 
Milli-Q water - ~49.50 ml 
(Storage temperature: 3-5°C; shelf life: 1 month) 
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(ii) Preparation of modified synthetic oviduct fluid working solution 
The mSOF working solution at 1x concentration was prepared by supplementing mSOF 
stock solution [10x] with chemical components as depicted in Table 3.29. The mSOF 
stock solution (5 ml) was dispensed into a measuring cylinder (100 ml). Subsequently, 
Milli-Q water (20 ml) was added into the measuring cylinder. The sodium pyruvate, L-
glutamine, sodium bicarbonate were weighed and added into the solution. Subsequently, 
sodium lactate syrup, BME and MEM were added into the solution using micropipette. 
The mSOF working solution was top up with Milli-Q water to the final volume of 50 ml. 
The entire solution was mixed well using magnetic stirrer at a moderate speed prior 
subjecting to filter-sterilisation (0.22 µm pore size). The resulting mSOF working 
solution was kept in screw cap bottle (100 ml) with shelf life of 1 month in the 
refrigerator (3-5°C). 
 
Table 3.29: Composition of modified synthetic oviduct fluid working solution  
Chemical component 
(catalogue number) 
Final concentration   Quantity/50 ml 
mSOF stock solution [10x] 1x 5 ml 
Sodium pyruvate (P4562) 0.33 mM 0.0018 g 
L-Glutamine (G3126) 1  mM 0.0073 g 
NaHCO3 (S5761) 25.1 mM 0.1053 g 
Na-Lactate (L7900) 2.83 mM 23.5 µl 
BME amino acids solution [50x] (B6766) 1x 1 ml 
MEM non-essential amino acids solution 
[100x] (M7145) 
1x 0.5 ml 
Milli-Q - ~43.48 ml 
PS stock [100x] 1x 50 µl 
(Storage temperature: 3-5°C; shelf life: 1 month) 
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 The final IVC medium was prepared by adding BSA-V (0.003 g) into the mSOF 
working solution as depicted in Table 3.30. The final IVC medium was kept in conical 
tube (15 ml) with the shelf life of 1 week in the refrigerator (3-5°C). Prior to use, the 
IVC medium was equilibrated in the incubator (5% CO2, 38.5°C) for a least 4 hours by 
loosening the cap of the tube. 
 
Table 3.30: Composition of in vitro culture medium-mSOF base 
Chemical component 
(catalogue number) 
Final concentration Quantity/ 10 ml 
mSOF working solution  
 
1x 10 ml 
BSA-V (A6003) 0.3% 0.03 g 
(Storage temperature: 3-5°C; shelf life: 1 week) 
 
3.3.2.11(b) Preparation of potassium simplex optimisation medium with amino 
         acid 
Potassium simplex optimisation medium (KSOM) was originally formulated by Lawits 
and Biggers (1993) using a computer model. Further modification on this medium was 
done with the supplementation of amino acids (KSOMaa) by Biggers et al. (2000). In 
this study, two types of KSOMaa base culture media were used: 
(a) KSOMaa A- classical/standard KSOMaa 
(b) KSOMaa B- KSOMaa supplemented with glucose (2.78 mM final concentration) 
 The KSOMaa B was a modification of KSOMaa and the effect of 
supplementation of glucose in KSOMaa B was part of the experimental design to 
improve the blastocyst rate of the caprine cloned embryos. 
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(i) Preparation of potassium simplex optimisation medium with amino acid stock          
    solution 
In each batch of KSOMaa stock solution preparation, usually 100 ml of the medium was 
prepared. All the chemical components in powdered form were weighed and added into 
a measuring cylinder contained Milli-Q water (50 ml) according to the sequence shown 
in Table 3.31. The sodium lactate (0.186 ml) was added into the solution (50 ml) using a 
micropipette (200 µl). Then the entire solution was mixed well using magnetic stirrer at 
a moderate speed before filter-sterilised (0.22 µm pore size). The resulting KSOMaa 
stock solution was dispensed into a screw cap bottle (100 ml) and kept in the 
refrigerator (3-5°C) with the shelf life of 1 month. 
Table 3.31: Composition of KSOMaa stock solution 
Chemical component 
(catalogue number) 
Final concentration  
(mM) 
Quantity/100 ml 
NaCl (S5886) 95.0   0.5553 g 
KCl (P5405)  2.50   0.0186 g 
KH2PO4 (P5655) 0.35   0.0048 g 
MgSO4 (M7506) 0.20   0.0024 g 
Na Lactate, 60% syrup (L7900) 10.0   0.1860 ml 
Sodium pyruvate (P4562) 0.20   0.0022 g 
D-Glucose (G6152) 0.20   0.0036 g 
NaHCO3 (S5761) 25.0   0.2101 g  
CaCl2 (C5670) 1.71   0.0190 g 
L-Glutamine (G3126) 1.0     0.0146 g 
EDTA (E9884) 0.01   0.0004 g 
Milli-Q water - 99.814 ml 
(Storage temperature: 3-5°C; shelf life: 1 month) 
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(ii) Preparation of potassium simplex optimisation medium with amino acid working          
    solution 
There were two types of KSOMaa base-IVC medium used in this study, which namely: 
(a) KSOMaa A- classical/standard KSOMaa 
(b) KSOMaa B- KSOMaa supplemented with glucose (2.78 mM final concentration) 
KSOMaa A and B were used as the IVC media in the two-step culture system of the 
cloned caprine embryos. The chemical composition of KSOMaa A was depicted in 
Table 3.32. KSOMaa A and 20 ml of the medium was prepared each time. 
 KSOMaa B was prepared by supplementing KSOMaa A (10 ml) with glucose 
(0.0046 g) at the final concentration of 2.78 mM (Table 3.33). Using only one syringe-
filter (0.22 µm pore size), the resulting KSOMaa A was first filter-sterilised followed by 
KSOMaa B. Both media was kept in the refrigerator (3-5°C) with the shelf-life of 1 
week. Prior to use, the IVC medium was equilibrated in the incubator (5% CO2, 38.5°C) 
for a least 4 hours by loosening the cap of the tube. 
 
 
Table 3.32: Composition of in vitro culture medium-KSOMaa A 
Chemical component 
(catalogue number) 
Final concentration Quantity/ 20 ml 
KSOMaa stock solution  
 
1x 20 ml 
BSA-V (A6003) 0.4% 0.08 g 
MEM non-essential amino acids 
solution [100x] (M7145) 
- 100 µl 
BME amino acids solution [50x] 
(B6766) 
- 200 µl 
(Storage temperature: 3-5°C; shelf life: 1 week) 
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Table 3.33: Composition of in vitro culture medium-KSOMaa B 
Chemical component 
(catalogue number) 
Final concentration Quantity/ 10 ml 
KSOMaa A solution 
 
1x 10 ml 
D-Glucose (G6152) 2.78 mM 0.0046 g 
(Storage temperature: 3-5°C; shelf life: 1 week) 
 
3.3.2.12 Preparation of nucleic acid staining solution 
In this present study, nucleic acid staining was conducted to determine the location of 
first polar body and oocyte nucleus of matured caprine oocyte subjected to in vitro 
maturation (IVM) at different durations and to determine the total cell number in the 
cloned and parthenogenesis blastocysts. In order to carry out the nucleic acid staining, 
fixative solution and Hoechst 33342 were prepared.  
 Fixative solution was used to preserve the biological material or morphology of 
the oocyte and blastocyst after staining. For the ease of observation and evaluation, the 
stained specimens were kept for several weeks in order to view them under the 
fluorescent microscope in one session. 
 Hoechst 33342 or bisBenzimide was used to stain the oocytes and blastocyst 
after fixation. Hoechst 33342 is a blue fluorescent dye that used to stain DNA. This dye 
bind to the minor groove of double stranded DNA with a preference for sequences rich 
in adenine and thymine. Hoechst 33342 dye is cell-permeable and can bind to DNA in 
live or fixed cells.  
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3.3.2.12 (a) Preparation of fixative solution 
Typically, the fixative solution was prepared by mixing PBS(-) with formaldehye, PVP-
40 and glutaraldehyde according to the sequence and concentration shown in Table 3.34. 
The PVP-360 was left to dissolve on its own without any stirring motion to avoid foam 
formation. After the PVP-40 was completely dissolved, the solution was mixed by 
gently inverting the conical tube (15 ml) containing the solution back and forth a few 
times (5x). The resulted fixative solution in the conical tube was wrapped with 
aluminium foil and stored in refrigerator (3-5°C) for the shelf life of 6 months. 
Table 3.34: Composition of fixative solution  
Chemical component 
(catalogue number) 
Final concentration Quantity/ 10 ml 
PBS(-) solution 1x ~9.78 ml 
Formaldehyde (40%) 
(F8775) 
0.8% 200 µl 
Polyvinylpyrolidone-40 
(Sigma PVP-40) 
0.1% 0.01 g 
Glutaraldehyde (25%) 
(G5882) 
0.06% 25 µl 
(Storage temperature: 3-5°C; shelf life: 6 months) 
 
3.3.2.12 (b) Preparation of Hoechst 33342 dye  
Hoechst 33342 stock solution was prepared according to the chemical composition 
depicted in Table 3.35. The Hoechst 33342 powder was dissolved in PBS(-) by gently 
inverting the conical tube (15 ml) containing the solution back and forth a few times 
(10x). The resulting Hoechst 33342 stock solution was aliquot (100 µl) in 
microcentrifuge tube (1.5 ml), wrapped with aluminum foil and kept in the refrigerator 
(3-5°C) for the shelf life of 6 months. 
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Table 3.35: Composition of Hoechst 33342 stock solution 
Chemical component 
(catalogue number) 
Final concentration Quantity/ 10 ml 
PBS(-) 1x 10 ml 
Hoechst 33342  
(B2261) 
0.025% 0.0025 g 
(Storage temperature: 3-5°C; shelf life: 6 months) 
 After the preparation of Hoechst 33342 stock solution, Hoechst 33342 working 
solution was prepared by adding Hoechst 33342 stock solution (100 µl) with PBS(-) 
(900 µl) in a conical tube (15 ml) using micropipette. The solution was mixed well 
before supplemented with glycerol (1 ml) as depicted in Table 3.36. The working 
solution was aliquot (1 ml) into microcentrifuge tubes (1.5 ml), wrapped with 
aluminium foil and kept in the refrigerator (3-5°C) for the shelf life of 6 months.  
 
Table 3.36: Composition of Hoechst 33342 working solution  
Chemical component 
(catalogue number) 
Final concentration Quantity/ 2 ml 
Hoechst 33342 stock solution 0.0025% 0.1 ml 
PBS(-) solution 1x 0.9 ml 
Glycerol (G2025) - 1 ml 
(Storage temperature: 3-5°C; shelf life: 6 months) 
 
3.3.3 Preparation of Mouth pipette assembly  
Mouth pipette assembly is a device used for all oocyte and embryo handling in this 
study. The mouth pipette assembly used in this study was prepared using a 200 µl tip (as 
an aspirator mouthpiece), silicone tubing, a syringe filter (0.22 µm pore size), a 1000 µl 
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tip (as Pasteur pipette holder) and a Pasteur pipette pulled on a flame to create a narrow 
opening (Figure 3.1).  
 Generally, when using the mouth-controlled pipette for oocytes or embryo 
handling, clean medium was first aspirated into the capillary before picking up embryos. 
This was an important precaution taken to reduce the capillary action that draws the 
embryos into the pipette and may causes embryo losses. It also helps to avoid accidental 
expelling of air bubbles when embryos were released from the capillary.   
 
 
 
 
 
 
 
 
3.3.3.1 Cleaning and sterilisation of Pasteur pipette 
The glass Pasteur pipette were rinsed thoroughly with RO water (3 times) before 
soaking overnight in the RO water. After 24 hours, the Pasteur pipettes were rinsed with 
Milli-Q water (5 times) before heat drying in the oven (56°C) for 1 to 2 days. The dried 
Pasteur pipettes were packed in the autoclave bag before sterilising in the autoclave 
machine (20 to 25 minutes at 121°C, 15 psi). The sterile Pasteur pipettes were dried in 
the oven before using. 
Figure 3.1: Preparation of mouth pipette assembly. (i) Original photograph; (ii) Labelled   
                   photograph (adapted from Nagy et al., 2003). 
i ii 
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3.3.3.2 Preparation of Mouthpiece-controlled pipette 
The mouthpiece-controlled pipette was prepared by narrowing the inner diameter of the 
existing glass Pasteur pipette to the appropriate diameter (160 to 180 µm for oocyte and 
embryos; 330 to 350 µm for COC). The tapered section of the Pasteur pipette was 
subjected to a fine spirit burner flame in a rotating motion until the glass softened 
(Figure 3.2). Once the glass softened, the Pasteur pipette was immediately withdrawn 
from the heat and in a speed second, both ends of the Pasteur pipette were pulled 
smoothly to the opposite direction. Both ends were held steady for a few seconds, until 
the capillary segment has cooled and the capillary was broken by a sharp pull in the 
opposite directions. The thinned portion of the Pasteur pipette was scribed with a 
diamond stone at the point in which the diameter suits the need of the usage. 
Subsequently, the scribe point was snapped gently and the diameter of the resulting 
mouthpiece-controlled pipette was examined under the microscope. Prior to use, the tip 
of the mouthpiece-controlled pipette was fire-polished by a quick touch of the tip to the 
flame. 
 
 
 
 
 
 
 
 
Figure 3.2: Preparation of mouthpiece-controlled pipette. (i) Original photograph;   
                  (ii) procedure for drawing micropipette (adapted from Rafferty, 1970). 
i ii 
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3.3.4 Preparation of microtools for SCNT manipulation  
Microtools such as holding pipette, enucleation needle and injection pipette were 
prepared in-house for SCNT manipulation. The microtools were prepared using thin-
walled borosilicate glass capillaries (inner diameter: 0.69 µm; outer diameter: 0.97 µm; 
length 10 cm) fabricated with three main instruments namely, horizontal micropipette 
puller, microforge and microgrinder (Figure 3.3).  
 Horizontal micropipette puller (P-97, Sutter Instrument, USA) was used to pull 
the borosilicate glass capillaries to form pipette with micro diameter tip. The length and 
diameter of the micropipette generated was controlled by adjusting a set of parameter 
that determines pulling mechanism of the machine shown in Table 3.37. 
Table 3.37: Description of the micropipette puller’s parameter  
Parameter Characteristics 
Heat  Heat controls the level of electrical current supplied to 
the filament that melt the glass. 
 Higher heat setting give longer and finer tips 
Pull strength   Controls the force of the hard pull 
 Higher pull, the smaller the pipette’s tip diameter and 
longer its taper 
 Injection needle with large tip (40-75) 
 Micropipette with smaller tip (120-250) 
Velocity  The velocity value determines the point of which the 
heat is turned off 
 Micropipette: 80-120 
 Microinjection: 50-80 
Pressure  The pressure of the cooling air delivered to the filament 
 Higher the pressure, the shorter the pipette taper 
 Thin wall glass: ≤ 300 unit 
 Thick wall: 500 unit 
Time  This parameter control the length of the cooling air is 
active (1 unit of time = 1/2 µsec) 
(Summarised from material adapted from: http://www.sutter.com/manuals/P-97-
DOM_OpMan.pdf) 
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 In this present study, the set of parameter (heat= 665 units, pull=150 units, 
velocity= 100, time= 150 units, pressure= 500 units) was used to shape the microneedle 
that has a long and uniform tapering end with a length of approximately 10 mm. The 
shape of the microneedle tip was further refined using microforge and microgrinder. 
  Microforge (Technical Products Internationals, USA) comprised of a horizontal 
microscope combined with fine adjustment filament, tool holder and an electrical air 
blower. This device is used to cut, shape, polish and bend the microneedle for the 
preparation of holding pipette, cutting needle and injection needle. Prior using this 
device to fabricate any microtools, a glass bead was made on top of the filament. In 
order to prepare the glass bead, the filament and microneedle were aligned vertically 
and the position was adjusted until a clear focus was observed under the microscope. 
The microneedle was raised above the filament before heating up the filament. Once the 
filament was heated until a red glow observed on it (heat control level= 4 to 5), the 
microneedle was lowered down gradually touching the filament. To shape the melted 
borosilicate glass into a ball shape, the microneedle was repeatedly pulled up and down 
until the glass bead with the diameter of 20 to 30 µm was obtained. The heat control 
power was switched off and the microneedle was detached from the glass bead by 
snapping the fine tip of the microneedle with a forceps. Once again, the glass bead was 
heated gradually to polish the bead surface. 
 Microgrinder (EG-4, Narashige Co. Ltd., Japan) was used to bevel the tip of the 
micropipette. This device comprises of a motorised grinder plane, pipette holder and a 
protractor mounted on the pipette holder fixing section to facilitate the adjustment of the 
required grinding angle. 
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3.3.4.1 Cleaning and sterilisation of capillaries  
The borosilicate glass capillaries were washed thoroughly with RO water. Subsequently, 
the borosilicate glass capillaries were soaked overnight in hydrochloric acid solution 
(10%). After 24 hours, the borosilicate glass capillaries were rinsed vigorously with 
Milli-Q water approximately twenty times to ensure all the traces of the acid completely 
removed. The borosilicate glass capillaries were kept in a conical tube (50 ml) and 
sterilised by autoclaving it. The sterilised capillaries were dried in the oven at 56°C, 
overnight. 
 
Figure 3.3: Equipment for microtools preparation. (i) Micropipette puller: (a) front-view, (b) 
         mechanical elements; (ii) Microforge: (a) side-view, (b) closed-up view of  
         microtools fabricating site; (iii) Microgrinder: (a) front-view, (b) closed-up view of 
         microtools grinding site. 
(b) 
(a) 
(i) (ii) 
(a) 
(b) 
(a) 
(b) 
(iii) 
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3.3.4.2 Preparation of holding pipette 
The holding pipette was used to hold and position oocytes for enucleation and sub- 
zonal injection of the donor cell in this study. The holding pipette with the inner 
diameter (I.D.) of 25 to 30 µm and outer diameter (O.D.) of 120 to 130 µm were 
fabricated using the microforge. In brief, the pulled capillary and filament were aligned 
to the same focus point. Then, the pulled capillary was placed on the glass bead at its 
required breaking point. The filament was heated to about 40 to 50% of its maximum 
capacity. As soon as the capillary melts to the glass bead, the power to the heat control 
was switched off. As the glass cools, the capillary will stick to the glass bead and once 
the filament relaxes from its expansion, the capillary was eventually broken evenly 
(Figure 3.4 (i)). The unwanted portion of the capillary that stick to the glass bead was 
removed. The glass bead was again heated up at about 60% of the maximum capacity 
and the tip of the capillary was moved closer to the glass bead so that the glass will melt 
and the inside diameter will shrink (polishing the tip) (Figure 3.4 (ii)). The micrometer 
scale in the eyepiece was used to judge when to stop the polishing process. The holding 
pipette was then bent at 30 to 35° angle using the heated glass bead (heat level= 50% of 
the maximum capacity) to allow a horizontal displacement on the microscope stage. 
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Note: (I.D.: inner diameter, O.D.: outer diameter) 
 
Figure 3.4: Preparation of holding pipette. (i) Cutting of the pulled capillary;  
                   (ii) Fire-polishing of the capillary tip. 
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2. Apply heat until glass melts 
3. Remove heat 
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3.3.4.3 Preparation of enucleation needle 
The enucleation needle was used in the process of removing the genomic DNA of the 
matured oocyte via squeezing approach. The sharp end needle was used to pierce a hole 
through the zona pellucida above the first polar body (PBI). Subsequently, the polar 
body and 10% of the cytoplasm adjacent to it was squeezed out through the breaking 
point of the zona pellucida. The sharp end of the enucleation needle was shaped using 
microforge. The pulled capillary was placed vertically with its tip touching the heated 
glass bead. Once the glass tip started to melt, the capillary was pulled up and down until 
a sharp needle end shape was formed (Figure 3.5 (i)). The enucleation needle was 
ultimately bent at 30 to 35° angle using the heated glass bead (heat level= 50% of the 
maximum capacity) to allow a horizontal displacement on the microscope stage (Figure 
3.5 (ii)).  
 
 
 
 
 
 
 
 
 
 Figure 3.5: Preparation of enucleation needle. (i) Procedure to shape a sharp tip; (ii)   
                  Tip of the enucleation needle showing measurement of tip and angle of  
                  bending. 
ii 
Glass tip 
melted 
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3.3.4.4 Preparation of injection pipette 
The injection pipette was used to introduce a single donor karyoplast into the 
perivitelline space of the enucleated oocyte. The injection pipette was fabricated by 
cutting the tip of the capillary to the desired diameter (I.D.=16 to 18 µm; O.D.= 18 to 20 
µm) using the microforge (Figure 3.4 (i)). Subsequently, the tip of the capillary was 
grinded approximately 3 to 4 minutes using a microgrinder to produce a bevelled edge 
with an angle of 40-45° (Figure 3.6). The capillary was then clean with EtOH (7%) and 
followed with Milli-Q water to remove the glass fragments accumulated on the grinded 
tip using an injection unit that assembled using an airtight syringe connected to the 
micropipette holder by a Teflon plastic tubing. The capillary was ultimately bent at 20 
to 25° angle using the heated glass bead (heat level= 30% of the maximum capacity) to 
allow a horizontal displacement on the microscope stage. 
 
 
 
 
 
 
 
3.3.5 Preparation of Caprine Donor Cell (Donor Karyoplast) Culture 
Caprine (Jermasia goat) ear skin fibroblast cells were used as the donor karyoplast in the 
production of caprine intraspSCNT and interspSCNT embryos. Prior to ear tissue 
biopsy, the Jermasia goat was anesthetised via intramuscular (i.m.) injection (1 ml) of 
20-25° 
angle 
40-45° 
angle 
(i) (ii) (iii) 
Note: (I.D.: inner diameter, O.D.: outer diameter) 
 
Figure 3.6: Preparation of injection needle. (i) Bevelled tip with the angle unit; (ii)  
                   Angle of bending; (iii) Measurement of the inner diameter and outer diameter. 
I.D.= 16-18 µm 
O.D.= 18-20 µm 
I.D. 
 
O.D. 
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mixed Xylazine hydrochloride and Ketamine hydrochloride (1:50). Then the surface of 
ear tissue to be biopsied was shaved to remove the hair. The incision area was swabbed 
with EtOH (7%) and by using a pair of surgical scissor, a piece of the ear tissue (~15-20 
mm
2
) was biopsied. The wounded area was then swabbed with EtOH (7%) and sprayed 
with iodine. The biopsied ear tissue was rinsed with mDPBS (3 times) before 
transported to the laboratory at 4°C in mDPBS.  
 In the laboratory, the biopsied ear tissues were rinsed again (3 times) with 
mDPBS before removing any remaining hair on the ear tissue by using a blade. The ear 
tissue was sprayed with EtOH (7%) and washed in primary cell culture medium (αMEM 
+ 10% FBS + 3x penicillin-streptomycin) (3 times) before dissecting apart the dermal 
layer from the cartilage. The dissection was conducted using a blade clamped with a 
pair of haemostat. Subsequently, the dermal layer was minced (~3-5 mm
2
) with a pair of 
sterile surgical scissor. The minced dermal tissues were then arranged at the centre of 
the tissue culture dish (60 mm, diameter) with the white surface facing down touching 
the bottom of the dish. In order to avoid the minced dermal tissues from floating, a glass 
cover slip was placed on top of the tissues. The primary tissue culture medium was then 
slowly dispensed into the tissue culture dish until the glass cover slip was fully 
immersed (~5 ml). This explant culture was incubated under a humidified atmosphere 
of 5% CO2 in air at 37°C for 8 to 10 days.  Once the outgrowth of cells was observed, 
usually from day 5 onwards, the primary explant culture medium was replenished with 
the cell line tissue culture medium that contain lower concentration of penicillin-
streptomycin [1x]. The procedures of the explant culture were shown in Figure 3.7. 
 
 
 
124 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 3.7: Procedure of caprine explant culture (ear tissue). (i) Caprine ear tissue  
        biopsied; (ii) Removal of hair; (iii) Dermal layer dissection; (iv) Dermal 
        layer mincing; (v) Arrangement of minced dermal tissue; (vi) Placement 
        of glass cover slip; (vii) Tissue culture medium dispensed; (viii)  
        Incubator for tissue culture. 
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At sub-confluence, outgrowths of the ear fibroblast cells were harvested using trypsin-
EDTA solution. The harvested cells in the trypsin-EDTA solution were washed in the 
tissue culture medium by centrifuging it for 5 minutes at 1.5 rpm. The ear fibroblast 
cells in pellet form were suspended in the cell line culture medium and seeded in a 
culture flask (25 cm
2
). The ear fibroblast cells were cryopreserved at passage 2 to 3 in 
freezing medium (cell line culture medium + 10% DMSO) and kept in liquid nitrogen. 
The frozen ear fibroblast cells were thawed and cultured in culture dishes (35 mm 
diameter) at least 3 days in advance before conducting nuclear transfer. A day before 
the nuclear transfer commence, serum starvation was done to synchronised cell cycle of 
the caprine ear fibroblast cell to be in G0 phase. 
 
 
3.3.6 Preparation of Caprine and Bovine Recipient Cytoplast Culture  
In this study, caprine oocytes were retrieved using two methods namely, LOPU and 
slicing of abattoir-derived ovaries, while bovine oocytes were retrieved solely from 
abattoir derived ovaries. 
 
3.3.6.1 Caprine oocyte retrieval through LOPU procedure 
Laparoscopic Oocyte Pick-up (LOPU) is a microsurgical procedure to retrieve oocytes 
from matured follicles in the ovary via four incisions on the abdomen of the does. Prior 
to LOPU, the donor does were oestrus synchronised and superstimulated. This 
procedure was carried out in Experiment 1, 2, 4 and 5. 
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3.3.6.1(a) Caprine hormonal stimulation protocol 
In Experiment 1, a comparative study between two hormonal stimulation protocols was 
conducted. The schematic representation of the two hormonal stimulation protocols was 
shown in Figure 3.8. 
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0900 hr: CIDR  
   insertion 
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0900 hr: Estrumate
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  (i.m.) (125 µg) 
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1600 hr: Folligon
®
 (i.m.)  
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2100 hr: Ovidrel
®
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Oestrus 
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Figure 3.8: Schematic representation of caprine hormonal stimulation protocols. (Protocol 
        1) Hormonal stimulation using Folligon
®
; (Protocol 2) Hormonal stimulation           
        using Folltropin
®
-V. 
Day-15 
 
0900 hr: Folltropin®-V (i.m.) (15 mg)  
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3.3.6.1(b) Oestrus synchronisation of donor does 
In order to plan the date and time of oocyte retrieval (OR) via LOPU, oestrus 
synchronisation was conducted to manipulate the oestrous cycle of the donor does. The 
oestrous cycle was synchronised by the insertion of a controlled internal drug release 
device (CIDR
®
, 0.3 g progesterone) into the vagina of the donor doe for 14 days (at 
0900 hour on Day-0) before removal. CIDR is made of an inert silicone elastomer that 
is non-porous and does not readily absorb bodily fluids; once it was inserted deep into 
the vagina with the help of a sterile CIDR applicator coated with lubricant (K-Y Jelly), 
the CIDR unfolds into a ‘T’ like formation that aids in retention. Daily monitoring of 
the device was performed to ensure that it had not been inadvertently removed. At 
approximately 36 hours prior to CIDR removal, a luteolytic treatment of Cloprostenol 
(Estrumate
®
, 125 µg) was administered intramuscularly (i.m.) (at 0900 hour on Day-13) 
to regress corpus luteum that facilitates initiation of pro-oestrus and eventually resulted 
in oestrogen sure for a rapid and highly visible onset of heat (oestrus). 
 
 
 
3.3.6.1(c) Superstimulation of donor does 
Superstimulation is a procedure to stimulate the growth of multiple follicles in the ovary. 
This procedure was conducted following oestrus synchronisation by the administration 
of hormonal treatments. The effect of superstimulation is morphologically seen as 
several fluid-filled ‘pimple-like’ protrusions on the surface of the ovary (Figure 3.12).  
Upon removal of CIDR, the donor does were superstimulated by administering FSH 
(Folligon
® 
or Folltropin
®
-V) and hCG (Ovidrel
®
) at doses and intervals depending on 
the protocols designed (Figure 3.8). Protocol 1 was designated using PMSG, Folligon
®
 
(1200 IU on does in oocyte retrieval cycle 1 (OR1) while 1500 IU was used on does in 
OR2) and hCG, Ovidrel
®
 (250 IU); while Protocol 2 was designated using pFSH, 
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Folltropin
®
-V with a total equivalent to 70 mg/doe, administered in decreasing doses 
(twice at Day-14 and once at Day-15) and hCG, Ovidrel
®
 (250 IU). In Experiment 1, 
the superstimulation effect of using Protocol 1 vs. Protocol 2 was studied. As for 
Experiment 2, 4 and 5, Protocol 2 was used. At approximately 48 hours after PMSG or 
pFSH and hCG administration for Protocol 1 and 2, the donor does were observed for 
the onset of oestrus behavior such as switching of the tail, increased vaginal secretion 
and willingness to be mounted on by a teaser buck. The onset of oestrus marked the 
urgency of initiating LOPU procedure.   
 
3.3.6.1(d) Anaesthesia and sedation of donor does 
The donor does were deprived of food and water for 16 hours (at 1600 hr on Day-16) 
prior to LOPU. On the day of performing LOPU, anaesthesia was induced with 
intramuscular administration of mixed Xylazine hydrochloride and Ketamine 
hydrochloride (1:50) at the dosage of 1 ml per 25 to 30 kg body weight. The doe was 
maintained under anaesthesia with the dosage of 0.5 ml every 20 to 30 minutes interval 
or as required. 
 
3.3.6.1(e) Disinfection of surgical instruments and skin area of doe 
On the day prior to surgery, non-autoclavable surgical instruments such as atraumatic 
grasper, trocar and cannula, fibre optic cable, light probe for endoscope, silicone tubing 
of flushing system and gas tubing with luer lock at both ends for CO2 system were 
disinfected by immersing completely in Gigasept
®
 solution (10%) for 10 minutes and 
subsequently rinsed with sterile autoclaved distilled water before placing on a sterile 
surgical table-cum-trolley. Autoclavable surgical instruments were assembled and 
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arranged in a consistent order on a sterile table-cum-trolley which was already covered 
with a sterile drape (Figure 3.9). 
 When the donor doe had been immobilised, it was fasten on a restraining cradle 
at dorsal recumbence tilted at approximately 45° angle. The abdominal area of the doe 
was scrubbed with diluted Hibiscrub (10%) using gauze for disinfection purpose. 
Subsequently, the hair was shaved and the bare skin was wiped with undiluted 
Hibiscrub before applying the surgical iodine solution on the surgical surface. A sterile 
drape (tailor-made cloth with an opening that revealed the disinfected bare skin) was 
then used to cover the abdominal and its position was secured in place using towel 
clamps. 
 
3.3.6.1(f) Laparoscopic ovum pick-up (LOPU) 
The surgical instruments (Figure 3.9), laparoscopic system and accessories used were 
purchased from Aesculap A.G. & Company, Germany (Appendix Table 1.1). The 
condition of the laparoscopic system and accessories were inspected regularly (weekly 
basis) to ensure no disruption occur due to machine break down during LOPU.  
 Typically, the LOPU procedure was conducted by the surgeons (Figure 3.10). 
The procedure began by assembling the light probe (a paediatric Storz laparoscope 
connected to a light system via a fibre optic cable). Subsequently, the light probe was 
connected to the Aesculap endoscopic camera which was connected to the CCD camera 
and monitor beforehand. The lens of the paediatric Storz laparoscope, fibre optic cable 
and the endoscopic camera system were wiped with EtOH (7%) soaked sterile gauze. 
The CCD camera was switched on, video system was tested and a white balance was 
performed. Subsequently, the ovum pick-up (OPU) needle, test tube (14 ml) and syringe 
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containing flushing medium (50 ml) were connected to the flushing and aspiration 
system prior to introducing any incision on the doe. 
 A pneumoperitoneum was created by inserting CO2 gas into the abdominal of 
the doe through the Verrus needle attached to the plastic tubing that was connected to a 
CO2 tank via CO2 gas insufflators unit. Once the pneumoperitoneum was created, small 
incision (3-5 mm) were made, one near the umbilicus to facilitate insertion of trocar for 
passing the laparoscope, one on the right side of lower-ventral abdomen to insert the 
trocar for passing aspiration needle. The paediatric Storz laparoscope that was 
connected to the CCD camera was inserted into the abdominal cavity through the trocar 
sheath. Then a paediatric grasper was passed through the small trocar sheath and finally 
the OPU needle was inserted into the left side of the abdominal cavity. The ovaries were 
visualised with the help of laparoscope and exposed by pulling the fimbria in different 
directions with the grasper. The number of visible antral follicles (2-3 mm sized or 
larger) on both ovaries were counted and recorded. Subsequently, one of the ovaries 
was held by the grasper and follicles were individually punctured, flushed with flushing 
medium and then the flushing medium plus the oocytes were aspirated back into the 
OPU needle to be collected into the test tubes (2-4 ml per tube). The collection tubes 
were then passed to the researcher for oocyte search. The procedure was repeated for 
the other ovary. The images of LOPU procedure and superstimulated ovary were shown 
in Figure 3.10- 3.12. 
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Figure 3.9: Surgical instruments and accessories. 
Figure 3.10: Surgeons conducting LOPU  
          procedure. 
Figure 3.11: Closed up image of the ovary 
          during LOPU. 
OPU needle 
Ovary 
Figure 3.12: Superstimulated caprine ovary.  
Follicle 
Ovary 
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3.3.6.2 Oocyte retrieval from abattoir-derived ovaries 
The abattoir-derived caprine and bovine ovaries were transported to the laboratory in 
ovary collection medium (normal saline supplemented with penicillin-G (60 µg/ml) and 
streptomycin (50 µg/ml)) at 30-37°C. All the ovaries were rinsed at least four times 
with ovary collection medium to remove off the blood prior oocyte retrieval. Oocytes 
were retrieved using two approaches namely ovary slicing and follicle aspiration 
(Figure 3.13). Typically, caprine oocytes were retrieved using only ovary slicing 
method due to the size of ovary and number of follicles that were relatively small 
compared to bovine.  
 In ovary slicing approach, the ovary was held with a sterile curved haemostat on 
the culture dish (60 mm diameter) and the excess tissues were cut with a sterile scissor. 
Subsequently, a quarter section of the stainless steel razor blade was held with a 
haemostat and checkerboard incision was made to the entire surface of the ovary by 
using the blade inside the culture dish containing pre-warmed (37°C) oocyte retrieval 
medium (4 ml). The sliced ovary was rinsed in a beaker (100 ml) containing oocyte 
retrieval medium (50 ml). All the steps in the process were repeated until all ovaries 
were sliced. Subsequently, the beaker and culture dish containing the oocyte retrieval 
medium and the sliced material were transfer into the embryo room for COCs pick-up 
under a stereomicroscope attached to a stage warmer (37°C). The beaker was left to 
stand (5 minutes) on a hot plate with the temperature maintained at 37°C in order to 
allow the tiny pieces of tissues and COCs in the beaker to settle down. While waiting 
for the sedimentation of the tissues and COCs to take place, COCs pick-up using the 
mouthpiece-controlled pipette from the culture dish was conducted. All the COCs 
collected were placed in a culture dish (35 mm diameter) containing oocyte retrieval 
medium (3 ml).  
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 As for follicle aspiration approach, the ovary was held using a sterile tissue and 
by using a needle (18 Gauge) connected to a sterile syringe (10 ml), the follicles were 
punctured and the follicle fluid was aspirated into the syringe. The syringe was filled 
with oocyte retrieval medium before aspirating the follicle fluid. Once the COCs were 
completely retrieved from all the ovaries, the mixture of oocyte retrieval medium and 
follicle fluid was dispensed from the syringe into the conical tube (50 ml) containing 
fresh oocyte retrieval medium (20 ml). The conical tube was left to stand on a rack (5 
minutes) in order to allow the COCs to sediment. Some of the sediment (1 ml) were 
transferred into a culture dish (60 mm diameter) and diluted with oocyte retrieval 
medium (2 ml) to ease the observation and pick-up of COCs under the stereomicroscope 
attached to a stage warmer (37°C). All the COCs collected were placed in a culture dish 
(35 mm diameter) containing oocyte retrieval medium (3 ml) prior to grading and in 
vitro maturation (IVM).  
 
 
 
 
 
 
 
 
 
 
(i) (ii) (iii) 
Figure 3.13: Oocyte retrieval from abattoir-derived ovaries. (i) Caprine ovaries; (ii) Caprine 
          oocyte retrieval via slicing technique; (iii) Bovine oocyte retrieval via  
          aspiration technique. 
Caprine ovary 
Caprine ovary 
Blade 
Curved haemostate 
Haemostate 
Caprine ovary 
18G needle 
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3.3.6.3 Oocyte grading 
All the COCs collected via LOPU and abattoir-derived ovaries were washed in oocyte 
retrieval medium (3 times) before visually assessed under the stereomicroscope to 
classify in grades according to cumulus cell investment and morphology of the oocyte. 
The classification of the COCs in this study was based on the criteria described by 
Rahman et al. (2008), presented in Table 3.38. 
 
 
Table 3.38: Grading of the recovered oocytes according to the cumulus cell investment 
         and morphology of the oocyte 
Grades Characteristics of COCs and CFOs 
A COCs with more than 5 complete layers of cumulus cells (CCs), finely 
granulated homogeneous ooplasm and normal morphological features. 
 
B COCs with 3-5 complete layers of CCs, finely granulated homogeneous 
ooplasm and normal morphological features. 
 
C COCs with 1-2 complete layers of CCs or COCs with 3-5 partially 
invested CC layers, finely granulated homogeneous ooplasm and normal 
morphological features. 
 
D CFOs or oocyte with incomplete investment of CCs (1-2 layers), finely 
granulated homogeneous ooplasm and normal morphological features. 
 
E Degenerating oocyte or oocyte with abnormal size, shape and 
heterogeneous ooplasm or apoptotic oocytes in jelly-like CC investment 
or very small oocytes. 
 
Adapted from: Rahman et al. (2008) 
Note: COCs – Cumulus oocyte complexes; CFOs – Cumulus free oocytes. 
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3.3.6.4 In vitro maturation (IVM) 
In vitro maturation medium (5 ml) was equilibrated in the incubator (5% CO2 in air in 
humidified atmosphere, 38.5°C) overnight (or 12 hours). Microdroplets (70 µl) of IVM 
medium were prepared and overlaid with equilibrated light mineral oil in a small 
polystyrene culture dish (35 mm diameter) on the day of experiment. The extra IVM 
medium (~3 ml) was kept in the incubator for COCs washing after grading before 
culturing in the IVM microdroplets. The COCs were cultured according to grade in 
different microdroplets (13-15 COCs/ 70 µl) of IVM medium under a humidified 
atmosphere of 5% CO2 in air, 38.5°C. The COCs collected in this study were cultured in 
IVM medium according to the following duration: 
a) Caprine COCs retrieved from LOPU: 18-22 hours or 23-27 hours of IVM 
duration (A comparative study in Experiment 4) 
b) Caprine COCs retrieved from abattoir derived ovary: 22-26 hours of IVM 
duration 
c) Bovine COCs retrieved from abattoir derived ovary: 22-24 hours of IVM 
duration  
 
3.3.6.5 Assessment of oocyte maturation 
In Experiment 2, assessment of the oocyte stages at 3 hours of IVM intervals (from 15-
27 hours after COCs cultured in IVM) were conducted by staining the denuded COCs 
with Hoechst 33342. On the other hand, assessment of the matured oocytes for 
Experiment 3, 4 and 5 were conducted at the IVM duration mentioned in section 3.3.6.4. 
Once the IVM duration approached, the COCs were treated with hyaluronidase (0.1%) 
not exceeding 5 minutes. The cumulus cells were stripped off the zona pellucida by 
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repeated pipetting (40-50 times) using micropipette (200 µl) adjusted to 100 µl in the 
hyaluronidase (0.1%) solution. Subsequently the denuded oocytes were washed in 
EMCARE
TM
 holding solution (3 times) to remove traces of hyaluronidase. The denuded 
oocytes were assessed for maturation under stereomicroscope by rotating the oocytes 
using mouthpiece-controlled pipette. Oocytes with a clear protrusion of first polar body 
(PB-1) were considered as matured (in metaphase II) and meiotic competent.  The 
matured oocytes were kept in incubated oocyte holding solution for subsequent nuclear 
transfer manipulation and parthenogenesis treatment (Experiments 3, 4 and 5). Oocytes 
without the present of PB-1 were considered immature and discarded. 
 
 
3.3.7 Somatic Cell Nuclear Transfer Procedure 
In this study, SCNT was carried out using ‘Roslin technique’ (a technique developed 
and used by Ian Wilmut from Roslin Institute, UK) that includes the following series of 
steps: (i) enucleation using squeezing technique, (ii) sub-zonal injection of donor 
karyoplast and (iii) electrofusion. All the three steps mentioned above were carried out 
using the micromanipulation system that incorporated an inverted microscope fitted 
with hydraulic micromanipulators and connected to a computer system (Figure 3.14). A 
summary on the SCNT procedure was shown in Figure 3.15. 
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Figure 3.14: Micromanipulation system.  
 
Figure 3.15: Summary of SCNT procedure.  
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3.3.7.1 Preparation of micromanipulation dish 
Generally, three micromanipulation dishes (‘blank’ dish, nuclear transfer dish and 
electrofusion dish) were prepared on the day of SCNT experiment. The ‘blank’ dish was 
prepared for the alignment of the enucleation needle or injection pipette with the 
holding pipette. This dish was prepared by dispensing a microdroplet (30 µl) of 
EMCARE
TM
 holding solution onto the lid of a polystyrene culture dish (35 mm 
diameter) and covered with light mineral oil. 
 After the preparation of ‘blank’ dish, nuclear transfer dish was prepared by 
dispensing two microdroplets of CB solution (100 µl first: for enucleation purposes; 30 
µl second: for washing the holding pipette and enucleation needle) on the lid of the 
polystyrene culture dish (35 mm diameter) at the upper end. Subsequently another two 
microdroplets of EMCARE
TM
 holding solution (100 µl; for donor karyoplast injection 
purpose and 30 µl; for washing the holding pipette and injection pipette) were dispensed 
on the opposite end of the dish (Figure 3.16).  
 The electrofusion dish was prepared for the fusion between the sub-zonal 
injected donor kayoplast with the recipient cytoplast using electrical pulse. The dish was 
prepared by drawing two parallel lines and another line inter-cross the centre point of 
the polystyrene culture dish (60 mm diameter) bottom with a labelling marker (Figure 
3.17). Subsequently, 400 µl of Zimmerman’s fusion medium (ZFM), was dispensed at 
the centre of the marked polystyrene culture dish (60 mm diameter) and the 
microdroplet was covered with light mineral oil. 
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CB 
EMCARE
TM
 holding 
solution 
Ø 35mm, polystyrene culture dish lid 
 
  
 
  
  
Enucleated oocyte Donor karyoplast 
Injected oocyte 
Mineral oil 
(i) (ii) 
Note: (CB: cytochalasin B) 
 
Figure 3.16: Nuclear transfer dish. (i) Arrangement of enucleation and donor karyoplast  
          injection microdroplets on the nuclear transfer dish; (ii) Placement of samples in 
          the microdroplet for donor karyoplast injection. 
Lines drawn with labeling marker Zimmerman’s Fusion Medium 
droplet (400 µl) 
Light mineral oil 
Figure 3.17: Electrofusion dish. 
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3.3.7.2 Alignment of microtools 
Alignment of microtools is the preliminary and crucial step that needs to be carried out 
before the commencement of any micromanipulation procedure. The performance of the 
subsequent micromanipulation procedures is highly dependent on the accuracy of the 
microtools alignment. The microtools (holding pipette with enucleation needle or 
injection pipette) alignment was conducted by first adjusting all the knobs (X-, Y-, Z- 
control) and syringes (3 ml) to the centre of the scale.  
 The ‘blank’ dish prepared earlier was then placed on the centre of the heated 
stage warmer (38.5°C) of the micromanipulator. The microscope (under 4x objective) 
connected to the micromanipulator was adjusted until the edge of the alignment droplet 
was sharply focused. Subsequently, the holding pipette inserted to the injection holder 
was fixed to the universal joint located on the left side of the micromanipulator. On the 
other hand, the enucleation needle inserted to the electrode holder was fixed to the 
universal joint located on the right side of the micromanipulator. The position of the 
holding pipette was lowered down until the tip touched the oil. This position was held 
for a few minutes (1 to 2 minutes) to allow the light mineral oil flowed into the tip by 
capillary action. This step was eliminated for the enucleation needle but is required for 
the injection pipette. Once the tip was filled with light mineral oil, both holding pipette 
and enucleation needle were moved to the alignment droplet. The holding pipette was 
focused with the enucleation needle and was aligned so that the working tips were 
parallel to the microscope stage (under 4x objective) (Figure 3.18). Finally both 
microtools were checked under high magnification to assure the accurate alignment 
(sharply in focus) and parallel. 
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3.3.7.3 Enucleation of matured oocyte using squeezing method 
In this study, squeezing technique was used to remove the genomic DNA from the 
matured oocyte. The matured oocytes were treated with cytochalasin B (5 µg/ml) 
solution for 5 minutes to destabilise the actin cytoskeleton before enucleation. 
 After the alignment of holding pipette and enucleation needle was completed, 
the ‘blank’ dish was replaced with nuclear transfer dish. The CB treated matured 
oocytes were then transferred into the CB droplet in the nuclear transfer dish using the 
mouthpiece-controlled pipette. By using the joysticks of the micromanipulator, the 
movement of the holding pipette and enucleation needle were controlled. The matured 
oocyte was rotated using the tip of the holding pipette and enucleation needle to locate 
the position of the first polar body. The oocyte was held firmly using the holding pipette 
with its first polar body (PB-1) located at 12 o’clock position. Subsequently, an 
enucleation needle was used to make a cut on the zona pellucida above the first polar 
Figure 3.18: Alignment of microtools on the ‘blank’ dish. (i) Original photograph; 
          (ii) Labelled photograph. 
Enucleation needle 
or injection pipette 
Holding pipette 
‘Blank’ dish 
Microscope 
objective lens 
(i) (ii) 
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body. The first polar body and 10% of the cytoplasm adjacent to the polar body was 
gently squeezed out. In order to confirm that the oocyte was successfully enucleated, the 
extruded polar body and cytoplasm was stained with Hoechst 33342. Only oocytes with 
positive enucleation were subjected to subzonal injection of donor karyoplast. Exposure 
of the oocytes to CB solution for the entire enucleation step was ensured not to exceed 
30 minutes. The enucleated oocytes were washed 3 times in EMCARE
TM
 holding 
solution and kept in the incubated holding medium (30-45 minutes) while waiting for 
the preparation of nuclear transfer via sub-zonal injection to complete. The 
micromanipulation procedure of oocyte enucleation using squeezing technique is shown 
in Figure 3.19.  
 
 
 
 
 
 
 
 
 
 
 
 
Note: (photomicrographs original magnification: 100x); (PB-1: first polar body) 
 
Figure 3.19: Oocyte enucleation using squeezing technique. (i) MII oocyte was held firmly 
          with holding pipette with PB-1 located at 12 o’clock position; (ii) Enucleation 
          needle was used to pierce through the zona pellucida above PB-1; (iii) The          
          oocyte was released from the holding pipette and brought down to opposite side, 
          few attritions were made between the enucleation needle and holding pipette to 
          break the zona pellucida; (iv) Relocate the oocyte with the broken point at 12 
          o’clock position; (v- vi) The PB-1 and cytoplasm (<10%) beneath the PB-1 were 
          gently squeezed out.   
(i) (ii) (iii) 
(iv) (v) (vi) 
PB-1 
Holding pipette 
Enucleation needle 
Zona pellucida 
Broken point PB-1 & <10% 
cytoplasm 
Squeezed 
nucleus 
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3.3.7.4 Nuclear transfer of the enucleated oocyte using sub-zonal injection method 
Ear skin fibroblast cells (donor karyoplast) were harvested using the method described 
in section 3.3.5. The harvested cells in pellet form were suspended with EMCARE
TM
 
holding solution (70-100 µl).  
 Once the preparation of donor karyoplast completed, the enucleation pipette was 
replaced with the injection pipette. The position of the nuclear transfer dish was 
adjusted in which the EMCARE
TM
 droplet (manipulation droplet) was in the centre of 
focus. Subsequently, the donor karyoplast suspension (10 µl) was dispensed into the 
manipulation droplet on the upper left corner, while the enucleated oocytes were 
transferred to the upper right corner (Figure 3.14 (ii)). 
 In order to inject the donor karyoplast into the perivitelline space of the 
enucleated oocyte, a single ear skin fibroblast cell was aspirated into the injection 
pipette and positioned near to its tip. By using the tip of the holding pipette and 
injection pipette, the enucleated oocyte was rotated to locate the oocyte in which its 
breaking point of the zona pellucida was at 1 to 2 o’clock. The oocyte was held firmly 
with the holding pipette and the tip of the injection pipette was inserted into the 
perivitelline space of the enucleated oocyte. Subsequently, the donor karyoplast was 
deposited into the perivitelline space at the point in which the donor cell could adhere 
closely to the recipient cytoplast. The injected oocytes were kept in the incubated 
holding medium for 30-45 minutes under a humidified atmosphere of 5% CO2 in air, 
38.5°C before fusing the couplets. The micromanipulation procedure of nuclear transfer 
using sub-zonal injection technique is shown in Figure 3.19.  
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Note: (photomicrographs original magnification: 100x) 
 
Figure 3.20: Nuclear transfer using sub-zonal injection technique. (i-ii) A single donor 
          karyoplast cell was aspirated into the injection pipette; (iii) The oocyte was 
          located in which the broken point of the zona pellucida was at 1-2  o’clock 
          position; (iv-vi) The donor karyoplast was deposited into the perivitelline 
          space of the enucleated oocyte through the breaking point of the zona 
          pellucida. 
(i) (ii) 
(iii) (iv) 
(v) (vi) 
Donor karyoplast  
Injection pipette 
Broken point 
on ZP 
Holding pipette 
Perivitelline space 
Donor karyoplast  
Karyoplast 
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injected 
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3.3.7.5 Fusion of donor karyoplast and recipient cytoplast couplet 
In this study, electrofusion method was used to fuse the donor cell- cytoplast couplets. 
Before introducing electrical stimulation, the couplets were equilibrated in fusion buffer 
(ZFM) formulated by Zimmermann and Vienken (1982) for 5 minutes.  
 The electrofusion was carried out using a fusion machine (SUT F-1, Suranaree 
University of Technology, Thailand) connected to a pair of chopstick type electrode. 
The electrodes were fixed on the left and right universal joint of the micromanipulator 
and alignment of the electrodes was conducted in the fusion dish (Figure 3.20 (i)). 
Subsequently, the pre-equilibrated couplets were transferred into the ZFM droplet and 
deposited between two vertical lines marked on the fusion dish. The donor cell-
cytoplast couplet was sandwiched between the two electrodes (Figure 3.20 (ii)) and two 
direct current pulses (20-21 V, 15 µsec for caprine and 24 V, 15 µsec for bovine and 
gaur) were introduced to fuse the couplets. The couplets were washed in EMCARE
TM
 
holding solution 5 times (15 minutes) and held in incubated holding medium for 1 hour 
(38.5°C, 5% CO2) before assessing fusion. The couplets successfully fused were 
subjected to activation treatment. 
 
 
 
 
 
 
 
Note: (photomicrograph (ii) original magnification: 100x) 
 
Figure 3.21: Electrofusion. (i) Placement of electrodes and fusion dish on the   
         micromanipulator; (ii) Position of donor karyoplast at 3 ‘clock, sandwiched          
         between 2 electrodes. 
(i) 
Donor karyoplast 
Electrodes (ii) 
Electrodes 
Fusion dish 
Microscope stage 
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3.3.7.6 Activation treatment 
Two activation protocols were used in this study to generate cloned embryos and 
parthenotes namely: 
 Protocol A: EtOH [7%] (5 min) followed with CD [1.25 µg/ml] + CHX [10 
          µg/ml] (5 h); for gaur iSCNT, bovine SCNT and bovine PA  
          embryos production 
 
 Protocol B: CaI [5 µM] (5 min) followed with 6-DMAP [2 mM] (4 h),  
        developed by Shen et al. (2008); for caprine SCNT,  iSCNT         
        and PA embryos production 
 
 Protocol A was carried out by treating the fused couplets in EtOH (7%) droplets 
(7 droplets) for 5 minutes at room temperature. Subsequently, the fused couplets were 
washed in CD-CHX solution before culturing them in CD-CHX droplets (70 µl) for 5 
hours at 38.5°C under a humidified atmosphere of 5% CO2 in air. 
 Protocol B was carried out by culturing the fused couplets in CaI droplets for 5 
minutes at 38.5°C under a humidified atmosphere of 5% CO2 in air. The fused couplets 
were washed in IVC medium (mSOFaa or KSOMaa according to the experimental 
design) before culturing them in 6-DMAP droplets for 4 hours at 38.5°C under a 
humidified atmosphere of 5% CO2 in air. 
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3.3.8 In Vitro Culture 
In this study, three IVC protocols were used namely: 
 Protocol I: mSOFaa medium for 8 days IVC (renewal of IVC medium was 
         done at Day- 2, 4, 6, 7, 8 post-activation). This protocol was used 
         in Experiments 3 and 4 
 Protocol II: KSOMaa A medium for 8 days IVC (renewal of IVC medium was 
         done at Day- 2, 4, 6, 7, 8 post-activation). This protocol  
         (Treatment A) was used in Experiment  4  
 Protocol III: KSOMaa A medium for the first 2 days of IVC followed by  
          KSOMaa B medium for the subsequent 6 days of IVC (renewal of 
          IVC medium was done at Day-2, 4, 6, 7, 8 post-activation). This 
          protocol (Treatment B) was used in Experiments  4 and 5 
 
The reconstructed oocytes were washed and cultured in equilibrated IVC medium 
according to the respective IVC protocols mentioned above at 38.5°C under a 
humidified atmosphere of 5% CO2 in air. Assessment of the embryos’ in vitro 
development (IVD) was conducted on the same day as the renewal of IVC medium was 
done. 
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3.3.9 Nucleic acid staining  
In the present study, nucleic acid staining using Hoechst 33342 dye was conducted on 
caprine matured oocyte to observe its nuclear progression approaching meiotic 
maturation. This staining method was also used to stain cloned blastocyst to determine 
the cell number. Besides that, Hoechst 33342 dye was also used to stain the extruded 
polar body- cytoplasm material for the confirmation of positive enucleation. 
 Typically, the specimen to be stained were first washed in PBS(-) droplets (5 
droplets; 100 µl/ droplet). Subsequently, the specimens were washed in 3 droplets of the 
fixative solution (100 µl/ droplet). The specimens were exposed to the fixative solution 
for 5 minutes. A glass slide was then wiped with EtOH (70%) and Vaseline-wax was 
placed onto the four corner of a box dimension (size of a cover slip) at the centre of the 
slide. The specimens were transferred onto the centre of the glass slide marked by the 
Vaseline-wax deposition and a cover slip was then mounted on it. Subsequently, 
Hoechst 33342 dye (~2 µl) was placed on the side of the mounted cover slip and by the 
capillary action, the dye was absorbed into the specimens. The 4 edges of the cover slip 
were finally sealed with adhesive (cutex). The specimen slide was labelled, wrapped 
with the aluminium foil and kept in the refrigerator (4°C) to be observed under the 
fluorescent microscope. 
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3.3.10 Embryo Transfer 
Embryo transfer was carried out only on cloned caprine embryos using two approaches 
namely, oviductal transfer and uterine transfer. Cloned caprine embryos (4 to 8-cell) at 
Day-2 post activation were transferred into the oestrus synchronised pseudo-pregnant 
doe via oviduct transfer method, while cloned caprine embryos (compact morula to 
blastocyst) at Day-6 post activation were transferred via uterine transfer method. 
 The oestrus cycle of the recipient doe was synchronised according to the 
protocol shown in Figure 3.20. On the day of surgery, the ovaries of the recipient does 
were checked for the presence of corpus luteum (CL) via laparoscopic procedure similar 
to the LOPU procedure described in sub-section 3.3.6.1(f). Embryos were transferred to 
the oviduct or uterine ipsilateral to the corpus luteum. 
   
 
 
 
 
 
 
 
  
 
Oestrus synchronisation Hormonal stimulation ET 
Day-0 
 
0900 hr: CIDR  
   insertion 
Day-13 
 
0900 hr: Estrumate
®
  
  (i.m.) (125 µg) 
Day-14 
 
0900 hr: Folligon
®
 (i.m.)  
  (500 IU) 
1700 hr: Ovidrel
®
 (i.m.) (500 IU) 
  & CIDR removal 
A teaser buck was placed in the 
same pen with the recipient doe 
Day-B 
 
0800 hr: Surgery 
Day-A 
 
1600 hr: Off-feed 
Note: 
1) Oviduct transfer: 
    Day A= Day-18; Day B= Day-19 
2) Uterine transfer: 
    Day A= Day-22; Day B= Day-23 
Figure 3.22: Protocol for recipient doe’s oestrus synchronisation. 
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 The oviduct transfer was carried out by making a mid-ventral incision (~5 to 6 
mm) at the lower abdomen near the udder. The ovary with corpus luteum were located 
and exteriorised. Embryo transfer was carried out with a customised embryo transfer 
catheter (flexible polythene tubing, threaded through a 25-G hypodermic needle). 
Loading of the embryos into the embryo catheter was performed by the embryologist. 
Briefly, an insulin syringe (1 ml) that was filled with EMCARE
TM
 holding solution (0.3 
ml) was connected to the embryo transfer catheter. The catheter was then flushed with 
the EMCARE
TM 
holding solution until 0.1 ml of the medium was left in the syringe. A 
small column of air was then aspirated into the catheter. Subsequently, 2 to 4 cloned 
embryos at 4-8 cell stages were aspirated into the catheter resulting in a 5 mm column 
containing the embryos and medium. A further 5 mm air column was made. The 
catheter was inserted through the ostium advancing the catheter as far as possible into 
the infundibulum of the oviduct and gently, the cloned embryos were released into the 
infundibulum by depressing the plunger of the syringe gradually. Once completed, the 
ovary was placed back into the cavity of the abdomen and the incision was sutured. The 
sutured incision area was sprayed with antiseptic and oxytetracycline (20 mg/kg body 
weight) was injected into the doe via i.m. once in every 4 days within the duration of 2 
weeks to prevent post-surgical infection. 
 Uterine transfer is considered a less invasive surgical approach as the uterine 
horn was exteriorised through the small incision made for the access of the grasping 
forceps during laparoscopic detection of the CL. The uterine horn was clamped with a 
haemostat before piercing a hole on the uterine using a sterile paper clip. The cloned 
embryos were loaded in a Unopette attached to a syringe (1 ml). The method of loading 
the embryos is similar to the approach using the customised catheter mention in the 
previous paragraph. Once the loading completed, the Unopette tip was inserted through 
the hole introduced on the uterine and the embryos were released into the uterine slowly. 
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The uterine was released from the haemostat and the incision was sutured. The recipient 
does were given antibiotic injection described previously and their diet was well taken 
care.  
 Pregnancy diagnosis was conducted 35 days after embryo transfer. A real-time 
ultrasound scanner (Aloka SSD500V, Tokyo, Japan) equipped with 5.0 mHz linear 
array transducer for the transrectal approach was used. The transducer was coated with 
carboxymethylcellulose gel before used. 
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3.4 EXPERIMENTAL DESIGN 
The present study of producing cloned goat embryos was the first attempt conducted in 
this laboratory, therefore the primary objective of this study was to develop a somatic 
cell nuclear transfer (SCNT) protocol to be served as a stepping stone for future study 
related to goat nuclear transfer research in this laboratory. There were two SCNT 
approaches investigated namely intraspecies SCNT (intraspSCNT) in which both the 
recipient oocytes and donor nucleus were derived from the same species and 
interspecies SCNT (interspSCNT) which describe that both recipient oocytes and donor 
nucleus derived from different species. This study focused not only on the aspect of 
SCNT, but also on the aspect of caprine superstimulation responses, sources of oocyte 
recovery, in vitro maturation (IVM) and in vitro culture (IVC) media for caprine 
embryos in some extent. The study was divided into five main experiments. The design 
of each experiment was described in the following section with a summary of 
experimental design flow chart and a methodology flow chart illustrated in Figure 3.21 
and Figure 3.22, respectively.  
 
 
3.4.1 Effect of Different Sources of Gonadotrophin on Caprine Superstimulation 
 Responses (Experiment 1) 
 
The objectives of this experiment was to evaluate the effect of: a) two different sources 
of gonadotrophin namely Folligon
® 
and Folltropin
®
-V on caprine ovarian responses and 
b) three repeated stimulation and  OR cycles on the ovarian responses. The parameters 
measured for both objectives were the number of follicles recruited, number of oocyte 
retrieved, oocyte retrieval rate and the percentage of oocytes retrieved after grading as a 
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mean of oocyte quality evaluation. Classification of the oocyte Grade was according to 
the cumulus cell investment and oocyte morphology described in Table 3.38.  
 A total of 33 does (aged 18 to 24 months) were synchronised (CIDR device and 
Estrumate
®
) and stimulated in this experiment. Out of the 33 synchronised does, 18 
does were stimulated with Folligon
®
 and Ovidrel
®
; while the remaining 15 does were 
stimulated with Folltropin
®
-V and Ovidrel
®
 according to the regime designated in 
Figure 3.8. The OR surgery was conducted at the onset of oestrus by LOPU technique. 
The number of follicles recruited, quantity and quality of oocytes retrieved from ovaries 
stimulated with Folligon
® 
versus Folltropin
®
-V and from OR1 to OR3 were analysed by 
analysis of variance (ANOVA), followed by Duncan’s multiple range test (DMRT). 
 
 
3.4.2 Effect of Different Sources of Caprine Oocytes on the Oocyte Yield, Grades 
 and Maturation Performance (Experiment 2) 
 
The experiment was designed to compare the quantity, quality and maturation rate of 
oocytes recovered from live does by LOPU versus slicing of abattoir-derived ovaries. In 
this experiment, oocytes of Grade E was not taken into consideration as generally 
abattoir source produces abundant Grade E oocytes and picking-up of this oocytes is 
rather time-consuming. Generally the live does were hormonally stimulated with pFSH 
regimen and the interval between the hormonal treatment and LOPU used was 70 to 72 
hours. 
 Prior evaluating the maturation competency of LOPU- versus abattoir-derived 
oocytes, determination of an optimum IVM duration range for both oocyte sources was 
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conducted. Oocytes from LOPU and abattoir sources were subjected to IVM and the 
maturation rates were recorded at the interval of 3 hours starting from 15 hours to 27 
hours post-IVM. The IVM durations selected (15 hour to 27 hours) were based on the 
range of IVM duration (16 to 27 hours) that was frequently used by other researchers 
(Cognié et al., 2003; Wang et al., 2003; Jimenez-Macedo et al., 2006; Rahman et al., 
2008) for caprine oocyte maturation regardless of their source of oocytes, 
superovulation protocols and the formulation of IVM medium. Observation on the 
morphology of PB-1 and the localisation of MII spindle and PB-1 for all the matured 
oocytes at 15, 18, 21, 24 and 27 hours were recorded. The optimum IVM duration range 
was determined based on the duration in which the maturation rate recorded is 
reasonably high, majority of the morphology of PB-1 is not fully extruded, less 
fragmentation and the location of the MII spindle is closely adjacent to the PB-1. The 
optimum IVM duration range determined in this sub-experiment was employed in the 
subsequent experiments that involve the IVM of caprine oocytes. 
 A total of 14 does (28 ovaries) were used for LOPU. On the other hand, 56 
ovaries from 28 does were collected from a local abattoir. Experimental does for LOPU 
were subjected to oestrus synchronisation and superstimulation using pFSH regime 
(Figure 3.8: Protocol 2). The recovered COCs from both LOPU- and abattoir-derived 
ovaries were graded and subjected to the same IVM medium (Table 3.8) incubated in 
the presence of CO2 (5%) at 38.5°C. The COCs were denuded at the optimum IVM 
duration using hyaluronidase to select the MII oocytes. A small portion of the MII 
oocytes were stained with Hoechst 33342 dye to observe the location of the MII spindle 
from PB-1. 
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 The quantity of oocytes retrieved and the maturation rates obtained from LOPU 
versus abattoir sources were analysed by the analysis of variance (ANOVA), followed 
by Duncan’s multiple range test (DMRT). 
 
3.4.3 Production of Cloned Bovine and Gaur Embryos via Intraspecies and 
 Interspecies SCNT Approaches: A Preliminary Study for Caprine SCNT 
 Research (Experiment 3) 
 
This experiment was conducted during a 4 months (August 2009 to December 2009) 
training programme in Embryo and Stem Cell Research Center (ESRC), Suranaree 
University of Technology, Thailand. Since the protocol for bovine intraspecies SCNT 
(intraspSCNT) and gaur interspecies SCNT (interspSCNT) were rather established 
compared to other animal model in ESRC and worldwide, as well as its physiology is 
closely related to caprine, thus this experiment was carried out as a scaffold for the 
development of caprine SCNT protocol in this laboratory. While adapting the SCNT 
protocol from this experiment, a comparison was made in the efficiency between 
intraspSCNT versus interspecies interspSCNT approach. The efficiency between both 
approaches was measured in terms of the fusion rate, cleavage rate and the cloned 
embryo in vitro developmental (IVD) rate from 2-cell stage to hatched blastocyst stage. 
The fusion rate was calculated based on the number of fused cells divided by the 
number of embryos that passed through the electric current generated by the fusion 
machine and the cleavage rate was calculated from the number of cleaved embryo 
divided by the number of fused embryos. The IVD rate was calculated based on the 
number of embryos at each developmental stages divided by the number of fused 
embryos subjected to in vitro culture (IVC).  
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 A total of 181 and 203 matured bovine oocytes were used in the bovine 
intraspSCNT and gaur interspSCNT experiment. Bovine oocytes were collected from 
the local abattoir and transported to the laboratory in 0.9% NaCl at 35 to 37°C. The 
COCs were collected by aspiration of follicles 2-8 mm in diameter using a 21 gauge 
needle attached to a 10 ml syringe. COCs were cultured in IVM medium for 22 to 24 
hours. After IVM, the cumulus cells were mechanically removed from the oocytes by 
repeated pipetting using fine-tip pipette in mDPBS supplemented with 0.2% 
hyaluronidase. Matured oocytes with the presence of PB1 were subjected to the SCNT 
manipulation that consists of 3 main steps: a) enucleation via squeezing technique, b) 
injection of donor karyoplast into the perivitelline space of the enucleated oocytes and c) 
electrofusion. Matured bovine oocytes were subjected to cytochalasin B (CB) treatment 
for 5 minutes prior enucleation. Complete enucleation was then confirmed by staining 
the squeezed out cytoplasm with Hoechst 33342 (5 µg/ml) and visualizing the stained 
nucleus in the cytoplasm under the fluorescence microscope. Bovine and gaur ear 
fibroblast (EF) cells at passage 3 (P3) to P5 were used as the donor karyoplast in the 
production of bovine intraspSCNT and gaur interspSCNT embryos, respectively. Both 
bovine or gaur karyoplast- bovine cytoplast couplets were fused in ZFM medium (Table 
3.18) using two direct current pulses (24 V, 15 µsec) and both successfully fused 
reconstructed oocytes were activated using the same chemical activation treatment of 
EtOH (7%), 5 minutes followed by CD-CHX, 5 hours cultured under a humidified 
atmosphere of 5% CO2 in air at 38.5°C. The bovine intraspSCNT and gaur interspSCNT 
reconstructed oocytes were cultured in mSOFaa medium at 38.5°C under humidified 
atmosphere of 5% CO2, 5% O2 and 90% N2 for 2 days. Embryos at the 8-cell stage were 
selected and co-cultured with bovine oviductal epithelial cells in mSOFaa medium at 
38.5°C under a humidified atmosphere of 5% CO2 in air for an additional 5 days (7 days 
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in total). Half of the IVC medium volume was replaced daily from Day 4 onwards and 
development of the embryos was recorded. 
 The fusion rate, cleavage rate and IVD rates obtained from bovine intraspSCNT 
approach versus gaur interspSCNT approach were analysed by the analysis of variance 
(ANOVA), followed by Duncan’s multiple range test (DMRT). 
 
3.4.4 Improvement on the In Vitro Cloned Caprine Embryos Production by 
 Considering the Effects of Maturation Duration, Activation Treatment and 
 In Vitro Culture Protocol (Experiment 4) 
 
As an effort to develop a caprine intraspSCNT protocol for the present laboratory 
setting and to contribute new findings to the field of caprine intraspSCNT, three sub-
experiments were conducted to evaluate the effects of: a) maturation duration, b) 
activation treatment and c) IVC medium on the developmental competency of cloned 
caprine intraspSCNT embryos. 
 In the first sub-experiment, the effect of two different maturation duration range, 
18 to 22 hours and 23 to 27 hours on the IVD competency of cloned caprine embryos 
using LOPU derived oocytes was evaluated. A total of 83 and 109 caprine oocytes 
derived from stimulated ovaries were subjected to IVM for a duration range of 18 to 22 
hours and 23 to 27 hours, respectively. Comparison was made in terms of the 
percentage of maturation, successful enucleation rate, cleavage rate and IVD rate from 
2-cell to morula stage between oocytes derived from the two IVM duration range tested. 
The matured caprine oocytes were enucleated and reconstructed with caprine ear 
fibroblast (EF) cell (P3 to P5) using the similar protocol described for bovine 
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intraspSCNT in Experiment 3. The successfully fused couplets were chemically 
activated using calcium ionophore [5 µM] (5 min) followed with 6-DMAP [2 mM] (4 h) 
adapted from Shen et al. (2008). In this experiment, the reconstructed caprine oocytes 
were cultured in mSOFaa medium without co-culture with bovine oviductal epithelial 
cells at 38.5°C under a humidified atmosphere of 5% CO2 in air. Changing of medium 
was done at Day-2, 4, 5, 6 and 7 post- activation. The IVD of the cloned embryos was 
recorded when changing of IVC medium was conducted. The optimum IVM duration 
range determined in this sub-experiment was employed in the subsequent caprine 
intraspSCNT experiment that utilised LOPU-derived oocytes. 
 In the second sub-experiment, the effect of two different sequential chemical 
activation treatments, namely:  
i. Protocol A: EtOH [7%] (5 minutes) followed with CD [1.25 µg/ml] + CHX [10 
          µg/ml] (5 hours), adapted from Experiment 3 
ii. Protocol B: CaI [5 µM] (5 minutes) followed with 6-DMAP [2 mM] (4 hours), 
        developed by Shen et al. (2008) on the IVD competency of caprine 
        intraspSCNT embryos was evaluated. 
 A total of 67 and 59 fused reconstructed caprine oocytes were subjected to 
chemical activation using protocol A and B, respectively. The activated reconstructed 
caprine oocytes were cultured in mSOFaa medium at 38.5°C under a humidified 
atmosphere of 5% CO2 in air for 8 days and changing of medium was done similarly as 
the first sub-experiment. The IVD of the cloned embryos was recorded from 2-cell stage 
onwards up to Day 8. 
 The third sub-experiment was conducted to compare the efficacy between 
mSOFaa medium and KSOMaa medium (denoted as KSOMaa A in this experiment) in 
supporting the IVD of cloned caprine embryos. Besides that the effect of using the two-
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step culture system (Treatment B) by increasing the glucose concentration in KSOMaa 
medium (denoted as KSOMaa B in this experiment) at Day 2 culture compared to the 
one-step culture system using the classical KSOMaa medium (Treatment A) on the IVD 
competency of cloned caprine embryos was also evaluated in the fourth sub-experiment. 
 A total of 77 and 70 reconstructed caprine oocytes activated using CaI [5 µM] (5 
minutes) followed with 6-DMAP [2 mM] (4 hours) were subjected to IVC using 
mSOFaa and KSOMaa A, respectively. In a separate experiment, a total of 122 and 131 
reconstructed caprine oocytes were cultured in IVC Treatment A and Treatment B, 
respectively. In IVC Treatment A, reconstructed caprine oocytes were cultured in 
classical KSOMaa A medium for 8 days, while for IVC Treatment B, reconstructed 
caprine oocytes were cultured in KSOMaa A medium for the first 2 days and 
subsequently in KSOMaa supplemented with glucose to the final concentration of 2.78 
mM (KSOMaa B) for another 6 days. The IVD of the cloned embryos was recorded 
from 2-cell stage onwards up to Day 8 during the renewal of IVC medium at Day 2, 
4,5,6,7 and 8. 
 
 
3.4.5 Efficacy of Producing Cloned Caprine Embryos Using Intraspecies versus 
 Interspecies SCNT Approaches (Experiment 5) 
 
This experiment was conducted to evaluate the efficacy of producing cloned caprine 
embryos using intraspSCNT and interspSCNT approaches and comparison was made 
between both approaches in terms of the maturation rate, enucleation rate, fusion rate, 
cleavage rate and IVD rate. The efficacy of each approach was evaluated by comparing 
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the IVD rate of reconstructed cloned caprine embryos of intraspSCNT and interspSCNT 
versus caprine and bovine parthenotes (as control), respectively. Besides that, the 
quality of caprine intraspSCNT, interspSCNT and PA hatched blastocyst were 
investigated by enumerating the number of cells in the hatched blastocyst obtained at 
Day- 8. An attempt to evaluate the implantation competency of caprine intraspSCNT 
and interspSCNT embryos was conducted by carrying out embryo transfer.   
 A total of 235 caprine oocytes retrieved from LOPU- and abattoir-derived 
ovaries were used in the production of caprine intraspSCNT embryos and parthenotes. 
On the other hand, 434 bovine oocytes retrieved from abattoir-derived ovaries were 
used in the caprine interspSCNT experiment and in the production of bovine 
parthenotes. In order to evaluate the efficacy of both the NT approaches, all the oocytes 
retrieved either from caprine or bovine were subjected to the same formulated IVM 
medium and the reconstructed caprine intraspSCNT, interspSCNT and parthenogenesis 
activated (PA) oocytes were subjected to the same chemical activation protocol B (CaI 
[5 µM], 5 min followed with 6-DMAP [2 mM], 4 hr) as well as cultured in the same 
IVC Treatment B at 38.5°C under a humidified atmosphere of 5% CO2 in air for 8 days. 
 A total of 4 to 5 hatched blastocysts derived from each IVP approaches, namely 
caprine intraspSCNT, interspSCNT, PA and bovine PA were stained with Hoechst 
33342. The quality of the hatched blastocysts obtained was evaluated by enumerating 
the number of stained nuclei of the cells that presence.   
 Embryo transfer attempts were conducted to evaluate the post-implantation 
competency of the caprine intraspSCNT and interspSCNT embryos. A total of 12 
female does were subjected to oestrus synchronisation and stimulation according to the 
regime depicted in Figure 3.20. Embryo transfer was conducted on the recipient does 
that were successfully synchronised and stimulated with the presence of at least 1 
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corpus luteum (CL). Two embryo transfer approaches namely oviductal transfer and 
uterine transfer were used for the 2-cell to 8-cell and 8-cell to morula stage cloned 
caprine embryos (intraspSCNT or interspSCNT), respectively. Pregnancy of the 
recipients was diagnosed at 35 days by a real time ultrasound scanner (SSD500V; Aloka, 
Japan) equipped with transrectal probe 
 
3.5 STATISTICAL ANALYSES 
Majority of the data collected in all the experimental designs in this present study were 
presented in mean±standard error of means (mean±SEM) and the data were analysed 
using one-way analysis of variance (ANOVA). The effects of different factors on donor 
does hormonal stimulation, OR, IVM and embryo development following nuclear 
transfer, specified in each experiment were compared and the significant differences 
between the means were further analysed using Duncan Multiple Range Test (DMRT) 
to show specific differences among the factors on the parameter measured and P<0.05 
was considered significant. The analysis was carried out with SPSS (Statistical 
Packages for Social Sciences) for windows, version 17.0, SPSS Inc (2010), USA. 
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Preparation of Donor Does (Oestrus Synchronisation & Superstimulation) for Oocyte 
Retrieval via LOPU (Experiment 1) 
 
Factors: 
a) Source of gonadotrophin (PMSG vs. pFSH) 
b) Number of OR cycles (OR1 vs. OR2 vs. OR3) 
Parameters: 
 No. of follicles per ovary 
 No. of oocytes retrieved per ovary 
 Oocyte retrieval rate 
 Percentage of oocytes retrieved according to oocyte quality (Grade A, B, C, D, E) 
 
Oocyte Retrieval & In Vitro Maturation (IVM) of Oocytes Derived from Different 
Sources (Experiment 2) 
 
Factors: 
a) Source of oocytes (LOPU vs. Abattoir) 
b) IVM durations (15, 18, 21, 24 and 27 hours) 
Parameters: 
 No. of oocytes retrieved per doe 
 Percentage of oocytes retrieved according to oocyte quality (Grade A, B, C and D) 
 Percentage of matured oocytes 
Observations: 
 Morphology of first polar body (PB-1) 
 Localisation of MII spindle and PB-1 
Production of Bovine intraspSCNT & Gaur interspSCNT Embryos: Preliminary 
Study for Caprine SCNT (Experiment 3) 
Factors: 
a) Approaches of SCNT (Bovine intraspSCNT vs. Gaur interspSCNT) 
Parameters: 
 Percentage of successful enucleation 
 Fusion rate 
 Cleavage rate 
 IVD rate (2-, 4-, 8- cell, morula, blastocyst and hatched blastocyst) 
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Production of Caprine intraspSCNT embryos: Effort to Develop Caprine 
intraspSCNT Protocol (Experiment 4) 
Factors: 
a) Optimum IVM durations for LOPU-derived oocytes (18-22 hr vs. 23-27 hr) 
b) Chemical activation protocols (Protocol A: 7% EtOH + CD-CHX vs. Protocol B: 
CaI + 6-DMAP) 
c) IVC medium (mSOFaa vs. KSOMaa) 
d) Modification of glucose concentration in KSOMaa medium (Treatment A IVC: 
IVC in KSOMaa for 8 days vs. Treatment B IVC: IVC in KSOMaa for 2 days + 
KSOMaa with final concentration of 2.78 mM glucose for another 6 days) 
 
Parameters: 
 Maturation rate 
 Percentage of successful enucleation 
 Fusion rate 
 Cleavage rate 
 IVD rate (2-, 4-, 8-cell, morula, blastocyst and hatched blastocyst) 
 
Production of Caprine intraspSCNT and interspSCNT embryos (Experiment 5) 
Factors: 
a) Type of IVP embryos (Cloned embryos vs. parthenotes) 
b) Nuclear transfer approaches (intraspSCNT vs. interspSCNT) 
 
Parameters: 
 Maturation rate 
 Percentage of successful enucleation 
 Fusion rate 
 Cleavage rate 
 IVD rate (2-, 4-, 8-cell, morula, blastocyst and hatched blastocyst) 
 Number of cells in hatched blastocyst 
 Pregnancy rate to evaluate implantation competency of cloned caprine embryos 
after embryo transfer 
 
Figure 3.23: Flow chart of experimental design. 
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Collection of Oocytes via LOPU from 
Oestrus Synchronised & Superstimulated 
Donor Does 
In Vitro Maturation (IVM) 
Collection of Abattoir-derived Ovaries 
Caprine Oocyte Bovine Oocyte 
Enucleation of MII Oocytes 
Injection of Donor Karyoplast (EF cell) into Perivitelline Space 
Electrofusion 
Establishment of Donor Karyoplast 
Gaur, Bovine and Caprine Ear 
Fibroblast (EF) cell 
Cryopreservation of Gaur, Bovine and 
Caprine EF cell line 
Activation 
In Vitro Culture (IVC) 
Staining with Hoechst 33342 dye Embryo Transfer 
Experiment 1 & 2 
Experiment 3, 4 & 5 
Figure 3.24: Flow chart of methodology. 
1
6
4
 
   
   
   
   
   
   
   
                Chapter 4  
                     4.0 RESULTS 
 
 
   
 
165 
 
Chapter 4 
4.0     RESULTS 
 
4.1 EFFECT OF DIFFERENT SOURCES OF GONADOTROPHIN ON 
CAPRINE SUPERSTIMULATION RESPONSES (EXPERIMENT 1) 
In order to study the effect of PMSG (Folligon
®
)
 
and pFSH (Folltropin
®
-V) as 
superstimulation hormones on caprine LOPU-derived oocyte retrieval rate and quality, a 
total of 18 healthy does were randomly selected for oestrus synchronisation and 
superstimulation using single dose injection of PMSG (1200 IU/doe) for oocyte 
retrieval (OR) cycle 1 and 1500 IU/doe for OR2 and OR3, while another 15 healthy 
does were subjected to multiple dose injection of pFSH (overall dosage: 70 mg/doe) in 
each OR cycle for all the 3 OR cycles. Both stimulation protocols using PMSG 
(Folligon
®
)
 
and pFSH (Folltropin
®
-V) were coupled with the administration of hCG 
(Ovidrel
®
) and does were recuperated for an interval of 3 months between the OR 
cycles. The duration between PMSG or pFSH injection and the onset of LOPU was 
standardised at the duration range of 64 to 67 hours and the cumulus oocyte complexes 
(COCs) were retrieved via aspiration from antral follicles of 2 to 3 mm or bigger in 
diameter during laparoscopic oocyte pick-up (LOPU) procedure. The oocytes yielded 
were graded according to cumulus cell investment and oocyte morphology, presented in 
Figure 4.1) 
The effect of PMSG and the number of OR cycles on the caprine ovarian 
response were summarised in Table 4.1.  Does stimulated with PMSG resulted in an 
average of 16.4 follicle formation and 11 oocytes yielded per doe in the three OR cycles 
measured. The effect of PMSG on the ovarian response seemed to decrease when 
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approaching OR3 as the number of follicles and oocytes retrieved (an average of 9.7 
and 6.3, respectively) decreased significantly (P<0.05) compared to its previous cycle 
(16 and 12.1, respectively). Even though the oocyte yield decreased in OR3, the quality 
of the oocytes was not affected as the percentages of oocytes for Grades A, B and C 
retrieved did not differ significantly (P>0.05) from the previous two OR cycles. In OR1 
and OR2, majority of the oocytes retrieved were of Grades A, B and C with the 
percentages ranged from 22.3 to 32.3%, and no significant differences (P>0.05) were 
observed among the percentages of these oocyte grades yielded within their respective 
OR cycles. As the number of OR cycles increased (OR1 to OR3), the percentages of 
Grades D and E oocyte yield increased correspondingly. Significant (P<0.05) increment 
in the percentages of Grades D and E oocytes was observed particularly between OR1 
(8.9% and 1.4%, respectively) vs. OR3 (23.6% and 13.8%, respectively). 
The effect of pFSH and the number of OR cycles on the caprine ovarian 
response were depicted in Table 4.2. The stimulation effect of pFSH apparently similar 
throughout the three OR cycles. Even though the number of follicle formation and 
number of oocytes oocytes retrieved in the first OR cycle was the highest and declined 
steadily for the consecutive OR cycles; however, this was not statistically significant 
(P>0.05). An average of 15.9 follicles was observed and 12.1 oocytes retrieved per doe 
in the three OR cycles. In terms of the oocyte quality, the average percentages of Grades 
A, B, C, D and E oocytes retrieved in three OR cycles were 35.8, 35.2, 18.4, 8.8 and 
1.9%, respectively. No significant differences (P>0.05) in the percentages of oocyte 
Grades A, B, C, D and E were observed between the three OR cycles. In OR1 and OR3, 
the pFSH gave a positive effect on oocyte quality that resulted in significantly (P<0.05) 
higher percentages of Grades A (36.2 and 41.3%, respectively) and B (41.4 and 26.8%, 
respectively) oocytes retrieved compared to Grades C, D and E. 
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Table 4.1: Number and percentages (mean±SEM) of oocytes retrieved from caprine superstimulated with PMSG according to OR cycle and           
      oocyte grade  
OR 
cycle 
No. of 
ovaries 
No. of 
follicles 
per ovary 
No. of 
oocytes 
retrieved 
per ovary 
*Oocyte 
retrieval rate 
Percentage of oocytes retrieved according to oocyte quality (n) 
Grade A Grade B Grade C Grade D Grade E 
 
OR1 
 
36 
 
8.83±0.5
b
 
(308/36) 
 
 
5.61±0.6
ab
 
(202/36) 
 
60.71±4.3
a
 
(202/308) 
 
29.30±4.6
a,y 
(55/202) 
 
28.17±5.1
a,y 
(44/202) 
 
32.25±4.5
a,y 
(78/202) 
 
8.88±2.2
a,x 
(22/202) 
 
1.39±1.4
a,x
 
(3/202) 
OR2 18 8.00±0.6
b
 
(144/18) 
 
6.06±0.5
b 
(109/18) 
76.70±4.3
a
 
(109/144) 
28.49±4.3
a,z
 
(34/109) 
29.49±4.1
a,z
 
(31/109) 
22.25±4.8
a,yz
 
(25/109) 
11.54±3.5
ab,xy
 
(12/109) 
8.24±4.0
ab,x
 
(7/109) 
OR3 6 4.83±0.8
a
 
(29/6) 
 
3.17±0.3
a
 
(19/6) 
72.36±10.5
a
 
(19/29) 
19.45±10.7
a,x
 
(4/19) 
16.67±7.5
a,x
 
(3/19) 
26.39±9.2
a,x
 
(5/19) 
23.61±11.9
b,x
 
(4/19) 
13.89±9.0
b,x
 
(3/19) 
 
Average 
 
20 
(60/3) 
 
8.18±0.4 
(481/60) 
 
5.5±0.4 
(330/60) 
 
66.7±3.2 
(330/481) 
 
28.1±3.2 
(93/330) 
 
27.4±3.3 
(78/330) 
 
28.7±3.2 
(108/330) 
 
11.2±2.1 
(38/330) 
 
4.7±1.8 
(13/330) 
 
ab
Means with different superscripts in a column within a group were significantly different (P<0.05). 
xyz
Means with different superscripts in a row within a group were significantly different (P<0.05). 
*Oocytes retrieval rate refer to the number of oocytes retrieved upon number of follicles observed. 
 
  
1
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Table 4.2: Number and percentage (mean±SEM) of oocytes retrieved from caprine superstimulated with pFSH according to OR cycle and oocyte 
      grade 
OR cycle No. of 
ovaries 
No. of 
follicles 
per ovary 
No. of 
oocytes 
retrieved 
per ovary 
*Oocyte 
retrieval rate 
Percentage of oocytes retrieved according to oocyte quality (n) 
Grade A Grade B Grade C Grade D Grade E 
 
OR1 
 
30 
 
8.20±0.5
a
 
(248/30) 
 
 
6.23±0.6
a
 
(187/30) 
 
74.28±4.1
a 
(187/248) 
 
36.23±4.0
a,z 
(63/187) 
 
41.38±3.8
a,z 
(78/187) 
 
16.44±3.6
a,y 
(29/187) 
 
5.18±1.6
a,x
 
(14/187) 
 
0.80±0.5
a,x 
(3/187) 
OR2 10 7.60±0.7
a 
(76/10) 
 
5.70±0.5
a 
(57/10) 
76.45±5.2
a
 
(57/76) 
32.50±9.0
a,y
 
(17/57) 
20.02±5.4
a,xy
 
(13/57) 
25.12±6.1
a,y
 
(14/57) 
16.52±5.0
a,xy
 
(10/57) 
5.83±3.9
a,x 
(3/57) 
OR3 4 7.00±0.9
a 
(28/4) 
5.75±0.8
a
 
(23/4) 
82.99±7.1
a
 
(23/28) 
41.25±6.6
a,y
 
(10/23) 
26.79±11.8
a,y
 
(6/23) 
15.72±6.0
a,xy
 
(4/23) 
16.25±9.9
a,xy
 
(3/23) 
0.00±0.0
a,x
 
(0/23) 
 
 
Average 
 
14.7 
(44/3) 
 
7.95±0.4 
(352/44) 
 
6.07±0.4 
(267/44) 
 
75.56±3.1 
(267/352) 
 
35.84±3.4 
(90/267) 
 
35.2±3.3 
(97/267) 
 
18.35±2.9 
(47/267) 
 
8.8±1.9 
(27/267) 
 
1.9±0.9 
(6/267) 
 
ab
Means with different superscripts in a column within a group were significantly different (P<0.05). 
xyz
Means with different superscripts in a row within a group were significantly different (P<0.05). 
*Oocytes retrieval rate refer to the number of oocytes retrieved upon number of follicles observed. 
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The results on the effect of PMSG vs. pFSH treatment on caprine ovarian 
response in each OR cycle are shown in Table 4.3. No significant difference (P>0.05) 
was observed in both the number of follicles and number of oocytes retrieved from does 
stimulated with either PMSG or FSH treatment in OR1 and OR2. However in OR3, the 
average number of oocytes retrieved from a doe stimulated with PMSG (6.4) was 
significantly (P<0.05) lower from a doe stimulated with pFSH (11.6).  
In terms of oocyte quality, significant difference (P<0.05) between oocyte 
quality derived from ovaries stimulated with PMSG vs. pFSH was only observed in 
OR1. Caprine ovaries stimulated with pFSH produced significantly higher percentage of 
Grade B oocyte (41.4%) compared to PMSG stimulated ovaries (28.2%) in OR1. On the 
other hand, percentage of Grade C oocytes (32.3%) yielded was significantly higher 
from PMSG stimulated ovaries compared to pFSH stimulated ovaries (16.4%). Both 
PMSG and pFSH stimulations did not result in a high percentages of Grades D and E 
oocyte yielded in OR1, in which this was a rather favourable effect.  
In OR2, no significant difference was observed in the percentages of oocyte 
yielded in each oocyte Grade between ovaries stimulated with PMSG vs. pFSH. 
Majority of the oocytes yielded from PMSG and pFSH stimulated ovaries distributed in 
the categories of Grades A, B and C.  
In OR3, no significant difference was observed in the quality of oocytes yielded 
from PMSG vs. pFSH stimulated ovaries. Majority of the oocytes yielded from PMSG 
stimulated ovaries distributed in the categories of Grades A, C and D, while for pFSH 
stimulated ovaries majority of the oocytes were of Grades A and B. 
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Table 4.3: Number and percentage (mean±SEM) of oocytes retrieved from caprine superstimulated with PMSG versus pFSH according to OR 
      cycle and oocyte grade 
OR cycle Type of 
hormone 
No. of 
follicles per 
ovary 
No. of 
oocytes 
retrieved per 
ovary 
Percentage of oocytes retrieved according to oocyte quality (n) 
Grade A Grade B Grade C Grade D Grade E 
OR1 PMSG 8.8±0.5
a
 
(308/36) 
5.6±0.6
a
 
(202/36) 
29.3±4.6
a
 
(55/202) 
28.2±5.1
a
 
(44/202) 
32.3±4.5
b
 
(78/202) 
8.9±2.2
a
 
(22/202) 
1.4±1.4
a
 
(3/202) 
pFSH 8.2±0.5
a
 
(248/30) 
6.2±0.6
a
 
(187/30) 
36.2±4.0
a
 
(63/187) 
41.4±3.8
b
 
(78/187) 
16.4±3.6
a
 
(29/187) 
5.2±1.6
a
 
(14/187) 
0.8±0.5
a
 
(3/187) 
OR2 PMSG 8.0±0.6
a
 
(144/18) 
6.1±0.5
a
 
(109/18) 
28.5±4.3
a
 
(34/109) 
29.5±4.1
a
 
(31/109) 
22.2±4.8
a
 
(25/109) 
11.5±3.5
a
 
(12/109) 
8.2±4.0
a
 
(7/109) 
pFSH 7.6±0.7
a
 
(76/10) 
5.7±0.5
a
 
(57/10) 
32.5±9.0
a
 
(17/57) 
20.0±5.4
a
 
(13/57) 
25.1±6.1
a
 
(14/57) 
16.5±4.9
a
 
(10/57) 
5.8±3.9
a
 
(3/57) 
OR3 PMSG 4.8±0.8
a
 
(29/6) 
3.2±0.3
a
 
(19/6) 
19.4±10.7
a
 
(4/19) 
16.7±7.5
a
 
(3/19) 
26.4±9.2
a
 
(5/19) 
23.6±11.9
a
 
(4/19) 
13.9±9.0
a
 
(3/19) 
pFSH 7.0±0.9
a
 
(28/4) 
5.8±0.8
b
 
(23/4) 
41.3±6.6
a
 
(10/23) 
26.8±11.8
a
 
(6/23) 
15.7±6.0
a 
(4/23) 
16.3±9.9
a
 
(3/23) 
0.0±0.0
a
 
(0/23) 
ab
Means with different superscripts in a column within a group were significantly different (P<0.05). 
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i ii iii 
iv v 
Note: (photomicrographs original magnification: 200x) 
Figure 4.1: Caprine oocyte graded according to cumulus cells (CCs) investment and  
       morphology of oocyte. (i) Grade A; (ii) Grade B; (iii) Grade C; (iv) Grade D; (v) 
       Grade E. 
Cumulus cells Caprine oocyte 
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4.2 EFFECT OF DIFFERENT SOURCES OF CAPRINE OOCYTES ON 
THE OOCYTE YIELD, GRADES AND MATURATION 
PERFORMANCE (EXPERIMENT 2) 
This present study was conducted to investigate the effect of two different sources of 
caprine oocytes namely the LOPU and abattoir sources on the quantity and quality of 
oocytes yielded. Besides that, the optimum IVM time range for oocytes derived from 
both LOPU and abattoir sources were determined and the meiotic competence of the 
oocytes was evaluated. 
 
4.2.1 Effect of Two Different Sources of Caprine Oocytes on the Quantity and 
 Quality  
Caprine oocytes used in this experiment were obtained from two different sources, 
namely retrieval from live does via LOPU and ovaries of slaughtered does from local 
abattoirs. Oocyte retrieval via LOPU procedure was carried out by aspirating only 
follicles of 2 to 3 mm or bigger in diameter; however, this could not be maintained in 
the case of abattoir-derived ovaries as during slicing, smaller follicles (<2 to 3 mm) 
could not be ignored. Evaluation on the oocyte quality from both sources did not 
include the percentage of Grade E oocytes. 
 The results for the oocyte yield and its quality from LOPU procedure and 
abattoir-derived ovaries are summarised in Table 4.4. A total of 154 oocytes were 
retrieved from 28 ovaries via LOPU and 549 oocytes from 56 sliced abattoir-derived 
ovaries. The oocyte recovery per doe was significantly (P<0.05) higher in abattoir 
(20.2) than LOPU (11) source. Abattoir source yielded higher oocyte recovery; 
however, better quality of oocytes was retrieved from LOPU source. This was 
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vividly apparent in the recovery of a significantly (P<0.05) higher proportion of 
Grade A oocytes retrieved from LOPU (39.2%) compared to abattoir source (18.4%). 
In addition, a significantly (P<0.05) lower proportion of Grade C (15.6% from 
LOPU vs. 33.8% from abattoir) and Grade D oocytes (5.0% from LOPU vs. 15.5% 
from abattoir) were retrieved from LOPU compared to the abattoir source. When 
considering different grades in each source, significantly (P<0.05) higher proportion 
of Grades A and B oocytes were retrieved from LOPU followed by Grades C and D. 
On the other hand, significantly (P<0.05) higher proportions of Grades B and C 
oocytes were retrieved from abattoir source followed by Grades A and D.
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Table 4.4: Percentage (%, mean±SEM) of caprine oocytes retrieved from LOPU- versus abattoir-derived ovaries 
Oocyte 
source 
No. of 
replicates 
No. of 
does 
(ovaries) 
used 
No. of oocytes 
retrieved per 
doe 
Percentage of oocytes retrieved according to oocyte quality (n) 
 Grade A Grade B Grade C Grade D 
 
LOPU 
 
14 
 
14 (28) 
 
11.0±0.86
a
 
(154/14) 
 
39.2±4.1
b,z
 
(58/154) 
 
40.1±2.8
a,z
 
(63/154) 
 
15.6±3.8
a,y
 
(24/154) 
 
5.0±1.8
a,x
 
(9/154) 
 
Abattoir 
 
6 
 
28 (56) 
 
20.2±1.2
b
 
(549/28) 
 
18.4±2.0
a,x
 
(104/549) 
 
32.3±2.1
a,y
 
(175/549) 
 
33.8±2.5
b,y
 
(182/549) 
 
15.5±2.8
b,x
 
(88/549) 
 
ab
Means with different superscripts in a column within a group were significantly different (P<0.05). 
xyz
Means with different superscripts in a row within a group were significantly different (P<0.05). 
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4.2.2 Determination of an Optimised IVM Time Range for Caprine Oocytes 
 Derived from Two Different Sources 
The results for the determination of an optimal in vitro maturation (IVM) duration range 
for LOPU and abattoir derived caprine oocytes are depicted in Table 4.5. Maturation 
rate was measured by observing the presence of the first polar body (PB-1) at five IVM 
durations (15, 18, 21, 24 and 27 hours).  Localisation of MII spindle on matured oocyte 
was examined by fluorescence staining using Hoechst 33345. 
 Maturation of LOPU-derived caprine oocytes were found to occur as early as 15 
hours; however, the maturation rate (6.7%) was rather low. The maturation rate started 
to increase significantly (P<0.05) at 18 hours (53.3%) and peaked at 21 hours (86.7%). 
At 24 hours, the maturation rate was slightly reduced and a significant (P<0.05) drop in 
the maturation rate was observed at 27 hours (46.7%). Morphological evaluation on the 
PB-1 extrusion and its shape under the light microscope showed that more than 80% of 
the matured oocytes at 18 and 21 hours and 50% of the 24 hours matured oocytes had 
polar body with smooth surface (normal matured oocyte) and was not fully extruded (80 
to 90%) from the cytoplast (Figure 4.2). However, at 27 hours, matured oocytes (>65%) 
had polar bodies that either fully extruded (100% separated from the cytoplast) or with 
fragmentation (abnormal oocyte) (Figure 4.3). In terms of the observation on the 
localisation of the MII spindle under the fluorescence microscope, matured oocytes at 
24 hours started to show translocation of its MII spindle apart from the polar body; 
while MII spindle translocated even further apart from PB-1 in matured oocytes at 27 
hours (Figure 4.4). In nuclear transfer experiment, the location of MII spindle close to 
PB-1 is important as it determines the success rate of enucleation using blind squeezing 
technique. 
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 In contrast to LOPU-derived oocytes, commencement of maturation for abattoir-
derived oocytes was found to occur later at 21 hours (53.3%). At 15 hours post-
maturation, the abattoir derived oocytes were found to be in either metaphase I or 
anaphase I. Maturation rate of abattoir-derived oocytes peaked at 24 hours (80.0%) and 
slightly reduced (P>0.05) approaching 27 hours (73.3%). Majority of the matured 
oocytes (>80%) at 21 and 24 hours had polar body with smooth surface (normal 
matured oocyte) and was not fully extruded (80 to 90%) from the cytoplast. On the 
other hand, at 27 hours, some of the matured oocytes (<30%) had PB-1 that fully 
extruded (100% separated from the cytoplast) (Figure 4.5). Translocation of the MII 
spindle apart from PB-1 was observed only on matured oocytes at 27 hours (<30%).  
 Even though there were no significant differences (P>0.05) observed in the 
maturation rates at 21, 24 and 27 hours between the LOPU- and abattoir-derived 
oocytes, the quality of matured LOPU-derived oocytes in terms of the PB-1 morphology 
showed sign of fragmentation at 27 hours and translocation of the MII spindle apart 
from PB-1 started at 24 hours.  
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Table 4.5: Maturation rates (%, mean±SEM) of caprine oocytes retrieved from LOPU and abattoir at different IVM durations 
Oocyte source No. of replicates Percentage of MII oocytes at different IVM durations 
15 hours 18 hours 21 hours 24 hours 27 hours 
 
LOPU 
 
3 
 
6.7±6.7
a,w
 
(1/15) 
 
53.3±6.7
b,xy
 
(8/15) 
 
86.7±6.7
a,z
 
(13/15) 
 
73.3±6.7
a,yz
 
(11/15) 
 
46.7±6.7
a,x
 
(8/15) 
 
Abattoir 
 
3 
 
0.0
a,x
 
(0/15) 
 
0.0
a,x 
(0/15) 
 
53.3±17.6
a,y
 
(9/15) 
 
80.0±11.5
a,y
 
(12/15) 
 
73.3±13.3
a,y
 
(11/15) 
 
ab
Means with different superscripts in a column within a group were significantly different (P<0.05). 
wxyz
Means with different superscripts in a row within a group were significantly different (P<0.05). 
 
 
 
 
 
 
1
7
7
 
178 
 
4.2.3 Evaluation on the Meiotic Competency of Caprine Oocyte Derived from 
 Two Different Sources According to Oocyte Quality 
 
The maturation rates according to oocyte quality from two different sources, LOPU- 
versus abattoir-derived oocytes are shown in Table 4.6. The LOPU- and abattoir-
derived oocytes were subjected to IVM duration of 18 to 22 hours and 22 to 26 hours, 
respectively, using the same formulation of IVM medium as depicted in Table 3.8. The 
overall maturation rate measured regardless of oocyte grades showed that LOPU-
derived oocytes have significantly (P<0.05) higher maturation rate compared to the 
abattoir-derived oocytes (79.6% versus 69.7%). However, when the comparison was 
made within each oocyte grades, no significant differences (P<0.05) was observed in 
the maturation rate between LOPU- and abattoir-derived oocyte. 
 When considering the maturation rate of different oocyte grades in LOPU source, 
significantly (P<0.05) higher maturation rates were observed in oocytes of Grades A, B 
and C (percentage range: 61.1 to 84.4 %) compared to Grade D (28.6%). Similar trend 
was observed for the abattoir source in which the maturation rates of Grades A, B and C 
(percentage range: 73.1 to 79.6%) were significantly (P<0.05) higher compared to 
Grade D (45.2%). 
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Table 4.6: Maturation rate (%, mean±SEM) of caprine oocytes retrieved from LOPU- versus abattoir-derived ovaries according to oocyte quality 
      using optimised IVM duration (LOPU: 18-22 hours; Abattoir: 22-26 hours) 
Oocyte 
source 
No. of 
oocytes 
retrieved 
per doe 
Maturation rate Percentage of matured oocytes according to oocyte quality (n) 
Grade A Grade B Grade C Grade D 
 
LOPU 
 
11.0±0.86
a
 
(154/14) 
 
79.6±2.6
b
 
(121/154) 
 
84.4±3.3
a,y
 
(47/58) 
 
82.1±4.9
a,y
 
(50/63) 
 
61.1±11.6
a,y
 
(19/24) 
 
28.6±11.4
a,x
 
(5/9) 
 
Abattoir 
 
20.2±1.2
b
 
(549/28) 
 
69.7±3.7
a
 
(386/549) 
 
76.4±4.2
a,y
 
(82/104) 
 
79.6±3.1
a,y
 
(139/175) 
 
73.1±5.7
a,y
 
(126/182) 
 
45.2±7.5
a,x
 
(39/88) 
 
ab
Means with different superscripts in a column within a group were significantly different (P<0.05). 
xy
Means with different superscripts in a row within a group were significantly different (P<0.05). 
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Note: (photomicrographs original magnification: 200x); (PB-1: first polar body) 
 
Figure 4.2: Caprine in vitro matured oocytes with normal morphology of PB-1 (smooth       
       surface and not fully extruded) obtained from:-  (i-ii) LOPU oocytes at IVM  
       duration 18-24 hours, (iii) abattoir oocyte at IVM duration 21-24 hours. Note: no         
                  difference was detected in oocyte morphology between LOPU and abattoir oocytes. 
Note: (photomicrographs original magnification: 200x); (PB-1: first polar body) 
 
Figure 4.3: Caprine in vitro matured oocytes with abnormal morphology of PB-1      
       (fragmented) obtained from:- (i) LOPU oocyte at IVM duration 27 hours, (ii-iii) 
        abattoir oocytes at IVM duration 27 hours. 
 
PB-1 PB-1 
(i) (ii) (iii) 
Fragments 
(i) (ii) (iii) 
PB-1 Fragmented PB-1 
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Note: (photomicrographs original magnification: 200x); (PB-1: first polar body); (MII: metaphase II) 
 
Figure 4.4: LOPU-derived caprine oocyte in vitro matured at:- (i) 15 hours showing 
        MII spindle located closely to PB-1, (ii) 18 hours showing MII spindle 
        located closely to PB-1, (iii) 21 hours showing MII spindle located close 
        to PB-1, (iv) 24 hours showing MII spindle start to translocate apart from 
        PB-1 and (v) 27 hours showing MII spindle translocated far apart from PB-1.  
PB I 
Note: (photomicrographs original magnification: 200x); (PB-1: first polar body); (MII: metaphase II) 
 
Figure 4.5: Abattoir-derived caprine oocyte at IVM duration of:- (i-ii) 15 hours  showing        
       oocyte at metaphase I and anaphase I, respectively; (iii) 18 hours showing MII 
       spindle located closely to PB-1, (iv) 21 hours showing MII spindle  located       
       closely to PB-1, (v) 24 hours showing MII spindle translocated apart from PB-      
       1 and (vi) 27 hours showing MII spindle translocated far apart from PB-1.  
(vi) (iv) 
(i) 
PB- 1 
MII spindle 
(iii) 
(v) 
Metaphase I (ii) Anaphase I 
 
 
 
(ii) 
PB -1 MII spindle 
(i) (iii) 
(iv) (v) 
PB -1 MII spindle PB -1 MII spindle 
MII spindle PB -1 PB -1 
MII spindle 
PB -1 PB -1 PB -1 MII spindle MII spindle MII spindle 
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4.3 PRODUCTION OF CLONED BOVINE AND GAUR EMBRYOS VIA 
INTRASPECIES AND INTERSPECIES SCNT APPROACHES: A 
PRELIMINARY STUDY FOR CAPRINE SCNT RESEARCH 
(EXPERIMENT 3) 
The manipulation efficiencies of bovine-bovine intraspecies SCNT (intraspSCNT) and 
gaur-bovine interspecies SCNT (interspSCNT) approaches are summarised in Table 4.7. 
There were a total of 181 and 203 matured bovine oocytes used in the bovine 
intraspSCNT and gaur interspSCNT studies, respectively. The success rate of 
manipulation in terms of enucleation and injection were high for both the bovine 
intraspSCNT (89.15% and 95.94%) and gaur interspSCNT (91.41% and 96.25%) in this 
preliminary attempt. Both bovine intraspSCNT and gaur interspSCNT approaches did 
not show any significant difference (P>0.05) in the fusion rate and cleavage rate. The 
morphology of matured bovine cumulus oocyte complexes (COCs) and the gaur ear 
fibroblast cell culture were presented in Figure 4.6. 
 The subsequent in vitro developmental (IVD) rates for both bovine intraspSCNT 
and gaur interspSCNT embryos are depicted in Table 4.8. There were a total of 93 out 
of 119 reconstructed bovine intraspSCNT oocytes developed to 2-cell stage giving an 
initial IVD percentage of 77.91%. The cloned bovine 2-cell embryo further developed 
to 4-cell, 8-cell, morula, compact morula, blastocyst and hatched blastocyst at the 
percentages of 69.85±2.48, 65.30±3.17, 46.12±2.42, 37.10±1.69, 20.29±2.59 and 
18.63±2.14, respectively. There were significant reductions (P<0.05) in the IVD rate 
from 2-cell to 4-cell and 8-cell up to blastocyst stages. However, there was no 
significant reduction (P>0.05) in the percentage of cloned bovine blastocysts developed 
to hatched blastocysts. 
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 As for the cloned gaur interspSCNT embryos, the IVD rate reduced non-
significantly (P>0.05) from one stage to another starting with 2-cell (73.76±2.16), 4-cell 
(69.87±2.50), 8-cell (62.52±4.06) up to morula (45.86±1.36). However, IVD rate of 
cloned gaur embryos started to portray a significant reduction (P<0.05) in each embryo 
stage from morula (45.86±1.36), compact morula (34.46±2.14) up to blastocyst stage 
(20.91±3.90). The percentage of hatched blastocyst obtained was 19.02±3.35 in which 
the percentage of reduction did not differ significantly (P>0.05) from the blastocyst 
stage. When comparing the IVD rate between bovine intraspSCNT vs. gaur 
interspSCNT embryos across stages from 2-cell to hatched blastocyst, the IVD rates 
within each cell stage for both bovine intraspSCNT and gaur interspSCNT did not differ 
significantly (P>0.05). The morphology of in vitro developed gaur interspSCNT 
embryos were presented in Figure 4.7. 
 
Table 4.7: Percentage (mean±SEM) of success in enucleation, injection, fusion and        
                 cleavage rate for bovine intraspSCNT and gaur interspSCNT embryos  
      production 
 
*Only fusion rate and cleavage rate were analysed with one-way ANOVA. 
a
Means with similar superscript in a column within a group were not significantly different 
(P>0.05). 
Type of SCNT 
approaches 
No. of 
replicates 
Percentage 
of oocytes 
successfully 
enucleated 
(n) 
Percentage 
of oocytes 
successfully 
injected 
with donor 
karyoplast 
(n) 
Percentage 
of couplets 
successfully 
fused* (n) 
Percentage of 
reconstructed 
embryos 
cleaved* (n) 
 
intraspSCNT 
(Bovine-bovine) 
 
 
6 
 
89.15±8.22 
(162/181) 
 
95.94±6.70 
(157/162) 
 
74.31±9.40
a
 
(119/157) 
 
77.70±2.26
a
 
(93/119) 
interspSCNT 
(Gaur-bovine) 
 
7 91.41±6.34 
(185/203) 
96.25±5.15 
(178/185) 
70.43±7.68
a
 
(127/178) 
73.75±5.71
a
 
(95/127) 
Total 13 90.37 
(347/388) 
96.55 
(335/347) 
73.44 
(246/335) 
76.43 
(188/246) 
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Table 4.8: Percentage (mean±SEM) of in vitro developmental rate for bovine intraspSCNT and gaur interspSCNT cloned embryos 
 
Type of SCNT 
approach 
 
Percentage of cleaved reconstructed embryos according to cell stage (n) 
2-cell 4-cell 8-cell Morula Compact 
morula 
Blastocyst Hatched 
blastocyst 
 
intraspSCNT 
(Bovine-bovine) 
 
77.91±0.93
a,z
 
(93/119) 
 
69.85±2.48
a.y
 
(83/119) 
 
65.30±3.17
a,y
 
(77/119) 
 
46.12±2.42
a,x
 
(54/119) 
 
37.10±1.69
a,w
 
(43/119) 
 
20.29±2.59
a,v
 
(25/119) 
 
18.63±2.14
a,v
 
(23/119) 
 
interspSCNT 
(Gaur- bovine) 
 
73.76±2.16
a,z
 
(95/127) 
 
 
69.87±2.50
a,yz
 
(90/127) 
 
62.52±4.06
a,xy
 
(79/127) 
 
45.86±1.36
a,x
 
(53/127) 
 
34.46±2.14
a,w
 
(45/127) 
 
20.91±3.90
a,v
 
(28/127) 
 
19.02±3.35
a,v
 
(25/127) 
Total 75.67±1.33 
(188/246) 
69.86±1.69 
(173/246) 
63.81±2.56 
(156/246) 
45.98±1.27 
(107/246) 
35.68±1.39 
(88/246) 
20.62±2.32 
(53/246) 
18.84±1.98 
(48/246) 
 
a
Means with similar superscript in a column within a group were not significantly different (P>0.05). 
vwwxyz
Means with different superscripts in a row within a group were significantly different (P<0.05). 
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Note: (photomicrographs original magnification: 40x) 
Figure 4.6: (i) Abattoir-derived bovine COCs after maturation; (ii) Gaur ear  
        fibroblast cell culture. 
(i) (ii) 
(i) (ii) 
(iii) (iv) 
Note: (Original magnification of photomicrographs (i, ii, iv):100x;  (iii) 40x) 
Figure 4.7: In vitro development of gaur interspSCNT embryos. (i) 8-cell stage; (ii) 
       compacting morula; (iii) early blastocyst and hatched blastocyst; (iv)         
       hatched blastocyst. 
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4.4 IMPROVEMENT ON THE IN VITRO CLONED CAPRINE EMBRYOS 
PRODUCTION BY CONSIDERING THE EFFECTS OF 
MATURATION DURATION, ACTIVATION TREATMENT AND IN 
VITRO CULTURE PROTOCOL (EXPERIMENT 4) 
 
The effect of three different factors, namely the maturation duration, activation 
treatment and in vitro culture (IVC) protocol on the in vitro developmental (IVD) rate of 
cloned caprine embryos were studied in this experiment. The best parameter that gave 
the highest IVD rate in each factor measured was used in the subsequent caprine nuclear 
transfer experiments. 
 
4.4.1 Effect of Two Different IVM Intervals on Cloned Caprine IVD Competency 
 using Ovarian- Superstimulated Caprine Oocyte 
In this experiment, the maturation and manipulation rate as well as the IVD competency 
of cloned caprine embryos reconstructed using LOPU-derived oocyte matured at the 
IVM durations of 18 to 22 hours and 23 to 27 hours were evaluated. The maturation rate, 
percentage of successful enucleation, fusion rate and cleavage rate for oocytes matured 
in both IVM durations are shown in Table 4.9. LOPU-derived caprine oocytes matured 
at 18 to 22 hours (75.2%) showed significantly (P<0.05) higher maturation rate 
compared to oocytes matured at 22 to 27 hours (62.6%). In terms of the percentage of 
successful enucleation using blind squeezing technique, oocytes matured at 18 to 22 
hours gave a significantly (P<0.05) higher success rate compared to oocytes matured at 
23 to 27 hours (80.2% vs. 64.2%). No significant difference (P>0.05) was observed in 
the fusion rate between oocytes matured at 18 to 22 hours versus 23 to 27 hours. The 
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cleavage rate of the reconstructed oocytes matured at 18 to 22 hours was significantly 
higher (P<0.05) compared to oocyte matured at 23 to 27 hours (84.2% vs. 67.7%). 
 The reconstructed oocyte matured at 18 to 22 hours had significantly (P<0.05) 
higher IVD competency compared to reconstructed oocyte matured at 23 to 27 hours 
(Table 4.10). This was evident by the significantly (P<0.05) higher percentages of 2-cell, 
8-cell and morula developed from reconstructed oocytes matured at 18 to 22 hours (84.2, 
65.9, and 46.6%) versus oocyte matured at 23 to 27 hours (67.7, 46.4 and 24.7%). No 
blastocyst was obtained from the reconstructed oocytes matured in both the IVM 
durations tested. 
 
 
Table 4.9: Percentage (%, mean±SEM) of maturation, enucleation, fusion and     
      cleavage rate of LOPU derived caprine oocyte treated in 2 different IVM  
                 durations 
 
IVM 
duration 
(hour) 
Percentage of (n) 
Maturation rate Successful 
enucleation  
Fusion rate Cleavage rate 
 
18-22 
 
75.2±3.3
b
 
(63/83) 
 
80.2±3.1
b
 
(50/63) 
 
82.5±3.1
a
 
(41/50) 
 
84.2±5.5
b
 
(34/41) 
 
23-27 
 
62.6±1.3
a
 
(68/109) 
 
64.2±4.7
a
 
(44/68) 
 
84.1±4.5
a
 
(37/44) 
 
67.7±1.7
a
 
(25/37) 
 
ab
Means with different superscripts in a column within a group were significantly different 
(P<0.05). 
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Table 4.10: Percentage (%, mean±SEM) of in vitro developmental rate for cloned    
        caprine embryos using LOPU derived oocytes matured in 2 different IVM  
        intervals  
 
IVM 
duration 
(hour) 
Percentage of in vitro development (n) 
2-cell 4-cell 8-cell Morula 
 
18-22 
 
84.2±5.5
b,z
 
(34/41) 
 
74.7±4.1
a,yz
 
(30/41) 
 
65.9±6.7
b,y
 
(26/41) 
 
46.6±4.4
b,x
 
(19/41) 
 
23-27 
 
67.7±1.7
a,z
 
(25/37) 
 
60.4±4.6
a,z
 
(22/37) 
 
46.4±3.4
a,y
 
(16/37) 
 
24.7±7.1
a,x
 
(9/37) 
 
ab
Means with different superscripts in a column within a group were significantly different 
(P<0.05). 
xyz
Means with different superscripts in a row within a group were significantly different 
(P<0.05). 
 
 
 
 
4.4.2 Effect of Two Different Activation Protocols on the In Vitro 
 Developmental Competency of Reconstructed Caprine Embryos  
The efficiency of two different type of sequential activation protocols on the IVD 
competency of reconstructed caprine embryos were evaluated in this experiment. A total 
of 67 successfully fused caprine oocytes were chemically activated using EtOH (7%) 
for 5 minutes followed with Cytochalasin D (1.25 µg/ml) and Cycloheximide (10 µg/ml) 
for 5 hours in the incubator (5% CO2, 38.5°C); While another 59 fused caprine oocytes 
were chemically activated using Calcium Ionophore (5 µM) for 5 minutes followed with 
6-Dimethylaminopurine (2 mM) for 4 hours in the incubator (5% CO2, 38.5°C). The 
IVD competency of the reconstructed oocytes activated using the above mentioned 
activation protocols are depicted in Table 4.11.  
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 No significant differences (P>0.05) observed between the IVD competency of 
reconstructed oocytes activated using 7% EtOH + CD-CHX versus CaI + 6-DMAP 
throughout the 2-cell (78.9% vs. 80.7%) to morula (40.0% vs. 42.8%) IVD stages. None 
of the activated reconstructed embryos cultured in this culture system using mSOFaa 
medium managed to develop beyond morula stage. Both activation protocol resulted in 
the similar decreasing in vitro development trend from 2-cell to morula. 
 
 
 
Table 4.11: Percentage (%, mean±SEM) of in vitro developmental rate for     
        reconstructed caprine embryos using two different sequential activation 
        protocols 
   
Type of activation 
protocol 
No. of 
fused 
oocytes 
activated 
Percentage of in vitro development (n) 
 2-cell 4-cell 8-cell Morula 
 
7% EtOH +  
CD-CHX 
 
67 
 
78.9±1.3
a,z
 
(53/67) 
 
68.8±0.8
a,y
 
(46/67) 
 
58.0±2.3
a,x
 
(39/67) 
 
40.0±1.2
a,w
 
(27/67) 
 
CaI +  
6-DMAP 
 
59 
 
80.7±2.9
a,z
 
(48/59) 
 
70.8±1.8
a,y
 
(42/59) 
 
57.4±1.5
a,x
 
(34/59) 
 
42.8±2.7
a,w
 
(25/59) 
 
a
Means with similar superscript in a column within a group were not significantly different 
(P>0.05). 
wxyz
Means with different superscripts in a row within a group were significantly different 
(P<0.05).  
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4.4.3 Effect of Two Different In Vitro Culture Media on the In Vitro 
 Developmental Competency of Reconstructed Caprine Embryos 
 
The IVD competency of reconstructed caprine embryos cultured in two in vitro culture 
(IVC) media namely, mSOFaa and KSOMaa (denoted as KSOMaa A in this experiment) 
were evaluated in this experiment (Table 4.12). A total of 58 and 70 reconstructed caprine 
oocytes activated with CaI (5 minutes) + 6-DMAP (4 hours) were cultured in mSOFaa and 
KSOMaa A respectively. Significant differences (P<0.05) were observed in the IVD 
competency between the reconstructed oocytes cultured in mSOFaa versus KSOMaa A at 
2-cell (73.1% vs. 84.2%) and 8-cell (50.2% vs. 60.4%). However at 4-cell stage, no 
significant difference (P>0.05) was observed in the IVD rate of embryos cultured in 
mSOFaa and KSOMaa A. The KSOMaa A favourably supported the in vitro development 
of reconstructed embryos at later developmental stages in which the percentage of morula 
(42.8%) was significantly (P<0.05) higher compared to the embryos cultured in mSOFaa 
(32.1%) and the positive effect of KSOMaa A was even prominent when none of the 
reconstructed embryos cultured in mSOFaa managed to developed up to blastocyst stage 
compared to embryos cultured in KSOMaa A (3.85%). The developmental rates for the 
various stages of embryos showed similar descending trend for both the IVC media used.  
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 Table 4.12: Percentage (%, mean±SEM) of in vitro developmental rate for cloned caprine embryos cultured in mSOFaa versus KSOMaa 
Type of 
IVC 
medium 
No of 
reconstructed 
oocyte 
cultured 
Percentage of  in vitro development (n) 
2-cell 4-cell 8-cell Morula Blastocyst Hatched 
blastocyst 
 
mSOFaa 
 
58 
 
73.1±2.3
a,z
 
(42/58) 
 
62.9±6.1
a,z
 
(35/58) 
 
50.2±2.7
a,y
 
(29/58) 
 
32.1±2.8
a,x
 
(18/58) 
 
0.0±0.0
a,w
 
(0/58) 
 
0.0 
(0/58) 
 
KSOMaa A 
 
70 
 
84.2±3.2
b,z
 
(59/70) 
 
71.5±3.9
a,y
 
(50/70) 
 
60.4±3.1
b,x
 
(42/70) 
 
42.8±2.7
b,w
 
(30/70) 
 
3.85±2.3
a,v
 
(3/70) 
 
0.0 
(0/70) 
 
 ab
Means with different superscripts in a column within a group were significantly different (P<0.05). 
 vwxyz
Means with different superscripts in a row within a group were significantly different (P<0.05). 
 
 
 
1
9
1
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4.4.4 Effect of Increasing Glucose Concentration in KSOMaa medium at Day 2 
 culture on the In Vitro Developmental Competency of Reconstructed 
 Caprine Embryos 
 
The effect of increasing glucose in KSOMaa B to the final concentration of 2.78 mM 
for Day- 2 to 8 (Treatment B IVC) versus the used of classic KSOMaa A formulation 
throughout the 8 days (Treatment A IVC) on the IVD competency of cloned caprine 
embryos were evaluated (Table 4.13). The IVD competency of reconstructed caprine 
embryos for early developmental stages (2- to 8-cell) cultured in Treatment A IVC 
versus Treatment B IVC did not differ significantly (P>0.05). However, the effect of 
increasing glucose concentration in Treatment B IVC increased the morula (46.7%), 
blastocyst (19.9%) and hatched blastocyst (15.6%) rates of the reconstructed caprine 
embryos significantly (P<0.05) compared to caprine embryos cultured in Treatment A 
IVC. None of the cloned caprine blastocyst cultured in Treatment A IVC managed to 
hatch. 
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 Table 4.13: Percentage (%, mean±SEM) of in vitro developmental rate for cloned caprine embryos cultured in two different IVC treatments 
Type of IVC 
treatment 
No of 
reconstructed 
oocyte 
cultured 
Percentage of  in vitro development (n) 
2-cell 4-cell 8-cell Morula Blastocyst Hatched 
blastocyst 
 
Treatment A 
 
122 
 
76.8±2.2
a,z
 
(94/122) 
 
68.1±1.7
a,y
 
(83/122) 
 
58.2±2.3
a,x
 
(71/122) 
 
34.9±2.3
a,w
 
(42/122) 
 
3.8±1.5
a,v 
(5/122) 
 
0.0±0.0
a,v
 
(0/122) 
 
Treatment B 
 
131 
77.4±1.9
a,z
 
(103/131) 
68.5±2.6
a,y
 
(91/131) 
60.4±1.6
a,x
 
(80/131) 
46.7±1.7
b,w
 
(61/131) 
19.9±1.5
b,v
 
(26/131) 
15.6±2.5
b,v
 
(18/131) 
 
 ab
Means with different superscripts in a column within a group were significantly different (P<0.05). 
 vwxyz
Means with different superscripts in a row within a group were significantly different (P<0.05). 
  Note: Treatment A IVC: IVC in KSOMaa for 8 days; 
  Treatment B IVC: IVC in KSOMaa for 2 days + KSOMaa with final concentration of 2.78 mM glucose for another 6 days. 
 
 
 
 
1
9
3
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4.5 EFFICACY OF PRODUCING CLONED CAPRINE EMBRYOS USING 
INTRASPECIES VERSUS INTERSPECIES SCNT APPROACHES 
(EXPERIMENT 5) 
 
The efficacy of two different SCNT approaches, namely the intraspecies SCNT 
(intraspSCNT) and interspecies SCNT (interspSCNT) on the in vitro developmental 
(IVD) rate of cloned caprine embryos were evaluated in this experiment. The quality of 
the cloned caprine hatched blastocysts generated using both approaches were evaluated 
by enumerating the embryonic cell number after fluorescence staining. Embryo transfer 
(ET) attempts were also conducted to test the implantation ability of both the 
intraspSCNT and interspSCNT caprine embryos. 
 The in vitro development of the cloned caprine embryos using intraspSCNT 
approach was compared with the in vitro development of caprine parthenotes that 
served as a control group (Table 4.14). A total of 102 successfully fused caprine 
intraspSCNT embryos and 70 activated caprine oocytes were cultured in IVC medium 
Treatment B. The in vitro development of caprine intraspSCNT and parthenotes were 
observed from Day 2 onwards to Day 8.  The results obtained in this experiment 
showed that the IVD rate of caprine intraspSCNT embryos at 2-cell and 4-cell stage did 
not differ significantly from the caprine parthenotes. However, the IVD competency of 
caprine intraspSCNT embryos were significantly (P<0.05) higher at 8-cell (61.2%) and 
morula (47.6%) stages compared to caprine parthenotes (55% and 35.3%, respectively). 
When approaching blastocyst stage and hatched blastocyst, the IVD competency of 
caprine intraspSCNT embryos (17.3% and 11.3% respectively) and parthenotes (15% 
and 9.0% respectively) were similar (P>0.05).  
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           Table 4.14: Percentage (%, mean±SEM) of in vitro developmental rate for caprine intraspSCNT and parthenogenesis embryos 
 
Type 
embryos  
 
Percentage of cleaved reconstructed caprine intraspSCNT and PA embryos according to cell stage (n) 
2-cell 4-cell 8-cell Morula Blastocyst Hatched 
blastocyst 
 
intraspSCNT 
caprine 
 
 
78.09±2.7
a,z
 
(81/102) 
 
67.97±3.33
a,y
 
(71/102) 
 
61.22±2.17
b,x
 
(63/102) 
 
47.60±2.07
b,w
 
(48/102) 
 
17.31±1.83
b,v
 
(19/102) 
 
11.27±1.02
b,v
 
(11/102) 
 
PA caprine 
 
74.10±2.72
a,z
 
(50/70) 
 
65.33±3.89
a,y 
(44/70) 
 
55.00±1.29
a,x
 
(38/70) 
 
35.33±2.00
a,w
 
(24/70) 
 
15.00±1.29
b,v
 
(11/70) 
 
9.00±2.77
b,v
 
(5/70) 
 
 ab
Means with different superscripts in a column within a group were significantly different (P<0.05). 
 vwxyz
Means with different superscripts in a row within a group were significantly different (P˂0.05). 
 
  
 
 
1
9
5
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 In a separate experiment, cloned caprine embryos were generated using 
interspSCNT approach in which, the bovine oocytes were used as the recipient 
cytoplasts and the caprine ear fibroblast cells were used as the donor karyoplasts. The 
IVD competency of caprine interspSCNT embryo was evaluated and comparison in the 
IVD competency was made with the IVD competency of bovine parthenotes (Table 
4.15).  
 A total of 165 reconstructed bovine oocytes using interspSCNT approach were 
cultured in Treatment B IVC; while for the bovine parthenotes, a total of 115 bovine 
oocytes were activated and subjected to the same culture system. The IVD competency 
at 2-cell stage for caprine interspSCNT (78%) embryos did not differ significantly 
(P>0.05) from bovine parthenotes (73.5%). However, at 4-cell and 8-cell, the IVD rates 
of bovine parthenotes (63.6% and 56.7%, respectively) was significantly (P<0.05) lower 
compared to the caprine interspSCNT embryos (74.3% and 63.2%, respectively). When 
approaching morula, blastocyst and hatched blastocyst stage, the IVD competency of 
caprine interspSCNT embryos (32.8%, 8.54% and 4.82%, respectively) did not differ 
significantly (P>0.05) from the bovine parthenotes (36.1%, 12.6% and 7.9%, 
respectively). 
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 Table 4.15: Percentage (%, mean±SEM) of in vitro developmental rate for caprine interspSCNT and bovine parthenogenesis embryos 
 
Type of 
embryos 
 
Percentage of cleaved reconstructed caprine interspSCNT and PA embryos according to cell stage (n) 
2-cell 4-cell 8-cell Morula Blastocyst Hatched 
blastocyst 
 
 
interspSCNT 
caprine 
 
 
78.03±1.00
a,z
 
(129/165) 
 
74.28±1.66
b,y
 
(122/165) 
 
63.16±1.32
b,x
 
(104/165) 
 
32.75±1.79
a,w
 
(54/165) 
 
8.54±0.60
b,v
 
(14/165) 
 
4.82±0.59
b,u
 
(8/165) 
 
PA bovine 
 
73.45±2.45
a,z
 
(84/115) 
 
63.56±2.78
a,y 
(73/115) 
 
56.72±1.52
a,x
 
(65/115) 
 
36.06±1.37
a,w
 
(41/115) 
 
12.56±1.67
b,v
 
(14/115) 
 
7.89±1.79
b,v
 
(10/115) 
  
 ab
Means with different superscripts in a column within a group were significantly different (P<0.05). 
 uvwxyz
Means with different superscripts in a row within a group were significantly different (P˂0.05). 
 
 
 
 
1
9
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 The efficacy between the intraspSCNT and interspSCNT approaches was 
evaluated in terms of the success in the manipulation procedure and the IVD 
competency. The percentage of caprine and bovine oocyte maturation, the success in 
enucleation, fusion and cleavage rate between the intraspSCNT and interspSCNT 
approaches are tabulated in Table 4.16. The maturation rate between caprine (79.7%) 
and bovine (78.1%) oocytes using the same IVM medium did not differ significantly 
(P>0.05). The percentage of oocytes successfully enucleated and fused for both matured 
caprine oocyte for intraspSCNT (90.9% and 82.6%) and bovine oocyte for interspSCNT 
(88.1% and 75.3%) did not differ significantly (P≥0.05) as well. 
 Both caprine intraspSCNT and interspSCNT reconstructed embryos also showed 
similar (P>0.05) cleavage rates (78.1% and 78.0%, respectively). The caprine 
interspSCNT approach gave significantly (P<0.05) higher 4-cell embryos compared to 
intraspSCNT approach (Table 4.17). However, the IVD competency reaching 8-cell 
stage did not differ significantly (P>0.05) between both approaches. The caprine 
intraspSCNT embryos were able to develop more favourably (P<0.05) compared to 
interspSCNT embryos at morula (47.6% and 32.8%, respectively), blastocyst (17.3% 
and 8.5%, respectively) and hatched blastocyst (11.3% and 4.8%, respectively). 
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Table 4.16: Percentage (%, mean±SEM) of success in enucleation, injection, fusion and  
         cleavage rate for caprine intraspSCNT and interspSCNT embryos 
             
 
ab
Means with different superscript in a column within a group were significantly different 
(P≤0.05). 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Type of SCNT 
approaches 
Percentage 
of 
maturation 
(n) 
Percentage of 
oocytes 
successfully 
enucleated (n) 
Percentage of 
couplets 
successfully 
fused (n) 
Percentage of 
reconstructed 
embryos 
cleaved (n) 
 
intraspSCNT 
(Caprine-caprine) 
 
 
79.7±2.9
a
 
(135/165) 
 
90.9±2.5
a
 
(121/135) 
 
82.6±3.4
b
 
(102/121) 
 
78.1±2.7
a
 
(81/102) 
interspSCNT 
(Caprine-bovine) 
 
78.1±1.9
a
 
(248/319) 
88.1±2.1
a
 
(219/248) 
75.3±0.9
a
 
(165/219) 
78.0±1.0
a
 
(129/165) 
Total 78.8±1.6 
(383/484) 
89.3±1.6 
(340/383) 
78.6±1.9 
(267/340) 
78.1±1.3 
(210/267) 
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 Table 4.17: Percentage (%, mean±SEM) of in vitro developmental rate for caprine intraspSCNT and interspSCNT embryos 
 
Type of NT 
approaches 
 
Percentage of cleaved reconstructed caprine intraspSCNT and interspSCNT embryos according to cell stage (n) 
2-cell 4-cell 8-cell Morula Blastocyst Hatched 
blastocyst 
 
intraspSCNT 
caprine 
 
78.09±2.7
a,z
 
(81/102) 
 
67.97±3.33
a,y
 
(71/102) 
 
61.22±2.17
a,x
 
(63/102) 
 
47.60±2.07
b,w
 
(48/102) 
 
17.31±1.83
b,v
 
(19/102) 
 
11.27±1.02
b,v
 
(11/102) 
 
interspSCNT 
caprine 
 
78.03±1.00
a,z
 
(129/165) 
 
74.28±1.66
b,y
 
(122/165) 
 
63.16±1.32
a,x
 
(104/165) 
 
32.75±1.79
a,w
 
(54/165) 
 
8.54±0.60
a,v
 
(14/165) 
 
4.82±0.59
a,u
 
(8/165) 
 
 ab
Means with different superscripts in a column within a group were significantly different (P<0.05). 
 uvwxyz
Means with different superscripts in a row within a group were significantly different (P˂0.05). 
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 The assessment on the embryonic cell number of caprine intraspSCNT, 
interspSCNT and parthenotes at hatched blastocyst stage are shown in Table 4.18. The 
mean cell number of caprine hatched blastocysts derived from interspSCNT (81.4) was 
significantly lower (P<0.05) compared to intraspSCNT (109), caprine parthenogenesis 
(107.3) and bovine parthenogenesis (112.2) hatched blastocysts. There was no 
significant difference between cell numbers of caprine intraspSCNT and caprine 
parthenogenesis hatched blastocyst. 
 
 
Table 4.18: Cell number (mean±SEM) of cloned caprine and PA hatched blastocysts 
Type of embryo Number of hatched 
blastocyst stained 
Cell number ± SEM 
Caprine intraspSCNT  5 109±4.7
b
 
Caprine interspSCNT  5 81.4±2.6
a
 
Caprine PA  4 107.3±5.1
b
 
Bovine PA  5 112.2±4.6
b
 
 
ab
Means with different superscripts in a column within a group were significantly different 
(P<0.05). 
 
 Eight ET attempts were conducted using two approaches, namely oviduct 
transfer and uterine transfer (Table 4.19). A total of 26 caprine intraspSCNT embryos 
(2-cell, 4-cell, 8-cell and morula) were transferred together with 4 caprine parthenotes 
(8-cell) into 5 recipients with the presence of at least 1 corpus luteum (CL). Another 3 
recipients with the presence of at least 1 CL were transferred with 12 caprine 
interspSCNT embryos (4-cell, 8-cell and morula). Ultrasound scanning conducted on 
day 30 post-ET revealed that there were no pregnancy detected on all the eight recipient 
does.  
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    Table 4.19: Embryo transfer attempts of intraspSCNT and interspSCNT cloned caprine embryos 
No. of 
Rep 
Recipient ID  
synchronised 
No. of corpus luteum Type of 
caprine 
embryo 
transferred 
Type of ET 
approach 
No. of embryos transferred  
(embryo stages) 
Pregnancy rate 
(detection 30 Days 
post-ET via 
ultrasonography) 
Left ovary Right ovary Left Right 
1 0019 1 2 intraspSCNT Oviduct 
transfer 
1 (2-cell),  
1 (4-cell)  
1 (2-cell),  
1 (4-cell) 
0 
0014 2 3 intraspSCNT Oviduct 
transfer 
3 (4-cell) 
 
2 (4-cell), 
1 (8-cell) 
0 
2 0112 2 1 intraspSCNT 
+ PA 
Oviduct 
transfer 
4 SCNT (8-cell), 
2 PA (8-cell) 
4 SCNT (8-cell), 
2 PA (8-cell) 
0 
0070 0 0 - - - - - 
3 0068 0 1 intraspSCNT Uterine 
transfer 
1 (4-cell), 
1 (8-cell) 
2 (8-cell) 0 
B0126 0 2 intraspSCNT Uterine 
transfer 
2 (morula) 
 
2 (morula) 0 
B0101 0 0 - - - - - 
4 0007 0 0 - - - - - 
0216 1 1 interspSCNT Oviduct 
transfer 
1 (4-cell), 
1 (8-cell) 
1 (8-cell), 
1 (morula) 
0 
B0114 1 0 interspSCNT Uterine 
transfer 
1 (8-cell), 
1 (morula) 
2 (8-cell) 0 
5 8675 0 3 interspSCNT Uterine 
transfer 
2 (8-cell) 2 (morula) 0 
B0163 0 0 - - - - - 
TOTAL 7 13   19 (NT embryos), 
2   (PA embryos) 
19 (NT embryos), 
2   (PA embryos) 
0 
2
0
2
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Note: (Original magnification of photomicrographs (i): 40x; ( ii, v, vi):100x;  (iii, iv) 200x) 
Figure 4.8: In vitro development of caprine intraspSCNT embryos. (i) four embryos at 4-cell 
       stage; (ii) three embryos at 8-cell stage and one early morula; (iii) two embryos 
       at morula stage; (iv) compacted morulae; (v) four blastocysts; (vi) two hatched 
        blastocyst. 
(i) (ii) 
(iii) (iv) 
(v) (vi) 
Embryos at 4-cell stage 
8-cell stage 
8-cell stage 
 Early morula stage 
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Note: (Original magnification of photomicrographs (i): 40x; (iii, v): 100x; ( ii, iv, vi): 200x) 
Figure 4.9: In vitro development of caprine interspSCNT embryos. (i) two embryos at 
        4-cell stage and six embryos at 8-cell stage; (ii) 8-cell stage embryo; (iii) 
       three morula; (iv) early blastocyst; (v) two blastocysts; (vi) hatched          
       blastocyst. 
(i) (ii) 
(iii) (iv) 
(v) (vi) 
4-cell stage 8-cell stage 
8-cell stage 
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Note: (Original magnification of photomicrographs (i-iv): 200x) 
Figure 4.10: Fluorescent staining of hatched blastocysts derived from; (i) caprine   
          intraspSCNT, (ii) caprine interspSCNT, (iii) caprine PA, (iv) bovine PA. 
(i) 
(ii) 
(iii) 
(iv) 
Blastomeres 
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Chapter 5 
5.0     DISCUSSION 
 
5.1 EFFECT OF DIFFERENT SOURCES OF GONADOTROPHIN ON 
CAPRINE SUPERSTIMULATORY RESPONSES (EXPERIMENT 1) 
It is important to select a suitable source(s) of gonadotrophin to superstimulate the 
donor goats in order to maximise the quantity and quality of caprine oocyte yield per 
LOPU session. The previous studies (Phua, 2006; Anna, 2007; Rahman, 2008) 
pertaining to caprine superstimulatory response in the present laboratory routinely used 
oFSH (Ovagen
®
) together with hCG (Ovidrel
®
) treatment. However, due to some 
technical problem at manufacture level, oFSH (Ovagen
®
) was temporarily discontinued 
from production. As an alternative to replace oFSH (Ovagen
®
), two different sources of 
gonadotrophin, namely PMSG (Folligon
®
)
 
and pFSH (Folltropin
®
-V) were employed in 
this study, and the efficacy of these sources of gonadotrophin on caprine ovarian 
responses for 3 OR cycles were evaluated.  
 Generally, the superstimulatory effect of PMSG (Table 4.1) in terms of the 
average number of follicles recruited and the quantity of oocytes retrieved in this study 
(16.4 and 11, respectively) were comparable to the results obtained by Kong (2010) in 
her study (17.7 and 10.1, respectively) on the effect of PMSG using 1200 IU and 1500 
IU dosages in caprine for 2 OR cycles. The present study also obtained similar findings 
with Kong (2010), in which no significant differences (P>0.05) were observed in the 
average numbers of follicles recruited and the quantity of oocytes retrieved between 
OR1 and OR2. The number of oocyte retrieved in OR2 slightly increased compared to 
OR1, and this might be due to the effect of increased dosage of PMSG (1500 IU).  
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administered in OR2. However, when approaching OR3, the number of follicles 
recruited (9.7) and the quantity of oocytes retrieved (6.3) decreased significantly 
(P<0.05) compared to the previous OR cycle. This indicated that the level of caprine 
ovarian response towards PMSG (1500 IU) was not greatly influence as in OR2 at the 
third repeated gonadotrophin stimulation and LOPU cycles. Similar decreasing effect of 
repeated ovarian stimulation using PMSG and hCG in mouse were observed and was 
reported by Combelles et al. (2003) in their study; fewer oocytes were retrieved from 
female mice at the fourth consecutive cycle of PMSG and hCG stimulation.  
 However, according to Anel et al. (1997) and Stangl et al. (1999), repeated 
gonadotrophin stimulation using PMSG (1500 IU) and LOPU cycles (6 and 20 cycles, 
respectively) had no negative influence on the ovine follicular response and oocyte yield. 
This contradictory outcome might be due to the additional usage of monoclonal 
antibodies against PMSG (antiPMSG) in their stimulation regime which was not 
employed in our present study. Repeated use of PMSG has been reported to result in 
poor fertility in goats (Chemineau et al., 1999). These reasons have been attributed to 
the presence of anti-PMSG antibodies developed as an immune response to previous 
gonadotrophin treatments (Baril et al., 1995). The presence of such antibody was 
reported to cause a delay in the occurrence of oestrus, LH peak and ovulation in the 
synchronised does, which may explain the lower fertility status (Bavister et al., 1986; 
Chemineau et al., 1999; Roy et al., 1999; Drion et al., 2001). In conjunction to this 
study, perhaps the caprine ovarian response decreased by OR3 was due the presence of 
accumulative anti-PMSG antibodies provoked from the previous gonadotrophin 
stimulation treatments in OR1 and 2. Nonetheless, there was possibility that the results 
obtained in OR3 might also be affected by the existence of variables in the hormonal 
responsiveness that occurred between animals and replicates as well as the different 
batches of hormone used as reported by Cognié et al. (2004).  
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 Even though the superstimulatory effect of PMSG decreased after 3 repeated OR 
cycles, the average number of oocytes retrieved (11) per doe for the overall 3 OR cycles 
was relatively higher compared to the studies conducted by Rosnina et al. (1992) on 
goats (3 oocytes per doe), Anel et al. (1997) and Stangl et al. (1999), who obtained 7 
and 7.6 oocytes per ewe, respectively, from repeatedly stimulated ewe using 
PMSG/antiPMSG regime. The effect of different stimulation regime and species 
difference might be the factors contributed to the variation in the overall average 
numbers of oocytes retrieved per doe in this study.   
 The repeated cycles of superstimulation using PMSG and LOPU did not affect 
the quality of oocytes yielded as oocytes of Grades A, B and C which were found to be 
the majority in all the 3 OR cycles.  Since the oocyte quality was not compromised in 
this repeated superstimulation and OR cycle tested, the application of PMSG as 
gonadotrophin to superstimulate donor does can be considered as well as improvement 
on the oocyte yield when the OR cycle increases could be carried out in future by 
incorporating the use of antiPMSG at the appropriate dosage.  
 The effect of repeated superstimulation using pFSH to the caprine ovarian 
response was evaluated (Table 4.2). No significant differences were observed in the 
number of oocytes retrieved per ovary among the 3 OR cycles. However, the number of 
oocytes retrieved in the first OR was the highest and this number steadily declined for 
the consecutive OR cycles. Similar finding was reported by Baldassarree et al. (2003) 
who repeatedly stimulated the donor does with pFSH coupled with eCG. Even though 
the stimulation regime in this study was not coupled with eCG administration, instead 
substitution was made using hCG, the overall caprine follicles and oocytes yielded from 
does stimulated for the first cycle (16.4 and 12.5, respectively) and the third repeated 
cycle (14 and 11.5, respectively) were comparable to the results reported by 
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Baldassarree et al. (2003) for OR1 (17.9 follicles and 16.3 oocytes) and OR3 (11.1 
follicles and 8.8 oocytes) cycles. Armstrong et al. (1992, 1994) reported that pFSH 
without accompanying with PMSG was ineffective in stimulating cattle follicle 
development, however, when coupled with hCG treatment, follicle development was 
enhanced and oocytes recovered were competent to undergo maturation in vitro. 
 The overall average number of oocytes yielded from ovaries stimulated with 
pFSH in this study (12.1 oocytes per doe) was relatively higher compared to the study 
conducted by Rosnina et al. (1992) who stimulated does using multiple injection of 10 
to 20 mg of FSH without coupling with hCG (6.8 oocytes per doe). The relatively 
higher oocyte yield obtained in this study showed that the stimulation regime using 
higher dosage of pFSH (70 mg) coupled with hCG was more efficient compared to the 
goat stimulation regime used by Rosnina et al. (1992).    
 The steadily and non-significant declining trend in the number of oocytes 
retrieved in the 3 consecutive OR cycles studied might be due to the effect of repeated 
follicular puncture which could alter the endocrine profiles slightly, and thus, cause 
minor morphological changes in the ovaries (Petyim et al., 2001). Generally, the 
oocytes yielded from does stimulated with pFSH for all the 3 OR cycles was of good 
quality as the distribution of oocytes graded were majority of Grades A and B 
categories. No significant differences were observed in the number of oocytes yielded 
within each grade for the 3 OR cycles. In other words, the quality of oocytes yielded via 
LOPU was not compromised, even though the donor does were subjected to 3 repeated 
stimulation cycles using pFSH. These findings are consistent and in agreement with 
Alberio et al. (2002), Baldassarre et al. (2003) and Gibbons et al. (2007) that good 
quality oocytes remained unaffected between OR cycles. 
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  The effect of PMSG vs. pFSH stimulation on the average number and 
quality of oocytes retrieved in each OR cycle were evaluated (Table 4.3). There were no 
significant differences in the number of follicles recruited and number of oocytes 
retrieved from does stimulated with PMSG vs. pFSH in OR1 and OR2. However, in 
OR3, the caprine ovary stimulation response using PMSG was significantly lower 
compared to pFSH in which the number of oocytes yielded from PMSG stimulated 
ovaries were significantly lower compared to pFSH stimulated ovaries. In terms of 
oocyte quality, the pFSH stimulated ovaries were likely to produce slightly better 
oocyte quality than PMSG stimulated ovaries. This is in conjunction with the 
observation that generally the percentages of Grades A and B oocyte yield from pFSH 
stimulated ovaries were relatively higher than PMSG stimulated ovaries.  
 The overall findings in this experiment revealed that repeated ovarian 
stimulation using PMSG was not as efficient as using pFSH which is in agreement with 
the findings reported by Nuti et al. (1987), Mahmood et al. (1991) and Nowshari et al. 
(1992). The differences in the ovarian responses to PMSG and pFSH could be attributed 
primarily to differences in the biological half-life of each gonadotrophin preparation 
(Armstrong et al., 1983). PMSG has been used to superovulate cattle and sheep because 
of its availability, relatively low cost and ease of use, with only a single injection 
needed (Goulding et al., 1996). However, PMSG is known to have a relatively long 
circulating half-life as it remains active in the blood for 5 to 7 days after administration 
(Siddiqui et al., 2002). The long circulating half-life of PMSG could result in the 
occurrence of excessive follicular development and failure of ovulation (Moor et al., 
1985 and Murphy et al., 1991). Furthermore, given its capacity to bind to luteinising 
hormone (LH) receptors, PMSG exhibits LH-like activity in non-equine species and 
excessive LH activity in gonadotrophin treatments has been associated with follicular 
atresia (Tajima et al., 2007) ) which is not an ideal effect for superovulation and embryo 
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recovery program. Even though PMSG stimulated ovaries prone to have failure in 
ovulation, it does not negatively affect the number of follicles recruited and oocyte 
retrieval via LOPU. The important concern of using PMSG which negatively affect the 
number of follicles and oocyte yield, however, is the provocation of anti-PMSG 
antibodies in repeated stimulation treatment. The presence of this anti-PMSG antibodies 
reduced caprine ovarian response towards PMSG resulting in lower follicular 
development and oocyte yield. Similar immunologically mediated ovarian refractoriness 
was also reported to occur in mice, rabbits, rhesus monkeys, cows and domestic cats 
that repeatedly injected with PMSG (Lin and Bailey, 1965; Onuma et al., 1969; 
Bavister et al., 1986; Swanson et al., 1996).  
 On the other hand, FSH either derived from sheep (oFSH) or swine (pFSH) has 
surpassed PMSG as the preferred gonadotrophin for goat superovulation because the 
stimulation and ovulation responses were reported higher in FSH- than in PMSG-treated 
goats (Armstrong et al., 1983; Tsunoda and Sugie, 1989; Goel and Agrawal, 1990; 
Pampoukidou et al., 1992; Pendelton et al., 1992). In contrast to PMSG, pFSH has a 
relatively short half-life and little LH-like activity. Thus, pFSH must be administered 
using multiple injection regime to ensure optimal superovulation. However, Riesenberg 
et al. (2001) reported that a single dose injection of FSH can be used to simplify the 
superovulation protocol, even though it is prone to premature luteal regression. In this 
study, in order to avoid the effect of single or multiple injection regime influencing the 
ovarian response, pFSH and PMSG was administered using multiple and single 
injection regimes, respectively.  
 In summary, results obtained from this experiment suggest that both PMSG and 
pFSH employed in the designated regimes have the potential to stimulate caprine 
ovaries for oocyte retrieval via LOPU. However, the efficacy of PMSG could not 
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surpass the pFSH, particularly, when it was employed in the repeated ovarian 
stimulation and oocyte retrieval programme.     
 
 
 5.2 EFFECT OF DIFFERENT SOURCES OF CAPRINE OOCYTES ON THE 
 OOCYTE YIELD, GRADES AND MATURATION PERFORMANCE 
 (EXPERIMENT 2) 
This experiment was conducted to evaluate the effect of oocyte source (LOPU versus 
slicing of abattoir derived ovaries) on the oocyte yield, grades and maturation 
performance. 
 
5.2.1 Effect of Two Different Sources of Caprine Oocytes on Quantity and 
 Quality of Oocytes Obtained 
 
 In this present experiment, OR via LOPU was conducted after 71 hours of 
ovarian stimulation with pFSH coupled with hCG. The number of oocytes retrieved 
(11.0 per doe) via LOPU in this experiment was comparable to the results obtained by 
Abdullah et al. (2008), who obtained 11.4 and 16 oocytes per doe at 60 and 72  hours 
post-ovarian stimulation, respectively. The present finding is also in general agreement 
with the findings reported by Baldassarre and Karatzas (2004) and Gibbons et al. (2007) 
that the minimum number of oocytes yields via LOPU per doe - usually more than 5 
oocytes.  
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 In comparison to abattoir source, the number of oocytes retrieved via LOPU was 
significantly lower in this experiment. This is due to the fact that in LOPU, only 
follicles bigger than 2 to 3 mm were aspirated, but in abattoir ovary irrespective of size, 
all the follicles were sliced including those of smaller follicles of less than 2 mm in 
diameter. Martino et al. (1994) compared different oocyte collection techniques 
(dissection, aspiration and slicing) in order to obtain the largest number of oocytes for 
IVM-IVF programmes, they concluded that slicing is the most useful technique. 
However, the drawback of this technique is that it does not allow the selection of oocyte 
by follicular diameter that may be negatively affecting the subsequent in vitro meiotic 
competence of the oocyte retrieved as well as its embryo development.  
 Although OR by LOPU produced lower oocyte yield than slicing abattoir-
derived ovaries source, this oocyte recovery procedure can be done repeatedly on the 
same donor without causing severe ovarian damage or decrease donor fertility. 
Moreover, unlike oocytes collected from abattoir-derived ovaries, LOPU-derived 
oocytes were retrieved from animals of known health status which could directly affect 
the oocyte yield in terms of the oocyte quantity and quality (Baldassarre et al., 2002). 
Due to the unavailability of records pertaining to breed, origin, health condition and 
phase of oestrus cycle for the does at the abattoir, there might be a possibility that the 
quality and quantity of the abattoir- derived oocytes obtained in this study affected by 
these factors.  
 The quality of oocytes yielded in this experiment was categorised according to 
the oocyte morphology and cumulus cell vestment (Rahman, 2008). The results 
obtained showed that, oocyte quality retrieved from LOPU was slightly better compared 
to those derived from abattoir ovaries. This was noted as the distribution of oocytes 
yielded via LOPU majority was in the categories of Grades A and B. Similar results 
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were obtained by Koeman et al. (2003) in which more than 80% of the caprine oocytes 
yielded via LOPU in their study were of Grades A and B.  However, abattoir derived 
oocytes in this experiment, majority were distributed in the categories of Grades B and 
C. In other words, the preservation of cumulus vestments in the recovered oocytes via 
LOPU was good, suggesting that the needle size and the vacuum pressure applied 
during LOPU were properly selected (Baldassarre et al., 1994; 2003).  In addition, the 
oocytes yielded via LOPU procedure were obtained from hormonally stimulated does in 
which the follicular growth was approaching preovulatory stage and logically, the 
COCs at this stage were less firmly attached to the follicle wall at the time of OR via 
LOPU. Thus, the cumulus cell vestment on the oocytes retrieved was not disrupted as 
lower vacuum pressure was required to detach the COCs from the follicle wall during 
LOPU. Besides that the ovarian stimulation treatment added credit to the quality of 
oocyte yielded via LOPU as they were homogenous during oocyte retrieval.  
 On the other hand, the quality of oocytes recovered from abattoir-derived 
ovaries was slightly compromised and heterogeneous, as the donors were not 
hormonally stimulated; thus, COCs collected were derived from follicles in different 
stages of growth and atresia (Rodríguez-González et al., 2002). Besides that several 
factors such as donor age, nutrition, season and genetic lineage are known to exert 
considerable influence on oocyte production and quality. Since the history and exact 
physiological state of oocyte donors from abattoir was unknown, the negative effect of 
the above mention factors might affect the quality of the oocytes yielded from abattoir-
derived ovaries (Brackett et al., 1992; Martins et al., 2011).  
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5.2.2 Determination of an Optimised IVM Time Range for Caprine Oocytes 
 Derived from Two Different Sources 
 
The present experiment was undertaken to evaluate the time required by the LOPU- and 
abattoir-derived caprine oocytes to complete its nuclear maturation in vitro by observing 
the extrusion of the first polar body (PB-1). Besides that, localisation of the PB-1 and 
MII plate in the in vitro matured caprine oocytes were also investigated. At present, 
there were variations in the in vitro maturation (IVM) durations employed in several 
caprine IVP studies. Thus, there is yet a definite optimal IVM duration established for 
caprine oocyte maturation. In order to determine the optimum IVM duration for LOPU- 
and abattoir-derived oocytes in this experiment, a standard IVM medium formulation 
and selection of oocytes from only Grades A and B for both sources were used.   
 The 5 IVM durations (15, 18, 21, 24 and 27 hours) evaluated in this experiment 
were selected based on the range commonly used (16 to 27 hours) by other researchers 
(Cognié et al., 2003; Le Gal et al., 1992; Martino et al., 1994). The results obtained in 
this experiment showed that maturation of caprine oocytes retrieved from stimulated 
ovaries via LOPU was found to occur as early as 15 hours. However, the maturation 
rate at this hour was rather low (6.7%). Cognié et al. (2003) and Pawshe et al. (1994a) 
also reported that caprine oocytes derived from stimulated ovaries generally started to 
mature as early as 16 hours after the initiation of maturation process and completed at 
24 hours. The IVM rate of caprine oocytes derived from stimulated ovaries in the 
present experiment peaked at 21 hours with the maturation rate of 86.7%. This IVM rate 
was comparable to the maturation rate obtained by Abdullah et al. (2008) (82.1%), and 
was relatively higher compared to those reported by Cognié et al. (2003) (75%) and 
Martino et al. (1995) (66.7%) who also used adult caprine oocytes derived from 
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stimulated ovaries in their studies. The relatively higher maturation rate reported in the 
present experiment and by Abdullah et al. (2008) might be attributed to the effect of 
prolonged interval from ovarian stimulation to LOPU (70 to 72 hours) as the interval 
used in the studies conducted by the other two research groups was shorter (48 hours).  
 Mammalian oocytes are known to undergoes significant changes to acquire 
meiotic competence while enclosed within the follicle and full meiotic competence 
could be achieved, especially when follicles becomes dominant and approaches 
ovulation (Hyttel et al., 1997). The effect of prolonged ovarian stimulation- LOPU 
intervals might enables oocytes to have sufficient time to acquired full meiotic 
competence, cytoplasmic as well as molecular maturation in the follicles. Once these 
oocytes are removed from its follicles, resumption of meiosis automatically commences 
and higher maturation potential might be attained by these oocytes (Sirard, 2001; 
Humbolt et al., 2005) compared to oocytes yielded from shorter ovarian stimulation-
LOPU intervals. 
 Even though the effect of prolonged interval from ovarian stimulation to LOPU 
could be the reason towards the similarity of high maturation rate obtained in this 
experiment and by Abdullah et al. (2008), one prominent difference was observed 
between both studies is the IVM duration required to reach the optimal maturation rate. 
In this experiment, maturation rate of caprine LOPU oocyte peaked at a relatively 
shorter IVM duration (21 hours) compared to the IVM duration of 27 hours reported by 
Abdullah et al. (2008). The variation in the IVM duration reported might be affected by 
the differences in the IVM medium used in both studies. However, further studies are 
required to validate it. 
 It is notable that the ability to obtain high maturation rate in any embryo in vitro 
production (IVP) is one of the goals in IVP; however, the quality of the matured oocytes 
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obtained must not be ignored as this will affect significantly the subsequent embryo 
developmental competency. It has been suggested that spindle analysis could be used as 
the assessment parameter for the oocyte quality (Hu et al., 2001, Eichenlaub-Ritter, 
2002; Albertini, 2003). In this experiment, matured caprine oocytes were also obtained 
at 27 hours however, evaluation on the quality of the matured oocytes in terms of the 
morphology of PB1 and localisation of the PB-1 and MII spindle in these matured 
oocytes showed that more than 65% of these oocytes had polar bodies that either fully 
extruded (100% separated from the cytoplast) or with fragmentation and the MII spindle 
was observed to had translocated further apart from the PB-1. This may indicate 
negation in the oocyte development competence. Since evaluation on the morphology of 
PB-1 and localisation of the PB-1 and MII spindle was not carried out in previous study 
in our laboratory (Abdullah et al., 2008), it is uncertain that the IVM duration of 27 
hours reported was an ideal for their IVP.  Hu et al. (2001) reported that prolongation of 
the IVM duration may further increase the yield of oocytes in MII as well as ageing of 
oocytes at MII in prolonged culture may cause concomitantly a deterioration of the 
spindle and displacement of the chromosomes. 
 Besides Abdullah et al. (2008), the studies conducted by Martino et al. (1995) 
and Gall et al. (1996) also incorporated 27 hours of IVM duration for goat oocytes 
derived from stimulated ovaries. Since the intervals from ovarian stimulation to LOPU 
in their studies were shorter (48 hours), it is rational that a longer IVM duration was 
required in their studies. However, further studies are needed to substantiate this 
phenomenon.  
 For abattoir-derived oocytes, maturation was observed to commence later at 21 
hours and the maturation rate peaked at 24 hours with the rate of 80%. The abattoir-
derived oocytes used slightly longer duration of IVM to reach MII phase compared to 
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LOPU-derived oocytes. This might be attributed to the fact that the abattoir–derived 
ovaries were not subjected to synchronisation and hormonal stimulation. Thus, the 
oocytes retrieved were heterogeneous, from follicles in different stages of growth and 
atresia (Rodríguez-González et al., 2002). When oocytes were retrieved from follicles 
less than 2 mm diameter and at pre-antral phase, the oocytes were yet to achieve full 
meiotic competency (Driancourt, 2001). Van den Hurk and Zhao (2005) also reported 
that the maturation rate of oocytes from late-stage follicles is more rapid than those 
from earlier-stages, however, oocyte yield from late-stage follicles are less abundant in 
non-stimulated ovary. Therefore it is reasonable that a slightly longer IVM duration 
might be required by the abattoir-derived oocytes to reach MII phase.  
 Even though, at the IVM duration of 27 hours, the maturation rate of abattoir-
derived oocytes in this experiment (73.3%) slightly reduced, the rate obtained is still 
comparable to Martino et al. (1995) who obtained 75.9%. On the other hand, Sharma et 
al. (1996) reported that a rather longer IVM duration (32 hours) was required by the 
abattoir-derived oocytes to achieve the peak of the maturation rate (71.6%). Variations 
in the optimum IVM duration reported by Martino et al. (1995) and Sharma et al. (1996) 
compared to our study might be influenced by the differences in the culture medium 
components and conditions used for IVM.  
 Evaluation on the morphology of PB-1 and localisation of the PB-1 and MII 
spindle for in vitro matured LOPU-derived oocytes were made in this experiment. At 
the IVM durations of 18 and 21 hours, morphological evaluation on the PB-1 extrusion 
and its shape under the light microscope showed that more than 80% of the LOPU in 
vitro matured oocytes had PB-1 with smooth surface (normal matured oocyte) and was 
not fully extruded (80 to 90%) from the cytoplast. In addition, majority of the matured 
oocytes obtained at these IVM durations had PB-1 and MII spindle that were co-
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localised. Similar morphology of PB-1 and localisation of the PB-1 and MII spindle 
were also portrayed by the abattoir-derived oocytes matured at the durations of 21 and 
24 hours. On the other hand, both LOPU- and abattoir-derived oocytes matured at 27 
hours showed that the MII spindle had translocated apart from the PB-1. Comparison on 
the observation obtained in this experiment with other researcher could not be carried 
out as to our understanding there were no study conducted up to date to evaluate 
morphology of PB-1 and localisation of the MII spindle in matured caprine oocytes. 
 It is worth to take note that the caprine in vitro matured oocytes obtained were 
subjected to nuclear transfer experiment, thus the location of MII spindle closed to PB-1 
is important as it determines the success rate of enucleation using ‘blind’ squeezing 
technique as needed in this caprine intraspSCNT study. The ‘blind’ enucleation method 
was carried out by removing PB-1 and the underlying oocyte cytoplasm (10 to 15%), 
assuming that the MII spindle located adjacent to PB-1 from the matured oocyte in the 
absence of fluorochrome. Thus, it is important to carry out the enucleation step before 
the MII spindle translocated. Dominko et al. (2000) reported that displacement of MII 
spindle from its previously assumed location subjacent to the PB-1 in matured oocyte 
could affect the efficiency of enucleation, especially using ‘blind’ enucleation method. 
However, if fluorochrome labelled enucleation method was employed, displacement of 
MII spindle phenomenon in matured oocytes would not be an influencing factor 
towards the success of enucleation. Fluorochrome labelled enucleation can only be 
carried out provided that the fluorescent filter was attached to the micromanipulator. 
Since this setup was not available in our laboratory, fluorochrome labelled enucleation 
method could not be employed. In conjunction to this, evaluation on the appropriate 
maturation duration in which most of the matured oocytes did not show displacement of 
MII spindle from its PB-1 was conducted to maximise the success rate of the ‘blind’ 
enucleation in our experiment. 
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 This research could be considered the first study conducted to examine the 
temporal and spatial relationships of the PB-1 and MII spindle on the matured caprine 
oocytes derived from two different sources (LOPU and abattoir). By taking into the 
consideration of the maturation rate, morphology and localisation of MII spindle 
obtained in this experiment, the findings of this experiment suggested that the optimal 
IVM duration range for LOPU- and abattoir-derived oocytes that could be employed in 
our laboratory are 18 to 22 hours and 22 to 26 hours, respectively. 
 
 
5.2.3 Evaluation on the Meiotic Competency of Caprine Oocyte Derived from 
 Two Different Sources According to Oocyte Quality 
 
Evaluation on the meiotic competency according to oocyte quality for both LOPU- and 
abattoir-derived oocytes was conducted in this experiment. The LOPU- and abattoir-
derived oocytes of different grades were subjected to IVM duration range of 18 to 22 
hours and 22 to 26 hours, respectively, using the same formulation of IVM medium as 
depicted in Table 3.8. When the maturation rate was measured from the oocyte pool 
regardless of grades, the maturation rate of LOPU-derived oocytes was significantly 
(P<0.05) higher than abattoir-derived oocytes (79.6% versus 69.7%). This was in 
agreement with the study conducted by Rahman (2008).  
 Several investigations have revealed that the size of follicles and oocytes 
retrieved correlated positively with the oocytes meiotic competency (Richard and Sirard, 
1996). In comparison to the LOPU-derived oocytes, abattoir-derived oocytes retrieved 
were heterogeneous in sizes. Due to the slicing technique of the abattoir- derived 
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ovaries, oocytes from smaller follicles (<2 mm) were also collected. Motlik et al. (1984) 
have demonstrated that oocytes retrieved from follicles of less than 2 mm diameter were 
less in meiotic competence. Thus, the lower maturation rate of the abattoir-derived 
oocytes compared to LOPU-derived oocytes might be attributed to the heterogeneity in 
oocyte sizes that were present from the abattoir source.   
 Both the maturation rates for LOPU- and abattoir-derived oocytes obtained in 
this experiment were slightly higher than that was obtained by Rahman et al. (2008) 
with the percentages of 73.8% and 54%, respectively. Variation in the maturation rates 
obtained in this experiment compared to Rahman et al. (2008) might be due to the 
differences in the IVM duration used and the chemical components supplemented into 
the IVM medium.  
 Even though the overall maturation rates of LOPU-derived oocytes were 
significantly (P<0.05) higher than abattoir-derived oocytes, when the comparison was 
made within each oocyte grades (Grades A, B, C and D), no significant difference 
(P<0.05) was observed in the maturation rate between LOPU- and abattoir-derived 
oocytes in their respective grades. The insignificance of the maturation rate observed 
within each oocyte grade was probably due to the relatively smaller sample size of the 
LOPU-derived oocytes compared to abattoir-derived oocytes subjected to IVM 
treatment in this experiment. The lower sample size of the LOPU source was due to the 
fact that the number of oocytes retrieved via LOPU per doe was usually lower compared 
to retrieval via slicing of abattoir-derived ovaries (Katska-Ksiaźkiewicz et al., 2004).  
 Oocyte quality is known to be an important prognostic factor to the nuclear and 
ooplasmic maturity of the oocyte which directly related to the success rate of embryo 
IVP (Kahraman et al., 2000). In this experiment, both LOPU- and abattoir-derived 
oocytes of Grades A (>5 layers of CCs investment), B (3-5 CCs layers) and C (1-2 CCs 
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layers) showed significantly (P<0.05) higher maturation competency compared to 
Grade D (<1 CCs layer). This showed that the presence of more than 1 layer of cumulus 
cells surrounding the COCs are essential in promoting the maturation of caprine oocytes 
regardless whether the COCs were retrieved from ovarian stimulated or non-stimulated 
ovaries. The presences of cumulus cells (CCs) are essential for oocyte growth, nuclear 
and cytoplasmic maturation as well as in genomic transcription activity (Van de Hurk 
and Zhao, 2005). No maturation or low rate of maturation in bovine (Fukui and Sakuma, 
1980; Zhang et al., 1995) and sheep (Shirazi et al., 2007) oocytes was obtained when 
CCs were removed before the oocytes were matured in vitro. In addition, Goud et al. 
(1998) and Nyholt et al. (2009) also suggested that in human and monkey, successful 
IVM has only been achieved with cumulus-enclosed oocytes, indicating that it is crucial 
for IVM to remain COCs intact. The CCs investment plays a significant role in allowing 
nutrient transfer (Haghight and Van Winkle, 1990; Laurincik et al., 1992), energy 
substrates (Sutton et al., 2003) and/or messenger molecules for the development of 
oocyte (Buccione et al., 1990) and to mediate the effects of hormones on the COCs. 
Besides that, Bruynzeel et al. (1997) and Kastrop et al. (1991) also reported that CCs 
seems to be essential, especially in the first hours of maturation.   
 Based on the findings in this experiment, LOPU-derived oocytes approach 
seems to provide oocytes with better meiotic competency compared to the abattoir-
derived oocytes. However, further study could be carried out to obtain a concrete 
conclusion by using a more homogeneous sample size for both the LOPU- and abattoir-
derived oocytes. Besides that, a less varied source of abattoir-derived oocytes could be 
used by standardising the age, weight and health condition of the donor does in which 
the oocytes were to be collected. 
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5.3 PRODUCTION OF CLONED BOVINE AND GAUR EMBRYOS VIA 
INTRASPECIES AND INTERSPECIES SCNT APPROACHES: A 
PRELIMINARY STUDY FOR CAPRINE SCNT RESEARCH 
(EXPERIMENT 3) 
 
The attempts to produce bovine-bovine intraspecies SCNT (intraspSCNT) and gaur-
bovine interspecies SCNT (interspSCNT) were conducted as a preliminary experiment 
for the caprine SCNT research which was the core interest of this study. The 
manipulation efficiencies for bovine intraspSCNT and gaur interspSCNT in terms of the 
enucleation rate was reasonably high with the average of 90.3% compared to the report 
by Daniel et al. (2008) who obtained 60.7% of successful enucleation rate using the 
same blind squeezing method for caprine MII oocytes. A direct comparison on the 
success enucleation rate for bovine MII oocytes could not be done as majority of the 
research work reported on bovine NT does not indicate the enucleation rate in their 
study.  
 The fusion rates, cleavage rates and blastocyst rate of the bovine intraspSCNT 
embryos in this experiment (74.3%, 77.7%, 20.3%) were comparable to the study 
conducted by Cho et al. (2004) who obtained 79.9%, 67% and 15.2%, respectively 
using EF cells as donor karyoplast. However, when comparison was made with 
Srirattana et al. (2010) who obtained 91.7% of fusion rate, 90.1% of cleavage rate and 
38.7% of blastocyst rate, the results obtained in this experiment was relatively lower, 
even though using the same type of donor karyoplast (EF cell), nuclear transfer protocol 
and IVC medium. The lower results obtained in this study compared to Srirattana et al. 
(2010) might be attributed to the relative disparities in operator skills and speed of 
manipulation (Yanagimachi, 2002; Perry and Wakayama, 2002) as the author of this 
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study were only exposed to the SCNT manipulation skill training for a short duration of 
3 months.  
 As for gaur interspSCNT, the fusion rate and cleavage rate obtained in this 
experiment were comparable with the banteng interspSCNT experiment conducted by 
Sansinena et al. (2005) who obtained 77% and 67%, respectively. Due to limited 
information available on the fusion rate for gaur interspSCNT, a direct comparison on 
this data could not be made with other researcher doing on the similar species. 
Therefore, the fusion and cleavage rate of banteng-bovine interspSCNT which also 
having the similar taxonomic closeness as gaur-bovine interspSCNT was used as a 
comparison in this experiment. The percentage of gaur interspSCNT blastocyst obtained 
in this experiment (19.03%) was slightly higher compared to the percentage obtained by 
Lanza et al. (2000) and Mastromonaco et al. (2007) who obtained 12% and 11.8%, 
respectively. The differences in the percentage of blastocyst obtained might be due to 
the positive effect of the oviductal epithelial cells co-culture system used in the present 
experiment which was not employed in their studies.  
 When comparison was made between bovine intraspSCNT and gaur 
interspSCNT approach, there were no significant difference (P>0.05) in the fusion rate, 
cleavage rate and IVD rate (2-cell to hatched blastocyst) obtained in this experiment. 
This result trends were in agreement with the trend obtained by the senior researcher in 
ESRC, Suranaree University of Technology, Thailand in an unpublished report (K. 
Srirattana, personal communication).  It is worth to note that the same optimal duration 
and field strength of electric pulsing (2 DC, 24 V, 15 µsec) were used for both bovine 
intraspSCNT and gaur interspSCNT in this experiment and interestingly the fusion rates 
obtained for both approaches were similar. This indicates that the gaur EF cell 
membrane properties are possibly compatible with bovine oocyte plasma membrane 
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(Dominko et al., 1999). In addition, the IVD competency of gaur interspSCNT embryos 
was comparable to the bovine intraspSCNT embryos in this experiment, and this 
reflects that bovine cytoplast is capable in reprogramming gaur EF cell. The report on 
the live birth of cloned gaur using interspSCNT approach by Lanza et al. (2000) proved 
that cloned gaur embryos generated using interspSCNT approach not only competent in 
the pre-implantation development but also competent at post-implantation after embryo 
transfer.  
 In general, the overall results in terms of the manipulation efficiency and IVD 
development of the reconstructed bovine intraspSCNT and gaur interspSCNT embryos 
obtained in this experiment using the SCNT protocol developed by ESRC Laboratory 
within just the short duration of skill acquisition were fairly convincing. This portrayed 
that the SCNT protocol developed by ESRC Laboratory for the production of cloned 
bovine and gaur embryos was effective, and could be used as a reference for the 
development of caprine SCNT protocol in the local laboratory setting (ABEL 
Laboratory). Due to species difference, modification of the adapted protocol was 
conducted in the following experimental design with the ultimate aim to develop a 
caprine SCNT protocol that could be used in ABEL Laboratory setting as well as in 
other laboratories in Malaysia.      
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5.4 IMPROVEMENT ON THE IN VITRO CLONED CAPRINE EMBRYOS 
PRODUCTION BY CONSIDERING THE EFFECTS OF 
MATURATION DURATION, ACTIVATION TREATMENT AND IN 
VITRO CULTURE PROTOCOL (EXPERIMENT 4) 
 
 
5.4.1 Effect of Two Different IVM Intervals on Cloned Caprine IVD Competency 
 using Ovarian-Superstimulated Caprine Oocyte 
 
In this experiment, the manipulation efficiency and IVD competency of cloned caprine 
embryos generated using oocytes from stimulated ovaries matured at two different IVM 
intervals, namely 18 to 22 hours and 23 to 27 hours were evaluated. The oocytes from 
stimulated ovaries or known as LOPU-derived caprine oocytes, matured at 18 to 22 
hours showed significantly (P<0.05) higher maturation rate, percentage of successful 
enucleation, cleavage and IVD rates compared to oocytes matured at 23 to 27 hours. 
The higher maturation and enucleation rate obtained for oocytes subjected to IVM 
duration of 18 to 22 hours further confirmed the findings in Experiment 4.2.2 in which, 
screening of optimum IVM duration for LOPU oocytes was conducted. The high 
enucleation rate correlated with the observation in Experiment 4.2.2 in which the 
location of MII spindle was closely adjacent with PB-1 in matured oocytes at the IVM 
duration of 18, 21 and before 24 hours. On the other hand, the lower maturation and 
enucleation rate for oocyte matured at 23 to 27 hours might be attributed to the 
prolonged MII arrest resulting in degenerated and fragmented PB-1 as well as 
translocation of the MII spindle apart from the PB-1 which affect the enumeration of 
matured oocyte based on the extrusion of PB-1 and the enucleation rate. 
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 It is worthwhile to take note that in this experiment, exogenous LH was 
administered in the stimulation regime and a prolonged interval between hormonal 
(pFSH) stimulation and LOPU (70 to 72 hours) was adapted prior to OR. During the 
period between the LH surge and ovulation in the stimulated ovaries, oocyte is known 
to undergo a series of marked changes in its nucleus and cytoplasm towards maturation 
(Van den Hurk et al., 1999). Thus, there might be a possibility that the maturation 
process had begun to occur in the follicle prior OR in this experiment. After OR, it is 
logical that a relatively shorter IVM duration is required by the oocytes to reach MII 
phase as reflected in the high maturation rate obtained at 18 to 22 hours in this study. In 
comparison to the results of this experiment, the caprine intraspSCNT study conducted 
by Reggio et al. (2001) who used the same IVM duration of 18 to 22 hours, reported a 
relatively lower maturation rate and cleavage rate (50% and 57%, respectively). The 
low maturation and cleavage rate of oocytes matured at 18 to 22 hours could be 
attributed to the effect of the short interval between hormonal (pFSH) stimulation and 
LOPU (24 hours post pFSH administration) used in their study. The study conducted by 
Keefer et al. (2002) further support the findings that oocytes retrieved from short 
hormonal stimulation-LOPU interval required slightly longer IVM duration to yield a 
high maturation rate. In their caprine intraspSCNT study, oocytes retrieved from a short 
oFSH stimulation-LOPU (36 hours) interval protocol were subjected to a slightly longer 
IVM duration of 23 to 24 hours and the maturation rate obtained was high (94%). Even 
though the hormonal stimulation-LOPU interval and IVM duration seems to be a factor 
influencing the maturation rate, we could not rule out that the maturation rate also 
influenced by the formulation of IVM medium used. Thus, further refinement studies 
using a standard IVM medium are required in order to validate the interpretation of the 
effect of hormonal stimulation-LOPU interval and IVM duration on the maturation rate. 
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 In regards to the IVD competency, the caprine reconstructed oocyte completing 
IVM early are more competent to develop to the morula stage than those completing 
IVM at a longer duration. This was indicated by the present results that significantly 
higher cleavage and morula rates were obtained from reconstructed oocytes matured at 
18 to 22 hours compared to 23 to 27 hours. It is known that the duration of IVM could 
affect the competency of embryo development (Hölker et al., 2005). Inappropriate 
timing of maturation was reported to result in oocyte aging (Hunter, 1989; Hunter and 
Greve, 1997), abnormal chromatin decondensation (Dominko and First, 1997) and 
ultimately reduced the embryo developmental competency (Marston and Chang, 1964). 
 Oocyte age was found to influence the activity of maturation or M-phase 
promoting factor (MPF) and the IVF competency of oocytes (Kikuchi et al., 2000 and 
Grupen et al., 1997). During the process of oocyte maturation, the activity of MPF 
increased and remained at a high level during the meiotic arrest. However, when oocyte 
age prolonged, the MPF activity gradually decreased and the activation ability and 
fragmentation frequency of the oocyte cytoplasm was found to increase (Kikuchi et al., 
1999, 2000). Thus oocytes matured at 23 to 27 hours in this experiment might be 
showing sign of oocyte aging gradually since the trend of IVD rate rapidly decreased 
from 2-cell to morula . Furthermore, the cleavage and IVD rate of these reconstructed 
oocytes were lower compared to oocyte matured at 18 to 22 hours at any cell stages. 
The interpretation of this observation was further strengthened with the findings by 
Yang et al. (1993) and Presicce and Yang (1994) that aged oocytes even though have 
high activation rates, the developmental potential of these oocytes were lower. In 
addition to this, Takano et al. (1993) and Tanaka and Kanagawa (1997) also reported 
that reconstructed oocytes cloned with young recipient oocytes were prone to produce 
embryos with a higher developmental rate. 
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 When comparison was made with other caprine IVF and ICSI studies conducted 
in the present laboratory (Chan, 2008; Rahman, 2008; Kong, 2010) using the same IVC 
system, the IVP rate of caprine embryos obtained in this experiment using LOPU-
derived oocytes matured early (18 to 22 hours) is higher compared to the results using 
oocytes matured later (27 hours) in their studies. Even though none of the IVP caprine 
embryos managed to develop beyond morula stage in this experiment as well as in the 
above mentioned IVF and ICSI studies, the relatively higher IVD rate up to morula 
stage obtained in this experiment suggested that the IVP of caprine embryos could be 
improved by using LOPU oocytes that matured earlier (18 to 22 hours). The author 
believes that the findings of this experiment has contributed one-step closer in solving 
the problem of caprine in vitro blastocyst production in the laboratory before further 
evaluating and refining the activation treatment and IVC system in the subsequent 
experimental designs.  
 
 
5.4.2 Effect of Two Different Activation Protocols on the In Vitro 
 Developmental Competency of Reconstructed Caprine Embryos 
 
The present experiment was conducted to compare the effectiveness of two different 
sequential activation protocols on the IVD competency of reconstructed caprine oocytes 
following SCNT. The two sequential activation protocols investigated were (a) 7% 
ethanol (EtOH) + cytochalasin D plus cylocheximide (CD-CHX) and (b) calcium 
ionophore (CaI) + 6-dimethylaminopurine (6-DMAP). These two combinations of 
chemical activation agents were selected because they are commonly used, and are 
known to be effective in inducing bovine and caprine parthenogenetic as well as 
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reconstructed cloned oocytes (Shen et al., 2008; Laowtammathron et al., 2005; Ongeri 
et al., 2001; Apimeteetumrong et al., 2004). In additional, since the 7% EtOH + CD-
CHX protocol was used in the preliminary experiment of this caprine SCNT research, 
and its efficiency was proven by the development of bovine blastocyst, thus it is worth 
to compare this activation protocol with the CaI + 6-DMAP protocol which is 
commonly used in caprine intraspSCNT research worldwide. To our understanding, this 
experiment is the first attempt in using 7% EtOH + CD-CHX to induce the development 
of caprine reconstructed oocytes. 
 The results obtained in this experiment demonstrated that both the 7% EtOH + 
CD-CHX and CaI + 6-DMAP activation protocols had the same efficiency in inducing 
the development of caprine reconstructed embryos since the IVD rates were similar at 
each embryonic stages. The high cleavage rate obtained in both activation protocols 
tested also indicated that the combinations of activation chemicals (7% EtOH + CD-
CHX) and (CaI + 6-DMAP) in each protocol were favourable. Furthermore, when 
reconstructed caprine oocytes were activated with other combinations of chemical 
activation such as electrical pulse (EP) + 6-DMAP (Shen et al., 2006), EP + CB 
(Melican et al., 2005), EP + CD-CHX (Daniel et al., 2008) and Ionomycin + 6-DMAP 
(Reggio et al., 2001; Tang et al., 2011), the cleavage rates (25% to 65%) reported seems 
to be lower compared to the results obtained in this experiment (78% to 80%). The 
effect of both the activation protocols on the late stage of cloned caprine embryo in vitro 
development could not be compared with the above mention research groups as they 
conducted embryo transfer at 1 to 2-cell stage, except Tang et al. (2011) who cultured 
the reconstructed embryos up to day 7.   
 Even though in this experiment, the reconstructed oocytes activated using both 
activation protocols failed to develop beyond morula stage, the percentage of morula 
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obtained (42.8%) is relatively higher compared to the study conducted by Tang et al. 
(2011) who obtained 31%. Failure in developing reconstructed blastocyst in this 
experiment compared to Tang et al. (2011) and Liu et al. (2011) might be attributed to 
slight difference in activation chemical employed as they used ionomycin instead of CaI 
to generate initial calcium transient (Ware et al., 1989). Moreover, both the research 
groups used foetal fibroblast cell as donor karyoplast and the IVC medium as well as 
culture apparatus used in their study differ from the present experiment. Thus, the 
reason that the reconstructed oocyte failed to develop to blastocyst stage might not be 
solely due to the activation protocols examined in this experiment as the suboptimal 
IVC medium and system might be affecting the blastocyst development as well (Han et 
al., 2003).  
 It is known that an increase in intracellular Ca
2+ 
concentration is a universal 
response elicited by the sperm during fertilisation of the oocyte (Whitacker and Patel, 
1990). Given the importance of the Ca
2+
 release during fertilisation, most of the 
currently used oocyte activation procedures rely on methods to induce an intracellular 
Ca
2+
 increase. The capability of Ca
2+
 rises to release oocytes from the meiotic arrest is 
related to the ability to trigger persistent inactivation of maturation promoting factor 
(MPF) and cytostatic factor (CSF), which is the result of c-mos and mitogen activated 
protein kinase (MAPK) activity (Lorca et al., 1993; Collas et al., 1993). There are 
several chemical substances that could be used to induce Ca
2+
 oscillation even without 
penetration of sperm such as ionomycin (Loi et al., 1998), ethanol (Loi et al., 1998), 
calcium ionophore A23187 (Liu et al., 2002) and strontium (Cuthbertson et al., 1981). 
 It was demonstrated that any activation procedures that evoke only a single Ca
2+
 
rise is not adequate for full oocyte activation as it causes only a transient decline of 
MPF and CSF activity (Lorca et al., 1993; Collas et al., 1993). Based on these, 
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alternative methods of activation have been developed that combine a transient 
inactivation of MPF obtainable with a single [Ca
2+
]i rise, with a persistent inhibition of 
MPF, induced by addition of either protein synthesis inhibitors (e.g., CHX; 
Zakhartchenko et al., 1999) or non-specific kinase inhibitors (e.g., 6-DMAP; Liu et al., 
1998). Protein synthesis inhibitors usually restrict the synthesis or re-accumulation of 
cyclin B, thereby, blocking the re-synthesis of MPF activity (Presicce and Yang, 1994). 
Non-specific protein kinase inhibitors inhibit kinase activity of MPF, by inactivating 
MAPK (Motlik et al., 1998; Gordo et al., 2000).  
 In the activation protocol using 7% EtOH + CD- CHX, the ethanol (EtOH) 
served to induce Ca
2+
 elevation  that would inactivate the existing cytostatic factor 
(CSF), the subsequent cycloheximide exposure served to prevent renewal of CSF 
synthesis in the oocyte and CD in turns inhibited the microfilament polymerisation. 
While for the combination treatment of CaI + 6-DMAP, the CaI first initiated a calcium 
flux and then inhibited protein phosphorylation that induces pronuclei formation 
without completion of meiosis.  Even though both the 7% EtOH + CD-CHX and CaI + 
6-DMAP activation protocols activated the reconstructed oocytes in different ways, 
these two sequential activation protocols fulfilled the mechanism of inducing calcium 
oscillation and preventing calcium levels from dropping before MPF inactivation takes 
place which is important for activation to take place. Thus, both activation protocols in 
this experiment portrayed similar efficiency as evident by the similarity in cleavage and 
morula rate obtained in this experiment since the mechanism of activation was fulfilled. 
The efficiency of both the combination of activation protocols tested were further 
confirmed as, other research groups employing either 7% EtOH + CHX or CaI + 6-
DMAP also reported to obtain high rate of pronulear formation, blastocyst and even 
offspring in their study (Presicce and Yang, 1994; Zakhartchenko et al., 1999; Loi et al., 
1998; Liu et al., 1998; Cibelli et al., 1998). However, the chromosomal analysis of the 
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embryos generated by these two activation protocols are suggested for future study as 
there were controversial in reports that the use of activation substances could affect the 
post-implantation of embryos after embryo transfer (Bhak et al., 2006). 
 Since the reports on successful production of cloned kids and calf also employed 
CaI + 6-DMAP protocols (Keefer et al., 2001, 2002; Reggio et al., 2001; Lan et al., 
2006; Shen et al., 2008) and due to the simplicity and shorter activation duration 
employed in the CaI + 6-DMAP protocols compared to 7% EtOH +CD-CHX, the 
former activation protocol was employed in the subsequent experiments to produce 
cloned and parthenogenesis caprine embryos. 
.   
 
5.4.3 Effect of Two Different In Vitro Culture Media on the In Vitro 
 Developmental Competency of Reconstructed Caprine Embryos 
 
In this experiment, the effect of two different basic culture media on the IVD of caprine 
intraspSCNT embryos was compared. The basic culture media evaluated were modified 
synthetic oviduct fluid medium with amino acid (mSOFaa) and potassium simplex 
optimisation medium with amino acid (KSOMaa). mSOFaa had been used as a standard 
medium in in this laboratory (ABEL Laboratory) for IVP of caprine embryos (Phua, 
2006; Chan, 2008; Rahman, 2008 and Kong, 2010) and it is also commonly used in 
other laboratory to culture IVF, ICSI as well as SCNT- derived caprine embryos 
(Keskintepe et al., 1998; Jiménez-Macedo et al., 2006; Romaguera et al., 2011; Tang et 
al., 2011). The outcome of the embryo development using this basal culture medium 
varies from one laboratory to another as modification by supplementing additional 
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substances as well as the differences in the incubation environment was implemented 
according to each laboratory setting.  
 The previous studies conducted in this laboratory, using the IVC system 
incorporating mSOFaa as basal culture medium could not support the IVD of caprine 
IVF and ICSI embryo up to blastocyst stage. Even in Experiment 4.4.1 and 4.4.2, none 
of the cloned caprine embryos manage to develop beyond morula stage using the similar 
culture medium. Thus, in this experiment, the efficiency of a new basal culture medium 
known as KSOMaa was evaluated as an attempt to improve the current IVC system in 
the laboratory for the production of in vitro caprine blastocyst. KSOM was originally 
formulated by Lawitts and Biggers (1991) for mouse embryo culture. An improvement 
on this medium, mKSOMaa, was formulated by Summers et al. (1995, 2000) with the 
addition of glucose (5.56 mM), BSA (4 mg/ml) and amino acids to increase the 
development rate of mouse IVF embryos. Since mKSOMaa supports mouse embryo 
development in vitro favorably. This culture medium was then tested in other domestic 
animals such as cattle (Bhuiyan et al., 2004; Nedambale et al., 2004) and pig (Hashem 
et al., 2006) using a low glucose concentration (0.2 mM) and it seems that KSOMaa 
basal medium could support the in vitro development of cattle and pig embryos up to 
blastocyst stage. To our understanding, this experiment is the first attempt in using 
KSOMaa as the basal culture medium for caprine embryos IVC. Thus, in this study a 
comparison was made between the efficiency of using mSOFaa versus KSOMaa on the 
IVD of caprine intraspSCNT embryos.  
 The results obtained in this experiment demonstrated that KSOMaa basal 
medium has better efficiency compared to mSOFaa in supporting the IVD of cloned 
caprine embryos. This was evident as the cleavage rate, 8-cell and morula rate of cloned 
caprine embryos in KSOMaa were significantly (P<0.05) higher compared to mSOFaa. 
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Additionally, only embryos cultured in KSOMaa managed to develop to blastocyst 
stage.  
 It is worth to note that in this experiment, both mSOFaa and KSOMaa medium 
were supplemented with BSA-FAF and changing of culture medium during the embryo 
IVC was conducted at Days 2, 4, 5, 6, 7 post-activation. Thus, the efficiency of both 
mSOFaa and KSOMaa culture medium was not affected by the type of albumin 
supplemented but rather the chemical components used in the formulation of the basal 
media. When comparison was made in the chemical components between mSOFaa and 
KSOMaa, there were two distinct chemical components identified namely, EDTA and 
glucose that were only present in KSOMaa. These two distinct chemical components 
are likely to be the factors that differentiate the efficiency of both the basal media.  
 The IVD rates of caprine embryos at early cell stages cultured in KSOMaa in 
this experiment has significantly improved compared to the embryos cultured in 
mSOFaa. The improvement could be due to the presence of EDTA in KSOMaa. Similar 
observation on the beneficial effect of EDTA during early stages of embryos 
development was reported in murine (Gardner et al., 1996; Orsi and Leese, 2001) and 
bovine (Gardner et al., 2000; Olson and Seidel, 2000) embryos. It is well known that 
EDTA plays an important role in metabolic manipulation by depressing glycolysis 
during embryo pre-compaction, whereby high glycolytic rate is detrimental for embryo 
development (Thompson, 2000). Furthermore, EDTA also sequesters the toxic effects 
of heavy metal cations by inhibiting the production of reactive oxygen species, 
catalysed by ions such as Fe
2+
 and Cu
2+
 in the embryo IVC system (Johnson and Nasr-
Esfahini, 1994).  
 Even though EDTA is known to be beneficial for embryo culture, prolonged 
exposure of embryos to EDTA in IVC medium is detrimental as reported by Brinster 
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(1965) and Gardner et al. (2000). They also found that in vitro development of post-
compaction embryos depends on energy derived from high glycolytic activity; therefore, 
presence of EDTA in the medium during later stages of development will inhibit 
glycolysis, thus is harmful for the in vitro development of blastocyst. However when 
comparison was made on the concentration of EDTA used in the study describe by  
Gardner et al. (2000) and this present study, the concentration of EDTA (0.01 mM) 
used in this study was lower compared to that reported by Gardner et al. (2000) (0.1 
mM). It is uncertain whether the lower concentration of EDTA in this study has positive 
effect on blastocyst production. 
 Besides that, the presence of glucose in KSOMaa might be the factor affecting 
the development of the cloned caprine embryos. The requirement for glucose in the 
culture medium for early stages of embryo development is controversial. Some reports 
stated that the presence of glucose during the first day of IVC is unfavourable to 
embryos in several species, namely mouse (Chatot et al., 1989), sheep (Thompson et al., 
1992) and cattle (Ellington et al., 1990). However, in this experiment high cleavage rate 
was obtained even though embryos were cultured in KSOMaa that contain glucose at 
the concentration of 0.2 mM. This result is in accordance with the findings by 
Matsuyama et al. (1993) who suggested that the presence of a low level of glucose 0.18 
mM in the IVC medium for Day 0 to 3 is preferable for the in vitro development of 
bovine embryos. Perhaps, the concentration of glucose is the main factor that causes all 
the controversial among reports on the detrimental effect of glucose during the early 
stage of embryo culture. It is worth to note that, at Days 0 to 3 of the embryo in vitro 
development, even though glucose is not being used as the main energy substrate, it is 
known that it plays an important biosynthetic role in nucleic acid production (Rieger, 
1992), which is essential for embryonic development at this early stage. Thus, the 
presence of trace amount of glucose in KSOMaa might be giving the beneficial effect to 
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the development of the cloned caprine embryos compared to the mSOFaa medium 
without glucose used in this experiment. 
  When comparison was made on the efficacy of mSOFaa used in this experiment 
and other research groups (Keskintepe et al., 1998; Jiménez-Macedo et al., 2006; Tang 
et al., 2011; Liu et al., 2011), the mSOFaa in this experiment could not support the in 
vitro development of cloned caprine embryos up to blastocyst stage which is in 
contradict to the results obtained by other research groups mention earlier. The 
discrepancy in the efficiency of mSOFaa might be attributed to the presence of sodium 
citrate (0.5 mM) in the formulation of mSOFaa used by the other research group which 
was not supplemented in this experiment. Sodium citrate is known to promote positive 
embryotrophic effect on embryo development as it stimulates fatty acid synthesis 
(Goodridge, 1973). Besides that, it also function as a chelator of metal ions (e.g., Ca
2+
), 
a feature that may be of importance for maintaining junctional integrity and thus, of 
importance for compaction and blastocoel formation (Gary et al., 1992).  
 Even though, in this experiment, KSOMaa could support the development of 
cloned caprine embryos up to blastocyst stage, the blastocyst rate obtained was still low. 
Thus, modification on the formulation of KSOMaa was conducted in the subsequent 
experimental design as an effort to improve the blastocyst rate of cloned caprine 
embryos.  The findings of this study has significantly contributed to the in vitro culture 
work of caprine embryos for this laboratory as this experiment was the first to 
successfully produced caprine blastocyst in vitro by using KSOMaa. 
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5.4.4 Effect of Increasing Glucose Concentration in KSOMaa medium at Day 2 
 culture on the In Vitro Developmental Competency of Reconstructed 
 Caprine Embryos 
 
As an attempt to further improve the in vitro cloned caprine blastocyst rate, a two-steps 
culture system was incorporated in this experiment by increasing the glucose 
concentration in KSOMaa medium at Day 2 culture (Treatment B). The efficacy of 
increasing glucose concentration in KSOMaa medium was evaluated by comparing the 
IVD and hatched blastocyst rate between embryos cultured in the one-step culture 
system of KSOMaa (Treatment A) and the two-step culture system (Treatment B) 
mentioned above.  
 In any culture medium, energy substrate is known to be one of the important 
ingredients for optimum in vitro development of embryos. Thus in this study, 
modification on the glucose concentration was conducted to optimise the in vitro 
development of cloned caprine embryos in particular blastocyst rate. At present, there 
are variations in the optimum concentration of glucose employed for different species 
and from one laboratory to another.  Furnus et al. (1997) reported that supplementation 
of glucose concentration at 1.5 mM onwards in mSOF was effective in increasing 
bovine blastocyst rate, while raising the concentration to 5 mM is detrimental. This 
finding is in contrast to the report by Kim et al. (1993) who reported that glucose at 2.78 
to 5.56 mM is favorable for increasing bovine blastocyst rates. In a study on mouse 
embryo culture, Summers et al. (1995) reported that glucose at 5.56 mM does not 
significantly inhibit blastocyst development. Thus, in view of widely varying reports on 
the optimal glucose concentration in different species, for the present study the author 
selected a glucose concentration of 2.78 mM supplemented in KSOMaa B which is 
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intermediate among the three reports mentioned above and compared it to the basal 
glucose concentration of 0.2 mM in KSOMaa A. 
 The results obtained in this study demonstrated that by increasing glucose 
concentration to 2.78 mM in Treatment B, the in vitro development of late embryo 
stages, (morula to blastocyst) significantly increased compared to embryos in Treatment 
A in which glucose concentration was not increased at Day 2 culture. The favorable 
effect of glucose increment in Day 2 culture was even prominent when the blastocysts 
cultured in Treatment B manage to hatch. The IVD rates of cloned caprine embryos at 
2-cell to 8-cell stages cultured in both Treatment A and B did not differ significantly, as 
expected because for the first 2 days of IVC, Treatments A and B shared the same 
formulation of KSOMaa.  
 Increasing the glucose concentration from 0.2 mM to 2.78 mM on Day 2 for 
embryo culture favored development of cloned caprine embryos as reflected in the 
percentages of morulae and blastocysts obtained. Telford et al. (1990) and Rieger et al. 
(1992a), studying changes in the metabolism of glucose by bovine embryos throughout 
in vitro development, demonstrated that glucose metabolism does increase between the 
8-cell and 16-cell stage, which is the time of embryonic genome activation. Similar 
observation on the marked glucose intake at the maternal zygotic transition phase of 
sheep (2 to 8- cell) and pig (4 to 8- cell) were reported (Thompson et al., 1991; Flood 
and Wiebold, 1988). Thus, the additional glucose incorporated into KSOMaa at Day 2 
in this study may be rationalised as promoting better maternal-zygotic transition 
competence in cloned caprine embryos. Furthermore, glucose is also beneficial for 
blastocyst expansion because energy derived from glycolysis is required for maintaining 
the blastocoel (Rieger et al., 1992b; Benos and Balaban, 1990). This explains why, in 
Treatment A without additional glucose, the percentage of cloned caprine blastocysts 
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was significantly lower than in Treatment B and furthermore none of the blastocyst in 
Treatment A managed to hatch.  
 The cloned caprine blastocyst rate obtained in IVC Treatment B (19.9%) was 
comparable with other caprine intraspSCNT research groups such as Apimeteetumrong 
et al. (2004), Liu et al. (2007), Tang et al. (2011); Liu et al. (2011)  who obtained 
average blastocyst range from 9.5% to 24% using different culture medium. Thus, this 
suggest that the two-step culture system (Treatment B) designed in this experiment is as 
effective as other culture system in use for caprine intraspSCNT research. 
   
 
 
5.5 EFFICACY OF PRODUCING CLONED CAPRINE EMBRYOS USING 
INTRASPECIES VERSUS INTERSPECIES SCNT APPROACHES 
(EXPERIMENT 5) 
 
This pioneering experiment was undertaken to produce caprine intraspecies SCNT 
(intraspSCNT) and interspecies SCNT (interspSCNT) embryos using KSOMaa as IVC 
medium in an effort to produce blastocyst. Besides that, it is believed that this 
experiment is the first attempt to produce cloned caprine interspSCNT embryo using 
caprine ear skin fibroblast cell as donor karyoplast and bovine oocyte as recipient 
cytoplast. The efficiency of caprine interspSCNT approach was compared with the 
intraspSCNT approach by evaluating the developmental ability, quality of blastocyst 
and the capability of post-implantation. The quality of blastocyst was evaluated in terms 
of hatching ability and total nuclei number. As a control, these parameters were also 
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evaluated for parthenogenetic activation (PA) embryos as Gupta et al. (2008) and Hong 
et al. (2005) had reported that the development characteristics of PA embryos 
resembled those of in vitro fertilised embryos and could be considered as a good model 
system to evaluate the influence of maternal factor (oocyte) on embryonic development 
by avoiding the confounding variation due to the influence of male/ sperm factor. 
 When the developmental competency of caprine intraspSCNT and caprine PA 
embryos were compared in this experiment, there were no significant difference 
(P>0.05) in the rate of cleavage and the development to the blastocyst stage (78% 
versus 74%, and 17% versus 15%). Both caprine intraspSCNT and PA blastocyst 
managed to proceed to hatched blastocyst stage with no significant difference in the 
hatching rate. Both IVD competency of caprine interspSCNT and bovine PA embryos 
showed similar trend in the cleavage rate (78% versus 73%), blastocyst rate (8.4% 
versus 12.6%) and hatched blastocyst rate (4.8% versus 7.9%) as obtained in the caprine 
intraspSCNT approach. The similarity in the IVD rate of intraspSCNT or interspSCNT 
versus the PA embryos indicated that the caprine ear skin fibroblast cell may be 
sufficiently reprogrammed in the recipient oocytes (Lu et al., 2005), and it also 
indirectly showed that the manipulation technique employed during this SCNT study 
was reliable and did not impact negatively the in vitro development of the cloned 
caprine embryos. 
 The ability of caprine interspSCNT embryos developed to blastocyst stage 
(8.54%) in this experiment portrayed that skin fibroblast cell from caprine could be 
reprogrammed by enucleated bovine oocyte. Similar observation was also reported by 
Dominko et al. (1999), in which 13.9 to 16.6% of embryos reconstructed by transfer of 
the skin fibroblast cells from sheep, pigs, monkeys and rats into bovine cytoplasts 
developed to blastocysts. This showed that bovine cytoplasm could support the nuclei of 
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various species to the early cleavage stages and beyond, suggesting that it has the ability 
to reprogramme, at least partially, diverse donor nuclei past the maternal-embryonic 
transition (Dominko et al., 1999; Lanza et al., 2000; Kitiyanant et al., 2001; Sansinena 
et al., 2005).  
 When comparison was made with the caprine interspSCNT studies conducted by 
other research groups, the blastocyst rate obtained in this experiment (8.5%) was 
slightly higher than the caprine interspSCNT (2.2%) using buffalo cytoplast (Selokar et 
al., 2011) and was comparable to the caprine interspSCNT  (7.4%) using ovine 
cytoplast (Ma et al., 2008). It is known that oocytes from different species may differ in 
their developmental competence, and this was shown in the study conducted by Lu et al. 
(2005) that buffalo oocytes were less efficacious than bovine oocytes in their ability to 
support the embryonic development of either buffalo or bovine fibroblasts after nuclear 
transfer (NT). Thus, the variations in the blastocyst rates observed in the comparative 
evaluation on the caprine interspSCNT mentioned above might indicate that bovine and 
ovine oocytes have a better efficacy than buffalo oocytes in supporting the embryonic 
development of caprine ear skin fibroblast cell. Besides that, when comparison was 
made with Song et al. (2008) who transferred foetal fibroblast cell into bovine ooplasm, 
the blastocyst rate obtained in their study (7.9%) was comparable to this experiment; 
suggesting that ear skin fibroblast cell might has similar reprogramming ability as foetal 
fibroblast cell. Similar observation was reported by Kato et al. (2000), Jang et al. (2004) 
and Srirattana et al. (2010) that there was only little if any difference between foetal and 
adult fibroblast following NT in terms of blastocyst development. However, further 
studies by standardising the SCNT procedure including laboratory personnel skill are 
required in order to validate the effect of oocyte cytoplast and type of donor cell factors 
on the efficiency of caprine interspSCNT discussed earlier. 
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 During the caprine intraspSCNT versus interspSCNT experiment, both caprine 
and bovine oocytes showed similar maturation rate. This reflects that the in vitro 
maturation medium used in this experiment was versatile to support the maturation of 
oocyte from two different species (caprine and bovine) used in this study. The fusion 
rate of interspSCNT approach was significantly lower than the intraspSCNT approach. 
Thus, this indicates that the fusion parameters applied in the caprine intraspSCNT 
experiment are not sufficient for the fusion of bovine cytoplast and modification in the 
fusion parameters for (caprine karyoplast-bovine cytoplast) interspSCNT is suggested 
for future study. 
 When the efficiency of intraspSCNT and interspSCNT approaches was 
compared, it seems that the bovine ooplasm has similar competency as caprine ooplasm 
in promoting dedifferentiation of caprine nuclei as well as in supporting the embryonic 
development prior maternal-zygotic transition (8-cell to morula). This was reflected by 
the non-significance difference in the cleavage rate and the developmental rate at the 8-
cell stage between both approaches. However, when approaching the late embryo 
developmental stages (morula to blastocyst), the interspSCNT approach was not as 
efficient as intraspSCNT approach when significantly lower morula and blastocyst yield 
were obtained in caprine interspSCNT approach. Li et al. (2006a) suggested that a 
closer genetic background between the donor cell and recipient oocyte could enhance 
blastocyst development in vitro. This suggests that the low blastocyst rate in caprine 
interspSCNT might be due to the genetic distance between bovine and caprine, which 
might result in incompatible genomic regulation and metabolic mechanism. The birth of 
a live cloned gaur by interspSCNT (Lanza et al., 2000) and successful implantation of 
yak interspSCNT embryo (Li et al., 2007) using bovine oocytes as recipient cytoplasm 
suggested that a close phylogenetic distance between donor nucleus and recipient 
cytoplasm resulted in a higher likelihood of success in delivering live offspring. Even 
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though gaur offspring was produced following interspSCNT using bovine cytoplasm, 
declination in blastocyst yield was observed, suggesting that sufficient differences that 
exist between the bovine and gaur at genetic and molecular level could be accountable 
for differences in embryo growth dynamics (Mastromonaco et al., 2006). 
 It is worth to mention that, the ability of cloned caprine embryos derived from 
both intraspSCNT and interspSCNT approaches in this experiment managed to develop 
beyond morula stage was influenced by the culture system employed. This was evident 
as none of the caprine intraspSCNT and interspSCNT embryos managed to develop 
beyond morula stage in our previous study (Abdullah et al., 2011) until changing of a 
new culture system was employed by using the optimised two-step culture system 
(Treatment B) using KSOMaa as basal medium in this experiment. Even though the 
culture system developed in this study could support the development of caprine 
interspSCNT blastocyst, the probability and fate of these embryos to develop to term is 
still unknown. 
In terms of the blastocyst quality evaluation, the cell number of caprine 
interspSCNT blastocysts seems to be lower than in caprine intraspSCNT and PA 
blastocysts. Similar observations were reported in other interspSCNT studies such as in 
buffalo-bovine cytoplast (Atabay et al., 2004), monkey-bovine cytoplast 
(Lorthongpanich et al., 2008) and bovine-buffalo cytoplast (Lu et al., 2005) 
interspSCNT. It is important to examine the blastocyst cell number because the 
developmental competence of embryos to term after embryo transfer correlates with the 
number of cells present in the blastocyst. Fleming et al. (2004) demonstrated that low 
blastocyst cell numbers are implicated in reduced development and may lead to large 
offspring syndrome.  
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At present, the available reports on the successful production of cloned caprine 
are through intraspSCNT (Baguisi et al., 1999; Keefer et al., 2002; Reggio et al., 2001), 
however, the overall pregnancy rate after transfer is still low. None of the domestic 
animals was successfully cloned using interspSCNT in particular intergeneric approach. 
Most of the cattle (Lu et al., 2005), buffalo (Kittiyanant et al., 2001), sheep (Dominko 
et al., 1999), pig (Uhm et al., 2007) and goat (Selokar et al., 2011) intergeneric SCNT 
embryos only managed to develop up to blastocyst stage. Similarly, in this experiment, 
no pregnancy was detected after 8 attempts of embryos transfer conducted on both 
caprine intraspSCNT and interspSCNT embryos. Failure in obtaining viable cloned kids 
might be attributed to fact that the number of intraspSCNT and interspSCNT embryos 
(4 to 8 embryos) transferred per recipient is not sufficient. Chen et al. (2007) and Liu et 
al. (2011) demonstrated that the pregnancy rates and kids born per recipient increased as 
more cloned caprine embryos (10 to 40 embryos) were transferred per female. This 
might be due to the fact that implantation competency of cloned embryos are rather low 
due to defects in the cloned placenta (Liu et al., 2011), thus by increasing the number of 
cloned embryos per transfer or co-transferred with parthenogenetic embryos, the 
probability of gaining pregnancy might increase. However, further investigation on this 
are required as there were also reports that viable cloned offspring was obtained by just 
transferring 1 to 4 cloned embryos into one surrogate mother (Baguisi et al., 1999; Tang 
et al., 2011). Besides that, the negative implantation rate of caprine interspSCNT 
embryos might also be due to the incompatibility of mitochondria and genomic DNA of 
donor nucleus (karyoplast) and recipient oocyte (cytoplast) which results in post-
implantation defect. Since this experiment was the first attempt to transfer cloned 
caprine interspSCNT embryo into the surrogate mother, it was unsure whether using 
goat or bovine as surrogate mother would be more suitable for the interspSCNT 
embryos to develop to term. However, further studies on the factors described above as 
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well as increasing the number of embryo transfer attempts are required before a firm 
conclusion could be made on the post-implantation competency of the intraspSCNT and 
interspSCNT embryos produced in this research. 
In a nutshell, both intraspSCNT and interspSCNT approaches could produce 
cloned caprine embryos to blastocyst stage using the protocol developed in this research. 
Even though both approaches could produce cloned caprine embryos, the efficiency of 
interspSCNT approach is still low compared to intraspSCNT approach. 
  
 
5.6 GENERAL DISCUSSION 
Generally, the overall production of cloned animals by SCNT involves multiple steps 
including oocyte collection, donor cell culture, oocyte maturation, enucleation, donor 
karyoplast transfer, activation, IVC and embryo transfer (Figure 5.1). As mentioned in 
the figure, both technical and biological factors underlying in each of these steps are 
known to influence the successful outcome of the overall SCNT performance. In this 
research, a comprehensive study to optimise all of the influencing factors in each steps 
of the SCNT depicted in Figure 5.1 could not be conducted due to the short time frame 
and furthermore, the present study was the first attempt of SCNT in this laboratory. 
Therefore, the author only selected a few factors targeting to optimise oocyte yield, 
oocyte maturation performance, activation treatments and IVC system in the present 
caprine intraspSCNT study with the vision that part of these findings could benefit other 
caprine embryo IVP research in the future.  
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 Oocyte is known as the “Holy grail” in the embryo IVP study. With the current 
advances in the ART, embryo can still be produced in vitro using somatic cell via 
nuclear transfer approach, that is without involvement of conventional sperm 
fertilisation, Thus, availability of a constant and sufficient supply of oocytes is the 
prime factor that determines the efficiency of embryo production in vitro. In goat 
intraspSCNT, immature oocyte generally can be retrieved from live does via LOPU and 
abattoir-derived ovaries.  
 Oocytes from abattoir-derived ovaries have been the principle choice for the 
caprine IVP research due to the fact that it is inexpensive and readily available in almost 
unlimited quantities in some of the countries (Martino et al., 1994; Pawshe et al., 1994b; 
Ongeri et al., 2001; Rho et al., 2001). However, in Malaysia the source of caprine 
Figure 5.1: Flow chart of steps involved in SCNT and factors affecting each step. 
 RECIPIENT CYTOPLAST 
(Oocyte) 
 DONOR KARYOPLAST 
(Somatic cell) 
Oocyte Collection 
(In vivo/ in vitro) 
Cell selection/ Collection 
(Age/ cell type) 
Oocyte Maturation 
(In vivo/ in vitro) 
Oocyte Enucleation 
(Cell cycle stage, physical/ chemical removal) 
Cell Culture 
(Condition/ duration) 
Cell Cycle Stage 
(Synchronised/ non-synchronised) 
Embryo Reconstruction 
(Age of recipient oocyte, cell fusion/WCICI) 
Activation 
(Timing, chemical/electrical pulse treatment) 
Embryo Culture 
(Type of IVC medium, culture condition) 
Embryo Transfer 
(Synchronisation of embryo with recipient) 
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oocytes from abattoir-derived ovaries is rather limited due to low slaughtering as a 
result of acute shortage of does in Malaysia (Rajikin, 1996). Moreover, slaughtering of 
does were often conducted in batches at only a selected period of time in a year, thus 
continuous weekly supply of goat ovaries from abattoir was not possible. To overcome 
this hurdle, LOPU is indeed an important alternative to obtain the supply of oocyte from 
live does in this local setting (Phua, 2006; Rahman, 2008; Kong, 2010). LOPU was 
proved to be an efficient and relatively non-invasive technique for OR from small 
ruminant like ewes (Baldassarre et al., 1994; Gibbons et al., 2007) and does 
(Baldassarre, 2002; Baldassarre and Karatzas, 2004; Gibbons et al., 2007) compared to 
transvaginal ultrasound-guided aspiration (TUGA) or laparotomy method. This is 
evident that LOPU may be repeated several times without causing ovarian damage or 
decrease in the donors’ fertility (Stangl et al., 1999; Alberio et al., 2002; Pierson et al., 
2005). Furthermore, LOPU after multi-dose hormonal treatment may be repeated 
(Tervit et al., 1992, 1993; Alberio et al., 2002), without diminishing good quality 
oocytes harvested (Tervit et al., 1992; Stangl et al., 1999; Alberio et al., 2002), which 
was also observed in this study after three repeated OR cycles. 
 Oocyte retrieval from live does using LOPU technique, often involves the 
application of oestrus synchronisation and ovarian superstimulation treatment on the 
live does to increase the number of follicle growth at a fixed time for OR. FSH from 
ovine (oFSH), porcine (pFSH) and PMSG or eCG are the commonly used 
gonadotrophins for livestock ovarian stimulation (Smartzi et al., 1995; Nowshari et al., 
1992). A number of experiments have been performed to compare the superovulatory 
response between FSH and PMSG in livestock animals, the evidence favours the use of 
FSH than PMSG (Tsunada and sugie, 1989; Pendelton et al., 1992; Mahmood et al., 
1991; Nowshari et al., 1992).  
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 Does that were treated with PMSG was frequently associated with a high 
number of  non-ovulated follicles, early regression of CL, short or irregular oestrous 
cycles and potential risk of embryo expulsion in MOET programme (Amoah and 
Gelaye, 1990). Furthermore, Tsunada and Sugie (1989) reported that the average 
number of oocytes recovered was significantly higher in FSH-treated does (9.4) than 
that in PMSG-treated ones (5.7). In contrast to the above findings, the present study 
showed that there were no significant difference in the average number of oocytes 
recovered via LOPU between FSH-treated (12) and PMSG-treated (11) does. Variation 
in the results obtained between the present study and Tsunoda and Sugie (1989) might 
be due to the differences in breeds, dosage and hormonal regime factors.  
 Even though PMSG was reported to negatively influence the superovulation 
treatment of livestock for embryo collection, especially the incident in which follicles 
fail to ovulate, this effect might not be a negative impact to the OR via LOPU 
programme as oocytes were retrieved from follicles prior ovulation. Furthermore, due to 
its lower cost, easy availability and it can be more easily administered (single injection ) 
than FSH (multiple injection), perhaps PMSG can be a good choice to be used in OR 
via LOPU programme, if refinement on the regime targeting to minimise the effect of  
provocation of anti-PMSG antibodies in the repeated stimulation treatment is carried out. 
The decline in the ovarian response in the repeated stimulation treatment using PMSG 
was often associated with the existence of antibodies anti-PMSG accumulated in the 
animals. A decrease in the number of oocyte retrieved from PMSG-treated does at OR 3 
was observed in this study, and this might be due to the provocation of anti-PMSG 
antibodies in the repeated stimulation treatment. However, Gibbon et al. (2007), in their 
study, found that neither follicle number nor oocyte recovery rate and viability were 
affected by the reiteration of the PMSG treatments in goats. A possible explanation to 
the variation in the observation might be related to the short time elapsed (4 days 
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interval) between treatments of LOPU on the stimulated does employed in their study as 
this time elapse might be too short for antibodies production. Perhaps in future, 
refinement of the present PMSG regime targeting on the time elapse between LOPUs 
and the incorporation of PMSG antiserum after PMSG injection could be carried out to 
improve the stimulatory response of PMSG used in the repeated LOPU sessions.  
 Oocyte retrieval from abattoir-derived ovaries produced a relatively higher 
number of oocyte yields than LOPU from stimulated does in this study. However, the 
quality and maturation rate of the oocytes retrieved from abattoir-derived ovaries were 
relatively lower than LOPU oocytes as observed in this study. According to Rahman et 
al. (2009), during IVM higher numbers of abattoir-derived oocytes died than LOPU 
source, which definitely affect the maturation rate of the abattoir-derived oocytes. 
Additionally, abattoir-derived oocytes were highly heterogeneous in nature and this 
heterogeneity came from different grades of growth and atresia of the oocytes obtained, 
which might have contributed to the lower maturity in some of these oocytes. On the 
other hand, in LOPU, as does were stimulated with hormones, and only follicles >2-3 
mm were punctured, chances of survivability and maturity were better than with abattoir 
oocytes. In the present study, all the oocytes of heterogeneous grades were cultured 
including COCs with <1 complete CC layer due to a shortage of oocytes in both sources. 
However, other authors whom reported to produce high IVM rate (>70% to >80%) 
cultured good grades of oocytes with at least 4 (Jiménez-Macedo et al., 2006), 2 and 
above (Rho et al., 2001; Tajik and Esfandabadi, 2003), or 1-2 (Martino et al., 1995) 
layers of CC. Thus, the lower maturation rate reported in this study might be due to the 
quality of COCs cultured in particular the number of cumulus cell layer. It has been 
suggested that both the presence of cumulus cells and cell-oocyte contact are crucial for 
oocyte maturation to attain developmental competence (Leibfried-Rutledge et al., 1989; 
Gall et al., 2005). In addition, the developmental competence of bovine oocytes 
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surrounded with corona cells was induced in a cell density-dependent manner in the 
maturation medium (Hashimoto et al., 1998). This supporting mechanism has been 
shown to be partially due to the soluble factors secreted from cumulus cells (Hashimoto 
et al., 1998). Thus, in order to promote the maturation rate of oocytes with less than 1 
complete layer of cumulus cells which are usually obtained from the pool of abattoir-
derived oocytes, perhaps these oocytes can be cultured along with oocytes that consist 
of more than 2 layers of cumulus cell in the same droplet of IVM medium. Furthermore, 
additional of epidermal growth factor was also reported to enhance the maturation and 
developmental rates of abattoir- derived oocytes (Lonergan et al., 1996).  
   The in vitro developmental competency of cloned embryos could be influenced 
by the oocyte age (duration of MII arrest after IVM), activation treatment and the IVC 
system. Inappropriate timing of maturation could lead to oocyte aging (Hunter, 1989; 
Hunter and Greve, 1997), the formation of abnormal chromatin (Dominko and First, 
1997) and impairment in embryo development (Marston and Chang, 1964). As the age 
of the oocytes at the time of MII arrest increased (extrusion of the polar body by 20 or 
24 hours), a decrease in the ability of bovine oocytes to cleave and develop to the 
blastocyst stage was observed by Dominko and First (1997). In SCNT, the activation 
response in oocytes by several activation agents has been demonstrated to be oocyte age 
dependent.  
 Before the discovery of activation treatment using combination of chemicals and 
or electrical stimulation, the single activation treatment responded favourably on aged 
oocytes. Thus, in the 1990s, aged oocytes were preferably used in nuclear transfer 
procedure (Bondioli et al., 1990; Nagai et al., 1992; Barnes et al., 1993) as they were 
reported to respond well to the single activation treatment compared to young (freshly 
matured) oocyte (Yang et al., 1993; Presicce and Yang, 1994). When a combination 
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treatment of activation was used in young matured oocyte, the developmental ability of 
the embryos was reported to be even higher than aged oocyte activated using single 
activation treatment (Takano et al., 1993; Tanaka and Kanagawa, 1997). Ever since then, 
using of combined activation treatment is ideally incorporated in SCNT procedure, 
however, in order to obtain high IVD competency post-SCNT, young matured oocyte 
are required. In order to avoid oocyte aging factor influencing the IVD competency of 
cloned embryos, determination of an optimum IVM duration range prior SCNT was 
conducted in this study.  
 The finding in this study suggested that by using the IVM medium and 
incubation system in the present protocol, the optimum IVM duration range for LOPU-
derived oocyte slightly shorter compared to abattoir-derived oocyte (18 to 22 hours 
versus 22 to 26 hours) in which at these IVM duration range, the maturation rate and 
percentage of successful enucleation was high as the location of MII spindle is closely 
adjacent to PB-1. Additionally, when LOPU-derived oocytes matured at a shorter IVM 
duration (18 to 22 hours) were used, the IVD rate of the reconstructed caprine embryos 
up to morula stage was significantly higher than the prolonged culture duration (23 to 
27 hours). In fact, the percentage of morula obtained in this caprine intraspSCNT study 
using LOPU oocyte matured at 18 to 22 hours was relatively higher compared to the 
caprine IVF and ICSI study using LOPU oocyte matured at 27 hours in this laboratory 
(Chan, 2008; Rahman, 2008). The author speculated that the oocyte aging might be the 
factor influencing the embryo developmental rate as the same IVC system was used in 
all the studies compared above.  
 Activation procedures used in somatic cell nuclear transfer (SCNT) are one of 
the critical factors affecting the efficiency of animal cloning. Currently, combined 
treatment of two activation stimuli are commonly used in cloning studies to ensure 
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better development of reconstructed oocytes (cattle: Cibelli et al., 1998; goat: Keefer et 
al., 2001). The combined activation treatments are usually designed to reduce MPF 
activity in reconstructed oocytes, which is followed by treatment with a protein 
synthesis inhibitor combined with a broad spectrum protein kinase inhibitor to block the 
activity of newly synthesised MPF (Liu et al., 1998; Tian et al., 2002). The author 
found that, the activation response using combined chemical activation treatment of 7% 
EtOH + CD-CHX was comparable to the treatment of CaI + 6-DMAP in the caprine 
intraspSCNT study as the IVD rate of reconstructed embryos up to morula stage was 
similar in both treatments. In bovine intraspSCNT study, Bhak et al. (2006) reported 
that 6-DMAP treatment could result in an increased incidence of chromosomal 
abnormalities compared to the use of CHX. Even though 6-DMAP was reported to 
increase the incidence of chromosomal abnormalities, the bovine intraspSCNT embryos 
using either 6-DMAP or CHX produced similar blastocyst developmental rate and the 
total cell number was similar as well. Even though the activation response was similar 
for both chemical activation treatments in this study, the author had chosen the CaI + 6-
DMAP activation protocol to be used in the overall caprine intraspSCNT and 
interspSCNT studies due to the fact that many reports on live cloned kids production 
used the similar activation treatment (Keefer et al., 2002; Tang et al., 2011) and in 
comparison to the 7% EtOH + CD-CHX treatment, the chosen treatment seems to be 
relatively convenient in the activation time and preparation. However, the cloned 
caprine embryos reconstructed using oocyte matured in the optimised IVM duration and 
activated with both treatments failed to developed to blastocyst stage, and similar in 
vitro developmental pattern was observed in the IVF and ICSI study conducted in this 
laboratory (Chan, 2008; Rahman, 2008; Kong, 2010).   
 Failure in obtaining caprine blastocyst development after SCNT and even in 
other previous IVF and ICSI studies conducted by other researchers in this laboratory 
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using the mSOFaa IVC medium for the past 7 years had been a big challenge and also 
the guiding light that indicated the need to improve or change the existing IVC system 
in this laboratory. There are various stressors in the IVC system that is reported to 
influence the in vitro development of embryos such as inappropriate medium 
formulation, medium supplementation, the oxygen tension in the incubation system, and 
technical issues (Gardner, 2004).  The utilisation of co-culture system and under low O2 
environment which mimic the physiological condition of the reproductive tract was 
reported to be beneficial for embryo development (Bavister, 1995; Edwards et al., 1997; 
Orsi and Reischl, 2007). Combination of both co-culture and low O2 environment in the 
in vitro culture of embryo was employed in several embryo IVP studies which resulted 
in favourable blastocyst production rate (Nagao et al., 1994; Rodríguez-Dorta et al., 
2007; Goovaerts et al., 2009; Srirattana et al., 2010). Incorporation of co-culture and 
low O2 environment in the preliminary experiment of this research conducted in ESRC 
Laboratory, Thailand, resulted in the development of cloned bovine and gaur blastocyst 
as well. However, the drawback of using co-culture is it bears a considerable risk of 
contamination (Bavister, 1995). Even though in the preliminary experiment, this culture 
system was shown to support the development of cloned blastocyst, the deficiency in 
laboratory facilities and the difficulties in obtaining continuous supply of oviduct cells 
from cattle at the ovulatory phase in Malaysia, render the feasibility of using this IVC 
system in the caprine intraspSCNT and interspSCNT studies.  
 In order to improve the IVC system besides focusing on the co-culture and low 
O2 culture system, the author substituted the use of mSOFaa basal medium with 
KSOMaa out of curiosity to test the IVD response of caprine embryos in this basal 
medium, since this medium was not used in any caprine IVC study. Interestingly, after 
incorporating KSOMaa in the IVC system, the reconstructed caprine embryos managed 
to develop up to blastocyst stage. However, the blastocyst rate obtained was lower 
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compared to other caprine intraspSCNT studies using mSOFaa as basal medium (Liu et 
al., 2011; Tang et al., 2011). For further improvement in the cloned caprine blastocyst 
rate, a two-step culture system was designated by increasing the glucose concentration 
in the KSOMaa for the IVC of late stage embryo development (second phase of IVC).  
The idea of increasing glucose supplementation in the two-step culture system 
designated in this study was based on the finding by Rieger et al. (1992) that the 
metabolism of glucose through the pentose-phosphate pathway increased almost 15 
times and the total metabolism of glucose 30 times, during development of embryo 
from the two-cell to the expanded blastocyst stage. The first marked increase in glucose 
metabolism was reported to occur only at the embryo stage between the 8- and 16-cell 
stages in which the time of activation of the embryonic genome take place. In 
accordance to this, perhaps the increase in glucose concentration done at Day 2 post-
activation in the designated IVC system supported the cloned caprine embryo 
development up to hatched blastocyst. The main achievement from this study was the 
finding of this new designated two-step culture system using KSOMaa as basal medium 
that could support the development of cloned caprine embryos up to blastocyst stage. 
Development of this IVC system is indeed a significant breakthrough for the production 
of caprine blastocyst in vitro regardless of using IVF, ICSI or SCNT approach in this 
present laboratory.  
 Most of the successful production of cloned animal often used the intraspSCNT 
approach (Wilmut et al., 1997; Kato et al., 1998; Baguisi et al., 1999). Even though the 
approach of interspSCNT are able to surmount the issue of acute oocyte supply of 
certain animal, particularly in saving the endangered animals, the overall efficiency of 
this approach is still low (Loi et al., 2011). It is important to note that in all the live 
offspring produced to date by interspSCNT, all the recipient oocytes were recovered 
from a species closely related to the one providing the donor somatic nuclei. It is 
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possible that incompatibilities between nuclear and ooplasmic components from more 
distant species are responsible for the limited success of the interspSCNT approach as 
observed in this study as well, in which the overall developmental competency of 
caprine interspSCNT embryos up to blastocyst stage was lower compared to 
intraspSCNT approach. Even though, the developmental rate of interspSCNT (caprine 
karyoplast-bovine cytoplast) embryos obtained in this study was low, it is worth 
mentioning that this study is first report in producing cloned caprine blastocyst using 
interspSCNT (caprine karyoplast-bovine cytoplast) approach. 
 
5.6.1 Summary of Significant Findings  
There were three novel findings achieved in this research which includes: (a) The 
optimal IVM duration range for LOPU-derived oocytes is slightly shorter (18 to 22 
hours) compared to abattoir-derived oocytes (22 to 26 hours); (b) KSOMaa basal 
medium could support the development of caprine intraspSCNT and interspSCNT 
embryos to blastocyst stage. The additional supplementation of glucose into KSOMaa 
medium on Day 2 of IVC enhanced the hatching of blastocyst; (c) Cloned caprine 
blastocyst could be produced using interspSCNT (caprine karyoplast-bovine cytoplast) 
approach. 
5.6.2 Constraints of the Studies and Future Directions 
The present research was a preliminary study to develop a protocol for the production of 
cloned caprine blastocysts through intraspSCNT and interspSCNT approaches. During 
the development of this caprine SCNT protocol, emphasis was given more on the 
improvement of oocyte factors on the production aspect of cloned caprine embryos. 
Therefore, it was beyond the scope to study other aspects pertaining to donor cell, the 
257 
 
mechanism or process at molecular level, particularly on nuclear reprogramming in a 
great detail. Since this study was the first caprine SCNT research conducted in this 
laboratory as well as in Malaysia, many fundamental issues on caprine SCNT at the 
local setting had to be faced and surmounted.  
 Along this research journey, the difficulties encountered included factors such as: 
a) Skill acquisition: 
Intensive learning curve phase in microtools preparation and handling of the 
micromanipulator were endured at the early stages of the research (approximately 
9 months) due to lack of facilities, skills and expertise in this laboratory in the area 
of cloning. 
b) Oocyte supply: 
Irregularity in obtaining abattoir-derived ovaries disrupted the completion of the 
sub-experiment according to the milestone set. To minimise this hurdle, OR from 
synchronised and stimulated does via LOPU was conducted, however, the 
consistency in the number of oocyte yield per replicate varied as factors such as 
age, breed, health and physiological status of oocyte donors could not be 
standardised and optimised throughout the research due to the shortage in the 
number of does available for selection and the sub-standard in the farm 
management level, especially in animal feeding. 
c) IVM duration: 
In the early attempt of intraspSCNT in this study, the IVM duration used for 
LOPU-derived oocyte was 27 hours. This duration was selected based on the 
duration for abattoir-derived oocytes which was generally used in other caprine 
258 
 
oocyte maturation study. Poor developmental competency was observed after 
using LOPU-derived oocytes matured at 27 hours in the early stage of this study. 
The author speculated that 27 hours might be slightly long for the MII arrest of the 
LOPU-derived oocyte which would cause oocyte aging that influenced the 
subsequent in vitro development of the intraspSCNT embryos. In conjunction to 
this, screening of the suitable IVM duration for LOPU and abattoir-derived oocyte 
was done and LOPU oocyte seems to mature at a shorter IVM duration and the 
IVD competency of the intraspSCNT embryo improved in the subsequent 
intraspSCNT experiments. However, it is worth mentioning that beside the IVM 
duration, the possibility of deficiency in skills acquired at the early phase of the 
research might influence the IVD competency of the early caprine intraspSCNT 
study as well.  
d) Embryo developmental arrest: 
One of the common and major problems faced by all the researchers in this 
laboratory was to obtain in vitro produced (via IVF, ICSI and SCNT) caprine 
blastocysts in their studies. The embryo development was unfailingly blocked at 
morula stage when the previous IVC system using mSOFaa was used. This 
frustrated scenario had led to the discovery of a new two-step IVC system using 
KSOMaa as basal medium that could support the development of caprine cloned 
blastocysts after a series of effort invested to troubleshoot other factors that was 
speculated to influence the blastocyst development as well such as IVM medium, 
duration, activation treatment, substitution of BSA with FBS in mSOFaa, among 
other factors. 
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e) Evaluation of blastocyst quality: 
One of the loop holes in this aspect was the failure to assess the quality of 
blastocyst in terms of the ratio of TE: ICM using the differential staining 
approach. Our laboratory had the technical limitation in producing the rabbit anti-
goat spleenocyte antibodies and therefore, this method of staining could not be 
carried out in this study instead was substituted by the normal Hoechst 33342 
staining. 
f) Facilities and man-power: 
It is worth to note that, the facilities and equipment available in the present 
laboratory was insufficient to enable this SCNT research to be carried out in a 
more comprehensive manner. Sharing of equipment, particularly the 
micromanipulator with other researchers who run their experiment concurrently do 
not permits SCNT experiment in each replicate to be carried out at the exact time 
point and this might influence slightly the outcome of the research. As retrieval of 
oocyte via LOPU require the assistance of several personnel, this poses challenges 
for the OR procedure if insufficient man-power was encountered. The author was 
fortunately to obtain the assistance from both the project supervisors and other 
laboratory members to overcome this hurdle during the OR procedure.    
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 Even though, there were some loop holes in this study, the overall findings of 
the present study formed a basis for more detailed studies to improve the protocol for 
the production of cloned embryos and kids via intraspSCNT and interspSCNT 
approaches. The suggested aspects for future studies encompass: 
a) Using cloned caprine blastocyst as a bringing step for embryonic stem cell 
research. 
b) Application of this study to increase animal production, alleviation in the 
production of endangered animal using interspSCNT. 
c) Optimisation of donor karyoplast factors such as the different somatic cell type, 
cell cycle coordination and number of passage 
d) Treatment of donor cells with chromatin remodeling prior nuclear transfer to 
facilitate nuclear reprogramming of the reconstructed caprine embryos. 
e) Optimisation of time interval between fusion and activation for caprine 
reconstructed oocytes using skin fibroblast cell as donor karyoplast. 
f) Improvement in the evaluation of blastocyst quality using assessment by 
differential counting of inner cell mass (ICM) and trophectoderm (TE) cells and 
by apoptosis detection in blastomeres using a terminal deoxynucleotidyl 
transferase-mediated d-UTP nick end-labeling (TUNEL) assay. 
g) Detailed study on the relevant biological question such as the mechanism behind 
the nuclear reprogramming, zygotic genome activation (ZGA) or how to 
overcome the issue of mitochondria genomic DNA composition incompatibility 
between oocyte and nuclei donors of large phylogenetic distance, particularly on 
the caprine- bovine interspSCNT. 
h) Improvement on the embryo transfer efficiency by increasing the number of 
cloned embryos transferred per recipient. 
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Chapter 6 
6.0     CONCLUSIONS 
 
This study presents the development of cloned caprine embryos produced through 
(caprine-caprine) intraspecies somatic cell nuclear transfer (intraspSCNT) and (caprine-
bovine) interspecies somatic cell nuclear transfer (interspSCNT) techniques using 
caprine and bovine oocytes as recipient cytoplasts, respectively. Caprine ear skin 
fibroblast cells were used as donor karyoplasts. From the findings obtained in this study, 
it can be concluded that: 
a) Cloned caprine embryos could be produced successfully up to blastocyst stage 
using both intraspSCNT and interspSCNT approaches in the local setting of 
Animal Biotechnology-Embryo Laboratory, University of Malaya. 
b) Both pregnant mare’s serum gonadotrophin (PMSG) and porcine-derived 
follicle stimulating hormone (pFSH) employed in the designated regimes have 
relatively similar potential to stimulate caprine ovaries for oocyte retrieval via 
laparoscopic ovum pick-up (LOPU). However, the efficacy of PMSG could not 
surpass the pFSH, particularly, when it was employed in the repeated ovarian 
stimulation and oocyte retrieval programme. [Objective (a)] 
c) Oocyte retrieval from LOPU source produced better quality oocytes (Grades A 
and B) even though the oocyte yield was lower compared to abattoir source. 
Correspondingly, caprine oocytes from LOPU gave higher maturation rate than 
abattoir-derived ovaries. [Objective (b)] 
d) The optimum in vitro maturation (IVM) duration for caprine oocytes retrieved 
from LOPU- and abattoir derived-ovaries in this laboratory setting were 18 to 22 
hours and 22 to 26 hours, respectively. [Objective (c)] 
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e) Both cloned bovine and gaur embryos could be produced in vitro up to hatched 
blastocyst stage; suggesting that the manipulation technique and protocol could 
be used as a reference for the caprine SCNT studies. [Objective (d)] 
f) Caprine oocytes from superstimulated does optimally matured at 18 to 22 hours 
gave a significantly higher maturation rate, enucleation rate and in vitro 
developmental (IVD) rates (2-cell to morula stage) than oocytes matured at 23 to 
27 hours after intraspSCNT. [Objective (e)] 
g) Both activation protocols [(7% EtOH + CD-CHX) and (CaI + 6-DMAP)] had 
comparable efficiency in inducing the development of caprine reconstructed 
embryos. [Objective (f)] 
h) Potassium simplex optimisation medium with amino acid (KSOMaa) basal 
medium supported the in vitro development of cloned caprine embryos better 
than modified synthetic oviduct fluid with amino acid (mSOFaa) in the one-step 
culture system, as cloned blastocyst could only be developed when cultured in 
KSOMaa in this study. [Objective (g)] 
i) Increasing glucose supplementation to 2.78 mM in KSOMaa medium at Day 2 
of IVC enhanced the cloned caprine blastocyst rate and promoted hatching of 
blastocyst. [Objective (h)] 
j) Both intraspSCNT and interspSCNT (caprine karyoplast-bovine cytoplast) 
approaches could be used to produce cloned caprine blastocyst, however, the 
efficiency of interspSCNT approach was still low compared to the intraspSCNT 
approach. [Objective (i)] 
k) No pregnancy was detected after the attempt of embryo transfer on the cloned 
caprine embryos. [Objective (i)] 
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l) In summary, cloned caprine embryos could be produced successfully up to 
blastocyst stage using ear skin fibroblast cell via intraspSCNT and interspSCNT 
approaches by incorporating the following summarised protocols: 
 
 
Table 6.1: A summary of the proposed protocol for the development of caprine  
      intraspSCNT and interspSCNT embryos 
Aspect intraspSCNT interspSCNT 
Source of recipient 
oocytes 
LOPU-derived 
caprine oocytes 
 
Abattoir-derived 
caprine oocytes 
Abattoir-derived 
bovine oocytes 
Source of 
gonadotrophins for 
repeated ovarian 
stimulation and oocyte 
retrieval programme 
 
pFSH regime 
 
Not applicable 
 
Not applicable 
IVM duration 18 to 22 hours 22 to 26 hours 22 to 24 hours 
Donor karyoplast Caprine ear skin fibroblast cell (Passages 3 to 5) 
Activation treatment CaI [5 µM] (5 min) followed with 6-DMAP [2 mM] (4 h) 
IVC  system  Two-step culture system: 
Day 0-2 (post-activation): KSOMaa 
Day 2-8: KSOMaa + glucose (2.78 mM) final concentration 
Incubation: 38.5°C under a humidified atmosphere of 5% CO2  
                    in air 
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APPENDICES 
APPENDIX 1: LIST OF MATERIALS 
Appendix Table 1.1: List of equipment and instruments 
Equipment/instrument Model no. Manufacturer 
Abrasive stone or oilstone  Hall’s Arkansas Oilstones, USA 
Atraumatic grasping forceps PO951R Aesculap 
®
, Germany 
Autoclave HA-300MII Hirayama Hiclave, Japan 
Centrifuge D37520 Heraeus, Germany 
CIDR applicator - Pharmacia and Upjohn, New 
Zealand 
CO2 incubator HeraCell 240 Heraeus,Germany 
CO2 insufflator system PG001 Aesculap
®
 , Germany 
Digital balance AB104 Mettler Toledo, Switzerland 
Digital camera (X-Cam-α) - microLAMBDA Sdn Bhd, Malaysia 
Dissecting microscope SZH10 Olympus, Japan 
Electrofusion machine SUTF-1 Suranaree University of 
Technology, Thailand 
Flushing and aspiration system:   
(a) Aspiration system KMAR-5100 Cook, Australia 
(b) Flushing system KMAR-4000 Cook, Australia 
(c)Test tube heater system  KFTH-1012 Cook, Australia 
(d) Pedal 6210-725350B Herga Electric Ltd, UK 
Heating stage (Thermoplate) HATS-
U55R30 
Tokai Hit, Japan 
Impulse sealer KF-300H Khind, Taiwan 
Inverted microscope IX71 Olympus, Japan 
Laminar flow cabinet HLF-120 Gelman Sciences, Australia 
Laparoscopic system :  Aesculap
®
 , Germany 
(a) Endoscopic camera system PV431  
(b) CCD camera PV430  
(c) Pediatric Storz  
      laparoscope(7mm) 
PE688A  
(d) Light probe with fibre optic  
      cable 
OP913  
(e) Light system (300W) OP927  
Liquid nitrogen tank (small) SC2/IV MVE, USA 
Microforge - Technical Products Internationals, 
USA 
Microgrinder EG-4 Narishige, Japan 
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(continued) 
Equipment/instrument Model no. Manufacturer 
Micropipette dispenser - Eppendorf, Germany 
Micropipette puller P-97 Sutter Instrument Co, USA 
Narishige hydraulic 
micromanipulators 
ON3-99D Narishige, Japan 
Oocyte pick-up needle FAS set C2 Gynetics Medical Product, Belgium 
Osmometer Vapro 5520 WESCOR Inc., USA 
Oven 40050-IP20 Memmert GmbH, Germany 
pH meter HI-122 Hanna Instruments, Singapore 
Pipette pump PI-PUMP Glasfirn, Germany 
Refrigerator and freezer SR-21NME Samsung Electronics, Korea 
Spirit burner - Shanghai Machinery, China 
Stereomicroscope SZH10 Olympus Optical, Japan 
Surgical set - Aesculap
®
 , Germany 
Surgical table - Syarikat Copens 
Enterprise,Malaysia 
Trocar and canula  
(5.5 mm & 7.0 mm) 
EJ456, EJ457 Aesculap
®
 , Germany 
Ultrapure water purification 
system 
Milli-Q PF 
Plus 
Millipore, USA 
Vapour pressure osmometer 5520 Vapro Wescor, USA 
Verrus needle PG3 Cook, Australia 
Vortex mixer VTX-3000L LMS, Japan 
Water bath GMP-GC-19 Memmert GmbH, Germany 
 
Appendix Table 1.2: List of chemicals, reagents and media 
Chemicals, reagents and media Catalogue no. Manufacturer 
6-dimethylaminopurine (6-DMAP) D2629 Sigma-Aldrich, USA 
70% ethanol - Prepared from absolute ethanol 
α- Minimum Essential Medium 
Eagle 
M0644  
Ethyl alcohol 99.8%  
(absolute ethanol) 
ET150-50 Systerm ChemAR
®
 , Poland 
Hibiscrub (antiseptic) HK-06770 SSL International Plc, UK 
BME amino acids solution (50X) B6766 Sigma-Aldrich, USA 
Bovine serum albumin fraction V 
(BSA-V) 
A6003 Sigma-Aldrich, USA 
Calcium acetate hydrate 
(Ca(C2H3O2)2.xH2O) 
C4705 Sigma-Aldrich, USA 
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(continued) 
Chemicals, reagents and media Catalogue no. Manufacturer 
Calcium chloride (CaCl2) C5670 Sigma-Aldrich, USA 
Calcium chloride dihydrate 
(CaCl2.2H2O) 
C7902 Sigma-Aldrich, USA 
Cleaning solution 7X® -PF - FlowLab™ , Australia 
Cloprostenol (Estrumate®) - Schering-Plough, Australia 
Cycloheximide (CHX) C7698 Sigma-Aldrich,USA 
Cysteamine M9768 Sigma-Aldrich, USA 
Cytochalasin B (C29H37NO5) C6762 Sigma-Aldrich, USA 
Cytochalasin D (C30H37NO6) C8273 Sigma-Aldrich, USA 
D-(+)-Glucose (C6H12O6) G6152 Sigma-Aldrich, USA 
Dimethyl sulphoxide (DMSO) D5879 Sigma-Aldrich, USA 
Disinfectant Gigasept FF - Schulke&Mary GmbH, Germany 
Ethylenediaminetetraacetic acid 
(EDTA) 
E9884 Sigma-Aldrich,USA 
EMCARE 
TM
 ECHM-500 ICPbio Reproduction, NZ 
Foetal Bovine Serum (FBS) 16000-044 Gibco BRL, USA 
Formaldehyde solution (40%) F8775 Sigma-Aldrich, USA 
FSH (pFSH) Folltropin-V
®
  Bioniche, NZ 
Gentamicin sulfate salt G3632 Sigma-Aldrich, USA 
Goat/sheep pellet feed - KMM Berhad, Malaysia 
Glutaraldehyde solution (25%) G5882 Sigma-Aldrich, USA 
Glycerol G2025 Sigma-Aldrich, USA 
Heparin H0777 Sigma-Aldrich, USA 
HEPES H7006 Sigma-Aldrich, USA 
Hoechst 33342 B2261 Sigma-Aldrich, USA 
Hyaluronidase (from bovine testes) H4272 Sigma-Aldrich, USA 
Hydrochloric acid HY450-70 Systerm ChemAR
®
 , Poland 
Hydrofluoric acid 1301030 HmbG Chemicals, Germany 
Intravaginal progesterone release 
device 
- Pharmacia and Upjohn, New 
Zealand 
Ketamil injection  
(ketamine hydrochloride) 
L100771 Troy Laboratories, Australia 
K-Y Lubricating Jelly - Pharmedica Lab, South Africa 
L-Cysteine hydrochloride C7477 Sigma-Aldrich, USA 
L-Glutamine  G3126 Sigma-Aldrich, USA 
L-Glutathione reduced G4251 Sigma-Aldrich, USA 
Liquid nitrogen - Mox Gases Berhad, Malaysia 
Magnesium acetate tetrahydrate 
(Mg(C2H3O2)2.4H2O) 
M0631 Sigma-Aldrich, USA 
Magnesium chloride hexahydrate 
(MgCl2.6H2O) 
M2393 Sigma-Aldrich, USA 
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(continued) 
Chemicals, reagents and media Catalogue no. Manufacturer 
Magnesium sulphate (MgSO4) M7506 Sigma-Aldrich, USA 
MEM non-essential amino acids 
solution [100x] 
M7145 Sigma-Aldrich, USA 
Mineral oil M8410 Sigma-Aldrich, USA 
Oestradiol-17β E4389 Sigma-Aldrich, USA 
Ovidrel® PreFilled Syringe - Laboratories Serono, Switzerland 
Oxytetracycline (Tetrasol 20%) E388 Richter Pharma, Austria 
Penicillin G sodium salt  P7794 Sigma-Aldrich,USA 
PBS Dulbecco A tablets BR0014G Oxoid, England 
Phenol red (0.5%) P0290 Sigma-Aldrich,USA 
PMSG  (eCG) - Intervet International, Holland 
Polyvinylpyrrolidone-360 PVP360 Sigma-Aldrich,USA 
Potassium chloride (KCl) P5405 Sigma-Aldrich,USA 
Potassium phosphate dibasic 
(K2HPO4) 
P3786 Sigma-Aldrich,USA 
Potassium phosphate monobasic 
(KH2PO4) 
P5655 Sigma-Aldrich,USA 
Sodium bicarbonate (NaHCO3) S5761 Sigma-Aldrich,USA 
Sodium chloride (NaCl) S5886 Sigma-Aldrich,USA 
Sodium DL-lactate  L7900 Sigma-Aldrich,USA 
Sodium phosphate dibasic 
(Na2HPO4) 
S5136 Sigma-Aldrich,USA 
Sodium pyruvate P4562 Sigma-Aldrich,USA 
Streptomycin sulfate salt S1277 Sigma-Aldrich,USA 
Sucrose (C12H22O11) S7903 Sigma-Aldrich,USA 
TCM-199 M4530 Sigma-Aldrich,USA 
Trypsin from porcine pancreas T4799 Sigma-Aldrich,USA 
Weak iodine solution - ICN Biomedicals, USA 
Xylazine hydrochloride (Ilium 
Xylazil-20) 
L10600 Troy Laboratories, Australia 
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Appendix Table 1.3: List of labwares and disposables 
Labwares and disposables Manufacturer 
Aluminium  foil Reynolds Consumer Products, USA 
Autoclave disposal bag Megalab supplies, Malaysia 
Blades (Super Nacet) Gillette, USA 
Borosilicate glass tubing (Microcaps®) Drummond Scientific Company, 
USA 
Chromic catgut and other suture materials Aesculap
®
, Germany 
Culture dish Nunc, Denmark 
Disposable glass Pasteur pipette Hirschmann® Laborgerete, 
Germany 
Disposable hand tissues Megalab supplies, Malaysia 
Falcon™ conical tube Becton Dickinson, USA 
Falcon™ polystyrene round-bottom test tube Becton Dickinson, USA 
Glassware (beaker, flask, measuring cylinder 
etc.) 
Pyrex
®
, Japan 
Lens cleansing tissue (Kimswipe®  EX-L) Kimberly-Clark, USA 
Microcentrifuge tube Elkay, Costelloe 
Micropipette tips without filter Axygen Scientific, USA 
Microscope slide Sail Brand, China 
Microscope glass cover slip Hirschmann
®
 Laborgerete, Germany 
Millex® –GS syringe driven filter Schleicher and Schuell, Germany 
Needle Terumo Corporation, Japan 
Parafilm Pechiney Plastic Packaging, USA 
Schott bottle Duran, Germany 
Serological pipette LP Italiana SPA, Italy 
Sterile glove Ansell International, Malaysia 
Syringe Terumo Corporation, Japan 
Tissue culture flask Nunc, Denmark 
Terumo venojector holder Terumo Corporation, Japan 
Vacutainer ® blood collection tubes Becton Dickinson, USA 
Vacutainer needle Becton Dickinson, USA 
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APPENDIX 2: STATISTICAL DATA 
 
Appendix Table 2.1: Number and percentages of oocytes retrieved from caprine  
            superstimulated with PMSG according to OR cycle (Experiment 1) 
 
Descriptives 
Goat superstimulated with PMSG 
  
N Mean 
Std. 
Deviation Std. Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
  Lower 
Bound 
Upper 
Bound 
Number of follicle OR1 36 8.8333 3.08452 .51409 7.7897 9.8770 4.00 15.00 
OR2 18 8.0000 2.42536 .57166 6.7939 9.2061 4.00 12.00 
OR3 6 4.8333 1.94079 .79232 2.7966 6.8701 3.00 8.00 
Total 60 8.1833 3.01123 .38875 7.4054 8.9612 3.00 15.00 
Number of oocyte 
retrieved per ovary 
OR1 36 5.6111 3.53172 .58862 4.4162 6.8061 1.00 15.00 
OR2 18 6.0556 2.20887 .52063 4.9571 7.1540 3.00 11.00 
OR3 6 3.1667 .75277 .30732 2.3767 3.9567 2.00 4.00 
Total 60 5.5000 3.08358 .39809 4.7034 6.2966 1.00 15.00 
Oocyte retrieval rate 
upon number of 
follicle predicted 
OR1 36 60.7083 25.66365 4.27728 52.0250 69.3917 16.67 100.00 
OR2 18 76.7889 18.10426 4.26722 67.7859 85.7919 37.50 100.00 
OR3 6 72.3617 25.82198 10.54178 45.2632 99.4602 37.50 100.00 
Total 60 66.6978 24.45146 3.15667 60.3814 73.0143 16.67 100.00 
 
ANOVA 
Goat superstimulated with PMSG 
  Sum of Squares df Mean Square F Sig. 
Number of follicle Between Groups 83.150 2 41.575 5.245 .008 
Within Groups 451.833 57 7.927   
Total 534.983 59    
Number of oocyte retrieved 
per ovary 
Between Groups 38.667 2 19.333 2.110 .131 
Within Groups 522.333 57 9.164   
Total 561.000 59    
Oocyte retrieval rate upon 
number of follicle 
predicted 
Between Groups 3316.871 2 1658.436 2.958 .060 
Within Groups 31957.676 57 560.661   
Total 35274.548 59    
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Post Hoc Tests 
 
Homogeneous Subsets 
 
 
 
Number of follicle for goat superstimulated with PMSG 
Duncana,,b 
 N 
Subset for alpha = 0.05 
1 2 
OR3 6 4.8333  
OR2 18  8.0000 
OR1 36  8.8333 
Sig.  1.000 .471 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 12.000. 
b. The group sizes are unequal. The harmonic mean of the group sizes is used. Type I error levels are not 
guaranteed. 
Number of oocyte retrieved per ovary for goat superstimulated with PMSG 
Duncana,,b 
 N 
Subset for alpha = 0.05 
1 2 
OR3 6 3.1667  
OR1 36 5.6111 5.6111 
OR2 18  6.0556 
Sig.  .053 .720 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 12.000. 
b. The group sizes are unequal. The harmonic mean of the group sizes is used. Type I error levels are not 
guaranteed. 
Oocyte retrieval rate upon number of follicle predicted for goat superstimulated with PMSG 
Duncana,,b 
 N 
Subset for alpha = 0.05 
1 
OR1 36 60.7083 
OR3 6 72.3617 
OR2 18 76.7889 
Sig.  .121 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 12.000. 
b. The group sizes are unequal. The harmonic mean of the group sizes is used. Type I error levels are not 
guaranteed. 
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Appendix Table 2.2: Percentages of oocytes retrieved from caprine superstimulated 
               with PMSG among 3 OR cycles within each oocyte grade  
               (Experiment 1) 
 
Descriptives 
Goat superstimulated with PMSG 
  
N Mean 
Std. 
Deviation Std. Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
  Lower 
Bound 
Upper 
Bound 
Grade A OR1 36 29.3019 27.49408 4.58235 19.9993 38.6046 .00 100.00 
OR2 18 28.4850 18.19354 4.28826 19.4376 37.5324 .00 62.50 
OR3 6 19.4450 26.17724 10.68682 -8.0263 46.9163 .00 66.67 
Total 60 28.0712 24.70667 3.18962 21.6888 34.4536 .00 100.00 
Grade B OR1 36 28.1681 30.41431 5.06905 17.8773 38.4588 .00 100.00 
OR2 18 29.4867 17.20109 4.05434 20.9328 38.0406 .00 60.00 
OR3 6 16.6650 18.25559 7.45281 -2.4931 35.8231 .00 33.33 
Total 60 27.4133 25.99327 3.35572 20.6986 34.1281 .00 100.00 
Grade C OR1 36 32.2547 27.23684 4.53947 23.0391 41.4703 .00 100.00 
OR2 18 22.2489 20.45400 4.82105 12.0774 32.4204 .00 62.50 
OR3 6 26.3883 22.61780 9.23368 2.6524 50.1243 .00 50.00 
Total 60 28.6663 24.99852 3.22730 22.2085 35.1241 .00 100.00 
Grade D OR1 36 8.8847 13.16613 2.19436 4.4299 13.3395 .00 50.00 
OR2 18 11.5367 14.81146 3.49109 4.1711 18.9022 .00 50.00 
OR3 6 23.6117 29.06828 11.86708 -6.8936 54.1170 .00 66.67 
Total 60 11.1530 16.01937 2.06809 7.0148 15.2912 .00 66.67 
Grade E OR1 36 1.3889 8.33333 1.38889 -1.4307 4.2085 .00 50.00 
OR2 18 8.2411 17.02125 4.01195 -.2234 16.7056 .00 66.67 
OR3 6 13.8883 22.15208 9.04355 -9.3589 37.1355 .00 50.00 
Total 60 4.6945 13.61478 1.75766 1.1774 8.2116 .00 66.67 
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ANOVA 
Goat superstimulated with PMSG 
  Sum of Squares df Mean Square F Sig. 
Grade A Between Groups 504.080 2 252.040 .405 .669 
Within Groups 35510.680 57 622.994   
Total 36014.761 59    
Grade B Between Groups 791.043 2 395.521 .577 .565 
Within Groups 39072.307 57 685.479   
Total 39863.349 59    
Grade C Between Groups 1235.996 2 617.998 .989 .378 
Within Groups 35634.640 57 625.169   
Total 36870.636 59    
Grade D Between Groups 1119.183 2 559.591 2.275 .112 
Within Groups 14021.418 57 245.990   
Total 15140.601 59    
Grade E Between Groups 1126.946 2 563.473 3.274 .045 
Within Groups 9809.421 57 172.095   
Total 10936.367 59    
 
Post Hoc Tests 
 
Homogeneous Subsets 
Grade A retrieved from goat superstimulated with PMSG 
Duncana,,b 
 N 
Subset for alpha = 0.05 
1 
OR3 6 19.4450 
OR2 18 28.4850 
OR1 36 29.3019 
Sig.  .368 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 12.000. 
b. The group sizes are unequal. The harmonic mean of the group sizes is used. Type I error levels are not guaranteed. 
 
 
Grade B retrieved from goat superstimulated with PMSG 
Duncana,,b 
 N 
Subset for alpha = 0.05 
1 
OR3 6 16.6650 
OR1 36 28.1681 
OR2 18 29.4867 
Sig.  .264 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 12.000. 
b. The group sizes are unequal. The harmonic mean of the group sizes is used. Type I error levels are not guaranteed. 
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Grade C retrieved from goat superstimulated with PMSG 
Duncana,,b 
 N 
Subset for alpha = 0.05 
1 
OR2 18 22.2489 
OR3 6 26.3883 
OR1 36 32.2547 
Sig.  .361 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 12.000. 
b. The group sizes are unequal. The harmonic mean of the group sizes is used. Type I error levels are not 
guaranteed. 
 
Grade D retrieved from goat superstimulated with PMSG 
Duncana,,b 
 N 
Subset for alpha = 0.05 
1 2 
OR1 36 8.8847  
OR2 18 11.5367 11.5367 
OR3 6  23.6117 
Sig.  .680 .064 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 12.000. 
b. The group sizes are unequal. The harmonic mean of the group sizes is used. Type I error levels are not 
guaranteed. 
 
Grade E retrieved from goat superstimulated with PMSG 
Duncana,,b 
 N 
Subset for alpha = 0.05 
1 2 
OR1 36 1.3889  
OR2 18 8.2411 8.2411 
OR3 6  13.8883 
Sig.  .206 .296 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 12.000. 
b. The group sizes are unequal. The harmonic mean of the group sizes is used. Type I error levels are not 
guaranteed. 
 
 
312 
 
Appendix Table 2.3: Percentages of oocytes retrieved from caprine superstimulated 
               with PMSG among oocyte grades within each OR cycle  
               (Experiment 1) 
 
Goat superstimulated with PMSG 
Descriptives 
  
N Mean 
Std. 
Deviation Std. Error 
95% Confidence Interval 
for Mean 
Minimum Maximum 
  
Lower 
Bound 
Upper 
Bound 
OR1 Grade A 36 29.30194 27.494080 4.582347 19.99929 38.60460 .000 100.000 
Grade B 36 28.16806 30.414307 5.069051 17.87733 38.45878 .000 100.000 
Grade C 36 32.25472 27.236840 4.539473 23.03910 41.47034 .000 100.000 
Grade D 36 8.88472 13.166133 2.194356 4.42994 13.33950 .000 50.000 
Grade E 36 1.38889 8.333333 1.388889 -1.43071 4.20848 .000 50.000 
Total 180 19.99967 26.014188 1.938983 16.17346 23.82587 .000 100.000 
OR2 Grade A 18 28.48500 18.193542 4.288259 19.43756 37.53244 .000 62.500 
Grade B 18 29.48667 17.201095 4.054337 20.93276 38.04057 .000 60.000 
Grade C 18 22.24889 20.454003 4.821055 12.07735 32.42043 .000 62.500 
Grade D 18 11.53667 14.811455 3.491094 4.17110 18.90223 .000 50.000 
Grade E 18 8.24111 17.021252 4.011948 -.22336 16.70558 .000 66.670 
Total 90 19.99967 19.316713 2.036160 15.95386 24.04547 .000 66.670 
OR3 Grade A 6 19.44500 26.177245 10.686815 -8.02633 46.91633 .000 66.670 
Grade B 6 16.66500 18.255593 7.452815 -2.49307 35.82307 .000 33.330 
Grade C 6 26.38833 22.617799 9.233678 2.65241 50.12426 .000 50.000 
Grade D 6 23.61167 29.068279 11.867075 -6.89362 54.11695 .000 66.670 
Grade E 6 13.88833 22.152084 9.043550 -9.35885 37.13552 .000 50.000 
Total 30 19.99967 22.700921 4.144602 11.52300 28.47633 .000 66.670 
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Goat superstimulated with PMSG 
ANOVA 
  
Sum of Squares df Mean Square F Sig. 
OR1 Between Groups 27840.398 4 6960.099 13.055 .000 
Within Groups 93295.701 175 533.118   
Total 121136.099 179    
OR2 Between Groups 6785.083 4 1696.271 5.457 .001 
Within Groups 26423.968 85 310.870   
Total 33209.051 89    
OR3 Between Groups 615.826 4 153.956 .269 .895 
Within Groups 14328.796 25 573.152   
Total 14944.622 29    
 
Post Hoc Tests 
 
Homogeneous Subsets 
OR1 
Duncana 
Treatment N 
Subset for alpha = 0.05 
1 2 
Grade E 36 1.38889  
Grade D 36 8.88472  
Grade B 36  28.16806 
Grade A 36  29.30194 
Grade C 36  32.25472 
Sig.  .170 .484 
Means for groups in homogeneous subsets are 
displayed. 
a. Uses Harmonic Mean Sample Size = 36.000. 
 
 
OR3 
Duncana 
Treatment N 
Subset for alpha = 0.05 
1 
Grade E 6 13.88833 
Grade B 6 16.66500 
Grade A 6 19.44500 
Grade D 6 23.61167 
Grade C 6 26.38833 Means for groups in homogeneous subsets are displayed. 
Sig.  .427 a. Uses Harmonic Mean Sample Size = 6.000. 
OR2 
Duncana 
Treatment N 
Subset for alpha = 0.05 
1 2 3 
Grade E 18 8.24111   
Grade D 18 11.53667 11.53667  
Grade C 18  22.24889 22.24889 
Grade A 18   28.48500 
Grade B 18   29.48667 
Sig.  .576 .072 .250 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 18.000. 
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Appendix Table 2.4: Number and percentages of oocytes retrieved from caprine  
            superstimulated with pFSH according to OR cycle (Experiment 1) 
Descriptives 
Goat superstimulated with pFSH 
  
N Mean 
Std. 
Deviation 
Std. 
Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
  Lower 
Bound 
Upper 
Bound 
No of 
follicle 
OR1 30 8.20000 2.975764 .543298 7.08883 9.31117 4.000 15.000 
OR2 10 7.60000 2.270585 .718022 5.97572 9.22428 5.000 12.000 
OR3 4 7.00000 1.825742 .912871 4.09484 9.90516 5.000 9.000 
Total 44 7.95455 2.727590 .411200 7.12528 8.78381 4.000 15.000 
No of 
oocyte 
OR1 30 6.23333 3.191404 .582668 5.04164 7.42502 2.000 15.000 
OR2 10 5.70000 1.636392 .517472 4.52940 6.87060 3.000 8.000 
OR3 4 5.75000 1.500000 .750000 3.36317 8.13683 4.000 7.000 
Total 44 6.06818 2.765214 .416872 5.22748 6.90888 2.000 15.000 
Retrieval 
rate 
OR1 30 74.27967 22.438950 4.096773 65.90083 82.65851 33.330 100.000 
OR2 10 76.44800 16.374905 5.178200 64.73410 88.16190 58.330 100.000 
OR3 4 82.98750 14.179406 7.089703 60.42490 105.55010 66.670 100.000 
Total 44 75.56409 20.400539 3.075497 69.36176 81.76642 33.330 100.000 
 
ANOVA 
  Sum of Squares df Mean Square F Sig. 
No of follicle Between Groups 6.709 2 3.355 .439 .648 
Within Groups 313.200 41 7.639   
Total 319.909 43    
No of oocyte Between Groups 2.579 2 1.289 .162 .851 
Within Groups 326.217 41 7.957   
Total 328.795 43    
Retrieval rate Between Groups 277.733 2 138.867 .323 .726 
Within Groups 17618.092 41 429.710   
Total 17895.825 43    
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Post Hoc Tests 
 
Homogeneous Subsets 
 
No of follicle 
Duncana,,b 
Treatment N 
Subset for alpha = 0.05 
1 
OR3 4 7.00000 
OR2 10 7.60000 
OR1 30 8.20000 
Sig.  .425 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 7.826. 
b. The group sizes are unequal. The harmonic mean of the group sizes is used. Type I error levels are 
not guaranteed. 
 
No of oocyte 
Duncana,,b 
Treatment N 
Subset for alpha = 0.05 
1 
OR2 10 5.70000 
OR3 4 5.75000 
OR1 30 6.23333 
Sig.  .728 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 7.826. 
b. The group sizes are unequal. The harmonic mean of the group sizes is used. Type I error levels are not 
guaranteed. 
 
 
Oocyte retrieval rate 
Duncana,,b 
Treatment N 
Subset for alpha = 0.05 
1 
OR1 30 74.27967 
OR2 10 76.44800 
OR3 4 82.98750 
Sig.  .440 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 7.826. 
b. The group sizes are unequal. The harmonic mean of the group sizes is used. Type I error levels are not 
guaranteed. 
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Appendix Table 2.5: Percentages of oocytes retrieved from caprine superstimulated 
    with PMSG among 3 OR cycles within each oocyte grade  
    (Experiment 1) 
Descriptives 
Goat superstimulated with pFSH 
  
N Mean 
Std. 
Deviation Std. Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
  Lower 
Bound 
Upper 
Bound 
Grade A OR1 30 36.23033 21.752476 3.971441 28.10783 44.35284 .000 80.000 
OR2 10 32.50000 28.360336 8.968326 12.21224 52.78776 .000 100.000 
OR3 4 41.25000 13.174587 6.587293 20.28629 62.21371 25.000 57.140 
Total 44 35.83886 22.472009 3.387783 29.00675 42.67098 .000 100.000 
Grade B OR1 30 41.37767 20.713003 3.781660 33.64330 49.11203 .000 100.000 
OR2 10 20.02400 17.027847 5.384678 7.84301 32.20499 .000 50.000 
OR3 4 26.78750 23.600163 11.800081 -10.76563 64.34063 .000 50.000 
Total 44 35.19818 21.809617 3.287924 28.56745 41.82891 .000 100.000 
Grade C OR1 30 16.44200 19.566429 3.572325 9.13578 23.74822 .000 66.670 
OR2 10 25.11900 19.331112 6.113034 11.29036 38.94764 .000 50.000 
OR3 4 15.71500 12.008387 6.004194 -3.39302 34.82302 .000 28.570 
Total 44 18.34795 18.981950 2.861637 12.57691 24.11899 .000 66.670 
Grade D OR1 30 5.18000 8.645736 1.578488 1.95163 8.40837 .000 25.000 
OR2 10 16.52400 15.639011 4.945490 5.33653 27.71147 .000 50.000 
OR3 4 16.25000 19.737865 9.868933 -15.15735 47.65735 .000 40.000 
Total 44 8.76455 12.528442 1.888734 4.95555 12.57354 .000 50.000 
Grade E OR1 30 .80300 2.471644 .451258 -.11993 1.72593 .000 9.090 
OR2 10 5.83300 12.452800 3.937921 -3.07520 14.74120 .000 33.330 
OR3 4 .00000 .000000 .000000 .00000 .00000 .000 .000 
Total 44 1.87318 6.430319 .969407 -.08181 3.82818 .000 33.330 
 
 
ANOVA 
  Sum of Squares df Mean Square F Sig. 
Grade A Between Groups 233.199 2 116.600 .223 .801 
Within Groups 21481.423 41 523.937   
Total 21714.622 43    
Grade B Between Groups 3731.097 2 1865.549 4.574 .016 
Within Groups 16722.257 41 407.860   
Total 20453.355 43    
Grade C Between Groups 595.180 2 297.590 .819 .448 
Within Groups 14898.340 41 363.374   
Total 15493.521 43    
Grade D Between Groups 1211.688 2 605.844 4.486 .017 
Within Groups 5537.672 41 135.065   
Total 6749.360 43    
Grade E Between Groups 205.196 2 102.598 2.675 .081 
Within Groups 1572.812 41 38.361   
Total 1778.007 43    
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Post Hoc Tests 
 
Homogeneous Subsets 
 
Grade A 
Duncana,,b 
Treatment N 
Subset for alpha = 
0.05 
1 
OR2 10 32.50000 
OR1 30 36.23033 
OR3 4 41.25000 
Sig.  .482 
Means for groups in homogeneous subsets 
are displayed. 
a. Uses Harmonic Mean Sample Size = 
7.826. 
b. The group sizes are unequal. The 
harmonic mean of the group sizes is used. 
Type I error levels are not guaranteed. 
 
 
Grade C 
Duncana,,b 
Treatment N 
Subset for alpha = 
0.05 
1 
OR3 4 15.71500 
OR1 30 16.44200 
OR2 10 25.11900 
Sig.  .364 
Means for groups in homogeneous subsets 
are displayed. 
a. Uses Harmonic Mean Sample Size = 
7.826. 
b. The group sizes are unequal. The 
harmonic mean of the group sizes is used. 
Type I error levels are not guaranteed. 
 
 
Grade E 
Duncana,,b 
Treatment N 
Subset for alpha = 0.05 
1 
OR3 4 .00000 
OR1 30 .80300 
OR2 10 5.83300 
Sig.  .085 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 7.826. 
b. The group sizes are unequal. The harmonic mean of the group sizes is used. Type I error levels 
are not guaranteed. 
Grade B 
Duncana,,b 
Treatment N 
Subset for alpha = 
0.05 
1 
OR2 10 20.02400 
OR3 4 26.78750 
OR1 30 41.37767 
Sig.  .053 
Means for groups in homogeneous subsets 
are displayed. 
a. Uses Harmonic Mean Sample Size = 
7.826. 
b. The group sizes are unequal. The 
harmonic mean of the group sizes is used. 
Type I error levels are not guaranteed. 
Grade D 
Duncana,,b 
Treatment N 
Subset for alpha = 
0.05 
1 
OR1 30 5.18000 
OR3 4 16.25000 
OR2 10 16.52400 
Sig.  .074 
Means for groups in homogeneous subsets 
are displayed. 
a. Uses Harmonic Mean Sample Size = 
7.826. 
b. The group sizes are unequal. The 
harmonic mean of the group sizes is used. 
Type I error levels are not guaranteed. 
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Appendix Table 2.6: Percentages of oocytes retrieved from caprine superstimulated 
    with PMSG among oocyte grades within each OR cycle  
    (Experiment 1) 
Descriptives 
Goat superstimulated with pFSH 
  
N Mean 
Std. 
Deviation Std. Error 
95% Confidence Interval 
for Mean 
Minimum Maximum 
  Lower 
Bound 
Upper 
Bound 
OR1 Grade A 30 36.23033 21.752476 3.971441 28.10783 44.35284 .000 80.000 
Grade B 30 41.37767 20.713003 3.781660 33.64330 49.11203 .000 100.000 
Grade C 30 16.44200 19.566429 3.572325 9.13578 23.74822 .000 66.670 
Grade D 30 5.18000 8.645736 1.578488 1.95163 8.40837 .000 25.000 
Grade E 30 .80300 2.471644 .451258 -.11993 1.72593 .000 9.090 
Total 150 20.00660 23.062286 1.883028 16.28571 23.72749 .000 100.000 
OR2 Grade A 10 32.50000 28.360336 8.968326 12.21224 52.78776 .000 100.000 
Grade B 10 20.02400 17.027847 5.384678 7.84301 32.20499 .000 50.000 
Grade C 10 25.11900 19.331112 6.113034 11.29036 38.94764 .000 50.000 
Grade D 10 16.52400 15.639011 4.945490 5.33653 27.71147 .000 50.000 
Grade E 10 5.83300 12.452800 3.937921 -3.07520 14.74120 .000 33.330 
Total 50 20.00000 20.583728 2.910979 14.15017 25.84983 .000 100.000 
OR3 Grade A 4 41.25000 13.174587 6.587293 20.28629 62.21371 25.000 57.140 
Grade B 4 26.78750 23.600163 11.800081 -10.76563 64.34063 .000 50.000 
Grade C 4 15.71500 12.008387 6.004194 -3.39302 34.82302 .000 28.570 
Grade D 4 16.25000 19.737865 9.868933 -15.15735 47.65735 .000 40.000 
Grade E 4 .00000 .000000 .000000 .00000 .00000 .000 .000 
Total 20 20.00050 19.885451 4.446522 10.69382 29.30718 .000 57.140 
 
 
ANOVA 
  Sum of Squares df Mean Square F Sig. 
OR1 Between Groups 39637.341 4 9909.335 36.274 .000 
Within Groups 39611.147 145 273.180   
Total 79248.488 149    
OR2 Between Groups 3952.412 4 988.103 2.645 .046 
Within Groups 16808.391 45 373.520   
Total 20760.803 49    
OR3 Between Groups 3720.226 4 930.056 3.678 .028 
Within Groups 3792.966 15 252.864   
Total 7513.192 19    
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Post Hoc Tests 
 
Homogeneous Subsets 
 
 
OR1 
Duncana 
Treatment N 
Subset for alpha = 0.05 
1 2 3 
Grade E 30 .80300   
Grade D 30 5.18000   
Grade C 30  16.44200  
Grade A 30   36.23033 
Grade B 30   41.37767 
Sig.  .307 1.000 .230 
Means for groups in homogeneous subsets are 
displayed. 
a. Uses Harmonic Mean Sample Size = 30.000. 
 
 
 
OR3 
Duncana 
Treatment N 
Subset for alpha = 0.05 
1 2 
Grade E 4 .00000  
Grade C 4 15.71500 15.71500 
Grade D 4 16.25000 16.25000 
Grade B 4  26.78750 
Grade A 4  41.25000 
Sig.  .190 .052 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 4.000. 
 
 
 
 
 
 
 
 
 
 
 
 
OR2 
Duncana 
Treatment N 
Subset for alpha = 0.05 
1 2 
Grade E 10 5.83300  
Grade D 10 16.52400 16.52400 
Grade B 10 20.02400 20.02400 
Grade C 10  25.11900 
Grade A 10  32.50000 
Sig.  .128 .097 
Means for groups in homogeneous subsets are 
displayed. 
a. Uses Harmonic Mean Sample Size = 10.000. 
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Appendix Table 2.7: Number of follicle recruited from does superstimulated with  
            PMSG vs. pFSH within each OR cycle (Experiment 1) 
Descriptives 
No of follicle 
  
N Mean 
Std. 
Deviation Std. Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
  Lower 
Bound 
Upper 
Bound 
OR1 PMSG  36 8.83333 3.084524 .514087 7.78968 9.87699 4.000 15.000 
pFSH 30 8.20000 2.975764 .543298 7.08883 9.31117 4.000 15.000 
Total 66 8.54545 3.028997 .372844 7.80083 9.29008 4.000 15.000 
OR2 PMSG  18 8.00000 2.425356 .571662 6.79390 9.20610 4.000 12.000 
pFSH 10 7.60000 2.270585 .718022 5.97572 9.22428 5.000 12.000 
Total 28 7.85714 2.336732 .441601 6.95105 8.76323 4.000 12.000 
OR3 PMSG  6 4.83333 1.940790 .792324 2.79660 6.87007 3.000 8.000 
pFSH 4 7.00000 1.825742 .912871 4.09484 9.90516 5.000 9.000 
Total 10 5.70000 2.110819 .667499 4.19001 7.20999 3.000 9.000 
 
ANOVA 
  Sum of Squares df Mean Square F Sig. 
OR1 Between Groups 6.564 1 6.564 .712 .402 
Within Groups 589.800 64 9.216   
Total 596.364 65    
OR2 Between Groups 1.029 1 1.029 .183 .673 
Within Groups 146.400 26 5.631   
Total 147.429 27    
OR3 Between Groups 11.267 1 11.267 3.126 .115 
Within Groups 28.833 8 3.604   
Total 40.100 9    
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Appendix Table 2.8: Number of oocyte retrieved from does superstimulated with  
            PMSG vs. pFSH within each OR cycle (Experiment 1) 
Descriptives 
No of oocyte 
  
N Mean 
Std. 
Deviation 
Std. 
Error 
95% Confidence Interval 
for Mean 
Minimum Maximum 
  Lower 
Bound 
Upper 
Bound 
OR1 PMSG  36 5.61111 3.531716 .588619 4.41615 6.80607 1.000 15.000 
pFSH 30 6.23333 3.191404 .582668 5.04164 7.42502 2.000 15.000 
Total 66 5.89394 3.370135 .414835 5.06546 6.72242 1.000 15.000 
OR2 PMSG  18 6.05556 2.208865 .520634 4.95711 7.15400 3.000 11.000 
pFSH 10 5.70000 1.636392 .517472 4.52940 6.87060 3.000 8.000 
Total 28 5.92857 1.998677 .377714 5.15357 6.70358 3.000 11.000 
OR3 PMSG  6 3.16667 .752773 .307318 2.37668 3.95665 2.000 4.000 
pFSH 4 5.75000 1.500000 .750000 3.36317 8.13683 4.000 7.000 
Total 10 4.20000 1.686548 .533333 2.99352 5.40648 2.000 7.000 
 
 
ANOVA 
  Sum of Squares df Mean Square F Sig. 
OR1 Between Groups 6.335 1 6.335 .554 .459 
Within Groups 731.922 64 11.436   
Total 738.258 65    
OR2 Between Groups .813 1 .813 .197 .661 
Within Groups 107.044 26 4.117   
Total 107.857 27    
OR3 Between Groups 16.017 1 16.017 13.370 .006 
Within Groups 9.583 8 1.198   
Total 25.600 9    
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Appendix Table 2.9: Percentage of Grade A oocyte retrieved from does superstimulated 
            with PMSG vs. pFSH within each OR cycle (Experiment 1) 
Descriptives 
Grade A 
  
N Mean 
Std. 
Deviation Std. Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
  Lower 
Bound 
Upper 
Bound 
OR1 PMSG  36 29.30194 27.494080 4.582347 19.99929 38.60460 .000 100.000 
pFSH 30 36.23033 21.752476 3.971441 28.10783 44.35284 .000 80.000 
Total 66 32.45121 25.104332 3.090130 26.27980 38.62263 .000 100.000 
OR2 PMSG  18 28.48500 18.193542 4.288259 19.43756 37.53244 .000 62.500 
pFSH 10 32.50000 28.360336 8.968326 12.21224 52.78776 .000 100.000 
Total 28 29.91893 21.916924 4.141909 21.42043 38.41742 .000 100.000 
OR3 PMSG  6 19.44500 26.177245 10.686815 -8.02633 46.91633 .000 66.670 
pFSH 4 41.25000 13.174587 6.587293 20.28629 62.21371 25.000 57.140 
Total 10 28.16700 23.776854 7.518902 11.15806 45.17594 .000 66.670 
 
 
ANOVA 
  Sum of Squares df Mean Square F Sig. 
OR1 Between Groups 785.497 1 785.497 1.251 .268 
Within Groups 40179.291 64 627.801   
Total 40964.788 65    
OR2 Between Groups 103.630 1 103.630 .209 .651 
Within Groups 12865.862 26 494.841   
Total 12969.492 27    
OR3 Between Groups 1141.099 1 1141.099 2.313 .167 
Within Groups 3946.950 8 493.369   
Total 5088.049 9    
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Appendix Table 2.10: Percentage of Grade B oocyte retrieved from does   
   superstimulated with PMSG vs. pFSH within each OR cycle 
   (Experiment 1) 
Descriptives 
Grade B 
  
N Mean 
Std. 
Deviation Std. Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
  Lower 
Bound 
Upper 
Bound 
OR1 PMSG  36 28.16806 30.414307 5.069051 17.87733 38.45878 .000 100.000 
pFSH 30 41.37767 20.713003 3.781660 33.64330 49.11203 .000 100.000 
Total 66 34.17242 27.081993 3.333563 27.51484 40.83001 .000 100.000 
OR2 PMSG  18 29.48667 17.201095 4.054337 20.93276 38.04057 .000 60.000 
pFSH 10 20.02400 17.027847 5.384678 7.84301 32.20499 .000 50.000 
Total 28 26.10714 17.443109 3.296438 19.34341 32.87087 .000 60.000 
OR3 PMSG  6 16.66500 18.255593 7.452815 -2.49307 35.82307 .000 33.330 
pFSH 4 26.78750 23.600163 11.800081 -10.76563 64.34063 .000 50.000 
Total 10 20.71400 19.953146 6.309739 6.44038 34.98762 .000 50.000 
 
ANOVA 
  Sum of Squares df Mean Square F Sig. 
OR1 Between Groups 2855.354 1 2855.354 4.077 .048 
Within Groups 44817.879 64 700.279   
Total 47673.233 65    
OR2 Between Groups 575.628 1 575.628 1.959 .173 
Within Groups 7639.448 26 293.825   
Total 8215.076 27    
OR3 Between Groups 245.916 1 245.916 .590 .465 
Within Groups 3337.236 8 417.155   
Total 3583.152 9    
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Appendix Table 2.11: Percentage of Grade C oocyte retrieved from does   
   superstimulated with PMSG vs. pFSH within each OR cycle 
   (Experiment 1) 
 
Descriptives 
Grade C 
  
N Mean 
Std. 
Deviation Std. Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
  Lower 
Bound 
Upper 
Bound 
OR1 PMSG  36 32.25472 27.236840 4.539473 23.03910 41.47034 .000 100.000 
pFSH 30 16.44200 19.566429 3.572325 9.13578 23.74822 .000 66.670 
Total 66 25.06712 25.163679 3.097435 18.88112 31.25313 .000 100.000 
OR2 PMSG  18 22.24889 20.454003 4.821055 12.07735 32.42043 .000 62.500 
pFSH 10 25.11900 19.331112 6.113034 11.29036 38.94764 .000 50.000 
Total 28 23.27393 19.746925 3.731818 15.61687 30.93099 .000 62.500 
OR3 PMSG  6 26.38833 22.617799 9.233678 2.65241 50.12426 .000 50.000 
pFSH 4 15.71500 12.008387 6.004194 -3.39302 34.82302 .000 28.570 
Total 10 22.11900 19.043332 6.022030 8.49622 35.74178 .000 50.000 
 
 
ANOVA 
  Sum of Squares df Mean Square F Sig. 
OR1 Between Groups 4091.599 1 4091.599 7.065 .010 
Within Groups 37067.099 64 579.173   
Total 41158.699 65    
OR2 Between Groups 52.956 1 52.956 .131 .720 
Within Groups 10475.453 26 402.902   
Total 10528.408 27    
OR3 Between Groups 273.408 1 273.408 .731 .417 
Within Groups 2990.428 8 373.804   
Total 3263.836 9    
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Appendix Table 2.12: Percentage of Grade D oocyte retrieved from does   
   superstimulated with PMSG vs. pFSH within each OR cycle 
   (Experiment 1) 
Descriptives 
Grade D 
  
N Mean 
Std. 
Deviation Std. Error 
95% Confidence Interval 
for Mean 
Minimum Maximum 
  Lower 
Bound 
Upper 
Bound 
OR1 PMSG  36 8.88472 13.166133 2.194356 4.42994 13.33950 .000 50.000 
pFSH 30 5.18000 8.645736 1.578488 1.95163 8.40837 .000 25.000 
Total 66 7.20076 11.408129 1.404244 4.39629 10.00523 .000 50.000 
OR2 PMSG  18 11.53667 14.811455 3.491094 4.17110 18.90223 .000 50.000 
pFSH 10 16.52400 15.639011 4.945490 5.33653 27.71147 .000 50.000 
Total 28 13.31786 15.019192 2.838361 7.49402 19.14169 .000 50.000 
OR3 PMSG  6 23.61167 29.068279 11.867075 -6.89362 54.11695 .000 66.670 
pFSH 4 16.25000 19.737865 9.868933 -15.15735 47.65735 .000 40.000 
Total 10 20.66700 24.773732 7.834142 2.94494 38.38906 .000 66.670 
 
 
ANOVA 
  Sum of Squares df Mean Square F Sig. 
OR1 Between Groups 224.590 1 224.590 1.745 .191 
Within Groups 8234.861 64 128.670   
Total 8459.451 65    
OR2 Between Groups 159.901 1 159.901 .701 .410 
Within Groups 5930.655 26 228.102   
Total 6090.556 27    
OR3 Between Groups 130.066 1 130.066 .193 .672 
Within Groups 5393.574 8 674.197   
Total 5523.640 9    
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Appendix Table 2.13: Percentage of Grade E oocyte retrieved from does   
   superstimulated with PMSG vs. pFSH within each OR cycle 
   (Experiment 1) 
Descriptives 
Grade E 
  
N Mean 
Std. 
Deviation Std. Error 
95% Confidence Interval 
for Mean 
Minimum Maximum 
  Lower 
Bound 
Upper 
Bound 
OR1 PMSG  36 1.38889 8.333333 1.388889 -1.43071 4.20848 .000 50.000 
pFSH 30 .80300 2.471644 .451258 -.11993 1.72593 .000 9.090 
Total 66 1.12258 6.340753 .780493 -.43618 2.68133 .000 50.000 
OR2 PMSG  18 8.24111 17.021252 4.011948 -.22336 16.70558 .000 66.670 
pFSH 10 5.83300 12.452800 3.937921 -3.07520 14.74120 .000 33.330 
Total 28 7.38107 15.345672 2.900059 1.43064 13.33150 .000 66.670 
OR3 PMSG  6 13.88833 22.152084 9.043550 -9.35885 37.13552 .000 50.000 
pFSH 4 .00000 .000000 .000000 .00000 .00000 .000 .000 
Total 10 8.33300 18.001543 5.692588 -4.54453 21.21053 .000 50.000 
 
 
ANOVA 
  Sum of Squares df Mean Square F Sig. 
OR1 Between Groups 5.617 1 5.617 .138 .712 
Within Groups 2607.717 64 40.746   
Total 2613.334 65    
OR2 Between Groups 37.279 1 37.279 .153 .699 
Within Groups 6320.941 26 243.113   
Total 6358.221 27    
OR3 Between Groups 462.926 1 462.926 1.509 .254 
Within Groups 2453.574 8 306.697   
Total 2916.500 9    
 
 
 
 
 
 
 
 
 
 
327 
 
Appendix Table 2.14: Percentage of caprine oocyte retrieved from LOPU vs. Abattoir 
    source for each oocyte grade (Experiment 2) 
Descriptives 
  
N Mean 
Std. 
Deviation Std. Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
  Lower 
Bound 
Upper 
Bound 
Grade A LOPU 14 39.24071 15.361739 4.105598 30.37111 48.11032 11.110 66.670 
Abattoir 6 18.44500 4.879917 1.992218 13.32384 23.56616 11.540 25.470 
Total 20 33.00200 16.227311 3.628537 25.40738 40.59662 11.110 66.670 
Grade B LOPU 14 40.06929 10.604320 2.834124 33.94653 46.19204 22.220 55.560 
Abattoir 6 32.30167 5.051742 2.062365 27.00019 37.60314 26.850 39.740 
Total 20 37.73900 9.848543 2.202201 33.12974 42.34826 22.220 55.560 
Grade C LOPU 14 15.61143 14.173496 3.788026 7.42790 23.79496 .000 55.560 
Abattoir 6 33.79333 6.196288 2.529624 27.29073 40.29594 28.130 44.440 
Total 20 21.06600 14.853596 3.321365 14.11430 28.01770 .000 55.560 
Grade D LOPU 14 4.98357 6.621994 1.769802 1.16015 8.80700 .000 18.180 
Abattoir 6 15.45833 5.083587 2.075366 10.12344 20.79323 8.330 23.150 
Total 20 8.12600 7.813960 1.747255 4.46895 11.78305 .000 23.150 
No of 
oocyte 
LOPU 14 11.00000 3.210560 .858058 9.14628 12.85372 5.000 17.000 
Abattoir 6 20.15833 2.918975 1.191667 17.09506 23.22161 16.000 24.000 
Total 20 13.74750 5.275950 1.179738 11.27828 16.21672 5.000 24.000 
 
ANOVA 
  Sum of Squares df Mean Square F Sig. 
Grade A Between Groups 1816.339 1 1816.339 10.259 .005 
Within Groups 3186.847 18 177.047   
Total 5003.187 19    
Grade B Between Groups 253.411 1 253.411 2.870 .107 
Within Groups 1589.471 18 88.304   
Total 1842.882 19    
Grade C Between Groups 1388.443 1 1388.443 8.915 .008 
Within Groups 2803.514 18 155.751   
Total 4191.957 19    
Grade D Between Groups 460.827 1 460.827 11.862 .003 
Within Groups 699.275 18 38.849   
Total 1160.101 19    
No of oocyte Between Groups 352.275 1 352.275 35.905 .000 
Within Groups 176.602 18 9.811   
Total 528.877 19    
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Appendix Table 2.15: Percentage of caprine oocyte retrieved according to oocyte grades 
   within each oocyte source (Experiment 2)   
Descriptives 
  
N Mean 
Std. 
Deviation Std. Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
  Lower 
Bound 
Upper 
Bound 
LOPU Grade A 14 39.24071 15.361739 4.105598 30.37111 48.11032 11.110 66.670 
Grade B 14 40.06929 10.604320 2.834124 33.94653 46.19204 22.220 55.560 
Grade C 14 15.61143 14.173496 3.788026 7.42790 23.79496 .000 55.560 
Grade D 14 4.98357 6.621994 1.769802 1.16015 8.80700 .000 18.180 
Total 56 24.97625 19.340395 2.584469 19.79686 30.15564 .000 66.670 
Abattoir Grade A 6 18.44500 4.879917 1.992218 13.32384 23.56616 11.540 25.470 
Grade B 6 32.30167 5.051742 2.062365 27.00019 37.60314 26.850 39.740 
Grade C 6 33.79333 6.196288 2.529624 27.29073 40.29594 28.130 44.440 
Grade D 6 15.45833 5.083587 2.075366 10.12344 20.79323 8.330 23.150 
Total 24 24.99958 9.681321 1.976191 20.91152 29.08765 8.330 44.440 
 
ANOVA 
  Sum of Squares df Mean Square F Sig. 
LOPU Between Groups 12861.544 3 4287.181 28.910 .000 
Within Groups 7711.255 52 148.293   
Total 20572.799 55    
Abattoir Between Groups 1587.891 3 529.297 18.642 .000 
Within Groups 567.853 20 28.393   
Total 2155.743 23    
 
Post Hoc Tests 
 
Homogeneous Subsets 
 
 
LOPU 
Duncana 
Treatment N 
Subset for alpha = 0.05 
1 2 3 
Grade D 14 4.98357   
Grade C 14  15.61143  
Grade A 14   39.24071 
Grade B 14   40.06929 
Sig.  1.000 1.000 .858 
Means for groups in homogeneous subsets are 
displayed. 
a. Uses Harmonic Mean Sample Size = 14.000. 
 
 
 
Abattoir 
Duncana 
Treatment N 
Subset for alpha = 0.05 
1 2 
Grade D 6 15.45833  
Grade A 6 18.44500  
Grade B 6  32.30167 
Grade C 6  33.79333 
Sig.  .343 .633 
Means for groups in homogeneous subsets are 
displayed. 
a. Uses Harmonic Mean Sample Size = 6.000. 
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Appendix Table 2.16: Percentage of oocyte maturation for LOPU vs. Abattoir oocyte 
   within each IVM duration screened (Experiment 2) 
 
Descriptives 
  
N Mean 
Std. 
Deviation Std. Error 
95% Confidence Interval 
for Mean 
Minimum Maximum 
  Lower 
Bound 
Upper 
Bound 
15 hr LOPU 3 6.66667 11.547005 6.666667 -22.01768 35.35102 .000 20.000 
Abattoir 3 .00000 .000000 .000000 .00000 .00000 .000 .000 
Total 6 3.33333 8.164966 3.333333 -5.23527 11.90194 .000 20.000 
18 hr LOPU 3 53.33333 11.547005 6.666667 24.64898 82.01768 40.000 60.000 
Abattoir 3 .00000 .000000 .000000 .00000 .00000 .000 .000 
Total 6 26.66667 30.110906 12.292726 -4.93279 58.26612 .000 60.000 
21 hr LOPU 3 86.66667 11.547005 6.666667 57.98232 115.35102 80.000 100.000 
Abattoir 3 53.33333 30.550505 17.638342 -22.55833 129.22499 20.000 80.000 
Total 6 70.00000 27.568098 11.254629 41.06906 98.93094 20.000 100.000 
24 hr LOPU 3 73.33333 11.547005 6.666667 44.64898 102.01768 60.000 80.000 
Abattoir 3 80.00000 20.000000 11.547005 30.31725 129.68275 60.000 100.000 
Total 6 76.66667 15.055453 6.146363 60.86694 92.46640 60.000 100.000 
27 hr LOPU 3 46.66667 11.547005 6.666667 17.98232 75.35102 40.000 60.000 
Abattoir 3 73.33333 23.094011 13.333333 15.96463 130.70204 60.000 100.000 
Total 6 60.00000 21.908902 8.944272 37.00802 82.99198 40.000 100.000 
 
 
ANOVA 
  Sum of Squares df Mean Square F Sig. 
15 hr Between Groups 66.667 1 66.667 1.000 .374 
Within Groups 266.667 4 66.667   
Total 333.333 5    
18 hr Between Groups 4266.667 1 4266.667 64.000 .001 
Within Groups 266.667 4 66.667   
Total 4533.333 5    
21 hr Between Groups 1666.667 1 1666.667 3.125 .152 
Within Groups 2133.333 4 533.333   
Total 3800.000 5    
24 hr Between Groups 66.667 1 66.667 .250 .643 
Within Groups 1066.667 4 266.667   
Total 1133.333 5    
27 hr Between Groups 1066.667 1 1066.667 3.200 .148 
Within Groups 1333.333 4 333.333   
Total 2400.000 5    
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Appendix Table 2.17: Percentage of oocyte maturation at different IVM durations 
   within each oocyte source (Experiment 2) 
 
Descriptives 
  
N Mean 
Std. 
Deviation Std. Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
  Lower 
Bound 
Upper 
Bound 
LOPU 15 hr 3 6.66667 11.547005 6.666667 -22.01768 35.35102 .000 20.000 
18 hr 3 53.33333 11.547005 6.666667 24.64898 82.01768 40.000 60.000 
21 hr 3 86.66667 11.547005 6.666667 57.98232 115.35102 80.000 100.000 
24 hr 3 73.33333 11.547005 6.666667 44.64898 102.01768 60.000 80.000 
27 hr 3 46.66667 11.547005 6.666667 17.98232 75.35102 40.000 60.000 
Total 15 53.33333 29.920530 7.725448 36.76390 69.90277 .000 100.000 
ABATTOIR 15 hr 3 .00000 .000000 .000000 .00000 .00000 .000 .000 
18 hr 3 .00000 .000000 .000000 .00000 .00000 .000 .000 
21 hr 3 53.33333 30.550505 17.638342 -22.55833 129.22499 20.000 80.000 
24 hr 3 80.00000 20.000000 11.547005 30.31725 129.68275 60.000 100.000 
27 hr 3 73.33333 23.094011 13.333333 15.96463 130.70204 60.000 100.000 
Total 15 41.33333 39.617216 10.229121 19.39405 63.27262 .000 100.000 
 
ANOVA 
  Sum of Squares df Mean Square F Sig. 
LOPU Between Groups 11200.000 4 2800.000 21.000 .000 
Within Groups 1333.333 10 133.333   
Total 12533.333 14    
ABATTOIR Between Groups 18240.000 4 4560.000 12.214 .001 
Within Groups 3733.333 10 373.333   
Total 21973.333 14    
 
 
Post Hoc Tests 
 
Homogeneous Subsets 
 
LOPU 
Duncana 
Treatment N 
Subset for alpha = 0.05 
1 2 3 4 
15 hr 3 6.66667    
27 hr 3  46.66667   
18 hr 3  53.33333 53.33333  
24 hr 3   73.33333 73.33333 
21 hr 3    86.66667 
Sig.  1.000 .496 .060 .188 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 3.000. 
 
 
ABATTOIR 
Duncana 
Treatment N 
Subset for alpha = 0.05 
1 2 
15 hr 3 .00000  
18 hr 3 .00000  
21 hr 3  53.33333 
27 hr 3  73.33333 
24 hr 3  80.00000 
Sig.  1.000 .137 
Means for groups in homogeneous subsets are 
displayed. 
a. Uses Harmonic Mean Sample Size = 3.000. 
331 
 
Appendix Table 2.18: Maturation rate of caprine oocyte from LOPU vs. Abattoir source 
   within each oocyte grade (Experiment 2) 
Descriptives 
  
N Mean 
Std. 
Deviation Std. Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
  Lower 
Bound 
Upper 
Bound 
Overall MII 
rate 
LOPU 14 79.59429 9.599481 2.565569 74.05171 85.13686 63.640 100.000 
Abattoir 6 69.70667 8.946701 3.652476 60.31768 79.09565 53.800 81.300 
Total 20 76.62800 10.282281 2.299188 71.81574 81.44026 53.800 100.000 
Grade A LOPU 14 84.40500 12.499331 3.340587 77.18810 91.62190 66.670 100.000 
Abattoir 6 76.43333 10.340342 4.221427 65.58181 87.28486 63.600 90.500 
Total 20 82.01350 12.209887 2.730214 76.29910 87.72790 63.600 100.000 
Grade B LOPU 14 82.05786 18.291341 4.888567 71.49675 92.61896 50.000 100.000 
Abattoir 6 79.63333 7.538877 3.077734 71.72177 87.54490 67.700 89.700 
Total 20 81.33050 15.658045 3.501245 74.00231 88.65869 50.000 100.000 
Grade C LOPU 14 61.07143 43.684999 11.675307 35.84846 86.29440 .000 100.000 
Abattoir 6 68.96667 12.406235 5.064824 55.94712 81.98621 50.000 85.200 
Total 20 63.44000 36.878398 8.246260 46.18038 80.69962 .000 100.000 
Grade D LOPU 14 28.57143 42.581531 11.380393 3.98558 53.15727 .000 100.000 
Abattoir 6 45.20500 18.379155 7.503259 25.91726 64.49274 16.700 66.700 
Total 20 33.56150 37.291479 8.338628 16.10855 51.01445 .000 100.000 
 
 
ANOVA 
  Sum of Squares df Mean Square F Sig. 
Overall MII rate Between Groups 410.613 1 410.613 4.625 .045 
Within Groups 1598.168 18 88.787   
Total 2008.781 19    
Grade A Between Groups 266.899 1 266.899 1.873 .188 
Within Groups 2565.646 18 142.536   
Total 2832.545 19    
Grade B  Between Groups 24.689 1 24.689 .096 .760 
Within Groups 4633.624 18 257.424   
Total 4658.313 19    
Grade C Between Groups 261.806 1 261.806 .184 .673 
Within Groups 25578.502 18 1421.028   
Total 25840.308 19    
Grade D Between Groups 1162.038 1 1162.038 .828 .375 
Within Groups 25260.395 18 1403.355   
Total 26422.433 19    
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Appendix Table 2.19: Percentage of caprine oocyte maturation according to oocyte 
     grades within each oocyte source (Experiment 2) 
Descriptives 
  
N Mean 
Std. 
Deviation Std. Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
  Lower 
Bound 
Upper 
Bound 
LOPU Grade A 14 84.40500 12.499331 3.340587 77.18810 91.62190 66.670 100.000 
Grade B 14 82.05786 18.291341 4.888567 71.49675 92.61896 50.000 100.000 
Grade C 14 61.07143 43.684999 11.675307 35.84846 86.29440 .000 100.000 
Grade D 14 28.57143 42.581531 11.380393 3.98558 53.15727 .000 100.000 
Total 56 64.02643 38.811373 5.186388 53.63267 74.42018 .000 100.000 
Abattoir Grade A 6 76.43333 10.340342 4.221427 65.58181 87.28486 63.600 90.500 
Grade B 6 79.63333 7.538877 3.077734 71.72177 87.54490 67.700 89.700 
Grade C 6 68.96667 12.406235 5.064824 55.94712 81.98621 50.000 85.200 
Grade D 6 45.20500 18.379155 7.503259 25.91726 64.49274 16.700 66.700 
Total 24 67.55958 18.219297 3.718998 59.86625 75.25292 16.700 90.500 
 
ANOVA 
  Sum of Squares df Mean Square F Sig. 
LOPU Between Groups 28086.907 3 9362.302 8.890 .000 
Within Groups 54760.841 52 1053.093   
Total 82847.748 55    
Abattoir Between Groups 4357.357 3 1452.452 8.864 .001 
Within Groups 3277.327 20 163.866   
Total 7634.684 23    
 
Post Hoc Tests 
 
Homogeneous Subsets 
 
 
LOPU 
Duncana 
Treatment N 
Subset for alpha = 0.05 
1 2 
Grade D 14 28.57143  
Grade C 14  61.07143 
Grade B 14  82.05786 
Grade A 14  84.40500 
Sig.  1.000 .077 
Means for groups in homogeneous subsets are 
displayed. 
a. Uses Harmonic Mean Sample Size = 
14.000. 
 
 
 
Abattoir 
Duncana 
Treatment N 
Subset for alpha = 0.05 
1 2 
Grade D 6 45.20500  
Grade C 6  68.96667 
Grade A 6  76.43333 
Grade B 6  79.63333 
Sig.  1.000 .187 
Means for groups in homogeneous subsets 
are displayed. 
a. Uses Harmonic Mean Sample Size = 
6.000. 
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Appendix Table 2.20: Percentage of fusion and cleavage for bovine intraspSCNT vs. 
    gaur interspSCNT (Experiment 3) 
 
Descriptives 
  
N Mean 
Std. 
Deviation Std. Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
  Lower 
Bound 
Upper 
Bound 
Fused intraspSCNT  
(Bovine-bovine) 
6 74.31000 9.401636 3.838202 64.44359 84.17641 60.000 86.210 
interspSCNT  
(Gaur-bovine) 
7 70.43000 7.676288 2.901364 63.33062 77.52938 60.000 83.870 
Total 13 72.22077 8.387210 2.326194 67.15243 77.28911 60.000 86.210 
Cleaved intraspSCNT  
(Bovine-bovine) 
6 77.91167 2.283948 .932418 75.51481 80.30852 75.000 81.480 
interspSCNT  
(Gaur-bovine) 
7 73.74571 5.708887 2.157757 68.46587 79.02555 66.670 80.770 
Total 13 75.66846 4.810587 1.334217 72.76145 78.57547 66.670 81.480 
 
ANOVA 
  Sum of Squares df Mean Square F Sig. 
Fused Between Groups 48.637 1 48.637 .673 .430 
Within Groups 795.506 11 72.319   
Total 844.143 12    
Cleaved Between Groups 56.071 1 56.071 2.783 .123 
Within Groups 221.630 11 20.148   
Total 277.701 12    
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Appendix Table 2.21: In vitro developmental rate for bovine intraspSCNT vs. gaur 
     interspSCNT (Experiment 3) 
Descriptives 
  
N Mean 
Std. 
Deviation 
Std. 
Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
  Lower 
Bound 
Upper 
Bound 
Two cell intraspSCNT 
(Bovine-bovine) 
6 77.911
7 
2.28395 .93242 75.5148 80.3085 75.00 81.48 
interspSCNT 
 (Gaur-bovine) 
7 73.745
7 
5.70889 2.15776 68.4659 79.0256 66.67 80.77 
Total 13 75.668
5 
4.81059 1.33422 72.7615 78.5755 66.67 81.48 
Four cell intraspSCNT 
(Bovine-bovine) 
6 69.846
7 
6.06915 2.47772 63.4775 76.2158 62.50 77.78 
interspSCNT 
 (Gaur-bovine) 
7 69.868
6 
6.61808 2.50140 63.7479 75.9893 58.33 77.27 
Total 13 69.858
5 
6.10306 1.69268 66.1704 73.5465 58.33 77.78 
Eight cell intraspSCNT 
(Bovine-bovine) 
6 65.301
7 
7.76832 3.17140 57.1493 73.4540 56.25 77.78 
interspSCNT 
 (Gaur-bovine) 
7 62.524
3 
10.74193 4.06007 52.5897 72.4589 41.67 73.08 
Total 13 63.806
2 
9.21498 2.55578 58.2376 69.3747 41.67 77.78 
morula intraspSCNT 
(Bovine-bovine) 
6 46.116
7 
5.91982 2.41676 39.9042 52.3291 37.50 55.56 
interspSCNT  
(Gaur-bovine) 
7 45.860
0 
3.60209 1.36146 42.5286 49.1914 41.18 50.00 
Total 13 45.978
5 
4.59424 1.27421 43.2022 48.7547 37.50 55.56 
Compact 
morula 
intraspSCNT 
(Bovine-bovine) 
6 37.098
3 
4.13523 1.68820 32.7587 41.4380 32.00 44.44 
interspSCNT  
(Gaur-bovine) 
7 34.464
3 
5.66648 2.14173 29.2237 39.7049 26.67 42.31 
Total 13 35.680
0 
5.00475 1.38807 32.6557 38.7043 26.67 44.44 
Blastocyst intraspSCNT 
(Bovine-bovine) 
6 20.291
7 
6.34730 2.59127 13.6306 26.9527 11.11 26.32 
interspSCNT  
(Gaur-bovine) 
7 20.910
0 
10.31163 3.89743 11.3733 30.4467 6.67 33.33 
Total 13 20.624
6 
8.36986 2.32138 15.5668 25.6825 6.67 33.33 
Hatched 
blastocyst 
intraspSCNT 
(Bovine-bovine) 
6 18.631
7 
5.23533 2.13732 13.1375 24.1258 11.11 26.32 
interspSCNT 
 (Gaur-bovine) 
7 19.018
6 
8.87485 3.35438 10.8107 27.2264 6.67 29.41 
Total 13 18.840
0 
7.13036 1.97761 14.5312 23.1488 6.67 29.41 
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ANOVA 
  Sum of Squares df Mean Square F Sig. 
Two cell Between Groups 56.071 1 56.071 2.783 .123 
Within Groups 221.630 11 20.148   
Total 277.701 12    
Four cell Between Groups .002 1 .002 .000 .995 
Within Groups 446.967 11 40.633   
Total 446.968 12    
Eight cell Between Groups 24.922 1 24.922 .276 .610 
Within Groups 994.069 11 90.370   
Total 1018.991 12    
Morula Between Groups .213 1 .213 .009 .925 
Within Groups 253.072 11 23.007   
Total 253.284 12    
Compact morula Between Groups 22.416 1 22.416 .886 .367 
Within Groups 278.155 11 25.287   
Total 300.570 12    
Blastocyst Between Groups 1.235 1 1.235 .016 .901 
Within Groups 839.419 11 76.311   
Total 840.654 12    
Hatched blastocyst Between Groups .484 1 .484 .009 .927 
Within Groups 609.622 11 55.420   
Total 610.105 12    
Post Hoc Tests 
 
Homogeneous Subsets 
 
intraspSCNT 
Duncana 
 N 
Subset for alpha = 0.05 
1 2 3 4 5 
Hatched 
blast. 
6 18.63 
    
Blastocyst 6 20.29     
Compact 
morula 
6 
 
37.1 
   
Morula 6   46.12   
Eight cell 6    65.30  
Four cell 6    69.85  
Two cell 6     77.91 
Sig.  .613 1.000 1.000 .171 1.000 
Means for groups in homogeneous subsets are 
displayed. 
a. Uses Harmonic Mean Sample Size = 6.000. 
 
 
 
interspSCNT 
Duncana 
 N 
Subset for alpha = 0.05 
1 2 3 4 5 
Hatched 
blastocyst 
7 19.02 
    
Blastocyst 7 20.91     
Compact 
morula 
7 
 
34.46 
   
Morula 7   45.86   
Eight cell 7    62.52  
Four cell 7    69.87 69.87 
Two cell 7     73.75 
Sig.  .651 1.000 1.000 .084 .356 
Means for groups in homogeneous subsets are 
displayed. 
a. Uses Harmonic Mean Sample Size = 7.000. 
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Appendix Table 2.22: Percentage of maturation, enucleation, fusion and in vitro  
   development for caprine reconstructed embryos using oocyte 
   matured at 18- 22 hours vs. 23-27 hours (Experiment 4)  
 
Descriptives 
  
N Mean 
Std. 
Deviation Std. Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
  Lower 
Bound 
Upper 
Bound 
Maturation rate 18-22 4 75.20750 6.685424 3.342712 64.56950 85.84550 68.420 81.820 
23-27 5 62.56000 2.889991 1.292443 58.97160 66.14840 57.890 65.200 
Total 9 68.18111 8.085155 2.695052 61.96631 74.39591 57.890 81.820 
Enucleation rate 18-22 4 80.20250 6.146936 3.073468 70.42135 89.98365 75.000 88.890 
23-27 5 64.24400 10.608425 4.744232 51.07190 77.41610 53.300 81.820 
Total 9 71.33667 11.881976 3.960659 62.20337 80.46996 53.300 88.890 
Fusion rate 18-22 4 82.50000 6.123724 3.061862 72.75579 92.24421 75.000 87.500 
23-27 5 84.06000 10.045795 4.492616 71.58650 96.53350 75.000 100.000 
Total 9 83.36667 8.074497 2.691499 77.16006 89.57327 75.000 100.000 
Cleavage 
rate/Two cell 
18-22 4 84.22500 11.052111 5.526056 66.63862 101.81138 75.000 100.000 
23-27 5 67.74000 3.755396 1.679464 63.07706 72.40294 62.500 71.400 
Total 9 75.06667 11.328945 3.776315 66.35847 83.77486 62.500 100.000 
Four cell 18-22 4 74.70250 8.092875 4.046437 61.82493 87.58007 66.670 85.710 
23-27 5 60.43600 10.376976 4.640725 47.55128 73.32072 44.440 71.430 
Total 9 66.77667 11.616292 3.872097 57.84759 75.70574 44.440 85.710 
Eight cell 18-22 4 65.92000 13.392000 6.696000 44.61034 87.22966 57.140 85.710 
23-27 5 46.38800 7.481478 3.345819 37.09852 55.67748 37.500 57.140 
Total 9 55.06889 14.184951 4.728317 44.16537 65.97241 37.500 85.710 
Morula 18-22 4 46.57750 8.751466 4.375733 32.65196 60.50304 37.500 57.140 
23-27 5 24.68200 15.973347 7.143498 4.84847 44.51553 .000 42.860 
Total 9 34.41333 17.013663 5.671221 21.33547 47.49119 .000 57.140 
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ANOVA 
  Sum of Squares df Mean Square F Sig. 
Maturation rate Between Groups 355.465 1 355.465 14.856 .006 
Within Groups 167.493 7 23.928   
Total 522.958 8    
Enucleation rate Between Groups 565.942 1 565.942 7.030 .033 
Within Groups 563.509 7 80.501   
Total 1129.451 8    
Fusion rate Between Groups 5.408 1 5.408 .073 .794 
Within Groups 516.172 7 73.739   
Total 521.580 8    
Cleavage rate/ Two 
cell 
Between Groups 603.900 1 603.900 9.997 .016 
Within Groups 422.860 7 60.409   
Total 1026.760 8    
Four cell Between Groups 452.296 1 452.296 5.048 .059 
Within Groups 627.210 7 89.601   
Total 1079.506 8    
Eight cell Between Groups 847.776 1 847.776 7.789 .027 
Within Groups 761.927 7 108.847   
Total 1609.703 8    
Morula Between Groups 1065.362 1 1065.362 5.964 .045 
Within Groups 1250.356 7 178.622   
Total 2315.718 8    
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Appendix Table 2.23: Percentage of in vitro development from 2-cell to morula stage 
    for caprine reconstructed embryos using oocyte matured within 
    each IVM duration range group (Experiment 4) 
 
Descriptives 
  
N Mean 
Std. 
Deviation Std. Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
  Lower 
Bound 
Upper 
Bound 
18-22 hour 2-cell 4 84.22500 11.052111 5.526056 66.63862 101.81138 75.000 100.000 
4-cell 4 74.70250 8.092875 4.046437 61.82493 87.58007 66.670 85.710 
8-cell 4 65.92000 13.392000 6.696000 44.61034 87.22966 57.140 85.710 
morula 4 46.57750 8.751466 4.375733 32.65196 60.50304 37.500 57.140 
Total 16 67.85625 17.158280 4.289570 58.71325 76.99925 37.500 100.000 
23-27 hour 2-cell 5 67.74000 3.755396 1.679464 63.07706 72.40294 62.500 71.400 
4-cell 5 60.43600 10.376976 4.640725 47.55128 73.32072 44.440 71.430 
8-cell 5 46.38800 7.481478 3.345819 37.09852 55.67748 37.500 57.140 
morula 5 24.68200 15.973347 7.143498 4.84847 44.51553 .000 42.860 
Total 20 49.81150 19.357082 4.328375 40.75211 58.87089 .000 71.430 
 
ANOVA 
  Sum of Squares df Mean Square F Sig. 
18-22 hour Between Groups 3085.366 3 1028.455 9.274 .002 
Within Groups 1330.733 12 110.894   
Total 4416.098 15    
23-27 hour Between Groups 5387.616 3 1795.872 16.594 .000 
Within Groups 1731.620 16 108.226   
Total 7119.236 19    
 
Post Hoc Tests 
 
Homogeneous Subsets 
 
 
18-22 hour 
Duncana 
Treatment N 
Subset for alpha = 0.05 
1 2 3 
morula 4 46.57750   
8-cell 4  65.92000  
4-cell 4  74.70250 74.70250 
2-cell 4   84.22500 
Sig.  1.000 .261 .225 
Means for groups in homogeneous subsets are 
displayed. 
a. Uses Harmonic Mean Sample Size = 4.000. 
 
23-27 hour 
Duncana 
Treatment N 
Subset for alpha = 0.05 
1 2 3 
morula 5 24.68200   
8-cell 5  46.38800  
4-cell 5   60.43600 
2-cell 5   67.74000 
Sig.  1.000 1.000 .283 
Means for groups in homogeneous subsets are 
displayed. 
a. Uses Harmonic Mean Sample Size = 5.000. 
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Appendix Table 2.24: Percentage of in vitro development for caprine reconstructed 
   embryos activated using (7% EtOH, CD-CHX) vs. (CaI, 6- 
                         DMAP) within each embryo developmental stage (Experiment 4) 
 
 
Descriptives 
  
N Mean 
Std. 
Deviation Std. Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
  Lower 
Bound 
Upper 
Bound 
2-cell 7%EtOH, CD-
CHX 
4 78.89750 2.552794 1.276397 74.83543 82.95957 76.470 81.250 
CaI, 6-DMAP 4 80.68750 5.771617 2.885808 71.50357 89.87143 75.000 87.500 
Total 8 79.79250 4.240841 1.499364 76.24707 83.33793 75.000 87.500 
4-cell 7%EtOH, CD-
CHX 
4 68.81000 1.625628 .812814 66.22326 71.39674 66.670 70.590 
CaI, 6-DMAP 4 70.78000 3.613705 1.806853 65.02979 76.53021 66.670 75.000 
Total 8 69.79500 2.799653 .989827 67.45443 72.13557 66.670 75.000 
8-cell 7%EtOH, CD-
CHX 
4 57.98750 4.692124 2.346062 50.52128 65.45372 53.850 64.710 
CaI, 6-DMAP 4 57.38500 3.085077 1.542538 52.47595 62.29405 53.850 61.110 
Total 8 57.68625 3.690280 1.304711 54.60110 60.77140 53.850 64.710 
Morula 7%EtOH, CD-
CHX 
4 40.00000 2.462627 1.231314 36.08141 43.91859 37.500 42.860 
CaI, 6-DMAP 4 42.77500 5.380945 2.690472 34.21272 51.33728 38.460 50.000 
Total 8 41.38750 4.148297 1.466644 37.91944 44.85556 37.500 50.000 
 
ANOVA 
  Sum of Squares df Mean Square F Sig. 
2-cell Between Groups 6.408 1 6.408 .322 .591 
Within Groups 119.485 6 19.914   
Total 125.893 7    
4-cell Between Groups 7.762 1 7.762 .989 .358 
Within Groups 47.105 6 7.851   
Total 54.866 7    
8-cell Between Groups .726 1 .726 .046 .837 
Within Groups 94.601 6 15.767   
Total 95.327 7    
Morula Between Groups 15.401 1 15.401 .880 .385 
Within Groups 105.057 6 17.510   
Total 120.459 7    
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Appendix Table 2.25: Percentage of in vitro development from 2-cell to morula stage 
   for caprine reconstructed embryos within each activation  
   treatment group (Experiment 4) 
 
 
 
Descriptives 
  
N Mean 
Std. 
Deviation Std. Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
  Lower 
Bound 
Upper 
Bound 
EtOH, CD-
CHX 
2-cell 4 78.89750 2.552794 1.276397 74.83543 82.95957 76.470 81.250 
4-cell 4 68.81000 1.625628 .812814 66.22326 71.39674 66.670 70.590 
8-cell 4 57.98750 4.692124 2.346062 50.52128 65.45372 53.850 64.710 
morula 4 40.00000 2.462627 1.231314 36.08141 43.91859 37.500 42.860 
Total 16 61.42375 15.131455 3.782864 53.36077 69.48673 37.500 81.250 
CaI, 6-
DMAP 
2-cell 4 80.68750 5.771617 2.885808 71.50357 89.87143 75.000 87.500 
4-cell 4 70.78000 3.613705 1.806853 65.02979 76.53021 66.670 75.000 
8-cell 4 57.38500 3.085077 1.542538 52.47595 62.29405 53.850 61.110 
morula 4 42.77500 5.380945 2.690472 34.21272 51.33728 38.460 50.000 
Total 16 62.90688 15.297514 3.824378 54.75541 71.05834 38.460 87.500 
 
ANOVA 
  
Sum of Squares df Mean Square F Sig. 
EtOH, CD-CHX Between Groups 3322.694 3 1107.565 118.965 .000 
Within Groups 111.720 12 9.310   
Total 3434.414 15    
CaI, 6-DMAP Between Groups 3255.681 3 1085.227 51.164 .000 
Within Groups 254.528 12 21.211   
Total 3510.209 15    
 
Post Hoc Tests 
 
Homogeneous Subsets 
 
EtOH, CD-CHX 
Duncana 
Treatmen
t N 
Subset for alpha = 0.05 
1 2 3 4 
morula 4 40.000    
8-cell 4  57.988   
4-cell 4   68.810  
2-cell 4    78.898 
Sig.  1.000 1.000 1.000 1.000 
Means for groups in homogeneous subsets are 
displayed. 
a. Uses Harmonic Mean Sample Size = 4.000. 
 
 
 
CaI, 6-DMAP 
Duncana 
Treatment N 
Subset for alpha = 0.05 
1 2 3 4 
morula 4 42.775    
8-cell 4  57.385   
4-cell 4   70.780  
2-cell 4    80.688 
Sig.  1.000 1.000 1.000 1.000 
Means for groups in homogeneous subsets are 
displayed. 
a. Uses Harmonic Mean Sample Size = 4.000. 
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Appendix Table 2.26: Percentage of in vitro development for caprine reconstructed 
   embryos cultured in mSOFaa vs. KSOMaa within each embryo 
   development stage (Experiment 4) 
 
 
Descriptives 
  
N Mean 
Std. 
Deviation 
Std. 
Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
  Lower 
Bound 
Upper 
Bound 
2-cell mSOFaa 6 79.27500 11.502544 4.695894 67.20382 91.34618 68.750 100.000 
KSOMaa 4 78.58000 9.435221 4.717611 63.56646 93.59354 70.590 90.480 
Total 10 78.99700 10.164054 3.214156 71.72607 86.26793 68.750 100.000 
4-cell mSOFaa 6 64.91667 10.100021 4.123316 54.31734 75.51599 50.000 75.000 
KSOMaa 4 68.60000 10.167232 5.083616 52.42167 84.77833 58.820 80.950 
Total 10 66.39000 9.733850 3.078114 59.42682 73.35318 50.000 80.950 
8-cell mSOFaa 6 52.72667 5.758513 2.350903 46.68348 58.76985 43.750 58.330 
KSOMaa 4 57.43750 9.255285 4.627642 42.71028 72.16472 47.060 66.670 
Total 10 54.61100 7.272810 2.299864 49.40835 59.81365 43.750 66.670 
Morula mSOFaa 6 31.68500 4.689404 1.914441 26.76377 36.60623 25.000 37.500 
KSOMaa 4 40.42250 7.158349 3.579174 29.03197 51.81303 33.330 47.620 
Total 10 35.18000 7.046700 2.228362 30.13909 40.22091 25.000 47.620 
Blastocyst mSOFaa 6 .00000 .000000 .000000 .00000 .00000 .000 .000 
KSOMaa 4 3.85000 4.687387 2.343694 -3.60868 11.30868 .000 9.520 
Total 10 1.54000 3.358055 1.061910 -.86221 3.94221 .000 9.520 
 
ANOVA 
  Sum of Squares df Mean Square F Sig. 
2-cell Between Groups 1.159 1 1.159 .010 .923 
Within Groups 928.613 8 116.077   
Total 929.772 9    
4-cell Between Groups 32.561 1 32.561 .318 .588 
Within Groups 820.170 8 102.521   
Total 852.731 9    
8-cell Between Groups 53.261 1 53.261 1.008 .345 
Within Groups 422.783 8 52.848   
Total 476.044 9    
Morula Between Groups 183.225 1 183.225 5.559 .046 
Within Groups 263.678 8 32.960   
Total 446.904 9    
Blastocyst Between Groups 35.574 1 35.574 4.318 .071 
Within Groups 65.915 8 8.239   
Total 101.489 9    
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Appendix Table 2.27: Percentage of in vitro development from 2-cell to blastocyst stage 
   for caprine reconstructed embryos within each IVC medium 
   treatment group (Experiment 4) 
 
Descriptives 
  
N Mean 
Std. 
Deviation 
Std. 
Error 
95% Confidence Interval 
for Mean 
Minimum Maximum 
  Lower 
Bound 
Upper 
Bound 
mSOFaa 2-cell 6 79.27500 11.502544 4.695894 67.20382 91.34618 68.750 100.000 
4-cell 6 64.91667 10.100021 4.123316 54.31734 75.51599 50.000 75.000 
8-cell 6 52.72667 5.758513 2.350903 46.68348 58.76985 43.750 58.330 
Morula 6 31.68500 4.689404 1.914441 26.76377 36.60623 25.000 37.500 
Blastocyst 6 .00000 .000000 .000000 .00000 .00000 .000 .000 
Total 30 45.72067 29.025796 5.299361 34.88226 56.55908 .000 100.000 
KSOMaa 2-cell 4 78.58000 9.435221 4.717611 63.56646 93.59354 70.590 90.480 
4-cell 4 68.60000 10.167232 5.083616 52.42167 84.77833 58.820 80.950 
8-cell 4 57.43750 9.255285 4.627642 42.71028 72.16472 47.060 66.670 
Morula 4 40.42250 7.158349 3.579174 29.03197 51.81303 33.330 47.620 
Blastocyst 4 3.85000 4.687387 2.343694 -3.60868 11.30868 .000 9.520 
Total 20 49.77800 27.920375 6.243186 36.71086 62.84514 .000 90.480 
 
ANOVA 
  Sum of Squares df Mean Square F Sig. 
mSOFaa Between Groups 22985.058 4 5746.265 99.255 .000 
Within Groups 1447.350 25 57.894   
Total 24432.408 29    
KSOMaa Between Groups 13757.590 4 3439.397 48.957 .000 
Within Groups 1053.810 15 70.254   
Total 14811.399 19    
 
Post Hoc Tests 
Homogeneous Subsets 
 
mSOFaa 
Duncana 
Treatmen
t N 
Subset for alpha = 0.05 
1 2 3 4 5 
Blastocys
t 
6 .000 
    
Morula 6 
 
31.68
5 
   
8-cell 6   52.727   
4-cell 6 
   
64.91
7 
 
2-cell 6     79.275 
Sig. 
 
1.00
0 
1.000 1.000 1.000 1.000 
Means for groups in homogeneous subsets are 
displayed. 
a. Uses Harmonic Mean Sample Size = 6.000. 
KSOMaa 
Duncana 
Treatment N 
Subset for alpha = 0.05 
1 2 3 4 
Blastocyst 4 3.850    
Morula 4  40.423   
8-cell 4   57.438  
4-cell 4   68.600 68.600 
2-cell 4    78.580 
Sig.  1.000 1.000 .079 .113 
Means for groups in homogeneous subsets are 
displayed. 
a. Uses Harmonic Mean Sample Size = 4.000. 
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Appendix Table 2.28: Percentage of in vitro development for caprine reconstructed 
   embryos cultured in Treatment A vs. Treatment B within each 
   embryo development stage (Experiment 4) 
 
Descriptives 
  
N Mean 
Std. 
Deviation 
Std. 
Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
  Lower 
Bound 
Upper 
Bound 
Two cell Treatment A 7 76.83714 5.688901 2.150202 71.57579 82.09850 71.430 85.710 
Treatment B 7 77.41857 5.080123 1.920106 72.72024 82.11690 73.330 87.500 
Total 14 77.12786 5.190306 1.387168 74.13106 80.12465 71.430 87.500 
Fou rcell Treatment A 7 68.06000 4.454503 1.683644 63.94027 72.17973 61.900 72.730 
Treatment B 7 68.51143 6.824782 2.579525 62.19956 74.82330 60.000 79.170 
Total 14 68.28571 5.541693 1.481080 65.08604 71.48539 60.000 79.170 
Eight cell Treatment A 7 58.20857 5.984152 2.261797 52.67415 63.74299 50.000 66.670 
Treatment B 7 60.46571 4.171142 1.576544 56.60805 64.32338 53.330 66.660 
Total 14 59.33714 5.092094 1.360919 56.39706 62.27723 50.000 66.670 
Morula Treatment A 7 34.94000 6.212123 2.347962 29.19474 40.68526 28.570 44.440 
Treatment B 7 46.67286 4.375807 1.653900 42.62591 50.71980 41.670 54.170 
Total 14 40.80643 7.981896 2.133252 36.19782 45.41504 28.570 54.170 
Blastocyst Treatment A 7 3.79571 3.885743 1.468673 .20200 7.38943 .000 9.520 
Treatment B 7 19.89571 3.972966 1.501640 16.22133 23.57010 13.330 25.000 
Total 14 11.84571 9.167399 2.450091 6.55262 17.13881 .000 25.000 
Hatched 
blastocyst 
Treatment A 7 .00000 .000000 .000000 .00000 .00000 .000 .000 
Treatment B 7 15.58000 6.549626 2.475526 9.52261 21.63739 7.690 25.000 
Total 14 7.79000 9.227730 2.466215 2.46207 13.11793 .000 25.000 
 
ANOVA 
  Sum of Squares df Mean Square F Sig. 
Two cell Between Groups 1.183 1 1.183 .041 .844 
Within Groups 349.027 12 29.086   
Total 350.211 13    
Four cell Between Groups .713 1 .713 .021 .886 
Within Groups 398.521 12 33.210   
Total 399.235 13    
Eight cell Between Groups 17.831 1 17.831 .670 .429 
Within Groups 319.251 12 26.604   
Total 337.082 13    
Morula Between Groups 481.810 1 481.810 16.689 .002 
Within Groups 346.429 12 28.869   
Total 828.239 13    
Blastocyst Between Groups 907.235 1 907.235 58.752 .000 
Within Groups 185.301 12 15.442   
Total 1092.536 13    
Hatched blastocyst Between Groups 849.577 1 849.577 39.610 .000 
Within Groups 257.386 12 21.449   
Total 1106.963 13    
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Appendix Table 2.29: Percentage of in vitro development from 2-cell to hatched  
   blastocyst stage for caprine reconstructed embryos within each 
   IVC treatment group (Experiment 4) 
 
Descriptives 
  
N Mean 
Std. 
Deviation Std. Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
  Lower 
Bound 
Upper 
Bound 
Treatment A 2-cell 7 76.83714 5.688901 2.150202 71.57579 82.09850 71.430 85.710 
4-cell 7 68.06000 4.454503 1.683644 63.94027 72.17973 61.900 72.730 
8-cell 7 58.20857 5.984152 2.261797 52.67415 63.74299 50.000 66.670 
Morula 7 34.94000 6.212123 2.347962 29.19474 40.68526 28.570 44.440 
Blastocyst 7 3.79571 3.885743 1.468673 .20200 7.38943 .000 9.520 
Hatched blast. 7 .00000 .000000 .000000 .00000 .00000 .000 .000 
Total 42 40.30690 30.735691 4.742620 30.72899 49.88482 .000 85.710 
Treatment B 2-cell 7 77.41857 5.080123 1.920106 72.72024 82.11690 73.330 87.500 
4-cell 7 68.51143 6.824782 2.579525 62.19956 74.82330 60.000 79.170 
8-cell 7 60.46571 4.171142 1.576544 56.60805 64.32338 53.330 66.660 
Morula 7 46.67286 4.375807 1.653900 42.62591 50.71980 41.670 54.170 
Blastocyst 7 19.89571 3.972966 1.501640 16.22133 23.57010 13.330 25.000 
Hatched blast. 7 15.58000 6.549626 2.475526 9.52261 21.63739 7.690 25.000 
Total 42 48.09071 24.191800 3.732876 40.55202 55.62941 7.690 87.500 
 
ANOVA 
  Sum of Squares df Mean Square F Sig. 
Treatment A Between Groups 37881.757 5 7576.351 320.792 .000 
Within Groups 850.234 36 23.618   
Total 38731.991 41    
Treatment B Between Groups 22989.290 5 4597.858 164.588 .000 
Within Groups 1005.681 36 27.936   
Total 23994.971 41    
 
Post Hoc Tests 
Homogeneous Subsets 
 
Treatment A 
Duncana 
Treatment N 
Subset for alpha = 0.05 
1 2 3 4 5 
Hatched blast. 7 .000     
Blastocyst 7 3.796     
Morula 7  34.94    
8-cell 7   58.20   
4-cell 7    68.06  
2-cell 7 
    
76.83
7 
Sig.  .153 1.000 1.000 1.000 1.000 
Means for groups in homogeneous subsets are 
displayed. 
a. Uses Harmonic Mean Sample Size = 7.000. 
Treatment B 
Duncana 
Treatment N 
Subset for alpha = 0.05 
1 2 3 4 5 
Hatched blast 7 15.58     
Blastocyst 7 19.89     
Morula 7  46.67    
8-cell 7   60.46   
4-cell 7    68.51  
2-cell 7     77.41 
Sig.  .135 1.000 1.000 1.000 1.000 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 7.000. 
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Appendix Table 2.30: Percentage of in vitro development for caprine intraspSCNT vs. 
          PA embryos within each embryo development stage (Experiment 5) 
Descriptives 
  
N Mean 
Std. 
Deviation 
Std. 
Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
  Lower 
Bound 
Upper 
Bound 
Two cell intraspSCNT caprine 5 78.09200 6.037986 2.700269 70.59485 85.58915 73.330 87.500 
PA caprine 5 74.09800 6.087895 2.722590 66.53888 81.65712 66.670 80.490 
Total 10 76.09500 6.091516 1.926306 71.73739 80.45261 66.670 87.500 
Four cell intraspSCNT caprine 5 67.97400 7.440923 3.327682 58.73487 77.21313 60.000 79.170 
PA caprine 5 65.33400 8.692398 3.887358 54.54096 76.12704 60.000 80.000 
Total 10 66.65400 7.754027 2.452039 61.10710 72.20090 60.000 80.000 
Eight cell intraspSCNT caprine 5 61.22000 4.855641 2.171509 55.19093 67.24907 53.330 66.660 
PA caprine 5 54.99800 2.888195 1.291640 51.41183 58.58417 53.330 60.000 
Total 10 58.10900 4.993984 1.579236 54.53652 61.68148 53.330 66.660 
Morula intraspSCNT caprine 5 47.59600 4.621870 2.066963 41.85719 53.33481 42.310 54.170 
PA caprine 5 35.33200 4.472882 2.000333 29.77818 40.88582 30.000 40.000 
Total 10 41.46400 7.756629 2.452861 35.91524 47.01276 30.000 54.170 
Blastocyst intraSCNT caprine 5 17.30800 4.081969 1.825512 12.23957 22.37643 12.500 20.830 
PA caprine 5 14.99800 2.888195 1.291640 11.41183 18.58417 13.330 20.000 
Total 10 16.15300 3.548972 1.122283 13.61422 18.69178 12.500 20.830 
Hatched 
blastocyst 
intraspSCNT caprine 5 11.26600 2.281881 1.020488 8.43267 14.09933 7.690 13.300 
PA caprine 5 9.00200 6.190450 2.768453 1.31554 16.68846 5.000 20.000 
Total 10 10.13400 4.557397 1.441176 6.87383 13.39417 5.000 20.000 
 
ANOVA 
  Sum of Squares df Mean Square F Sig. 
Two cell Between Groups 39.880 1 39.880 1.085 .328 
Within Groups 294.079 8 36.760   
Total 333.959 9    
Four cell Between Groups 17.424 1 17.424 .266 .620 
Within Groups 523.700 8 65.463   
Total 541.124 9    
Eight cell Between Groups 96.783 1 96.783 6.064 .039 
Within Groups 127.676 8 15.959   
Total 224.459 9    
Morula Between Groups 376.014 1 376.014 18.179 .003 
Within Groups 165.473 8 20.684   
Total 541.488 9    
Blastocyst Between Groups 13.340 1 13.340 1.067 .332 
Within Groups 100.017 8 12.502   
Total 113.357 9    
Hatched blastocyst Between Groups 12.814 1 12.814 .589 .465 
Within Groups 174.115 8 21.764   
Total 186.929 9    
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Appendix Table 2.31: Percentage of in vitro development from 2-cell to hatched  
   blastocyst stage for caprine embryos within each approach  
   (intraspSCNT or PA) (Experiment 5) 
Descriptives 
  
N Mean 
Std. 
Deviation Std. Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
  Lower 
Bound 
Upper 
Bound 
intraspSCNT 
caprine 
2-cell 5 78.09200 6.037986 2.700269 70.59485 85.58915 73.330 87.500 
4-cell 5 67.97400 7.440923 3.327682 58.73487 77.21313 60.000 79.170 
8-cell 5 61.22000 4.855641 2.171509 55.19093 67.24907 53.330 66.660 
Morula 5 47.59600 4.621870 2.066963 41.85719 53.33481 42.310 54.170 
Blastocyst 5 17.30800 4.081969 1.825512 12.23957 22.37643 12.500 20.830 
Hatched 
blast 
5 11.26600 2.281881 1.020488 8.43267 14.09933 7.690 13.300 
Total 30 47.24267 25.911891 4.730842 37.56701 56.91833 7.690 87.500 
PA caprine 2-cell 5 74.09800 6.087895 2.722590 66.53888 81.65712 66.670 80.490 
4-cell 5 65.33400 8.692398 3.887358 54.54096 76.12704 60.000 80.000 
8-cell 5 54.99800 2.888195 1.291640 51.41183 58.58417 53.330 60.000 
Morula 5 35.33200 4.472882 2.000333 29.77818 40.88582 30.000 40.000 
Blastocyst 5 14.99800 2.888195 1.291640 11.41183 18.58417 13.330 20.000 
Hatched 
blast 
5 9.00200 6.190450 2.768453 1.31554 16.68846 5.000 20.000 
Total 30 42.29367 25.446806 4.645930 32.79167 51.79566 5.000 80.490 
 
ANOVA 
  Sum of Squares df Mean Square F Sig. 
intraspSCNT caprine Between Groups 18836.825 5 3767.365 142.494 .000 
Within Groups 634.532 24 26.439   
Total 19471.357 29    
PA caprine Between Groups 18028.130 5 3605.626 115.299 .000 
Within Groups 750.528 24 31.272   
Total 18778.657 29    
Post Hoc Tests 
Homogeneous Subsets 
 
intraspSCNTcaprine 
Duncana 
Treatment N 
Subset for alpha = 0.05 
1 2 3 4 5 
Hatched 
blast 
5 11.27 
    
Blastocyst 5 17.31     
Morula 5  47.60    
8-cell 5   61.22   
4-cell 5    67.97  
2-cell 5     78.09 
Sig.  .075 1.000 1.000 1.000 1.000 
Means for groups in homogeneous subsets are 
displayed. 
a. Uses Harmonic Mean Sample Size = 5.000. 
PA caprine 
Duncana 
Treatment N 
Subset for alpha = 0.05 
1 2 3 4 5 
Hatched 
blast 
5 9.00 
    
Blastocyst 5 14.99     
Morula 5  35.33    
8-cell 5   54.99   
4-cell 5    65.33  
2-cell 5     74.10 
Sig.  .103 1.000 1.000 1.000 1.000 
Means for groups in homogeneous subsets are 
displayed. 
a. Uses Harmonic Mean Sample Size = 5.000. 
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Appendix Table 2.32: Percentage of in vitro development for caprine interspSCNT vs. 
           PA embryos within each embryo development stage (Experiment 5) 
Descriptives 
  
N Mean 
Std. 
Deviation Std. Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
  Lower 
Bound 
Upper 
Bound 
Two cell interspSCNT caprine 6 78.02500 2.444379 .997914 75.45978 80.59022 73.910 80.770 
PA Bovine 6 73.44500 5.998012 2.448678 67.15047 79.73953 66.670 80.000 
Total 12 75.73500 4.978909 1.437287 72.57155 78.89845 66.670 80.770 
Four cell interspSCNT caprine 6 74.27500 4.071215 1.662066 70.00252 78.54748 70.000 80.770 
PA Bovine 6 63.55500 6.821448 2.784844 56.39633 70.71367 53.330 70.000 
Total 12 68.91500 7.747668 2.236559 63.99237 73.83763 53.330 80.770 
Eight cell interspSCNT caprine 6 63.16167 3.235666 1.320955 59.76604 66.55729 60.610 69.230 
PA Bovine 6 56.72167 3.714945 1.516620 52.82307 60.62026 52.000 60.000 
Total 12 59.94167 4.726834 1.364519 56.93838 62.94495 52.000 69.230 
Morula interspSCNT caprine 6 32.74667 4.390962 1.792603 28.13863 37.35470 26.920 39.130 
PA Bovine 6 36.05500 3.349948 1.367610 32.53945 39.57055 32.000 40.000 
Total 12 34.40083 4.104861 1.184971 31.79273 37.00894 26.920 40.000 
Blastocyst interspSCNT caprine 6 8.53500 1.458009 .595230 7.00491 10.06509 6.060 10.000 
PA Bovine 6 12.55500 4.096846 1.672531 8.25562 16.85438 8.000 20.000 
Total 12 10.54500 3.605941 1.040945 8.25389 12.83611 6.060 20.000 
Hatched 
blastocyst 
interspSCNT caprine 6 4.81667 1.450388 .592119 3.29458 6.33876 3.030 6.670 
PA Bovine 6 7.88833 4.389398 1.791964 3.28194 12.49472 .000 13.330 
Total 12 6.35250 3.505290 1.011890 4.12535 8.57965 .000 13.330 
 
ANOVA 
  Sum of Squares df Mean Square F Sig. 
Two cell Between Groups 62.929 1 62.929 3.000 .114 
Within Groups 209.756 10 20.976   
Total 272.685 11    
Four cell Between Groups 344.755 1 344.755 10.926 .008 
Within Groups 315.535 10 31.553   
Total 660.290 11    
Eight cell Between Groups 124.421 1 124.421 10.253 .009 
Within Groups 121.352 10 12.135   
Total 245.773 11    
Morula Between Groups 32.835 1 32.835 2.153 .173 
Within Groups 152.513 10 15.251   
Total 185.349 11    
Blastocyst Between Groups 48.481 1 48.481 5.128 .057 
Within Groups 94.550 10 9.455   
Total 143.031 11    
Hatched blastocyst Between Groups 28.305 1 28.305 2.649 .135 
Within Groups 106.852 10 10.685   
Total 135.158 11    
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Appendix Table 2.33: Percentage of in vitro development from 2-cell to hatched  
   blastocyst stage for caprine embryos within each approach  
   (interspSCNT or PA) (Experiment 5) 
Descriptives 
  
N Mean 
Std. 
Deviation 
Std. 
Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
  Lower 
Bound 
Upper 
Bound 
interSCNT 
caprine 
2-cell 6 78.02500 2.444379 .997914 75.45978 80.59022 73.910 80.770 
4-cell 6 74.27500 4.071215 1.662066 70.00252 78.54748 70.000 80.770 
8-cell 6 63.16167 3.235666 1.320955 59.76604 66.55729 60.610 69.230 
Morula 6 32.74667 4.390962 1.792603 28.13863 37.35470 26.920 39.130 
Blastocyst 6 8.70167 1.141252 .465914 7.50400 9.89934 7.060 10.000 
Hatched blast 6 4.81667 1.450388 .592119 3.29458 6.33876 3.030 6.670 
Total 36 43.62111 30.411322 5.068554 33.33140 53.91082 3.030 80.770 
PA bovine 2-cell 6 73.44500 5.998012 2.448678 67.15047 79.73953 66.670 80.000 
4-cell 6 63.55500 6.821448 2.784844 56.39633 70.71367 53.330 70.000 
8-cell 6 56.72167 3.714945 1.516620 52.82307 60.62026 52.000 60.000 
Morula 6 36.05500 3.349948 1.367610 32.53945 39.57055 32.000 40.000 
Blastocyst 6 12.55500 4.096846 1.672531 8.25562 16.85438 8.000 20.000 
Hatched blast 6 7.88833 4.389398 1.791964 3.28194 12.49472 .000 13.330 
Total 36 41.70333 25.707856 4.284643 33.00505 50.40162 .000 80.000 
 
ANOVA 
  Sum of Squares df Mean Square F Sig. 
interSCNT caprine Between Groups 32091.167 5 6418.233 691.298 .000 
Within Groups 278.530 30 9.284   
Total 32369.697 35    
PA bovine Between Groups 22413.374 5 4482.675 187.322 .000 
Within Groups 717.911 30 23.930   
Total 23131.285 35    
Post Hoc Tests 
 
Homogeneous Subsets 
 
interSCNT caprine 
Duncana 
Treatment N 
Subset for alpha = 0.05 
1 2 3 4 5 6 
Hatched 
blast 
6 4.82 
     
Blastocyst 6  8.70     
Morula 6   32.74    
8-cell 6    63.16   
4-cell 6     74.27  
2-cell 6      78.02 
Sig.  1.000 1.000 1.000 1.000 1.000 1.000 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 6.000. 
PA bovine 
Duncana 
Treatment N 
Subset for alpha = 0.05 
1 2 3 4 5 
Hatched 
blast 
6 7.89 
    
Blastocyst 6 12.50     
Morula 6  36.05    
8-cell 6   56.72   
4-cell 6    63.55  
2-cell 6     73.44 
Sig.  .109 1.000 1.000 1.000 1.000 
Means for groups in homogeneous subsets are 
displayed. 
a. Uses Harmonic Mean Sample Size = 6.000. 
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Appendix Table 2.34: Percentage of maturation, enucleation, fusion for caprine  
   intraspSCNT vs. interspSCNT approach (Experiment 5) 
 
 
Descriptives 
  
N Mean 
Std. 
Deviation Std. Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
  Lower 
Bound 
Upper 
Bound 
Maturation 
rate 
intraspSCNT 
caprine 
5 79.69000 6.426908 2.874201 71.70994 87.67006 73.080 86.670 
interspSCNT 
caprine 
6 78.04500 4.708438 1.922212 73.10380 82.98620 73.100 86.050 
Total 11 78.79273 5.323980 1.605240 75.21603 82.36943 73.080 86.670 
Positive 
enucleation 
rate 
intraspSCNT  
caprine 
5 90.85800 5.516223 2.466930 84.00870 97.70730 86.360 100.000 
interspSCNT 
caprine 
6 88.05500 5.212672 2.128064 82.58464 93.52536 78.380 93.330 
Total 11 89.32909 5.282067 1.592603 85.78055 92.87763 78.380 100.000 
Fusion rate intraspSCNT 
caprine 
5 82.62400 7.660312 3.425796 73.11247 92.13553 72.730 92.310 
interspSCNT 
caprine 
6 75.26500 2.296717 .937631 72.85474 77.67526 71.880 78.570 
Total 11 78.61000 6.393678 1.927766 74.31467 82.90533 71.880 92.310 
 
ANOVA 
  Sum of Squares df Mean Square F Sig. 
Maturation rate Between Groups 7.380 1 7.380 .241 .636 
Within Groups 276.068 9 30.674   
Total 283.448 10    
Positive enucleation rate Between Groups 21.428 1 21.428 .749 .409 
Within Groups 257.575 9 28.619   
Total 279.002 10    
Fusion rate Between Groups 147.695 1 147.695 5.091 .050 
Within Groups 261.096 9 29.011   
Total 408.791 10    
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Appendix Table 2.35: Percentage of in vitro development for caprine intraspSCNT 
      vs. interspSCNT approach within each embryo development 
      stage (Experiment 5) 
 
Descriptives 
  
N Mean 
Std. 
Deviation Std. Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
  Lower 
Bound 
Upper 
Bound 
Two cell intraspSCNT caprine 5 78.09200 6.037986 2.700269 70.59485 85.58915 73.330 87.500 
interspSCNT caprine 6 78.02500 2.444379 .997914 75.45978 80.59022 73.910 80.770 
Total 11 78.05545 4.191852 1.263891 75.23933 80.87158 73.330 87.500 
Four cell intraspSCNT caprine 5 67.97400 7.440923 3.327682 58.73487 77.21313 60.000 79.170 
interspSCNT caprine 6 74.27500 4.071215 1.662066 70.00252 78.54748 70.000 80.770 
Total 11 71.41091 6.423574 1.936781 67.09549 75.72633 60.000 80.770 
Eight cell intraspSCNT caprine 5 61.22000 4.855641 2.171509 55.19093 67.24907 53.330 66.660 
interspSCNT caprine 6 63.16167 3.235666 1.320955 59.76604 66.55729 60.610 69.230 
Total 11 62.27909 3.961549 1.194452 59.61769 64.94050 53.330 69.230 
Morula intraspSCNT caprine 5 47.59600 4.621870 2.066963 41.85719 53.33481 42.310 54.170 
interspSCNT caprine 6 32.74667 4.390962 1.792603 28.13863 37.35470 26.920 39.130 
Total 11 39.49636 8.849974 2.668368 33.55087 45.44186 26.920 54.170 
Blastocyst intraspSCNT caprine 5 17.30800 4.081969 1.825512 12.23957 22.37643 12.500 20.830 
interspSCNT caprine 6 8.70167 1.141252 .465914 7.50400 9.89934 7.060 10.000 
Total 11 12.61364 5.245650 1.581623 9.08956 16.13771 7.060 20.830 
Hatched 
blastocyst 
intraspSCNT caprine 5 11.26600 2.281881 1.020488 8.43267 14.09933 7.690 13.300 
interspSCNT caprine 6 4.81667 1.450388 .592119 3.29458 6.33876 3.030 6.670 
Total 11 7.74818 3.805049 1.147265 5.19192 10.30445 3.030 13.300 
ANOVA 
  Sum of Squares df Mean Square F Sig. 
Two cell Between Groups .012 1 .012 .001 .981 
Within Groups 175.704 9 19.523   
Total 175.716 10    
Four cell Between Groups 108.280 1 108.280 3.202 .107 
Within Groups 304.343 9 33.816   
Total 412.623 10    
Eight cell Between Groups 10.282 1 10.282 .631 .447 
Within Groups 146.657 9 16.295   
Total 156.939 10    
Morula Between Groups 601.371 1 601.371 29.763 .000 
Within Groups 181.849 9 20.205   
Total 783.220 10    
Blastocyst Between Groups 202.006 1 202.006 24.850 .001 
Within Groups 73.162 9 8.129   
Total 275.168 10    
Hatched blastocyst Between Groups 113.438 1 113.438 32.570 .000 
Within Groups 31.346 9 3.483   
Total 144.784 10    
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Appendix Table 2.36: Percentage of in vitro development from 2-cell to hatched  
   blastocyst for caprine embryos within each nuclear transfer  
   approach (Experiment 5) 
Descriptives 
  
N Mean 
Std. 
Deviation 
Std. 
Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
  Lower 
Bound 
Upper 
Bound 
intraspSCNT  
caprine 
2-cell 5 78.09200 6.037986 2.700269 70.59485 85.58915 73.330 87.500 
4-cell 5 67.97400 7.440923 3.327682 58.73487 77.21313 60.000 79.170 
8-cell 5 61.22000 4.855641 2.171509 55.19093 67.24907 53.330 66.660 
Morula 5 47.59600 4.621870 2.066963 41.85719 53.33481 42.310 54.170 
Blastocyst 5 17.30800 4.081969 1.825512 12.23957 22.37643 12.500 20.830 
Hatched blast 5 11.26600 2.281881 1.020488 8.43267 14.09933 7.690 13.300 
Total 30 47.24267 25.911891 4.730842 37.56701 56.91833 7.690 87.500 
interspSCNT  
caprine 
2-cell 6 78.02500 2.444379 .997914 75.45978 80.59022 73.910 80.770 
4-cell 6 74.27500 4.071215 1.662066 70.00252 78.54748 70.000 80.770 
8-cell 6 63.16167 3.235666 1.320955 59.76604 66.55729 60.610 69.230 
Morula 6 32.74667 4.390962 1.792603 28.13863 37.35470 26.920 39.130 
Blastocyst 6 8.70167 1.141252 .465914 7.50400 9.89934 7.060 10.000 
Hatched blast 6 4.81667 1.450388 .592119 3.29458 6.33876 3.030 6.670 
Total 36 43.62111 30.411322 5.068554 33.33140 53.91082 3.030 80.770 
 
ANOVA 
  Sum of Squares df Mean Square F Sig. 
intraspSCNT caprine Between Groups 18836.825 5 3767.365 142.494 .000 
Within Groups 634.532 24 26.439   
Total 19471.357 29    
interspSCNT caprine Between Groups 32091.167 5 6418.233 691.298 .000 
Within Groups 278.530 30 9.284   
Total 32369.697 35    
Post Hoc Tests 
 
Homogeneous Subsets 
 
intraspSCNT caprine 
Duncana 
Treatment N 
Subset for alpha = 0.05 
1 2 3 4 5 
Hatched 
blast 
5 11.27 
    
Blastocyst 5 17.31     
Morula 5  47.59    
8-cell 5   61.22   
4-cell 5    67.97  
2-cell 5     78.09 
Sig.  .075 1.000 1.000 1.000 1.000 
Means for groups in homogeneous subsets are 
displayed. 
a. Uses Harmonic Mean Sample Size = 5.000. 
interspSCNT caprine 
Duncana 
Treatment N 
Subset for alpha = 0.05 
1 2 3 4 5 6 
Hatched 
blast 
6 4.82 
     
Blastocyst 6  8.701     
Morula 6   32.74    
8-cell 6    63.16   
4-cell 6     74.27  
2-cell 6      78.02 
Sig.  1.000 1.000 1.000 1.000 1.000 1.000 
Means for groups in homogeneous subsets are 
displayed. 
a. Uses Harmonic Mean Sample Size = 6.000. 
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Appendix Table 2.37: Number of cell count in the hatched blastocyst derived from 
     intraspSCNT, interspSCNT, caprine PA and bovine PA   
     (Experiment 5) 
 
 
Descriptives 
Cell no of H. Blast 
 
N Mean 
Std. 
Deviation 
Std. 
Error 
95% Confidence Interval 
for Mean 
Minimum Maximum 
 Lower 
Bound 
Upper 
Bound 
Caprine SCNT 5 109.0000 10.55936 4.72229 95.8888 122.1112 97.00 121.00 
Caprine iSCNT 5 81.4000 5.77062 2.58070 74.2348 88.5652 73.00 88.00 
Caprine PA 4 107.5000 10.08299 5.04149 91.4557 123.5443 97.00 121.00 
Bovine PA 5 112.2000 10.35374 4.63033 99.3441 125.0559 98.00 124.00 
Total 19 102.2632 15.49137 3.55396 94.7966 109.7298 73.00 124.00 
 
ANOVA 
 
 Sum of Squares df Mean Square F Sig. 
Between Groups 3006.684 3 1002.228 11.450 .000 
Within Groups 1313.000 15 87.533   
Total 4319.684 18    
Post Hoc Tests 
 
Homogeneous Subsets 
 
 
VAR00001 
Duncana,,b 
TREATMENT N 
Subset for alpha = 0.05 
1 2 
Caprine interspSCNT 5 81.4000  
Caprine PA 4  107.5000 
Caprine intraspSCNT 5  109.0000 
Bovine PA 5  112.2000 
Sig.  1.000 .477 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 4.706. 
b. The group sizes are unequal. The harmonic mean of the group sizes is 
used. Type I error levels are not guaranteed. 
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Appendix 3.2: Proceeding (Oral Presentation) 
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